data_2kc9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kc9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.094 0 CA-C-O 121.048 0.452 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.17 172.47 6.79 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -94.87 164.84 12.75 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.42 HD21 ' HB ' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -125.72 132.29 52.4 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -135.7 160.43 38.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.01 141.86 49.39 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.776 0.43 . . . . 0.0 110.604 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -76.86 150.22 36.08 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.95 -28.92 70.15 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.32 -41.62 66.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.33 85.52 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.713 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.56 -37.77 87.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.9 -44.31 90.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.51 -38.76 77.74 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.16 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -60.47 -46.72 89.05 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.136 0.974 . . . . 0.0 110.951 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.86 -21.17 59.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.229 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -77.31 -34.88 55.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.4 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.53 150.52 18.78 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.09 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 140.36 48.04 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -50.01 -52.33 34.91 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.175 0.99 . . . . 0.0 112.083 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.0 m -68.7 -29.99 68.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.32 -49.1 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -68.84 -35.11 76.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.946 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 9.6 mm-40 -57.14 -46.8 82.38 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 116.858 -0.156 . . . . 0.0 111.346 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -70.33 -37.09 74.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.791 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 79.4 mt -63.99 -41.33 97.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 31' ' ' VAL . 34.3 ttpt -60.09 -44.32 94.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 92.9 mttt -64.06 -35.45 80.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.632 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.4 mmtt -64.06 -39.61 94.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.592 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -63.65 -42.87 98.05 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 123.653 0.596 . . . . 0.0 109.558 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 27' ' ' LYS . 69.9 t -63.45 -45.96 96.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.537 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.7 pt-20 -69.76 -39.37 76.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.98 -29.89 48.3 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.73 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.724 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.2 mt -53.32 -24.44 11.82 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.6 pt-20 -66.07 -27.36 68.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.149 0.5 . . . . 0.0 110.699 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.542 ' O ' HG13 ' A' ' 39' ' ' ILE . 12.3 t -160.16 77.92 2.66 Favored Pre-proline 0 C--O 1.205 -1.253 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.32 -25.41 49.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.988 1.792 . . . . 0.0 112.785 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.3 60.74 6.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.284 1.04 . . . . 0.0 113.122 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 36' ' ' SER . 85.5 mt -89.96 115.93 30.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.606 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.59 -30.88 61.64 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 123.732 0.813 . . . . 0.0 112.493 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -18.33 61.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.967 0.413 . . . . 0.0 111.59 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.3 m-20 -103.16 -16.02 15.85 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -63.19 145.75 54.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.603 0.761 . . . . 0.0 112.559 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 91.9 mt -96.75 123.78 40.54 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 169.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -87.25 130.87 34.41 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.18 -34.01 6.06 Favored Glycine 0 C--N 1.306 -1.12 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 94.5 mmm -86.37 125.5 67.52 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -35.84 -66.56 0.11 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 124.733 3.622 . . . . 0.0 114.029 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 55.54 0.98 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.75 142.3 34.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 21.2 m-85 -135.04 152.19 51.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.29 139.96 53.25 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.103 178.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.6 mt -122.89 132.69 70.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.37 149.98 33.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.907 0.384 . . . . 0.0 111.961 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.47 136.66 34.52 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -62.09 -32.21 72.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.462 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -71.68 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p -102.45 2.21 36.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.56 46.04 9.11 Favored Glycine 0 C--N 1.32 -0.319 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.86 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -97.25 145.45 26.07 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -120.98 149.59 42.42 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.88 130.88 45.75 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.12 122.84 70.24 Favored 'Isoleucine or valine' 0 C--O 1.251 1.155 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.544 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 25.9 p90 -132.75 159.35 39.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.668 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.6 138.43 48.15 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.31 111.62 25.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.24 95.81 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.22 -31.0 71.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.133 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.0 -40.27 76.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.377 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB2' HG12 ' A' ' 72' ' ' VAL . 53.1 mttm -107.65 -6.74 16.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.714 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t 65.83 33.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 122.881 1.324 . . . . 0.0 110.066 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.2 p -133.8 140.22 46.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 O-C-N 121.35 -0.844 . . . . 0.0 110.353 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 5' ' ' LEU . 91.2 t -96.69 117.98 42.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -108.22 117.94 35.46 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.501 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -77.45 121.08 29.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.72 -41.89 13.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.573 0.701 . . . . 0.0 109.119 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -148.79 153.37 38.04 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.0 p -148.85 138.99 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.88 -114.8 0.64 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.38 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -127.82 155.73 43.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.516 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.227 0.537 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -81.17 -24.34 37.61 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.55 -35.49 80.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.958 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -72.04 -50.44 28.4 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.158 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.782 . . . . 0.0 113.05 -177.206 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.987 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.15 172.93 6.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.43 160.57 17.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.3 128.9 47.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -142.59 169.11 18.19 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -129.63 141.68 50.89 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.083 0.553 . . . . 0.0 110.178 -175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.59 154.9 41.1 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 4.6 pt-20 -61.31 -31.91 71.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.424 0.556 . . . . 0.0 110.634 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 75.3 mtt180 -63.81 -42.59 97.65 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.6 82.27 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.89 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.4 mt -63.8 -43.13 97.19 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.657 0.265 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -61.25 -43.73 98.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.368 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.21 -39.71 78.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.923 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -62.55 -43.73 98.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -75.58 -20.93 58.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.341 0.591 . . . . 0.0 110.893 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -74.54 -35.47 63.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.405 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.59 156.95 21.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.376 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.33 149.85 47.71 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.515 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 22.8 t -57.86 -49.05 78.01 Favored 'General case' 0 C--O 1.205 -1.251 0 C-N-CA 122.555 0.342 . . . . 0.0 111.812 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 25' ' ' GLN . 15.6 m -68.53 -38.19 80.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.38 -47.13 94.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.274 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.37 -35.29 79.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.333 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 20' ' ' SER . 44.5 mt-10 -63.51 -39.51 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.452 ' OE1' HG23 ' A' ' 21' ' ' THR . 2.0 mp0 -63.75 -41.29 98.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.401 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 93.0 mt -62.44 -41.98 99.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.06 -42.28 89.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 99.5 mttt -59.54 -36.98 77.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.678 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.6 mptp? -69.0 -37.89 78.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.32 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.6 mt -62.51 -47.53 83.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.573 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.44 -41.08 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.319 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 13.1 pt-20 -69.65 -44.0 71.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.708 0.29 . . . . 0.0 111.709 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.7 -29.67 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.5 mt -53.05 -25.3 12.07 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.7 pt-20 -68.77 -26.81 65.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.122 0.419 . . . . 0.0 110.924 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -162.55 80.21 1.78 Allowed Pre-proline 0 C--O 1.212 -0.884 0 C-N-CA 123.138 0.575 . . . . 0.0 109.504 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -82.62 5.75 6.2 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.139 1.893 . . . . 0.0 112.662 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 36.15 0.87 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.328 0.585 . . . . 0.0 111.614 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.8 mt -81.89 105.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.33 -32.12 62.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.833 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.99 72.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.382 0.61 . . . . 0.0 110.929 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -94.17 -2.5 52.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.016 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -78.22 138.35 38.6 Favored 'General case' 0 N--CA 1.4 -2.948 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.09 155.55 21.45 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.666 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -87.12 122.66 31.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.4 83.68 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.58 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.6 mmm -111.15 131.44 22.2 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.18 95.13 0.17 Allowed 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 122.804 2.336 . . . . 0.0 112.362 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 48.16 45.99 19.7 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.696 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.1 m -102.58 141.29 35.64 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 58.4 m-85 -133.66 150.98 51.56 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 55.2 pttt -118.98 144.86 46.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.134 0.492 . . . . 0.0 110.569 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 82.0 mt -109.39 132.9 56.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.93 137.75 40.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 124.06 0.85 . . . . 0.0 109.255 173.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' O ' HD22 ' A' ' 55' ' ' LEU . 4.2 tt -88.9 -11.75 43.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 74.27 -62.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.502 1.521 . . . . 0.0 111.29 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -75.59 -59.77 2.6 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -68.61 -25.9 65.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.55 49.16 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.197 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -98.75 149.19 23.1 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 120.837 0.351 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 mpt_? -131.51 144.22 50.96 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.812 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -127.01 127.72 45.23 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.33 123.17 69.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-O 121.073 0.463 . . . . 0.0 110.009 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.1 p90 -133.57 159.51 40.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -111.89 140.82 46.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.47 111.46 25.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.1 mt -97.8 95.45 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.07 -29.23 63.92 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.416 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.58 -40.55 87.75 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.37 -7.15 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.334 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.87 36.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.775 1.274 . . . . 0.0 109.237 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.22 138.72 49.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.71 115.34 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -111.34 112.82 24.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.03 124.96 33.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.1 mt -98.03 -41.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.461 0.648 . . . . 0.0 110.095 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.1 m -148.11 151.55 35.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.219 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.43 147.57 16.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.92 -124.23 1.93 Allowed Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -123.09 167.67 13.36 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 121.495 0.664 . . . . 0.0 109.306 -175.352 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -82.87 -41.57 18.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -58.79 -43.67 90.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.834 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.21 -49.86 70.32 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.861 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.275 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -134.43 167.23 21.14 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.45 157.77 24.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -125.69 122.56 36.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -140.41 169.34 17.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -129.89 147.9 51.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.69 154.46 38.83 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -32.53 72.51 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.452 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 57.5 mtp180 -72.8 -34.21 66.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.716 0.293 . . . . 0.0 111.034 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.04 79.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 mt -66.99 -43.54 82.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.924 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 89.2 mttt -59.49 -44.59 93.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.269 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 16.7 mm-40 -69.5 -37.67 77.29 Favored 'General case' 0 C--O 1.202 -1.406 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.5 -42.5 96.47 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 110.132 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.86 -24.11 58.52 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.096 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -78.3 -29.64 47.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.375 1.07 . . . . 0.0 111.175 177.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mp -63.67 161.11 15.55 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.71 0.804 . . . . 0.0 111.322 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.77 145.37 33.83 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -46.6 64.95 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.149 0.98 . . . . 0.0 111.287 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 m -62.43 -46.54 88.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.173 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -47.29 85.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.713 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.5 ptt180 -67.01 -35.04 79.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.077 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 35.4 mt-10 -59.71 -39.12 83.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.072 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.07 -39.32 79.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.831 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.3 mt -63.04 -43.83 97.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.684 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.22 -34.04 77.18 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.1 mttm -58.79 -43.87 90.58 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -66.62 -34.69 78.44 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.8 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 82.1 mt -61.82 -47.96 82.75 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.576 0.547 . . . . 0.0 110.491 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.22 -40.92 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 10.9 pt-20 -68.76 -42.91 76.84 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.99 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 65.4 mt -54.78 -26.35 33.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 pt-20 -79.16 -18.76 52.53 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.492 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.9 m -157.47 67.47 3.92 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 123.027 0.531 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.82 -0.34 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.847 0 C-N-CA 122.112 1.875 . . . . 0.0 114.218 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 25.75 0.23 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -82.31 100.33 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.642 0.734 . . . . 0.0 110.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.93 -20.42 57.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.626 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.76 64.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.431 0.634 . . . . 0.0 110.813 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -104.27 -1.22 27.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.364 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -84.22 138.88 32.72 Favored 'General case' 0 N--CA 1.404 -2.73 0 CA-C-O 121.357 0.598 . . . . 0.0 112.009 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -91.49 124.55 35.75 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.869 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.93 120.41 28.17 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.859 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.92 46.37 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.9 mmm -117.58 131.42 24.09 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.03 94.4 0.16 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.773 2.316 . . . . 0.0 112.937 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 45.57 50.05 10.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 125.117 1.367 . . . . 0.0 113.532 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.2 m -100.28 142.01 32.34 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.428 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.599 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 59.3 m-85 -133.28 154.99 50.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -126.15 147.44 49.62 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.893 0.854 . . . . 0.0 112.653 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 78.5 mt -109.19 141.57 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 138.41 41.6 Favored 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 123.213 0.32 . . . . 0.0 110.3 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.0 mt -79.73 161.94 25.47 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.967 0.413 . . . . 0.0 111.139 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 -99.46 -40.91 7.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -88.78 0.22 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -152.57 163.7 39.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.21 29.82 10.62 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.022 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -83.02 136.56 34.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.088 0.471 . . . . 0.0 110.99 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.3 mpt_? -128.31 149.63 50.42 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.112 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -129.9 125.15 34.88 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.07 127.65 72.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 16.8 p90 -136.01 158.62 43.97 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.271 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' HD11 ' A' ' 76' ' ' ILE . 4.1 pt20 -112.81 139.6 48.3 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.4 t -93.22 111.7 25.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.69 95.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.13 -30.95 65.55 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.074 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.65 -32.51 71.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.114 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -100.02 -3.26 32.47 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.334 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.24 25.1 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 CA-C-O 122.451 1.119 . . . . 0.0 110.403 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.55 138.83 52.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.985 -1.072 . . . . 0.0 111.281 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.2 t -97.96 117.37 42.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -107.57 114.56 28.63 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.351 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.96 121.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.423 HD11 ' HB3' ' A' ' 65' ' ' GLN . 57.8 mt -95.84 -42.86 12.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.406 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 m -150.41 150.34 31.24 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.116 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.2 136.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -130.6 2.36 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -113.55 165.9 12.04 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 117.505 0.652 . . . . 0.0 111.01 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.656 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.214 -0.765 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -85.22 -47.33 10.2 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.056 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 p -66.57 -36.44 82.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.438 0.637 . . . . 0.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.57 -44.64 86.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.461 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.589 -179.235 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.11 169.87 9.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.687 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -92.88 162.1 14.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.53 125.12 41.49 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -130.27 151.61 50.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.21 135.48 54.66 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.625 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 18.0 t70 -71.45 154.09 41.77 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.83 -32.48 69.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.304 0.502 . . . . 0.0 112.164 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.625 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 7.7 ptm180 -62.64 -39.22 93.18 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.194 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 -38.61 84.23 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.079 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.25 -43.5 97.83 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 122.579 0.351 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -63.01 -43.99 97.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.989 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.4 mm-40 -69.38 -37.17 77.44 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.05 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -60.62 -42.72 97.43 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 124.419 1.088 . . . . 0.0 110.224 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -74.63 -23.68 58.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.693 0.759 . . . . 0.0 110.194 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 85.4 tttt -74.44 -21.57 59.54 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.9 1.28 . . . . 0.0 109.864 177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -76.75 165.26 24.96 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.386 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.13 154.16 40.58 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 p -55.21 -46.72 75.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.567 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 12.0 m -69.52 -42.45 74.65 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.39 -47.89 91.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.355 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HG3' ' N ' ' A' ' 24' ' ' GLU . 9.8 ptt180 -63.29 -41.44 98.97 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 23' ' ' ARG 0.324 42.6 mt-10 -67.84 -33.63 75.15 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 21' ' ' THR . 30.4 mm-40 -60.05 -44.43 94.69 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -66.93 -41.51 86.9 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.323 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -56.99 -43.59 81.87 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -58.95 -41.82 88.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.565 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.18 -38.31 87.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.545 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.636 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.5 mt -64.7 -47.31 78.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.534 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.42 -40.87 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.377 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.5 pt-20 -69.73 -42.88 73.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.78 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 30' ' ' LEU . 3.1 p -63.43 -30.99 51.2 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 C-N-CA 122.392 0.277 . . . . 0.0 111.201 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 73.4 mt -54.5 -26.36 31.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.9 pt-20 -67.58 -26.52 66.32 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.658 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p -162.9 77.66 1.85 Allowed Pre-proline 0 N--CA 1.436 -1.132 0 C-N-CA 122.685 0.394 . . . . 0.0 111.483 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.11 12.12 1.59 Allowed 'Trans proline' 0 C--O 1.209 -0.937 0 C-N-CA 122.891 2.394 . . . . 0.0 113.554 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.52 28.16 0.78 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 111.836 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.7 94.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.771 0.796 . . . . 0.0 110.119 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.25 -23.29 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.041 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.97 66.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.129 0.49 . . . . 0.0 110.772 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.17 -8.09 18.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -75.71 136.53 40.35 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.482 0.658 . . . . 0.0 112.658 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.42 HD23 ' HD3' ' A' ' 52' ' ' LYS . 92.1 mt -81.44 139.45 35.23 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.793 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -92.03 121.31 33.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.35 58.4 Favored Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.991 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 81.3 mmm -126.26 131.32 23.91 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.43 90.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.228 2.618 . . . . 0.0 113.419 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 49.55 44.61 24.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.911 1.684 . . . . 0.0 112.629 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -100.18 142.74 31.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.564 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 22.4 m-85 -129.74 152.85 48.79 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HD3' HD23 ' A' ' 44' ' ' LEU . 55.6 pttt -125.93 139.82 53.14 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.574 0.546 . . . . 0.0 109.569 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.18 144.71 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 140.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.573 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.0 tt -83.08 137.22 34.18 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -74.34 -57.35 4.0 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -61.37 -63.84 1.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.592 0.557 . . . . 0.0 110.709 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 5.5 p -103.86 122.94 46.18 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.5 73.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.67 0 O-C-N 123.837 0.71 . . . . 0.0 114.537 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.67 144.53 36.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -125.52 150.68 47.2 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.75 133.15 39.59 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.01 127.66 75.97 Favored 'Isoleucine or valine' 0 C--O 1.255 1.362 0 C-N-CA 123.169 0.588 . . . . 0.0 109.431 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 12.9 p90 -138.32 158.63 43.91 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.7 pt20 -109.55 141.0 42.67 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.7 112.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.47 94.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.38 -25.22 62.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.617 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.09 -41.25 92.09 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.134 0.897 . . . . 0.0 110.142 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -105.72 -3.43 22.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.155 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t 65.19 34.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 122.66 1.219 . . . . 0.0 109.437 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.91 138.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.37 122.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -110.23 110.58 21.47 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.353 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.15 127.74 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.6 mt -110.73 -42.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.954 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -133.75 140.38 46.94 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.72 135.89 12.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.38 -146.5 18.12 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -95.25 140.17 30.53 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.532 0.666 . . . . 0.0 109.358 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -77.42 -50.45 12.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -62.34 -42.91 99.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.294 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.09 -30.49 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 110.381 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.913 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.909 -178.874 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.05 159.64 15.34 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -81.13 160.58 24.38 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -125.68 127.95 47.04 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -138.92 155.16 48.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.6 143.15 45.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.73 156.36 32.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.6 pt-20 -53.51 -37.14 62.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.913 0.485 . . . . 0.0 110.975 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -70.43 -44.79 67.15 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.79 70.25 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.613 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.08 -36.92 75.29 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.787 0.327 . . . . 0.0 111.681 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 57.3 mttm -67.98 -43.86 77.98 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -67.56 -39.32 84.94 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -60.9 -38.5 85.93 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.842 0.857 . . . . 0.0 109.999 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -73.15 -37.81 66.46 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.655 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -74.88 -16.34 60.68 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.721 0.772 . . . . 0.0 111.131 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 149.63 38.27 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.486 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.14 139.35 42.26 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 16.4 m -50.97 -46.48 61.24 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.918 0.887 . . . . 0.0 111.227 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.536 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 43.2 m -62.88 -43.22 99.37 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.06 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.21 -47.09 79.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.731 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.9 ptt180 -66.41 -33.92 76.79 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.016 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 26.5 mm-40 -60.24 -41.08 92.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 118.111 0.414 . . . . 0.0 111.136 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 21' ' ' THR . 73.9 mm-40 -65.76 -46.56 78.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.6 mt -61.47 -40.67 95.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.065 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.7 ttpt -57.25 -44.63 84.06 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.174 0.59 . . . . 0.0 110.245 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.3 mttt -57.7 -43.39 85.15 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.4 mptp? -62.34 -40.54 96.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.703 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -62.94 -45.73 91.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 123.516 0.51 . . . . 0.0 109.767 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 27' ' ' LYS . 62.5 t -64.49 -45.1 96.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.451 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.4 pt-20 -68.86 -44.06 74.11 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.621 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 37' ' ' PRO . 3.4 p -62.22 -29.78 47.37 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 123.327 0.651 . . . . 0.0 112.099 -173.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 87.9 mt -53.03 -25.36 12.14 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.37 -22.09 59.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.723 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -164.52 78.78 1.42 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 121.308 0.575 . . . . 0.0 111.683 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HA ' HG21 ' A' ' 33' ' ' VAL . 93.5 Cg_endo -85.89 -9.73 7.46 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.384 2.056 . . . . 0.0 112.764 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.62 34.16 0.48 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.623 0.725 . . . . 0.0 112.956 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -83.25 110.57 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.819 0.818 . . . . 0.0 109.16 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -55.02 -29.34 57.18 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 126.246 1.818 . . . . 0.0 113.303 -175.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.23 -13.81 62.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -111.44 8.25 21.11 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.986 -0.446 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 17.2 ptmt -89.58 147.47 23.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.072 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 96.3 mt -69.91 155.69 40.19 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.46 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.64 -55.29 36.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.68 23.22 7.12 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.011 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.413 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -102.12 132.37 21.6 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 122.548 -0.384 . . . . 0.0 110.632 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.87 95.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.273 2.649 . . . . 0.0 112.642 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 50.83 47.06 25.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 113.015 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.0 m -106.64 141.09 38.48 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.557 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 38.5 m-85 -128.7 153.33 47.44 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 139.69 43.91 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.168 0.509 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.36 131.26 61.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.86 140.86 36.59 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.76 112.77 24.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -78.71 81.81 4.98 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.184 0.516 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 m -165.57 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.116 1.366 . . . . 0.0 109.137 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -161.17 179.17 8.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.04 51.78 4.15 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 121.108 -0.568 . . . . 0.0 114.397 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -108.14 142.64 38.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 151.05 38.27 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 123.689 0.796 . . . . 0.0 109.17 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.62 128.13 50.27 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.08 124.79 70.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.061 0 O-C-N 123.619 0.574 . . . . 0.0 110.248 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.3 p90 -136.67 158.83 43.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -108.86 137.99 45.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.92 114.77 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.01 95.6 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.58 -36.61 84.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.722 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -60.93 -30.14 70.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.28 -5.32 16.86 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.627 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t 60.79 39.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.707 1.241 . . . . 0.0 109.624 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -132.31 139.01 51.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 121.335 -0.853 . . . . 0.0 111.173 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.63 115.39 42.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -110.63 111.62 22.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.45 122.49 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -100.17 -42.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.204 0.526 . . . . 0.0 110.409 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m -147.98 149.85 32.92 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 122.152 -0.342 . . . . 0.0 110.43 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.14 139.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.97 -144.03 12.98 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.7 155.31 16.83 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.016 0.408 . . . . 0.0 110.022 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--O 1.214 -0.779 0 CA-C-O 120.724 0.297 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.94 -41.48 67.75 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -59.27 -51.15 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.981 0.8 . . . . 0.0 110.833 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.41 -35.67 73.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.539 179.795 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.04 168.85 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.11 160.13 14.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.86 132.36 52.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -141.79 156.86 45.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.67 147.59 41.81 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.035 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.04 154.77 40.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -32.42 72.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.626 0.25 . . . . 0.0 110.863 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -66.99 -46.53 74.3 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.552 0.691 . . . . 0.0 109.598 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.15 75.42 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.219 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.57 -40.83 96.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.024 0.44 . . . . 0.0 111.326 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.48 -43.4 85.53 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.58 -37.29 76.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.274 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.49 1.116 . . . . 0.0 110.824 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -74.69 -23.14 58.58 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.915 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.82 -40.32 61.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.128 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mp -58.95 147.11 35.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 124.541 1.136 . . . . 0.0 112.725 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -70.49 146.49 42.32 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.666 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 m -52.75 -45.88 67.24 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.058 0.943 . . . . 0.0 112.213 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 m -68.4 -36.7 79.5 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.893 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.14 -47.18 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.277 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.8 ptt180 -67.38 -33.83 76.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.186 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.07 -48.68 75.61 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.615 0.189 . . . . 0.0 110.702 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -57.85 -41.97 83.47 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.014 0.821 . . . . 0.0 110.546 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 96.6 mt -66.65 -45.15 79.9 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.186 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.8 -44.2 94.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.515 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 94.9 mttt -62.97 -35.14 79.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.198 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.74 -35.03 72.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.81 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 mt -68.61 -46.12 70.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.04 -39.91 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.245 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.1 pt-20 -69.19 -42.8 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 37' ' ' PRO . 2.2 p -63.87 -29.71 48.02 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.207 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 94.4 mt -53.73 -25.04 16.78 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.4 pt-20 -80.39 -19.71 45.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.078 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -155.2 70.99 5.66 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.839 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HA ' HG23 ' A' ' 33' ' ' VAL . 79.0 Cg_endo -77.3 -14.3 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.528 1.485 . . . . 0.0 111.606 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -83.11 61.08 5.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.71 0.767 . . . . 0.0 112.833 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -101.95 110.59 29.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.025 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.48 -22.04 66.84 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.51 -19.89 60.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 111.536 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -107.04 -7.6 16.86 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.013 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -70.35 133.64 47.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 123.568 0.747 . . . . 0.0 110.269 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.3 121.61 28.28 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -64.04 123.38 18.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.254 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.26 -29.4 8.91 Favored Glycine 0 C--N 1.324 -0.129 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.698 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.9 mmm -75.8 139.53 70.18 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 122.817 0.447 . . . . 0.0 110.053 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.92 90.88 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.869 2.379 . . . . 0.0 112.603 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 46.54 46.09 14.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 125.159 1.384 . . . . 0.0 113.014 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.5 m -99.88 142.34 31.5 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.564 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.3 m-85 -133.92 151.55 51.54 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -120.47 140.41 51.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 123.447 0.467 . . . . 0.0 110.62 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.01 134.94 61.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 157.86 17.68 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.479 0.487 . . . . 0.0 111.9 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 58' ' ' SER . 9.0 tp -94.11 166.06 12.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.501 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 37.9 mmt180 -90.22 -55.15 3.72 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.259 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 m -58.03 -59.86 4.63 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.481 ' H ' HD23 ' A' ' 55' ' ' LEU . 66.7 m -133.59 -177.42 4.54 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 122.069 -0.394 . . . . 0.0 110.692 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.75 62.83 4.46 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -103.32 139.66 38.45 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.47 HH11 ' HB1' ' A' ' 81' ' ' ALA . 2.9 mpt_? -136.26 142.93 44.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.15 0.5 . . . . 0.0 109.775 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -119.98 129.02 54.09 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.27 126.49 73.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.9 p90 -135.44 159.23 42.24 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.617 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -109.09 140.66 42.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.45 111.89 31.48 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mt -97.11 94.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.31 -29.84 68.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.168 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.2 -38.9 74.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.779 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -108.65 2.61 22.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.195 0.522 . . . . 0.0 111.374 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 t 61.54 34.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.824 1.249 . . . . 0.0 109.957 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.93 138.83 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.292 -0.88 . . . . 0.0 111.513 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -98.27 115.75 39.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -110.86 114.75 28.33 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.623 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.09 123.94 29.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.5 -42.49 11.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.096 0.474 . . . . 0.0 110.485 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 m -146.83 145.78 29.99 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.096 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.1 141.38 17.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.73 -152.93 24.6 Favored Glycine 0 CA--C 1.497 -1.05 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -91.44 149.04 21.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB1' HH11 ' A' ' 61' ' ' ARG . . . . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.292 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.08 -42.09 10.14 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.233 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 m -68.09 -45.22 74.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.152 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -29.66 63.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.591 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.733 179.06 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -116.47 172.31 7.29 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -87.23 156.92 19.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.25 127.92 50.51 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.87 155.17 50.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.61 133.58 54.99 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 33.9 t70 -71.99 151.94 42.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pp20? -58.55 -34.34 70.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.0 mtt180 -69.69 -44.91 69.46 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.17 73.38 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 17.0 tp -72.3 -34.84 68.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.9 mttm -66.41 -42.09 88.3 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 36.0 mm-40 -63.65 -39.15 93.63 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -60.87 -39.56 89.65 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.09 1.356 . . . . 0.0 110.754 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 88.3 mtt180 -74.55 -32.75 62.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -72.81 -28.12 62.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 110.842 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -63.77 152.76 38.49 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.33 0.652 . . . . 0.0 112.103 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -68.78 143.37 39.97 Favored Glycine 0 N--CA 1.424 -2.119 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.602 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 8.1 m -48.99 -54.55 15.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.584 1.154 . . . . 0.0 112.411 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.8 m -64.66 -34.77 79.07 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.879 0.472 . . . . 0.0 110.713 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.83 -48.18 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 6.1 ptt180 -68.57 -35.54 77.54 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 20' ' ' SER . 54.1 mt-10 -58.03 -50.06 74.72 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.992 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -63.28 -35.3 79.91 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.213 0.32 . . . . 0.0 111.691 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.4 mt -66.77 -44.94 80.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.987 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.82 -41.98 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.5 mttt -59.47 -35.44 74.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.146 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.5 mptp? -70.96 -35.81 72.3 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.144 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.6 mt -66.32 -46.27 77.44 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.754 0.312 . . . . 0.0 110.897 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.83 -38.54 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.43 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 pt-20 -69.99 -43.43 71.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.85 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.406 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -63.08 -30.12 48.9 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.478 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 77.2 mt -54.18 -25.38 22.36 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -84.0 -8.54 59.11 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.022 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.48 ' O ' HG13 ' A' ' 39' ' ' ILE . 26.8 p -159.29 62.19 1.99 Allowed Pre-proline 0 C--O 1.206 -1.185 0 C-N-CA 124.038 0.935 . . . . 0.0 110.576 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' HG23 ' A' ' 33' ' ' VAL . 73.0 Cg_endo -75.01 -20.6 16.69 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.777 1.651 . . . . 0.0 113.752 -172.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -89.69 54.76 2.97 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.148 0.975 . . . . 0.0 113.247 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 36' ' ' SER . 98.1 mt -83.19 110.86 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.732 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.15 -27.18 68.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.74 68.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.088 0.471 . . . . 0.0 111.067 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.02 -1.44 57.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.987 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HZ3' ' HB3' ' A' ' 43' ' ' LYS . 8.3 mtpm? -62.74 146.55 52.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.62 173.02 12.75 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.459 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -85.75 -55.02 4.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.33 52.51 0.82 Allowed Glycine 0 CA--C 1.5 -0.887 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.299 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.9 mmm -135.78 132.34 19.47 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.53 102.25 0.34 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.906 2.404 . . . . 0.0 113.309 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.8 35.3 24.22 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 124.347 1.059 . . . . 0.0 111.952 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.5 m -101.65 141.23 34.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.245 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.604 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 18.4 m-85 -131.75 153.66 49.84 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 47.9 pttt -126.5 140.35 52.53 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.41 0.624 . . . . 0.0 111.246 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.48 129.26 65.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 133.51 53.2 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.44 96.32 10.33 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -44.82 -41.77 7.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 126.598 1.959 . . . . 0.0 113.963 -172.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -82.38 -44.36 16.23 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 m -77.31 -36.0 54.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.7 14.63 49.25 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.354 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.99 158.26 15.54 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.402 ' N ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -144.75 147.59 33.14 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.461 0.648 . . . . 0.0 111.843 177.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -119.59 126.98 52.5 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.63 123.34 66.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 121.032 0.444 . . . . 0.0 110.297 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.604 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -133.82 157.63 45.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.677 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -107.71 131.67 54.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.53 111.05 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.8 mt -99.04 96.01 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.32 -32.77 73.96 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.34 -35.52 74.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.082 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.46 -2.41 25.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.811 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.53 33.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.525 1.13 . . . . 0.0 109.754 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.15 138.99 50.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 O-C-N 121.161 -0.962 . . . . 0.0 111.304 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -99.14 114.81 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 81.8 t80 -107.94 111.21 23.19 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.469 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -73.15 121.43 23.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.431 ' CG2' ' HA ' ' A' ' 90' ' ' ALA . 29.8 mt -98.09 -42.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.613 0.571 . . . . 0.0 110.373 -174.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 t -153.38 151.85 30.4 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.11 138.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.15 -139.86 8.43 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.394 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -101.83 158.7 15.93 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.999 0.428 . . . . 0.0 109.921 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.845 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.77 -48.59 16.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.272 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.7 m -60.95 -42.93 99.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.557 0.536 . . . . 0.0 110.828 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -68.35 -35.83 78.33 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.91 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.431 ' HA ' ' CG2' ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 CA--C 1.503 -0.865 0 CA-C-O 121.169 0.509 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.35 167.09 9.97 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.738 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.51 153.39 24.43 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -125.56 124.39 41.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.65 156.05 49.46 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.413 0.625 . . . . 0.0 110.385 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.88 134.95 47.14 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.27 142.34 57.78 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 10.1 pt-20 -56.27 -31.32 63.5 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -72.34 -40.11 67.63 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.274 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.27 -31.19 70.48 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.869 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -68.16 -34.91 77.2 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.3 mttm -63.61 -42.8 98.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.893 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 42.0 mm-40 -68.69 -37.47 79.59 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.088 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -60.68 -45.01 95.77 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.83 0.852 . . . . 0.0 110.643 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -74.78 -21.18 59.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.587 0.708 . . . . 0.0 110.175 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 80.2 tttt -74.86 -25.43 58.96 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.79 1.236 . . . . 0.0 110.154 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 14' ' ' GLU . 5.5 mp -68.06 168.07 12.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.253 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.03 -138.68 1.56 Allowed Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.056 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -106.5 -60.47 1.65 Allowed 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.585 -0.95 . . . . 0.0 108.86 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -52.23 -43.36 64.24 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.93 1.292 . . . . 0.0 113.096 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.13 -48.35 79.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.135 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -69.08 -33.91 74.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -56.07 -45.96 79.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -70.61 -38.98 74.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.953 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 92.5 mt -63.46 -44.04 95.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.36 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -58.87 -43.2 90.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.186 0.517 . . . . 0.0 110.346 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.8 mttt -62.89 -37.7 87.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -64.32 -37.57 87.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.582 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.1 mt -68.36 -45.28 73.26 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 28' ' ' LYS . 7.8 p -68.75 -36.21 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.799 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -68.75 -44.94 72.7 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 37' ' ' PRO . 3.7 p -62.93 -30.66 50.1 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.124 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.627 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 71.0 mt -53.91 -25.62 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 8.1 pt-20 -64.48 -28.85 69.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.084 0.856 . . . . 0.0 111.19 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -160.1 77.5 2.72 Favored Pre-proline 0 C--O 1.206 -1.207 0 C-N-CA 124.059 0.944 . . . . 0.0 108.493 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HA ' HG23 ' A' ' 33' ' ' VAL . 89.8 Cg_endo -85.25 -1.27 9.21 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.679 2.253 . . . . 0.0 113.537 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 40.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.549 0.69 . . . . 0.0 110.885 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.15 100.88 5.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.359 1.076 . . . . 0.0 110.352 -173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -55.42 -27.48 48.15 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.706 2.003 . . . . 0.0 112.509 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.23 61.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.064 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.73 1.47 17.88 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -80.25 135.63 36.28 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 121.07 0.462 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.8 mt -82.68 122.87 28.7 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.595 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -89.27 120.03 30.26 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.09 6.77 42.07 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.2 mmm -127.0 138.68 33.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -67.2 95.13 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.601 2.201 . . . . 0.0 112.971 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 52.5 39.02 27.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.041 1.337 . . . . 0.0 113.573 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.5 m -99.99 142.49 31.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.9 m-85 -132.4 156.24 47.04 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -133.37 141.97 48.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.27 0.557 . . . . 0.0 112.402 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.78 122.85 68.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.87 128.61 49.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.423 174.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.12 102.95 5.93 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -56.44 -39.58 73.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -88.26 20.38 3.28 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -156.05 -45.53 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.668 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.99 22.5 7.21 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.672 -1.251 . . . . 0.0 112.341 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -95.69 154.09 17.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 122.222 -0.575 . . . . 0.0 109.818 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -122.95 135.62 54.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.74 124.95 34.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -117.07 128.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.6 p90 -133.48 158.16 43.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.747 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -105.46 138.19 42.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.63 111.2 34.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.1 mt -97.35 101.75 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.01 -36.57 80.18 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.561 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.64 -40.31 96.59 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.17 -6.05 42.62 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.6 t 58.49 37.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.429 1.109 . . . . 0.0 109.711 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.1 140.31 40.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 121.365 -0.834 . . . . 0.0 110.902 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.83 124.99 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 124.461 1.104 . . . . 0.0 108.771 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.08 116.92 29.91 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.7 t -68.99 121.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.0 mt -96.28 -43.11 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.993 0.425 . . . . 0.0 110.638 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 p -141.3 143.5 34.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 120.877 0.37 . . . . 0.0 110.567 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.1 141.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.22 -140.24 7.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -116.71 155.44 28.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.351 0.575 . . . . 0.0 110.002 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.768 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -79.75 -44.92 19.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -62.84 -43.15 99.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.853 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.1 -28.18 68.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.847 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.158 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -118.33 168.57 10.5 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -99.03 163.17 12.69 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 123.062 0.226 . . . . 0.0 111.172 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.11 130.96 53.17 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.52 149.6 46.89 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.91 134.85 46.14 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 20.2 t70 -72.05 153.43 41.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 9.7 pt-20 -56.96 -32.53 66.13 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -68.27 -42.25 79.85 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.12 75.25 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.737 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.0 mt -69.84 -39.29 76.51 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.443 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 55.1 mttp -62.36 -44.29 96.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.068 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 32.5 mt-10 -70.01 -37.51 75.69 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.066 0.46 . . . . 0.0 111.4 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -62.37 -42.0 99.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 123.737 0.815 . . . . 0.0 110.33 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -75.24 -23.26 57.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 48.5 tttp -67.84 -45.4 74.75 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 14' ' ' GLU . 6.5 mp -58.69 151.15 21.6 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.623 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -75.42 152.12 42.7 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.5 t -52.44 -53.24 47.95 Favored 'General case' 0 C--O 1.201 -1.454 0 C-N-CA 123.058 0.543 . . . . 0.0 111.291 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.0 m -57.82 -38.0 74.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 123.507 0.723 . . . . 0.0 111.577 -176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -72.18 -47.87 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 109.944 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 9.2 ptt180 -68.45 -34.57 76.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.4 mt-10 -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.817 0.447 . . . . 0.0 111.599 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -66.01 -35.31 80.21 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.673 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.5 mt -67.24 -43.43 81.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.667 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -59.33 -44.37 92.63 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 110.5 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 90.5 mttt -62.49 -35.1 78.29 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.555 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.6 mptp? -65.71 -39.56 91.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.869 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.69 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.3 mt -61.63 -44.61 96.67 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 27' ' ' LYS . 87.9 t -61.67 -45.31 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.84 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -69.65 -42.49 74.18 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.746 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 30' ' ' LEU . 2.9 p -62.59 -29.67 47.44 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.7 mt -53.16 -25.77 14.73 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.5 pt-20 -66.24 -28.92 69.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.491 0.662 . . . . 0.0 110.966 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.4 m -158.42 76.66 3.47 Favored Pre-proline 0 C--N 1.315 -0.894 0 C-N-CA 124.227 1.011 . . . . 0.0 108.805 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HA ' HG21 ' A' ' 33' ' ' VAL . 61.1 Cg_endo -75.59 -24.43 11.93 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.472 1.448 . . . . 0.0 111.466 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 2.4 ppt_? -78.38 62.57 3.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.166 0.984 . . . . 0.0 112.907 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.84 124.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.25 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -35.94 67.37 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.16 0.984 . . . . 0.0 112.263 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.62 -15.98 61.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.549 0.69 . . . . 0.0 111.399 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.427 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.4 m-20 -104.68 -7.0 19.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 21.8 ttmt -85.9 138.59 31.92 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -172.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -86.45 129.09 34.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.948 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -74.87 116.52 15.68 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.847 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.49 49.66 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.862 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.1 mmm -101.93 137.18 19.45 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.07 95.16 0.14 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 123.205 2.604 . . . . 0.0 112.71 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 45.86 46.27 12.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 125.015 1.326 . . . . 0.0 113.012 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.38 141.61 33.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 43' ' ' LYS . 79.6 m-85 -131.66 145.84 51.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.424 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -115.86 141.15 48.48 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 123.618 0.573 . . . . 0.0 110.066 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.13 138.44 51.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.42 132.78 55.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.285 0.366 . . . . 0.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 tt -84.27 117.78 23.76 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -51.74 -57.28 9.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -76.12 -53.59 8.09 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.184 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -63.86 -34.84 78.84 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.67 26.68 49.63 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.327 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.54 150.33 20.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -123.5 141.53 51.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -126.3 131.89 51.77 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.18 122.72 67.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 CA-C-O 121.405 0.621 . . . . 0.0 110.494 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -131.78 157.97 42.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.055 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.16 139.77 48.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.5 t -88.63 112.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 mt -98.54 95.64 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.466 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.26 -35.76 76.25 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.28 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -104.8 -1.31 26.27 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.013 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t 59.14 33.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.378 0 CA-C-O 122.722 1.248 . . . . 0.0 110.267 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.04 141.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.528 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.6 m -98.17 128.07 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.112 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 87.1 t80 -103.09 110.04 21.83 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.401 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -75.52 120.79 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.4 mt -95.06 -42.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.341 0.591 . . . . 0.0 109.521 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.7 m -153.0 153.31 32.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.014 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.06 148.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.81 -111.86 0.72 Allowed Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.3 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -124.59 142.81 51.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.533 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.204 -1.292 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -92.31 -52.08 4.85 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -61.46 -49.91 74.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.49 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.98 -29.55 67.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.298 -179.102 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -87.47 164.91 15.9 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.652 0.595 . . . . 0.0 109.544 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.4 157.48 22.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -126.16 128.55 47.46 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -140.37 157.13 46.01 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.18 142.23 49.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 122.395 0.278 . . . . 0.0 110.433 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.69 155.02 40.19 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.49 -29.64 67.99 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 12.6 mmt85 -71.75 -43.02 66.52 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.32 81.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.04 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.6 mt -63.16 -43.26 98.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 110.774 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.212 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 37.3 mm-40 -68.36 -37.54 80.57 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 123.528 0.517 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.69 -45.11 94.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.064 0.945 . . . . 0.0 111.033 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.3 -22.71 57.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.858 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -77.09 -31.67 56.1 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.427 1.491 . . . . 0.0 110.732 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.71 152.2 27.35 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.932 0.893 . . . . 0.0 111.786 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -69.49 147.19 45.1 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 15.0 m -49.18 -54.6 15.73 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.289 1.035 . . . . 0.0 112.455 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -63.54 -34.55 78.04 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.277 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.83 -48.85 61.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 7.3 ptt180 -69.24 -35.58 76.29 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 43.2 mt-10 -57.15 -49.46 75.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 120.45 0.166 . . . . 0.0 110.6 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.486 ' CB ' HD13 ' A' ' 55' ' ' LEU . 2.9 mp0 -68.51 -34.98 76.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.1 mt -66.91 -42.77 84.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.56 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -59.05 -41.9 89.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.185 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.4 mttt -59.23 -41.29 88.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.1 mptp? -64.32 -34.79 78.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.158 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -68.92 -47.31 66.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.44 -38.63 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.886 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 10.5 pt-20 -68.31 -43.14 78.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.945 0.402 . . . . 0.0 110.563 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 37' ' ' PRO . 2.7 p -64.47 -30.56 50.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.838 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.8 mt -54.03 -25.46 21.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 14.6 pt-20 -75.17 -25.45 58.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.058 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.0 p -158.09 74.46 3.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.702 0.401 . . . . 0.0 110.125 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' HG21 ' A' ' 33' ' ' VAL . 94.3 Cg_endo -85.04 -1.34 9.37 Favored 'Trans proline' 0 C--O 1.206 -1.106 0 C-N-CA 122.057 1.838 . . . . 0.0 113.796 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 32.78 0.74 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.55 112.37 20.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -57.75 -29.04 64.46 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.82 -15.94 63.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.953 0.406 . . . . 0.0 111.725 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -102.41 -1.63 30.38 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.743 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 42.5 mtpt -74.03 144.67 45.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.084 0.469 . . . . 0.0 111.474 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 59.7 mt -74.41 133.46 42.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -73.26 107.61 5.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 32.41 9.23 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.736 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 77.2 mmm -133.98 142.72 44.45 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.64 93.47 0.6 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.765 2.31 . . . . 0.0 112.714 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 50.0 41.73 23.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 124.993 1.317 . . . . 0.0 113.986 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.412 ' SG ' ' HE1' ' A' ' 47' ' ' MET . 53.1 m -100.31 141.58 32.96 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.1 m-85 -130.01 146.24 51.68 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -115.14 140.4 49.11 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.28 0.562 . . . . 0.0 110.869 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.44 127.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -104.51 145.12 30.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.502 178.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.527 ' HB3' ' O ' ' A' ' 58' ' ' SER . 15.5 tp -85.59 143.32 28.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -89.83 -30.27 18.06 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.639 0.733 . . . . 0.0 109.219 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -65.47 -29.77 70.47 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.069 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 23.4 t -164.17 158.71 19.43 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.06 50.63 3.08 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -99.02 143.42 29.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -122.96 142.65 50.59 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -120.64 126.85 51.29 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.9 t -116.59 123.46 71.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.181 0.515 . . . . 0.0 109.947 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.5 p90 -135.58 158.96 43.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.188 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -112.08 139.53 47.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.5 t -97.74 111.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.622 0.725 . . . . 0.0 110.056 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.08 95.06 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.37 -29.88 64.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.476 0.655 . . . . 0.0 109.76 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.73 -40.16 75.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.97 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -108.06 4.29 24.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.509 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p 51.86 40.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.704 1.602 . . . . 0.0 111.879 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.91 138.96 50.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.748 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.86 115.24 42.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -108.87 112.92 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.665 -173.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.52 121.48 27.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -95.42 -42.74 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.374 0.606 . . . . 0.0 109.624 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -149.43 149.97 31.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.315 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.21 131.97 6.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.02 -155.78 26.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -81.09 152.92 27.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.369 0.604 . . . . 0.0 110.839 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.994 -176.827 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -81.56 -44.07 17.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 t -66.57 -34.68 78.44 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -60.88 -47.89 84.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.543 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.913 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.178 -178.217 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.95 168.86 14.6 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.727 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -89.01 161.05 16.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.06 132.37 51.95 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.79 155.49 47.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -123.36 135.49 54.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 117.791 0.269 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.85 155.71 38.76 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 6.5 pt-20 -53.19 -40.82 64.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 117.809 0.277 . . . . 0.0 111.429 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 25.5 mmm180 -69.86 -38.06 76.3 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.99 93.32 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.925 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.45 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 44.7 mt -66.58 -42.85 86.34 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.164 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -61.32 -43.92 98.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -69.97 -39.57 75.89 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.765 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.11 -42.22 98.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.1 0.96 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 81.9 mtp180 -73.07 -26.63 61.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.041 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -71.84 -35.71 69.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.497 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -60.85 152.74 26.46 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.514 0.673 . . . . 0.0 112.528 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.0 155.77 49.67 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.778 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 3.0 p -55.73 -53.97 50.05 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 124.138 0.975 . . . . 0.0 112.801 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -57.62 -42.14 82.71 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 124.225 1.01 . . . . 0.0 110.899 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -68.58 -48.21 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.99 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.3 ptt-85 -68.72 -35.42 77.11 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 20' ' ' SER . 37.5 mt-10 -59.7 -45.41 92.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.399 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HB3' HD12 ' A' ' 55' ' ' LEU . 2.6 mp0 -70.86 -34.74 71.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 85.1 mt -62.92 -44.06 97.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.397 174.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -56.38 -42.61 78.16 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.945 0.403 . . . . 0.0 110.498 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 98.9 mttt -60.24 -45.48 93.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.67 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.0 mptp? -59.95 -38.52 82.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.86 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.4 mt -65.96 -46.33 78.49 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.296 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.21 -37.73 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.737 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 8.2 pt-20 -68.6 -42.66 77.87 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.705 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.98 -29.37 47.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.49 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -52.85 -24.95 10.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.91 -30.37 70.95 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.683 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 t -161.72 75.81 2.32 Favored Pre-proline 0 C--O 1.2 -1.541 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 33' ' ' VAL . 85.3 Cg_endo -83.46 -9.68 10.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.0 1.8 . . . . 0.0 114.461 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 43.3 0.63 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.45 0.643 . . . . 0.0 111.881 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.14 101.32 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.793 0.806 . . . . 0.0 110.185 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.15 -25.2 65.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.629 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.75 -15.23 63.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.983 0.42 . . . . 0.0 110.81 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -113.87 11.12 17.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.383 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -80.49 144.69 32.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 120.98 0.419 . . . . 0.0 111.917 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.82 150.73 23.93 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.494 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -95.08 127.74 41.37 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.349 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.54 12.62 84.06 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.36 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.0 mmm -121.83 120.1 28.71 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.6 100.67 0.16 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.194 2.596 . . . . 0.0 113.598 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 65' ' ' GLN . 4.5 m-20 62.16 31.37 17.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 111.793 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.91 141.72 32.35 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.773 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.467 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 68.8 m-85 -136.5 156.54 48.45 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 140.46 47.11 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 112.536 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.26 141.28 34.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 1.1 mppt? -113.23 144.3 42.93 Favored 'General case' 0 N--CA 1.403 -2.813 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 25' ' ' GLN . 18.5 tp -98.51 118.47 35.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -70.78 -34.59 71.95 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.196 0.522 . . . . 0.0 110.346 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 m -61.9 -39.49 92.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -124.96 -12.37 7.02 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 21.36 57.3 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.493 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -93.52 156.64 16.62 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.096 -0.65 . . . . 0.0 110.938 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -121.8 143.73 49.23 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.69 0.796 . . . . 0.0 108.982 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.43 127.67 37.93 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.41 125.66 72.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 CA-C-O 121.035 0.445 . . . . 0.0 110.022 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.1 p90 -136.93 158.83 43.56 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.245 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 4.0 pt20 -111.44 133.72 53.54 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 173.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -98.0 110.88 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.7 mt -99.65 95.79 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.69 -25.03 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.055 0.455 . . . . 0.0 110.247 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.57 -36.28 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.636 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -107.68 -1.87 20.68 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.835 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t 58.5 32.52 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.234 1.414 . . . . 0.0 110.388 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 p -129.67 139.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.018 -1.051 . . . . 0.0 110.964 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -98.88 114.98 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -106.07 110.33 22.56 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.682 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.18 121.95 24.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.4 mt -94.89 -42.27 12.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.734 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.8 m -152.99 153.18 32.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.97 142.97 18.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.34 -131.72 3.18 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.176 -1.011 . . . . 0.0 111.797 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -124.03 167.06 14.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.468 -0.431 . . . . 0.0 110.641 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.943 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.481 -176.587 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.213 -0.848 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -80.92 -42.85 20.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.983 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -64.53 -41.49 96.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -62.42 -46.8 86.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.076 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.535 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.819 -176.415 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -91.06 162.88 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.89 155.03 23.1 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.06 124.1 47.26 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -130.62 160.81 33.1 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.11 144.73 50.92 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 13.1 t70 -79.42 154.4 28.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 169.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -29.54 66.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 4.4 mmt85 -63.82 -45.0 91.56 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.07 93.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.386 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.99 -41.03 99.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 123.207 0.317 . . . . 0.0 111.749 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.67 -43.83 97.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.272 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 57.4 mm-40 -69.09 -39.5 78.97 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.272 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -61.3 -46.61 89.58 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.571 1.148 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -73.03 -28.58 62.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.529 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.4 -38.73 88.14 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.377 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.56 153.91 12.2 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.644 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.19 147.51 37.84 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.3 m -50.15 -48.04 53.96 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -67.27 -36.87 82.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.689 0.28 . . . . 0.0 110.966 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.16 -48.59 68.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 19.4 ptt180 -68.77 -35.43 77.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 24.0 mt-10 -57.93 -42.44 84.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.512 ' CB ' HD11 ' A' ' 55' ' ' LEU . 43.5 mt-30 -70.64 -35.11 72.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.128 0.489 . . . . 0.0 110.193 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.04 -41.87 85.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.956 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' O ' HG21 ' A' ' 31' ' ' VAL . 18.6 ptmt -63.18 -36.73 84.59 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.898 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -59.63 -39.02 82.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.9 mmtt -65.02 -36.21 83.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.689 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 71.7 mt -63.72 -43.62 96.0 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 27' ' ' LYS . 96.2 t -63.73 -45.46 97.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.717 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.2 pt-20 -69.09 -43.92 73.55 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.754 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.88 -29.76 47.9 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 81.5 mt -53.45 -25.32 15.71 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -75.09 -25.45 58.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.197 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -154.2 74.19 6.15 Favored Pre-proline 0 C--O 1.213 -0.829 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' HG23 ' A' ' 33' ' ' VAL . 84.4 Cg_endo -80.98 -7.31 13.23 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 121.515 1.476 . . . . 0.0 113.386 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 38.69 0.94 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.58 0.705 . . . . 0.0 112.074 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.52 108.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.4 -24.68 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.54 -8.19 44.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 87.0 m-20 -108.94 3.8 22.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 9.9 mtpm? -71.18 142.41 50.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.11 126.17 32.84 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 168.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -85.77 114.56 22.82 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 6.47 16.74 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -131.28 139.05 34.23 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.75 -71.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.323 2.682 . . . . 0.0 112.677 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -137.96 78.04 1.66 Allowed 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.9 m -126.88 141.38 51.83 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 40.4 m-85 -133.75 155.43 49.78 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -126.39 139.83 52.97 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.641 0.588 . . . . 0.0 110.033 177.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 mt -108.71 142.55 21.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -117.1 129.34 55.92 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.512 HD11 ' CB ' ' A' ' 25' ' ' GLN . 14.6 tp -81.71 143.52 31.8 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -73.66 -36.64 65.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.1 m -99.62 150.2 22.5 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 71.82 -43.88 0.58 Allowed 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.68 35.16 5.25 Favored Glycine 0 C--O 1.239 0.447 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.767 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.44 155.76 17.16 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 122.622 -0.34 . . . . 0.0 110.22 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.8 mpt_? -129.52 151.33 50.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -128.26 131.32 48.75 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.1 t -118.38 124.37 73.02 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-O 121.229 0.538 . . . . 0.0 110.943 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.4 p90 -137.48 158.88 43.44 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.977 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -112.23 141.28 46.12 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 m -101.37 123.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.561 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.83 94.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.168 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.2 -23.38 62.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.975 0.893 . . . . 0.0 109.51 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.99 -36.55 83.92 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.262 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HB2' HG13 ' A' ' 72' ' ' VAL . 99.5 mttt -107.31 -4.27 18.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.463 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t 63.35 34.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-O 122.678 1.228 . . . . 0.0 109.616 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 70' ' ' LYS . 12.1 p -131.9 139.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.26 115.37 38.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 88.4 t80 -106.11 110.55 22.84 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.27 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.81 121.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.8 -42.61 12.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.881 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 m -151.39 153.92 35.65 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.3 139.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.85 -137.97 6.85 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -99.03 91.21 4.91 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.291 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.773 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.446 -0.625 0 CA-C-O 120.567 0.223 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -67.64 -47.5 69.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 120.691 0.281 . . . . 0.0 110.621 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.1 m -59.21 -41.79 89.42 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.37 -42.1 72.23 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.423 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.42 175.68 5.85 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.87 159.35 15.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.1 130.84 51.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -145.35 158.35 43.85 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.24 144.17 45.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.006 0.431 . . . . 0.0 111.987 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.39 155.97 28.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.96 -38.23 64.77 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.911 0.323 . . . . 0.0 111.229 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.81 -45.36 93.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.79 98.02 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.835 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -63.4 -45.42 91.11 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -63.29 -44.12 95.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.776 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -70.05 -37.97 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.432 ' O ' ' HD3' ' A' ' 23' ' ' ARG . 61.9 t-105 -63.04 -45.01 94.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.789 1.236 . . . . 0.0 110.674 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -72.19 -27.14 62.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.298 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.65 -38.5 64.95 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.479 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.4 150.65 17.98 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 124.434 1.094 . . . . 0.0 111.923 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.54 144.32 48.22 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -50.03 -50.25 48.18 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.144 . . . . 0.0 111.972 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.8 m -68.99 -37.77 78.94 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.271 0.628 . . . . 0.0 111.148 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.37 -47.67 80.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 10.1 ptt-85 -68.75 -35.96 77.76 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.571 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 33.4 mt-10 -66.69 -31.69 72.52 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.568 ' N ' HE21 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -70.83 -34.37 71.61 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.649 175.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -65.48 -42.13 92.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.579 172.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.9 ttpt -55.3 -44.76 76.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.648 0.779 . . . . 0.0 109.585 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -58.42 -38.02 76.56 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.929 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.7 mptp? -69.99 -35.22 74.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.155 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 85.7 mt -65.78 -41.63 91.77 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.154 0.502 . . . . 0.0 109.698 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 27' ' ' LYS . 92.7 t -62.64 -44.47 99.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.374 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -68.85 -45.73 70.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.988 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.435 HG23 ' OH ' ' A' ' 64' ' ' TYR . 3.4 p -62.94 -30.27 49.18 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.805 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 72.4 mt -53.35 -25.53 15.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -76.71 -28.03 55.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.118 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 m -152.37 69.41 7.37 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.686 -0.633 . . . . 0.0 110.454 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' HG22 ' A' ' 33' ' ' VAL . 95.1 Cg_endo -87.63 -2.94 7.5 Favored 'Trans proline' 0 C--O 1.21 -0.887 0 C-N-CA 121.961 1.774 . . . . 0.0 112.828 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 37.94 0.94 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.949 0.881 . . . . 0.0 111.93 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.3 mt -82.7 100.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.48 -24.5 56.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.64 66.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.851 0.358 . . . . 0.0 111.143 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -99.5 3.89 45.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.437 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 43' ' ' LYS . 10.1 mtpm? -72.23 139.39 48.11 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.213 0.53 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 63.0 mt -80.14 138.25 36.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.398 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -72.31 106.61 4.53 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.56 32.46 10.23 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.103 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -135.75 132.68 19.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.65 99.08 0.37 Allowed 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.682 2.255 . . . . 0.0 113.319 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 60.36 31.92 20.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.637 1.175 . . . . 0.0 111.681 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -100.09 141.44 32.91 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.801 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.556 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 7.4 m-85 -132.0 160.4 35.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -130.51 146.95 52.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -124.93 139.6 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.3 131.01 56.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 25' ' ' GLN . 19.2 tp -77.61 96.59 4.84 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.421 0.629 . . . . 0.0 110.423 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -68.44 78.8 0.27 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.078 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t 172.63 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.279 1.432 . . . . 0.0 107.886 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 m -111.37 -23.44 10.79 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.82 49.32 Favored Glycine 0 C--O 1.241 0.544 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.585 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -88.01 150.21 23.55 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 122.61 -0.347 . . . . 0.0 110.16 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.13 147.88 46.31 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.181 0.515 . . . . 0.0 109.77 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -132.18 129.05 39.26 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.2 127.13 73.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 O-C-N 123.606 0.566 . . . . 0.0 110.102 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.2 p90 -138.08 158.78 43.63 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -108.92 130.37 55.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -99.52 110.5 26.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.0 mt -99.01 100.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.83 -34.48 78.02 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.039 0.536 . . . . 0.0 111.828 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.44 -36.74 85.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.321 0.388 . . . . 0.0 111.595 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.51 -6.97 29.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.05 0.453 . . . . 0.0 110.473 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 t 61.33 32.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 124.951 1.3 . . . . 0.0 109.936 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.42 138.78 53.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 111.148 -176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.3 114.88 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.03 110.69 21.34 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.94 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.77 121.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.14 -42.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.533 0.682 . . . . 0.0 110.218 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 m -145.87 149.91 35.14 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.17 145.91 17.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.65 -144.94 12.63 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -98.54 162.79 12.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 118.095 0.948 . . . . 0.0 109.388 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.682 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 121.03 0.443 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -89.24 -44.53 10.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.931 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -64.99 -48.03 75.45 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.94 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -60.6 -31.6 70.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.804 0.335 . . . . 0.0 110.421 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.344 179.785 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -96.05 168.93 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.157 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.2 159.88 16.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.65 123.53 39.17 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -137.55 152.71 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.86 137.82 52.53 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -70.48 154.8 41.5 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.256 0.7 OUTLIER -59.75 -31.15 69.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.03 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -70.94 -38.11 72.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.205 0.526 . . . . 0.0 109.638 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.36 88.05 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.202 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 63.7 mt -61.28 -43.79 98.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.406 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -61.66 -44.76 96.35 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -69.76 -37.43 76.4 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.275 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -60.93 -37.24 81.63 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.997 0.919 . . . . 0.0 110.593 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 97.5 mtt180 -74.86 -28.98 60.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.597 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -77.04 -26.3 53.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.444 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.11 151.25 43.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.931 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.68 145.62 42.26 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -45.56 -53.02 9.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.623 1.169 . . . . 0.0 112.114 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -68.61 -36.29 78.47 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.372 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.0 -48.47 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.14 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -69.3 -35.59 76.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.6 mt-10 -57.41 -41.53 80.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.514 ' CB ' HD13 ' A' ' 55' ' ' LEU . 41.4 mt-30 -70.93 -35.75 72.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.012 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.2 mt -68.63 -39.81 80.62 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.268 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' O ' HG21 ' A' ' 31' ' ' VAL . 36.4 ttpt -60.11 -42.61 95.08 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.477 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.6 mttm -57.06 -41.6 79.05 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.7 mmtt -64.0 -37.6 88.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.298 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.1 mt -64.97 -41.19 95.66 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.333 0.587 . . . . 0.0 109.809 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 27' ' ' LYS . 95.8 t -65.37 -45.66 92.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.576 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.4 pt-20 -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.905 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' OH ' ' A' ' 64' ' ' TYR . 5.0 p -64.08 -31.3 52.76 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -55.21 -27.42 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.15 -8.01 34.33 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.097 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -154.81 63.72 4.05 Favored Pre-proline 0 C--O 1.211 -0.973 0 C-N-CA 122.62 0.368 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 33' ' ' VAL . 97.5 Cg_endo -80.54 -4.73 13.09 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.103 1.869 . . . . 0.0 114.902 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.02 40.2 1.04 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -82.34 113.68 22.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.832 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 41' ' ' ALA . 3.6 pt-20 -58.49 -33.2 69.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.715 0.806 . . . . 0.0 111.828 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 40' ' ' GLU . . . -70.0 -23.36 63.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.675 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 94.8 m-20 -103.04 -11.87 17.83 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.208 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -65.9 142.41 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 120.802 0.334 . . . . 0.0 111.772 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 mt -72.24 168.33 18.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -58.61 -46.36 87.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 111.161 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.19 86.77 0.09 OUTLIER Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 89.7 mmm -149.01 146.1 20.81 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.92 89.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.424 2.75 . . . . 0.0 113.998 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 48.46 44.9 20.83 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.923 1.289 . . . . 0.0 112.099 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 58.8 m -101.85 142.34 33.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.377 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.646 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 29.3 m-85 -130.48 161.47 31.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 15.3 ptpt -116.28 158.94 22.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.983 0.913 . . . . 0.0 109.165 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 70.6 mt -129.55 133.77 64.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.73 123.21 46.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.514 HD13 ' CB ' ' A' ' 25' ' ' GLN . 16.6 tp -73.79 136.16 43.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.074 0.464 . . . . 0.0 110.805 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.43 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -84.15 -63.48 1.34 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 18.3 m -104.96 160.77 14.76 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.48 64.95 3.73 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.504 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -114.05 139.59 49.16 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 98.0 mtt180 -128.13 137.91 52.3 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.823 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -122.23 136.65 54.94 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.3 t -124.66 128.06 73.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 17.1 p90 -137.69 158.3 44.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.8 pt20 -108.53 133.89 52.05 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.86 111.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.9 mt -91.62 95.38 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -22.96 63.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.764 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.65 -40.12 96.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.193 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -107.41 -1.97 20.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.1 t 62.96 41.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 122.48 1.134 . . . . 0.0 109.242 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.84 139.01 48.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.601 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.57 115.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.59 -1.634 . . . . 0.0 106.59 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.03 111.72 23.26 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -173.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.76 121.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.22 -42.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.045 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -154.38 154.01 32.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.01 143.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.61 -139.83 7.86 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.581 -1.295 . . . . 0.0 112.435 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -107.44 91.22 3.56 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.545 0.688 . . . . 0.0 109.741 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.643 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.347 -179.382 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -63.71 -41.82 98.03 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.183 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 m -67.58 -43.09 81.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.517 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.02 -37.23 81.84 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 123.42 0.45 . . . . 0.0 110.773 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.281 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -91.2 173.42 7.94 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.025 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.51 162.56 13.42 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.48 HD11 ' N ' ' A' ' 6' ' ' ASP . 1.5 tm? -126.77 136.59 52.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.48 ' N ' HD11 ' A' ' 5' ' ' LEU . 38.2 t70 -141.25 154.12 45.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 173.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.79 128.58 56.47 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.473 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.69 156.64 36.45 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 123.969 0.793 . . . . 0.0 111.247 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 8.7 pt-20 -52.89 -38.88 62.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.148 0.979 . . . . 0.0 111.359 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 74.3 mtt180 -72.31 -42.06 65.87 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.244 0.545 . . . . 0.0 110.104 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.16 78.55 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.511 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.3 mt -66.92 -37.79 84.99 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 53.9 mttm -62.28 -46.77 87.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.66 -38.74 73.84 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.968 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -60.81 -43.31 98.35 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.546 0.738 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.29 -20.79 58.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -81.51 -24.01 36.94 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 124.673 1.189 . . . . 0.0 109.812 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.45 157.75 35.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.987 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.12 141.86 28.62 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 1.9 p -53.39 -41.96 66.47 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -175.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -40.89 83.93 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.1 -47.25 85.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 120.835 0.35 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -65.48 -34.85 79.24 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.798 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 20' ' ' SER . 35.3 mt-10 -58.35 -38.54 77.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -70.12 -38.41 75.56 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 89.2 mt -64.25 -42.68 96.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.695 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' O ' HG21 ' A' ' 31' ' ' VAL . 31.5 ttpt -56.66 -44.46 81.4 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 123.302 0.641 . . . . 0.0 110.595 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.19 -42.11 90.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.833 0.349 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.5 mptp? -64.55 -34.68 78.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.182 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.3 mt -68.44 -43.7 76.53 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 27' ' ' LYS . 92.4 t -60.84 -45.5 97.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.988 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.6 pt-20 -69.29 -43.34 74.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.673 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 37' ' ' PRO . 2.3 p -64.0 -29.87 48.49 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.785 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.997 -175.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 90.2 mt -54.38 -25.94 27.3 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.7 pt-20 -77.11 -20.81 55.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.927 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 p -155.27 69.67 5.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' HG23 ' A' ' 33' ' ' VAL . 94.5 Cg_endo -80.13 -9.65 14.0 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 121.823 1.682 . . . . 0.0 112.484 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -89.04 38.7 0.9 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.767 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.19 109.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.505 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.949 0.404 . . . . 0.0 111.703 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -101.44 -2.94 29.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.095 -0.378 . . . . 0.0 112.002 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 21.1 mtpp -70.96 146.28 49.57 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.886 0.374 . . . . 0.0 110.985 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.29 164.09 15.08 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.165 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -91.81 131.08 37.42 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.13 0.572 . . . . 0.0 109.914 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.79 76.58 Favored Glycine 0 CA--C 1.506 -0.506 0 O-C-N 123.505 0.503 . . . . 0.0 113.198 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.427 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 95.9 mmm -126.17 129.99 24.07 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.25 98.9 0.34 Allowed 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.49 2.127 . . . . 0.0 112.859 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 52.51 42.03 31.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.204 1.002 . . . . 0.0 113.022 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 61.9 m -100.26 141.48 33.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.12 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.579 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 45.1 m-85 -134.0 159.6 40.26 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -134.39 140.54 46.37 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.858 177.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.56 144.06 29.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -127.13 140.26 52.38 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 120.907 0.384 . . . . 0.0 111.668 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.0 mt -85.62 115.65 23.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -66.13 -30.53 71.04 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -66.49 -65.1 0.72 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.93 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -89.98 -22.48 21.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.66 64.46 Favored Glycine 0 C--O 1.239 0.455 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.154 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -96.55 144.69 26.38 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.397 0.279 . . . . 0.0 110.403 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -122.2 147.57 46.02 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -131.4 134.36 46.18 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.23 128.55 75.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 C-N-CA 123.188 0.595 . . . . 0.0 110.262 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.579 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 7.5 p90 -138.84 158.78 43.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -112.03 137.47 50.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.85 112.81 29.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -95.79 95.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.84 -26.63 65.25 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 0.0 110.661 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.66 -30.26 69.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.424 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -105.47 -6.25 19.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.245 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.42 29.36 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 122.569 1.176 . . . . 0.0 109.089 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.87 139.09 52.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 O-C-N 121.206 -0.934 . . . . 0.0 111.197 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.8 120.85 46.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -109.08 110.6 21.9 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.834 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.3 t -76.56 121.72 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.6 mt -98.35 -42.04 10.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.565 0.698 . . . . 0.0 110.076 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.8 m -142.48 147.46 36.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.224 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.23 142.11 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.0 -115.36 0.71 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.295 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -137.54 149.57 46.84 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 110.577 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.178 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.217 -0.637 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -91.72 -40.91 10.99 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 m -56.98 -51.18 70.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.963 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.14 -28.91 69.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.107 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.058 -179.313 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.192 0 CA-C-O 121.107 0.479 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -124.64 173.99 8.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -86.72 159.55 19.12 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -124.8 125.9 44.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.69 167.1 22.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.31 141.05 51.55 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 10' ' ' ARG . 19.5 t70 -80.23 154.87 27.63 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.14 -29.33 65.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 25.5 mtp-105 -68.37 -48.18 65.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.38 68.44 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.52 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -70.91 -37.46 72.96 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.931 0.396 . . . . 0.0 110.998 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.81 -42.87 90.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.44 -43.13 86.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.948 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -63.2 -41.4 99.16 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.329 1.052 . . . . 0.0 110.795 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.23 -24.61 57.73 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.491 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -67.57 -32.16 72.72 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.12 141.44 58.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.609 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.48 -83.43 0.05 OUTLIER Glycine 0 C--N 1.312 -0.8 0 O-C-N 124.837 1.336 . . . . 0.0 114.392 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 t -163.74 -60.85 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.516 HG21 ' OE1' ' A' ' 25' ' ' GLN . 4.9 m -63.07 -45.37 92.48 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.359 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.41 -47.52 90.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.899 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -68.42 -35.4 77.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.557 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.3 mt-10 -63.6 -42.17 98.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.555 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.0 mp0 -62.64 -45.24 93.77 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.131 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.514 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 88.9 mt -58.61 -43.15 89.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.422 0.451 . . . . 0.0 111.46 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' HG21 ' A' ' 31' ' ' VAL . 35.2 ttpt -58.16 -44.33 87.86 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.295 0.372 . . . . 0.0 110.254 175.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -64.93 -34.68 78.99 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.75 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 13.0 mmmm -67.38 -34.47 77.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.4 mt -68.96 -40.77 78.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.81 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 27' ' ' LYS . 76.6 t -61.11 -45.68 98.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -69.29 -38.17 78.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.036 0.446 . . . . 0.0 111.281 177.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -67.02 -30.34 49.23 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.791 -176.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 mt -53.86 -24.57 16.31 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.1 pt-20 -70.71 -24.96 62.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.318 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 39' ' ' ILE . 43.8 p -162.05 76.04 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 123.152 0.581 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HA ' HG23 ' A' ' 33' ' ' VAL . 73.7 Cg_endo -80.37 -4.97 13.33 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.722 1.615 . . . . 0.0 112.175 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 40.91 1.05 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.89 0.852 . . . . 0.0 111.624 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 36' ' ' SER . 85.0 mt -82.42 93.58 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 43' ' ' LYS . 9.7 pt-20 -55.57 -18.74 8.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.05 1.34 . . . . 0.0 113.993 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.72 74.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.975 0.417 . . . . 0.0 110.97 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -100.77 9.47 42.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.892 0.377 . . . . 0.0 110.625 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 56.9 tttt -80.96 144.33 31.94 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.0 mt -79.54 152.53 30.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.657 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -63.15 -74.28 0.1 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.44 43.28 1.7 Allowed Glycine 0 CA--C 1.502 -0.756 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.886 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.412 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 92.6 mmm -124.57 124.96 25.62 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.91 99.11 0.13 Allowed 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 123.139 2.559 . . . . 0.0 112.809 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 52.75 39.27 28.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.823 1.249 . . . . 0.0 113.395 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 56.0 m -100.09 141.55 32.77 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 47.3 m-85 -131.84 157.77 43.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.13 144.43 51.03 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.29 129.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.17 140.09 39.68 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.681 174.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.46 139.4 39.64 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -66.04 -48.7 70.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.24 123.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.8 m 69.51 -173.69 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.004 0.922 . . . . 0.0 111.585 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.35 42.31 1.99 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.46 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -91.38 136.96 32.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -133.99 141.89 47.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.789 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -123.75 138.18 54.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.7 t -123.85 129.59 74.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 18.9 p90 -138.84 159.26 42.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.164 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -119.74 138.08 53.54 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.2 m -95.81 121.26 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -99.29 95.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.18 -28.57 67.39 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.673 0.749 . . . . 0.0 109.046 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.21 -38.68 77.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.959 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.6 mttt -107.84 -4.17 18.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.615 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.4 t 61.9 29.46 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 CA-C-O 122.382 1.087 . . . . 0.0 109.868 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.1 p -131.32 141.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 121.008 -1.057 . . . . 0.0 111.214 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.46 121.14 53.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 124.146 0.978 . . . . 0.0 108.588 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -107.78 120.55 42.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -74.86 124.08 31.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -93.65 -42.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 123.464 0.477 . . . . 0.0 110.83 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 t -155.45 150.85 27.09 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.25 132.95 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.237 0.542 . . . . 0.0 110.551 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.14 -111.58 0.48 Allowed Glycine 0 N--CA 1.418 -2.548 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.425 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -132.9 158.07 43.51 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -2.547 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.022 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -84.67 -28.47 26.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 m -69.59 -43.73 72.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.15 -36.56 80.13 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.909 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.478 179.178 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -108.84 167.63 9.94 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.73 151.59 35.99 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -125.83 122.17 35.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -132.83 157.04 46.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.78 140.84 52.56 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.79 155.59 40.26 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -53.56 -38.91 64.32 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.275 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.5 ptm180 -67.14 -38.75 86.07 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.37 -37.4 87.38 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.191 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 mt -67.73 -43.09 80.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.651 0.262 . . . . 0.0 110.852 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.35 -42.02 98.89 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 46.7 mt-10 -69.41 -39.59 77.84 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.833 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -60.69 -41.27 94.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 0.0 110.376 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -73.42 -31.16 63.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.401 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.8 -43.93 82.58 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.821 0.701 . . . . 0.0 109.818 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mp -53.08 153.05 3.76 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.464 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.37 142.06 41.98 Favored Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 1.8 p -54.17 -46.11 72.26 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.875 0.87 . . . . 0.0 113.085 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 m -68.51 -36.29 78.67 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.025 0.441 . . . . 0.0 110.88 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.73 -47.97 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.23 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.369 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -57.23 -43.61 83.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.695 0.225 . . . . 0.0 110.575 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.92 -38.64 86.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 -179.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.7 mt -67.25 -42.69 83.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 176.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -57.09 -43.38 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.036 0.534 . . . . 0.0 110.594 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -56.94 -43.21 81.29 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.397 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 75.3 mmtt -65.48 -38.47 89.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.912 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.4 mt -65.46 -46.94 77.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.57 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.26 -41.37 89.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.401 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.564 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -69.9 -37.72 76.08 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.694 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -64.45 -30.22 49.56 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.774 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.404 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.2 mt -54.47 -26.46 31.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 1.9 pp20? -80.41 -29.63 37.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.382 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -142.87 72.49 19.12 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' HG23 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -73.45 -27.94 12.65 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 121.547 1.498 . . . . 0.0 112.223 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.49 65.95 4.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -103.71 115.08 45.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 11.0 pt-20 -59.81 -28.67 67.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.21 65.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.41 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -107.1 -2.25 21.18 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.029 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 38.5 mtpt -75.42 139.57 42.4 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.7 mt -78.19 149.47 33.71 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.677 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.38 -65.07 0.75 Allowed 'General case' 0 C--N 1.311 -1.084 0 O-C-N 124.072 0.857 . . . . 0.0 111.945 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.83 61.43 0.36 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.475 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.439 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 94.3 mmm -141.2 140.97 21.96 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.4 95.76 0.53 Allowed 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.984 2.456 . . . . 0.0 112.787 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 48.21 44.64 19.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.764 1.226 . . . . 0.0 112.145 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 60.5 m -100.8 142.07 32.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.593 ' CE2' ' HG2' ' A' ' 43' ' ' LYS . 25.7 m-85 -130.91 156.47 45.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -126.02 139.51 53.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.426 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.2 mt -111.98 138.89 39.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.84 123.57 38.99 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 -178.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.7 91.37 6.99 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -62.88 -8.69 7.51 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.916 1.686 . . . . 0.0 113.279 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -100.13 -13.06 19.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.765 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -134.78 -36.03 0.86 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.249 -0.981 . . . . 0.0 113.083 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.44 28.92 6.17 Favored Glycine 0 C--O 1.247 0.932 0 C-N-CA 119.415 -1.374 . . . . 0.0 112.007 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.09 146.35 29.26 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -135.1 147.3 49.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.43 133.48 45.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.91 128.73 75.73 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 CA-C-O 121.015 0.436 . . . . 0.0 109.884 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 15.9 p90 -139.14 158.86 43.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.729 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 17.2 pt20 -110.27 138.89 46.04 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.0 t -103.15 112.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.81 94.68 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.35 -34.08 74.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.09 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.22 -35.42 71.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.141 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -103.81 -1.1 28.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.277 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p 54.81 40.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.405 1.882 . . . . 0.0 111.821 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.65 138.36 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.814 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -102.46 115.36 44.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -110.23 112.22 24.05 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.5 t -77.06 121.45 29.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.73 -42.32 12.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.133 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -151.01 148.07 27.91 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.042 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.07 141.25 21.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.04 -97.63 0.19 Allowed Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -137.61 144.18 41.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.095 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.94 -43.6 13.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.428 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.0 m -67.4 -29.27 68.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.17 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.15 -50.08 74.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.017 -176.935 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 120.605 0.24 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.84 171.29 7.96 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.03 156.89 18.58 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -126.18 130.09 50.3 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.63 158.11 44.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -119.21 133.83 55.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.67 155.95 39.1 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.167 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.506 ' OE1' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -56.43 -36.85 69.45 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.33 0.394 . . . . 0.0 110.783 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HG3' ' OE1' ' A' ' 9' ' ' GLU . 35.8 mtt180 -60.06 -48.93 79.66 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.65 77.23 Favored 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.861 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.9 mt -64.02 -38.66 91.89 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 120.988 0.423 . . . . 0.0 110.753 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -65.11 -43.49 91.85 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.5 mt-10 -69.39 -36.41 76.74 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.181 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.37 -38.41 90.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.021 0.928 . . . . 0.0 109.864 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -75.06 -26.4 59.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 61.4 tttm -72.36 -39.99 67.67 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.785 0.834 . . . . 0.0 109.102 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.36 151.53 43.73 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.54 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.95 147.8 40.34 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 23.2 m -51.05 -49.83 59.81 Favored 'General case' 0 C--O 1.205 -1.259 0 C-N-CA 123.994 0.918 . . . . 0.0 112.014 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -63.67 -38.55 91.55 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.244 0.545 . . . . 0.0 110.849 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.07 -47.48 81.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.399 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -68.42 -34.77 76.59 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.173 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 20' ' ' SER . 70.0 mt-10 -57.53 -42.25 82.52 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.052 0.387 . . . . 0.0 111.32 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.17 -39.35 89.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.549 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.7 mt -66.48 -40.92 89.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' HG22 ' A' ' 31' ' ' VAL . 32.0 ttpt -56.5 -44.62 80.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.137 0.575 . . . . 0.0 110.38 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.62 -39.64 88.95 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.262 0.553 . . . . 0.0 110.234 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 mptp? -65.29 -37.41 87.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.068 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.7 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -66.25 -41.44 89.95 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 27' ' ' LYS . 99.5 t -65.26 -44.74 94.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 9.5 pt-20 -68.75 -44.15 74.36 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.948 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.3 p -62.66 -29.92 48.08 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.228 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 89.9 mt -53.59 -25.56 17.89 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.6 pt-20 -71.46 -27.86 63.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 39' ' ' ILE . 48.2 m -152.6 73.95 7.28 Favored Pre-proline 0 C--O 1.209 -1.046 0 C-N-CA 123.558 0.743 . . . . 0.0 109.167 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' HG23 ' A' ' 33' ' ' VAL . 61.2 Cg_endo -74.72 -13.21 22.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.057 1.838 . . . . 0.0 112.622 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -87.51 41.45 0.98 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.427 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 36' ' ' SER . 91.9 mt -80.61 98.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.75 -19.32 10.75 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.738 1.615 . . . . 0.0 114.288 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.4 -25.86 65.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.594 0.711 . . . . 0.0 109.912 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.67 -1.75 39.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.811 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.9 142.07 49.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-O 121.201 0.524 . . . . 0.0 110.658 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.6 176.61 9.55 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.816 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -110.09 120.02 41.14 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.022 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.28 54.37 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.126 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.53 131.54 23.41 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -47.02 -59.06 1.39 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 124.401 3.401 . . . . 0.0 114.256 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.67 ' OD1' ' HB ' ' A' ' 66' ' ' VAL . 7.7 t70 -154.66 83.65 1.1 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.1 m -139.47 141.77 37.39 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.7 m-85 -138.23 153.78 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.3 pttt -126.18 139.43 53.36 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.2 mt -111.68 130.88 64.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 145.28 29.98 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.78 143.08 27.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -93.48 -42.56 9.18 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.217 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 m -89.32 5.08 46.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.7 m -152.89 138.3 17.6 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.39 73.04 2.07 Favored Glycine 0 C--N 1.314 -0.673 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.533 -175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -135.23 156.45 48.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.572 ' N ' ' HD2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -144.82 149.48 35.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -119.88 133.37 55.6 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.95 126.42 70.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.2 p90 -136.4 158.94 43.24 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -113.51 140.03 48.46 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.67 ' HB ' ' OD1' ' A' ' 49' ' ' ASP . 81.7 t -99.59 113.03 33.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.748 0.785 . . . . 0.0 109.849 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.69 94.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.25 -27.9 65.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.866 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.08 -37.34 76.86 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.037 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -107.78 -1.76 20.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.149 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t 62.32 35.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.638 1.209 . . . . 0.0 109.69 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -133.3 138.7 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.96 121.76 49.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.26 115.48 29.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.5 t -80.85 121.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.66 -42.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 123.585 0.553 . . . . 0.0 110.909 -174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 p -145.56 149.68 35.03 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.108 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.04 127.19 2.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.261 0.553 . . . . 0.0 112.112 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.78 -123.31 1.28 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 119.141 -1.504 . . . . 0.0 112.936 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -113.74 157.1 22.66 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 -175.593 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.95 -44.64 15.08 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.1 t -58.81 -49.44 77.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.52 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -62.04 -29.77 70.51 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 110.667 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.898 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -121.3 160.66 23.5 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -80.35 160.31 25.47 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.08 131.56 52.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.76 155.8 43.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -120.05 137.06 54.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.729 0.411 . . . . 0.0 111.19 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.54 154.8 31.39 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 170.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 6.8 pt-20 -53.55 -41.89 66.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.117 0.417 . . . . 0.0 111.934 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 90.0 mtt180 -72.25 -37.77 69.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.627 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.36 75.83 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.5 tp -73.47 -34.16 65.22 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.799 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 87.6 mttt -66.15 -44.41 84.2 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -67.43 -38.73 84.99 Favored 'General case' 0 C--O 1.199 -1.598 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.459 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -60.26 -40.25 89.65 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.604 0.762 . . . . 0.0 111.469 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -74.21 -33.94 63.55 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.601 0.715 . . . . 0.0 110.917 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.02 -19.41 58.68 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.29 162.5 29.38 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.317 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.08 152.58 43.96 Favored Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.897 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -53.58 -54.05 42.93 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 125.033 1.333 . . . . 0.0 112.248 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 m -63.1 -34.67 78.09 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.301 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.15 -48.18 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.756 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -63.35 -40.52 97.52 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.509 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.8 mt-10 -61.43 -43.6 98.59 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.667 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -69.84 -43.27 72.29 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.546 178.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.8 mt -58.81 -40.79 85.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 117.612 0.187 . . . . 0.0 110.92 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.3 ttpt -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 123.59 0.557 . . . . 0.0 110.07 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.1 mttt -63.09 -38.07 89.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 28.7 mmmt -66.82 -35.1 79.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 88.9 mt -68.87 -43.6 75.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 27' ' ' LYS . 53.9 t -60.54 -44.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.831 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 9.7 pt-20 -69.07 -44.76 71.9 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.3 p -62.79 -29.64 47.53 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.343 -173.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.54 -26.65 22.12 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.09 -24.76 43.25 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.387 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -148.66 69.3 10.19 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' HG23 ' A' ' 33' ' ' VAL . 83.0 Cg_endo -83.2 -11.29 9.8 Favored 'Trans proline' 0 C--O 1.209 -0.939 0 C-N-CA 121.542 1.495 . . . . 0.0 111.799 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.48 39.22 0.72 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -82.94 107.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.33 -24.35 67.28 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.61 67.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.888 0.375 . . . . 0.0 111.677 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 90.6 m-20 -97.66 -0.4 45.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.553 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 43' ' ' LYS . 10.0 mtpm? -73.95 138.57 44.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.197 0.522 . . . . 0.0 111.402 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 67.6 mt -82.43 141.77 32.48 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -68.61 -42.53 77.99 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.03 18.56 57.3 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.435 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.482 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 83.8 mmm -130.71 145.68 58.65 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.88 -74.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.942 1.761 . . . . 0.0 114.722 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.14 36.8 4.21 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 40.0 m -100.32 141.24 33.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.507 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 29.6 m-85 -132.86 156.89 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.23 142.44 50.85 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.251 0.548 . . . . 0.0 111.025 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.91 144.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -120.17 126.43 50.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 2.1 tt -99.04 90.39 4.6 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -75.62 95.03 3.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.826 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.409 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . 35.9 t 171.61 -39.75 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.869 1.667 . . . . 0.0 107.298 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 p -125.37 -17.04 5.72 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.24 9.86 61.51 Favored Glycine 0 C--O 1.241 0.579 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.15 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.89 148.97 25.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.123 0.487 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -125.25 151.84 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.85 125.36 29.82 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.15 126.94 70.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.217 0.532 . . . . 0.0 109.955 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -139.22 159.71 41.51 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.952 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.405 ' NE2' HG12 ' A' ' 67' ' ' ILE . 11.0 pt20 -114.08 141.24 47.71 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 170.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -91.21 114.23 28.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.405 HG12 ' NE2' ' A' ' 65' ' ' GLN . 22.7 mt -99.95 95.15 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.84 -33.17 73.37 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.79 0.329 . . . . 0.0 110.581 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.54 -33.71 70.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.982 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB2' HG11 ' A' ' 72' ' ' VAL . 93.2 mttt -104.09 -6.7 20.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.204 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t 63.01 32.26 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.31 0 C-N-CA 124.449 1.1 . . . . 0.0 109.671 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' LYS . 13.6 p -131.58 138.83 52.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 111.065 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.1 t -96.37 115.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -106.07 111.78 24.55 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.981 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.33 121.9 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.6 mt -95.08 -40.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.258 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -155.75 151.95 27.93 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -149.44 147.03 16.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.6 -151.4 23.59 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.259 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -89.75 137.58 32.21 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.506 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.088 -175.207 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -74.38 -45.3 47.73 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 m -64.82 -40.0 94.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.14 -47.33 77.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -115.89 163.91 15.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.21 161.72 17.87 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.89 123.17 36.64 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.89 169.18 17.48 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.8 136.9 47.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.08 155.65 16.63 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 7.3 pt-20 -52.6 -41.93 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.317 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -63.87 -48.16 77.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.23 0.538 . . . . 0.0 111.055 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.6 71.55 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.051 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 9' ' ' GLU . 1.1 mptm? -65.06 -42.09 94.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.77 -35.74 77.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.672 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -60.56 -38.0 83.12 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 110.121 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.38 -35.03 65.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.666 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.38 -32.89 74.69 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.325 1.05 . . . . 0.0 110.71 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.25 147.61 52.04 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.272 0.558 . . . . 0.0 112.495 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.24 147.92 41.69 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 11.9 p -51.04 -54.93 20.26 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 124.334 1.053 . . . . 0.0 112.839 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -59.08 -40.39 85.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.039 0.535 . . . . 0.0 111.402 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.14 -47.06 80.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.016 0.436 . . . . 0.0 109.885 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -67.61 -34.96 78.05 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 46.8 mt-10 -58.57 -45.73 88.39 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 117.781 0.264 . . . . 0.0 111.435 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.89 -35.23 78.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.76 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 81.7 mt -65.34 -41.76 93.58 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.214 174.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -59.29 -43.18 92.6 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.1 mttm -59.24 -42.7 91.73 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.208 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -64.33 -41.06 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.166 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 91.8 mt -64.3 -47.18 80.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.24 -36.48 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.579 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -69.46 -45.72 68.37 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.877 175.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -62.37 -29.65 47.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 C-N-CA 123.229 0.612 . . . . 0.0 112.393 -174.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.41 -24.93 13.83 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.4 pt-20 -68.23 -31.44 70.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 111.049 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.2 m -157.57 77.58 3.73 Favored Pre-proline 0 C--O 1.208 -1.127 0 C-N-CA 123.356 0.663 . . . . 0.0 110.056 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.0 Cg_endo -80.96 -0.12 10.39 Favored 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 121.771 1.647 . . . . 0.0 112.08 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 27.63 1.08 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.517 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.89 103.55 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 12.0 pt-20 -66.02 -15.68 63.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.75 -26.21 68.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.232 0.539 . . . . 0.0 109.987 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -103.86 8.51 37.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.848 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.667 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 2.6 tttm -72.25 148.29 45.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.465 0.65 . . . . 0.0 112.522 -177.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 81.2 mt -91.47 127.25 36.84 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.74 -1.118 . . . . 0.0 107.993 171.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -81.11 128.76 34.09 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 122.953 0.501 . . . . 0.0 110.591 -177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.52 11.26 66.55 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.4 mmm -123.61 140.91 35.19 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.87 101.62 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.496 1.464 . . . . 0.0 111.911 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 47.54 54.99 8.93 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.169 1.387 . . . . 0.0 113.911 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -113.24 141.7 46.67 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.667 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 38.0 m-85 -136.61 160.22 39.45 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HD2' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.76 140.27 47.97 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.789 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -110.57 140.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -126.74 133.36 50.89 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.022 0.439 . . . . 0.0 109.917 -177.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.09 135.79 33.69 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -106.76 -15.6 14.7 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.811 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -78.07 -27.93 48.69 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.346 0.593 . . . . 0.0 109.632 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -144.11 140.35 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.62 74.62 0.9 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.815 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -124.14 141.27 52.2 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.883 0.473 . . . . 0.0 110.333 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -126.43 149.38 49.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 tt -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.8 t -116.27 129.14 73.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.5 p90 -138.64 158.77 43.62 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.59 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -109.24 140.92 42.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.21 112.18 29.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 mt -91.3 95.87 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.61 -30.5 71.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.817 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.77 -39.91 90.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.394 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.6 mttt -107.46 -5.0 17.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.2 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.2 t 60.54 41.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 123.067 1.413 . . . . 0.0 109.537 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -135.79 138.93 47.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.359 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -94.22 115.35 32.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -107.19 110.42 22.48 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.197 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.1 123.41 27.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.0 mt -89.99 -42.26 14.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.57 0.7 . . . . 0.0 109.664 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -154.68 149.91 27.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.93 134.44 18.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.59 -147.75 18.38 Favored Glycine 0 C--N 1.3 -1.419 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.21 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -93.1 141.54 28.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 117.226 0.513 . . . . 0.0 110.315 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.376 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 121.003 0.43 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.33 -40.63 11.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.41 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 p -63.04 -42.15 99.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.591 0.71 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.24 -34.24 77.9 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.678 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.374 -178.679 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.71 141.44 51.16 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.048 0.452 . . . . 0.0 110.002 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.17 172.47 6.79 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -94.87 164.84 12.75 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.42 HD21 ' HB ' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -125.72 132.29 52.4 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -135.7 160.43 38.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.01 141.86 49.39 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.776 0.43 . . . . 0.0 110.604 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -76.86 150.22 36.08 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.95 -28.92 70.15 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.32 -41.62 66.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.33 85.52 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.713 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.56 -37.77 87.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.9 -44.31 90.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.51 -38.76 77.74 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.16 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -60.47 -46.72 89.05 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.136 0.974 . . . . 0.0 110.951 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.86 -21.17 59.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.229 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -77.31 -34.88 55.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.4 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.53 150.52 18.78 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.09 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 140.36 48.04 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -50.01 -52.33 34.91 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.175 0.99 . . . . 0.0 112.083 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.0 m -68.7 -29.99 68.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.32 -49.1 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -68.84 -35.11 76.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.946 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 9.6 mm-40 -57.14 -46.8 82.38 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 116.858 -0.156 . . . . 0.0 111.346 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -70.33 -37.09 74.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.791 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 79.4 mt -63.99 -41.33 97.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 31' ' ' VAL . 34.3 ttpt -60.09 -44.32 94.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 92.9 mttt -64.06 -35.45 80.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.632 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.4 mmtt -64.06 -39.61 94.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.592 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.572 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -63.65 -42.87 98.05 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 123.653 0.596 . . . . 0.0 109.558 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 27' ' ' LYS . 69.9 t -63.45 -45.96 96.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.537 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.7 pt-20 -69.76 -39.37 76.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.98 -29.89 48.3 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.73 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.724 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.2 mt -53.32 -24.44 11.82 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.6 pt-20 -66.07 -27.36 68.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.149 0.5 . . . . 0.0 110.699 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.542 ' O ' HG13 ' A' ' 39' ' ' ILE . 12.3 t -160.16 77.92 2.66 Favored Pre-proline 0 C--O 1.205 -1.253 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.32 -25.41 49.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.988 1.792 . . . . 0.0 112.785 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.3 60.74 6.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.284 1.04 . . . . 0.0 113.122 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 36' ' ' SER . 85.5 mt -89.96 115.93 30.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.606 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.59 -30.88 61.64 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 123.732 0.813 . . . . 0.0 112.493 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -18.33 61.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.967 0.413 . . . . 0.0 111.59 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.3 m-20 -103.16 -16.02 15.85 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -63.19 145.75 54.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.603 0.761 . . . . 0.0 112.559 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 91.9 mt -96.75 123.78 40.54 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 169.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -87.25 130.87 34.41 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.18 -34.01 6.06 Favored Glycine 0 C--N 1.306 -1.12 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 94.5 mmm -86.37 125.5 67.52 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -35.84 -66.56 0.11 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 124.733 3.622 . . . . 0.0 114.029 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 55.54 0.98 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.75 142.3 34.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 21.2 m-85 -135.04 152.19 51.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.29 139.96 53.25 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.103 178.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.6 mt -122.89 132.69 70.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.37 149.98 33.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.907 0.384 . . . . 0.0 111.961 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.47 136.66 34.52 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -62.09 -32.21 72.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.462 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -71.68 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p -102.45 2.21 36.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.56 46.04 9.11 Favored Glycine 0 C--N 1.32 -0.319 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.86 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -97.25 145.45 26.07 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -120.98 149.59 42.42 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.88 130.88 45.75 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.12 122.84 70.24 Favored 'Isoleucine or valine' 0 C--O 1.251 1.155 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.544 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 25.9 p90 -132.75 159.35 39.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.668 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.6 138.43 48.15 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.31 111.62 25.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.24 95.81 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.22 -31.0 71.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.133 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.0 -40.27 76.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.377 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB2' HG12 ' A' ' 72' ' ' VAL . 53.1 mttm -107.65 -6.74 16.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.714 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t 65.83 33.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 122.881 1.324 . . . . 0.0 110.066 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.2 p -133.8 140.22 46.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 O-C-N 121.35 -0.844 . . . . 0.0 110.353 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 5' ' ' LEU . 91.2 t -96.69 117.98 42.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -108.22 117.94 35.46 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.501 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -77.45 121.08 29.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.72 -41.89 13.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.573 0.701 . . . . 0.0 109.119 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -148.79 153.37 38.04 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.0 p -148.85 138.99 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.88 -114.8 0.64 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.38 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.551 ' HB3' ' OE1' ' A' ' 82' ' ' GLU . 63.0 mtpt -127.82 155.73 43.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.6 6.07 4.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -78.81 -15.54 58.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 122.064 -0.398 . . . . 0.0 111.917 -177.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.17 -2.79 30.45 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.314 0.578 . . . . 0.0 109.502 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m 63.73 15.19 8.81 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.844 1.258 . . . . 0.0 113.813 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.79 -28.7 68.6 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.162 0.585 . . . . 0.0 112.22 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.0 m -72.72 -21.26 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.227 0.537 . . . . 0.0 111.303 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -81.17 -24.34 37.61 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.55 -35.49 80.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.958 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -72.04 -50.44 28.4 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.158 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.514 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -55.35 -51.5 66.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.782 . . . . 0.0 113.05 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 -37.91 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -77.06 -24.53 51.96 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -77.71 -28.45 50.91 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.66 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 90' ' ' ALA . 43.7 mm -80.38 79.35 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.166 0.507 . . . . 0.0 111.682 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.425 -1.713 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 172.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.78 163.51 32.0 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.15 172.93 6.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.43 160.57 17.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.3 128.9 47.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -142.59 169.11 18.19 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -129.63 141.68 50.89 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.083 0.553 . . . . 0.0 110.178 -175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.59 154.9 41.1 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 4.6 pt-20 -61.31 -31.91 71.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.424 0.556 . . . . 0.0 110.634 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 75.3 mtt180 -63.81 -42.59 97.65 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.6 82.27 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.89 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.4 mt -63.8 -43.13 97.19 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.657 0.265 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -61.25 -43.73 98.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.368 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.21 -39.71 78.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.923 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -62.55 -43.73 98.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -75.58 -20.93 58.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.341 0.591 . . . . 0.0 110.893 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -74.54 -35.47 63.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.405 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.59 156.95 21.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.376 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.33 149.85 47.71 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.515 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 22.8 t -57.86 -49.05 78.01 Favored 'General case' 0 C--O 1.205 -1.251 0 C-N-CA 122.555 0.342 . . . . 0.0 111.812 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 25' ' ' GLN . 15.6 m -68.53 -38.19 80.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.38 -47.13 94.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.274 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.37 -35.29 79.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.333 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 20' ' ' SER . 44.5 mt-10 -63.51 -39.51 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.452 ' OE1' HG23 ' A' ' 21' ' ' THR . 2.0 mp0 -63.75 -41.29 98.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.401 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 93.0 mt -62.44 -41.98 99.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.06 -42.28 89.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 99.5 mttt -59.54 -36.98 77.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.678 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.6 mptp? -69.0 -37.89 78.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.32 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.6 mt -62.51 -47.53 83.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.573 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.44 -41.08 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.319 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 13.1 pt-20 -69.65 -44.0 71.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.708 0.29 . . . . 0.0 111.709 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.7 -29.67 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.5 mt -53.05 -25.3 12.07 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.7 pt-20 -68.77 -26.81 65.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.122 0.419 . . . . 0.0 110.924 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -162.55 80.21 1.78 Allowed Pre-proline 0 C--O 1.212 -0.884 0 C-N-CA 123.138 0.575 . . . . 0.0 109.504 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -82.62 5.75 6.2 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.139 1.893 . . . . 0.0 112.662 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 36.15 0.87 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.328 0.585 . . . . 0.0 111.614 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.8 mt -81.89 105.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.33 -32.12 62.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.833 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.99 72.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.382 0.61 . . . . 0.0 110.929 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -94.17 -2.5 52.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.016 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -78.22 138.35 38.6 Favored 'General case' 0 N--CA 1.4 -2.948 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.09 155.55 21.45 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.666 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -87.12 122.66 31.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.4 83.68 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.58 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.6 mmm -111.15 131.44 22.2 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.18 95.13 0.17 Allowed 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 122.804 2.336 . . . . 0.0 112.362 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 48.16 45.99 19.7 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.696 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.1 m -102.58 141.29 35.64 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 58.4 m-85 -133.66 150.98 51.56 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 55.2 pttt -118.98 144.86 46.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.134 0.492 . . . . 0.0 110.569 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 82.0 mt -109.39 132.9 56.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.93 137.75 40.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 124.06 0.85 . . . . 0.0 109.255 173.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' O ' HD22 ' A' ' 55' ' ' LEU . 4.2 tt -88.9 -11.75 43.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 74.27 -62.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.502 1.521 . . . . 0.0 111.29 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -75.59 -59.77 2.6 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -68.61 -25.9 65.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.55 49.16 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.197 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -98.75 149.19 23.1 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 120.837 0.351 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 mpt_? -131.51 144.22 50.96 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.812 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -127.01 127.72 45.23 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.33 123.17 69.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-O 121.073 0.463 . . . . 0.0 110.009 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.1 p90 -133.57 159.51 40.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -111.89 140.82 46.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.47 111.46 25.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.1 mt -97.8 95.45 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.07 -29.23 63.92 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.416 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.58 -40.55 87.75 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.37 -7.15 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.334 -175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.87 36.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.775 1.274 . . . . 0.0 109.237 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.22 138.72 49.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.71 115.34 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -111.34 112.82 24.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.03 124.96 33.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.1 mt -98.03 -41.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.461 0.648 . . . . 0.0 110.095 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.1 m -148.11 151.55 35.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.219 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.43 147.57 16.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.92 -124.23 1.93 Allowed Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -123.09 167.67 13.36 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.58 31.78 5.63 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.495 0.664 . . . . 0.0 109.306 -175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.73 -40.61 95.62 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.695 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.22 15.63 15.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.6 m 66.1 22.6 11.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.508 1.123 . . . . 0.0 110.76 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -58.86 -41.45 87.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.92 0.888 . . . . 0.0 112.672 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.01 -24.3 32.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.403 ' O ' HG13 ' A' ' 91' ' ' VAL . 57.2 m-85 -82.87 -41.57 18.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -58.79 -43.67 90.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.834 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.21 -49.86 70.32 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.861 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -51.19 68.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.275 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 87' ' ' TYR . 11.3 p -66.65 -32.32 57.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -77.41 -15.37 59.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -79.9 -34.92 38.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.31 -34.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.081 -176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.464 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.504 -0.798 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.3 165.5 13.76 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -134.43 167.23 21.14 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.45 157.77 24.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -125.69 122.56 36.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -140.41 169.34 17.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -129.89 147.9 51.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.69 154.46 38.83 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -32.53 72.51 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.452 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 57.5 mtp180 -72.8 -34.21 66.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.716 0.293 . . . . 0.0 111.034 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.04 79.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 mt -66.99 -43.54 82.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.924 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 89.2 mttt -59.49 -44.59 93.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.269 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 16.7 mm-40 -69.5 -37.67 77.29 Favored 'General case' 0 C--O 1.202 -1.406 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.5 -42.5 96.47 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 110.132 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.86 -24.11 58.52 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.096 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -78.3 -29.64 47.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.375 1.07 . . . . 0.0 111.175 177.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mp -63.67 161.11 15.55 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.71 0.804 . . . . 0.0 111.322 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.77 145.37 33.83 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -46.6 64.95 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.149 0.98 . . . . 0.0 111.287 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 m -62.43 -46.54 88.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.173 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -47.29 85.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.713 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.5 ptt180 -67.01 -35.04 79.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.077 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 35.4 mt-10 -59.71 -39.12 83.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.072 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.07 -39.32 79.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.831 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.3 mt -63.04 -43.83 97.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.684 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.22 -34.04 77.18 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.1 mttm -58.79 -43.87 90.58 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -66.62 -34.69 78.44 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.8 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 82.1 mt -61.82 -47.96 82.75 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.576 0.547 . . . . 0.0 110.491 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.22 -40.92 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 10.9 pt-20 -68.76 -42.91 76.84 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.99 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 65.4 mt -54.78 -26.35 33.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 pt-20 -79.16 -18.76 52.53 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.492 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.9 m -157.47 67.47 3.92 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 123.027 0.531 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.82 -0.34 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.847 0 C-N-CA 122.112 1.875 . . . . 0.0 114.218 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 25.75 0.23 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -82.31 100.33 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.642 0.734 . . . . 0.0 110.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.93 -20.42 57.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.626 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.76 64.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.431 0.634 . . . . 0.0 110.813 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -104.27 -1.22 27.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.364 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -84.22 138.88 32.72 Favored 'General case' 0 N--CA 1.404 -2.73 0 CA-C-O 121.357 0.598 . . . . 0.0 112.009 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -91.49 124.55 35.75 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.869 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.93 120.41 28.17 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.859 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.92 46.37 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.9 mmm -117.58 131.42 24.09 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.03 94.4 0.16 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.773 2.316 . . . . 0.0 112.937 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 45.57 50.05 10.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 125.117 1.367 . . . . 0.0 113.532 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.2 m -100.28 142.01 32.34 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.428 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.599 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 59.3 m-85 -133.28 154.99 50.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -126.15 147.44 49.62 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.893 0.854 . . . . 0.0 112.653 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 78.5 mt -109.19 141.57 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 138.41 41.6 Favored 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 123.213 0.32 . . . . 0.0 110.3 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.0 mt -79.73 161.94 25.47 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.967 0.413 . . . . 0.0 111.139 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 -99.46 -40.91 7.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -88.78 0.22 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -152.57 163.7 39.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.21 29.82 10.62 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.022 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -83.02 136.56 34.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.088 0.471 . . . . 0.0 110.99 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.3 mpt_? -128.31 149.63 50.42 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.112 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -129.9 125.15 34.88 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.07 127.65 72.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 16.8 p90 -136.01 158.62 43.97 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.271 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' HD11 ' A' ' 76' ' ' ILE . 4.1 pt20 -112.81 139.6 48.3 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.4 t -93.22 111.7 25.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.69 95.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.13 -30.95 65.55 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.074 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.65 -32.51 71.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.114 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -100.02 -3.26 32.47 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.334 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.24 25.1 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 CA-C-O 122.451 1.119 . . . . 0.0 110.403 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.55 138.83 52.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.985 -1.072 . . . . 0.0 111.281 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.2 t -97.96 117.37 42.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -107.57 114.56 28.63 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.351 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.96 121.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.423 HD11 ' HB3' ' A' ' 65' ' ' GLN . 57.8 mt -95.84 -42.86 12.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.406 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 m -150.41 150.34 31.24 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.116 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.2 136.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -130.6 2.36 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 85' ' ' GLU . 32.6 mtmm -113.55 165.9 12.04 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 117.505 0.652 . . . . 0.0 111.01 -176.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.17 70.55 1.41 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -40.18 64.23 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.753 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.77 -67.13 0.32 Allowed 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.5 m -151.53 26.32 0.67 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 29.2 tt0 -56.27 -51.91 66.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -82.37 -9.94 11.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -85.22 -47.33 10.2 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.056 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 p -66.57 -36.44 82.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.438 0.637 . . . . 0.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.57 -44.64 86.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.461 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 94' ' ' ILE . . . -63.02 -56.24 18.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.589 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.4 p -60.95 -35.82 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -76.56 -15.25 59.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.914 -0.491 . . . . 0.0 112.105 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -89.03 -28.29 20.27 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.059 -0.401 . . . . 0.0 110.248 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 90' ' ' ALA . 57.0 mt -82.67 -52.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.834 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--O 1.252 1.192 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.746 -179.395 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.31 135.54 33.41 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.146 0.498 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.11 169.87 9.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.687 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -92.88 162.1 14.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.53 125.12 41.49 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -130.27 151.61 50.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.21 135.48 54.66 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.625 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 18.0 t70 -71.45 154.09 41.77 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.83 -32.48 69.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.304 0.502 . . . . 0.0 112.164 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.625 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 7.7 ptm180 -62.64 -39.22 93.18 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.194 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 -38.61 84.23 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.079 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.25 -43.5 97.83 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 122.579 0.351 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -63.01 -43.99 97.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.989 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.4 mm-40 -69.38 -37.17 77.44 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.05 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -60.62 -42.72 97.43 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 124.419 1.088 . . . . 0.0 110.224 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -74.63 -23.68 58.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.693 0.759 . . . . 0.0 110.194 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 85.4 tttt -74.44 -21.57 59.54 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.9 1.28 . . . . 0.0 109.864 177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -76.75 165.26 24.96 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.386 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.13 154.16 40.58 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 p -55.21 -46.72 75.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.567 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 12.0 m -69.52 -42.45 74.65 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.39 -47.89 91.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.355 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HG3' ' N ' ' A' ' 24' ' ' GLU . 9.8 ptt180 -63.29 -41.44 98.97 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 23' ' ' ARG 0.324 42.6 mt-10 -67.84 -33.63 75.15 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 21' ' ' THR . 30.4 mm-40 -60.05 -44.43 94.69 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -66.93 -41.51 86.9 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.323 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -56.99 -43.59 81.87 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -58.95 -41.82 88.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.565 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.18 -38.31 87.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.545 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.636 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.5 mt -64.7 -47.31 78.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.534 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.42 -40.87 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.377 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.5 pt-20 -69.73 -42.88 73.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.78 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 30' ' ' LEU . 3.1 p -63.43 -30.99 51.2 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 C-N-CA 122.392 0.277 . . . . 0.0 111.201 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 73.4 mt -54.5 -26.36 31.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.9 pt-20 -67.58 -26.52 66.32 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.658 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p -162.9 77.66 1.85 Allowed Pre-proline 0 N--CA 1.436 -1.132 0 C-N-CA 122.685 0.394 . . . . 0.0 111.483 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.11 12.12 1.59 Allowed 'Trans proline' 0 C--O 1.209 -0.937 0 C-N-CA 122.891 2.394 . . . . 0.0 113.554 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.52 28.16 0.78 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 111.836 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.7 94.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.771 0.796 . . . . 0.0 110.119 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.25 -23.29 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.041 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.97 66.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.129 0.49 . . . . 0.0 110.772 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.17 -8.09 18.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -75.71 136.53 40.35 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.482 0.658 . . . . 0.0 112.658 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.42 HD23 ' HD3' ' A' ' 52' ' ' LYS . 92.1 mt -81.44 139.45 35.23 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.793 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -92.03 121.31 33.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.35 58.4 Favored Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.991 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 81.3 mmm -126.26 131.32 23.91 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.43 90.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.228 2.618 . . . . 0.0 113.419 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 49.55 44.61 24.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.911 1.684 . . . . 0.0 112.629 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -100.18 142.74 31.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.564 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 22.4 m-85 -129.74 152.85 48.79 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HD3' HD23 ' A' ' 44' ' ' LEU . 55.6 pttt -125.93 139.82 53.14 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.574 0.546 . . . . 0.0 109.569 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.18 144.71 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.26 140.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.573 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.0 tt -83.08 137.22 34.18 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -74.34 -57.35 4.0 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -61.37 -63.84 1.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.592 0.557 . . . . 0.0 110.709 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 5.5 p -103.86 122.94 46.18 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.5 73.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.67 0 O-C-N 123.837 0.71 . . . . 0.0 114.537 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.67 144.53 36.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -125.52 150.68 47.2 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.75 133.15 39.59 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.01 127.66 75.97 Favored 'Isoleucine or valine' 0 C--O 1.255 1.362 0 C-N-CA 123.169 0.588 . . . . 0.0 109.431 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 12.9 p90 -138.32 158.63 43.91 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.7 pt20 -109.55 141.0 42.67 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.7 112.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.47 94.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.38 -25.22 62.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.617 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.09 -41.25 92.09 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.134 0.897 . . . . 0.0 110.142 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -105.72 -3.43 22.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.155 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t 65.19 34.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 122.66 1.219 . . . . 0.0 109.437 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.91 138.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.37 122.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -110.23 110.58 21.47 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.353 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.15 127.74 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.6 mt -110.73 -42.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.954 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -133.75 140.38 46.94 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.72 135.89 12.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.38 -146.5 18.12 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -95.25 140.17 30.53 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.532 0.666 . . . . 0.0 109.358 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.71 101.3 9.94 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -113.3 -34.19 5.71 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.368 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.08 8.84 32.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.5 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 66.49 25.39 10.16 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.967 1.365 . . . . 0.0 109.847 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -69.04 -37.4 78.57 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.791 -176.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m -58.37 -26.56 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -77.42 -50.45 12.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -62.34 -42.91 99.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.294 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 51.1 mt-10 -66.09 -30.49 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 110.381 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 -53.34 13.48 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.909 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.13 -36.59 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.879 0.371 . . . . 0.0 111.407 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -76.59 -10.85 59.68 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -86.26 -32.64 21.01 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.42 -49.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.817 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.488 -179.109 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 CA--C 1.505 -0.784 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.97 151.08 20.67 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.05 159.64 15.34 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -81.13 160.58 24.38 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -125.68 127.95 47.04 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -138.92 155.16 48.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.6 143.15 45.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.73 156.36 32.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.6 pt-20 -53.51 -37.14 62.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.913 0.485 . . . . 0.0 110.975 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -70.43 -44.79 67.15 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.79 70.25 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.613 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.08 -36.92 75.29 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.787 0.327 . . . . 0.0 111.681 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 57.3 mttm -67.98 -43.86 77.98 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -67.56 -39.32 84.94 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -60.9 -38.5 85.93 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.842 0.857 . . . . 0.0 109.999 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -73.15 -37.81 66.46 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.655 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -74.88 -16.34 60.68 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.721 0.772 . . . . 0.0 111.131 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 149.63 38.27 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.486 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.14 139.35 42.26 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 16.4 m -50.97 -46.48 61.24 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.918 0.887 . . . . 0.0 111.227 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.536 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 43.2 m -62.88 -43.22 99.37 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.06 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.21 -47.09 79.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.731 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.9 ptt180 -66.41 -33.92 76.79 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.016 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 26.5 mm-40 -60.24 -41.08 92.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 118.111 0.414 . . . . 0.0 111.136 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 21' ' ' THR . 73.9 mm-40 -65.76 -46.56 78.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.6 mt -61.47 -40.67 95.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.065 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.7 ttpt -57.25 -44.63 84.06 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.174 0.59 . . . . 0.0 110.245 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.3 mttt -57.7 -43.39 85.15 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.4 mptp? -62.34 -40.54 96.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.703 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -62.94 -45.73 91.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 123.516 0.51 . . . . 0.0 109.767 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 27' ' ' LYS . 62.5 t -64.49 -45.1 96.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.451 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.4 pt-20 -68.86 -44.06 74.11 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.621 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 37' ' ' PRO . 3.4 p -62.22 -29.78 47.37 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 123.327 0.651 . . . . 0.0 112.099 -173.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 87.9 mt -53.03 -25.36 12.14 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.37 -22.09 59.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.723 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -164.52 78.78 1.42 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 121.308 0.575 . . . . 0.0 111.683 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HA ' HG21 ' A' ' 33' ' ' VAL . 93.5 Cg_endo -85.89 -9.73 7.46 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.384 2.056 . . . . 0.0 112.764 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.62 34.16 0.48 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.623 0.725 . . . . 0.0 112.956 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -83.25 110.57 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.819 0.818 . . . . 0.0 109.16 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -55.02 -29.34 57.18 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 126.246 1.818 . . . . 0.0 113.303 -175.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.23 -13.81 62.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -111.44 8.25 21.11 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.986 -0.446 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 17.2 ptmt -89.58 147.47 23.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.072 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 96.3 mt -69.91 155.69 40.19 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.46 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.64 -55.29 36.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.68 23.22 7.12 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.011 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.413 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -102.12 132.37 21.6 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 122.548 -0.384 . . . . 0.0 110.632 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.87 95.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.273 2.649 . . . . 0.0 112.642 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 50.83 47.06 25.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 113.015 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.0 m -106.64 141.09 38.48 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.557 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 38.5 m-85 -128.7 153.33 47.44 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 139.69 43.91 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.168 0.509 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.36 131.26 61.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.86 140.86 36.59 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.76 112.77 24.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -78.71 81.81 4.98 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.184 0.516 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 m -165.57 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.116 1.366 . . . . 0.0 109.137 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -161.17 179.17 8.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.04 51.78 4.15 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 121.108 -0.568 . . . . 0.0 114.397 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -108.14 142.64 38.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 151.05 38.27 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 123.689 0.796 . . . . 0.0 109.17 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.62 128.13 50.27 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.08 124.79 70.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.061 0 O-C-N 123.619 0.574 . . . . 0.0 110.248 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.3 p90 -136.67 158.83 43.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -108.86 137.99 45.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.92 114.77 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.01 95.6 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.58 -36.61 84.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.722 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -60.93 -30.14 70.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -108.28 -5.32 16.86 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.627 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t 60.79 39.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.707 1.241 . . . . 0.0 109.624 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -132.31 139.01 51.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 121.335 -0.853 . . . . 0.0 111.173 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.63 115.39 42.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -110.63 111.62 22.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.45 122.49 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -100.17 -42.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.204 0.526 . . . . 0.0 110.409 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m -147.98 149.85 32.92 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 122.152 -0.342 . . . . 0.0 110.43 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.14 139.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.97 -144.03 12.98 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.7 155.31 16.83 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.016 0.408 . . . . 0.0 110.022 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.97 101.79 4.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -68.2 -45.87 72.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.049 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -149.44 -61.62 0.22 Allowed 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.828 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -129.05 10.53 5.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -58.12 -52.48 65.36 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.328 0.585 . . . . 0.0 111.688 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.16 -25.61 16.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.518 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.94 -41.48 67.75 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -59.27 -51.15 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.981 0.8 . . . . 0.0 110.833 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.41 -35.67 73.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.51 -49.35 69.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.539 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.57 -36.86 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.039 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.29 -11.01 59.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.134 0.492 . . . . 0.0 111.993 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -82.67 -34.65 27.36 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.4 mt -79.2 -48.71 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.739 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.411 -0.805 . . . . 0.0 110.799 -179.565 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.2 ttt . . . . . 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.92 143.41 46.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.04 168.85 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.11 160.13 14.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.86 132.36 52.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -141.79 156.86 45.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.67 147.59 41.81 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.035 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.04 154.77 40.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -32.42 72.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.626 0.25 . . . . 0.0 110.863 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -66.99 -46.53 74.3 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.552 0.691 . . . . 0.0 109.598 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.15 75.42 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.219 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.57 -40.83 96.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.024 0.44 . . . . 0.0 111.326 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.48 -43.4 85.53 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.58 -37.29 76.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.274 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.49 1.116 . . . . 0.0 110.824 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -74.69 -23.14 58.58 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.915 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.82 -40.32 61.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.128 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mp -58.95 147.11 35.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 124.541 1.136 . . . . 0.0 112.725 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -70.49 146.49 42.32 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.666 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 m -52.75 -45.88 67.24 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.058 0.943 . . . . 0.0 112.213 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 m -68.4 -36.7 79.5 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.893 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.14 -47.18 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.277 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.8 ptt180 -67.38 -33.83 76.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.186 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.07 -48.68 75.61 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.615 0.189 . . . . 0.0 110.702 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -57.85 -41.97 83.47 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.014 0.821 . . . . 0.0 110.546 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 96.6 mt -66.65 -45.15 79.9 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.186 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.8 -44.2 94.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.515 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 94.9 mttt -62.97 -35.14 79.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.198 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.74 -35.03 72.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.81 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 mt -68.61 -46.12 70.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.04 -39.91 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.245 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.1 pt-20 -69.19 -42.8 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 37' ' ' PRO . 2.2 p -63.87 -29.71 48.02 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.207 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 94.4 mt -53.73 -25.04 16.78 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -80.39 -19.71 45.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.078 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -155.2 70.99 5.66 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.839 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HA ' HG23 ' A' ' 33' ' ' VAL . 79.0 Cg_endo -77.3 -14.3 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.528 1.485 . . . . 0.0 111.606 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -83.11 61.08 5.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.71 0.767 . . . . 0.0 112.833 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -101.95 110.59 29.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.025 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.48 -22.04 66.84 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.51 -19.89 60.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 111.536 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -107.04 -7.6 16.86 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.013 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -70.35 133.64 47.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 123.568 0.747 . . . . 0.0 110.269 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.3 121.61 28.28 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -64.04 123.38 18.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.254 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.26 -29.4 8.91 Favored Glycine 0 C--N 1.324 -0.129 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.698 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.9 mmm -75.8 139.53 70.18 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 122.817 0.447 . . . . 0.0 110.053 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.92 90.88 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.869 2.379 . . . . 0.0 112.603 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 46.54 46.09 14.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 125.159 1.384 . . . . 0.0 113.014 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.5 m -99.88 142.34 31.5 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.564 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.3 m-85 -133.92 151.55 51.54 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -120.47 140.41 51.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 123.447 0.467 . . . . 0.0 110.62 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.01 134.94 61.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 157.86 17.68 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.479 0.487 . . . . 0.0 111.9 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 58' ' ' SER . 9.0 tp -94.11 166.06 12.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.501 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.421 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 37.9 mmt180 -90.22 -55.15 3.72 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.259 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 m -58.03 -59.86 4.63 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.481 ' H ' HD23 ' A' ' 55' ' ' LEU . 66.7 m -133.59 -177.42 4.54 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 122.069 -0.394 . . . . 0.0 110.692 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.75 62.83 4.46 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -103.32 139.66 38.45 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.47 HH11 ' HB1' ' A' ' 81' ' ' ALA . 2.9 mpt_? -136.26 142.93 44.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.15 0.5 . . . . 0.0 109.775 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -119.98 129.02 54.09 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.27 126.49 73.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.9 p90 -135.44 159.23 42.24 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.617 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -109.09 140.66 42.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.45 111.89 31.48 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mt -97.11 94.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.31 -29.84 68.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.168 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.2 -38.9 74.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.779 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -108.65 2.61 22.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.195 0.522 . . . . 0.0 111.374 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 t 61.54 34.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.824 1.249 . . . . 0.0 109.957 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.93 138.83 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.292 -0.88 . . . . 0.0 111.513 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -98.27 115.75 39.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -110.86 114.75 28.33 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.623 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.09 123.94 29.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.5 -42.49 11.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.096 0.474 . . . . 0.0 110.485 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 m -146.83 145.78 29.99 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.096 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.1 141.38 17.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.73 -152.93 24.6 Favored Glycine 0 CA--C 1.497 -1.05 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -91.44 149.04 21.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB1' HH11 ' A' ' 61' ' ' ARG . . . -85.79 71.48 10.66 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.292 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.76 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 60.2 18.09 7.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 112.385 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.7 m 60.89 32.67 20.04 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.164 0.986 . . . . 0.0 111.811 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.391 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 m -66.65 -17.25 22.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.338 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.08 -42.09 10.14 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.233 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 m -68.09 -45.22 74.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.152 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -29.66 63.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.591 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.07 -52.31 65.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.733 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.41 -40.75 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.966 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -68.68 -17.59 64.11 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -79.52 -28.04 41.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.28 -62.99 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.443 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 N--CA 1.429 -1.506 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.765 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 CA--C 1.5 -0.961 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 158.78 37.82 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -116.47 172.31 7.29 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -87.23 156.92 19.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.25 127.92 50.51 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.87 155.17 50.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.61 133.58 54.99 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 33.9 t70 -71.99 151.94 42.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pp20? -58.55 -34.34 70.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.0 mtt180 -69.69 -44.91 69.46 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.17 73.38 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 17.0 tp -72.3 -34.84 68.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.9 mttm -66.41 -42.09 88.3 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 36.0 mm-40 -63.65 -39.15 93.63 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -60.87 -39.56 89.65 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.09 1.356 . . . . 0.0 110.754 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 88.3 mtt180 -74.55 -32.75 62.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -72.81 -28.12 62.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 110.842 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -63.77 152.76 38.49 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.33 0.652 . . . . 0.0 112.103 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -68.78 143.37 39.97 Favored Glycine 0 N--CA 1.424 -2.119 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.602 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 8.1 m -48.99 -54.55 15.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.584 1.154 . . . . 0.0 112.411 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.8 m -64.66 -34.77 79.07 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.879 0.472 . . . . 0.0 110.713 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.83 -48.18 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 6.1 ptt180 -68.57 -35.54 77.54 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 20' ' ' SER . 54.1 mt-10 -58.03 -50.06 74.72 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.992 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -63.28 -35.3 79.91 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.213 0.32 . . . . 0.0 111.691 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.4 mt -66.77 -44.94 80.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.987 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.82 -41.98 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.5 mttt -59.47 -35.44 74.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.146 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.5 mptp? -70.96 -35.81 72.3 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.144 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.6 mt -66.32 -46.27 77.44 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.754 0.312 . . . . 0.0 110.897 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.83 -38.54 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.43 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 pt-20 -69.99 -43.43 71.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.85 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.406 HG23 ' HA ' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -63.08 -30.12 48.9 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.478 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 77.2 mt -54.18 -25.38 22.36 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -84.0 -8.54 59.11 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.022 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.48 ' O ' HG13 ' A' ' 39' ' ' ILE . 26.8 p -159.29 62.19 1.99 Allowed Pre-proline 0 C--O 1.206 -1.185 0 C-N-CA 124.038 0.935 . . . . 0.0 110.576 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' HG23 ' A' ' 33' ' ' VAL . 73.0 Cg_endo -75.01 -20.6 16.69 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.777 1.651 . . . . 0.0 113.752 -172.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -89.69 54.76 2.97 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.148 0.975 . . . . 0.0 113.247 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 36' ' ' SER . 98.1 mt -83.19 110.86 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.732 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.15 -27.18 68.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.74 68.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.088 0.471 . . . . 0.0 111.067 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.02 -1.44 57.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.987 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 8.3 mtpm? -62.74 146.55 52.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.62 173.02 12.75 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.459 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -85.75 -55.02 4.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.33 52.51 0.82 Allowed Glycine 0 CA--C 1.5 -0.887 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.299 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.9 mmm -135.78 132.34 19.47 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.53 102.25 0.34 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.906 2.404 . . . . 0.0 113.309 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.8 35.3 24.22 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 124.347 1.059 . . . . 0.0 111.952 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.5 m -101.65 141.23 34.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.245 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.604 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 18.4 m-85 -131.75 153.66 49.84 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 47.9 pttt -126.5 140.35 52.53 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.41 0.624 . . . . 0.0 111.246 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.48 129.26 65.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 133.51 53.2 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.44 96.32 10.33 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -44.82 -41.77 7.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 126.598 1.959 . . . . 0.0 113.963 -172.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -82.38 -44.36 16.23 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 m -77.31 -36.0 54.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.7 14.63 49.25 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.354 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.99 158.26 15.54 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.402 ' N ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -144.75 147.59 33.14 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.461 0.648 . . . . 0.0 111.843 177.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -119.59 126.98 52.5 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.63 123.34 66.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 121.032 0.444 . . . . 0.0 110.297 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.604 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -133.82 157.63 45.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.677 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -107.71 131.67 54.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.53 111.05 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.8 mt -99.04 96.01 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.32 -32.77 73.96 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.34 -35.52 74.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.082 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.46 -2.41 25.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.811 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.53 33.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.525 1.13 . . . . 0.0 109.754 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.15 138.99 50.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 O-C-N 121.161 -0.962 . . . . 0.0 111.304 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -99.14 114.81 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 81.8 t80 -107.94 111.21 23.19 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.469 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -73.15 121.43 23.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.431 ' CG2' ' HA ' ' A' ' 90' ' ' ALA . 29.8 mt -98.09 -42.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.613 0.571 . . . . 0.0 110.373 -174.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 t -153.38 151.85 30.4 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.11 138.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.15 -139.86 8.43 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.394 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -101.83 158.7 15.93 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.999 0.428 . . . . 0.0 109.921 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.04 95.78 4.52 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.85 -41.91 2.33 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.278 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB1' ' OE2' ' A' ' 85' ' ' GLU . . . -123.86 29.48 6.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m 72.89 35.92 0.95 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.858 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.448 ' OE2' ' HB1' ' A' ' 83' ' ' ALA . 18.3 mp0 -57.58 -51.93 67.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.28 -27.51 26.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.514 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.77 -48.59 16.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.272 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.7 m -60.95 -42.93 99.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.557 0.536 . . . . 0.0 110.828 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -68.35 -35.83 78.33 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.91 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -65.84 -54.84 21.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.0 -35.68 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.905 0.383 . . . . 0.0 111.75 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -77.12 -19.28 57.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HE ' ' CG ' ' A' ' 8' ' ' ASP . 21.8 tpt180 -93.97 -6.71 44.81 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.528 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 90' ' ' ALA . 48.5 mm -74.42 102.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 170.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -174.006 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -92.66 128.12 38.41 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.595 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.35 167.09 9.97 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.738 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.51 153.39 24.43 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -125.56 124.39 41.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.65 156.05 49.46 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.413 0.625 . . . . 0.0 110.385 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.88 134.95 47.14 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.27 142.34 57.78 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 10.1 pt-20 -56.27 -31.32 63.5 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -72.34 -40.11 67.63 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.274 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.27 -31.19 70.48 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.869 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -68.16 -34.91 77.2 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.3 mttm -63.61 -42.8 98.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.893 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 42.0 mm-40 -68.69 -37.47 79.59 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.088 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -60.68 -45.01 95.77 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.83 0.852 . . . . 0.0 110.643 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -74.78 -21.18 59.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.587 0.708 . . . . 0.0 110.175 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 80.2 tttt -74.86 -25.43 58.96 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.79 1.236 . . . . 0.0 110.154 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 14' ' ' GLU . 5.5 mp -68.06 168.07 12.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.253 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.03 -138.68 1.56 Allowed Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.056 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -106.5 -60.47 1.65 Allowed 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.585 -0.95 . . . . 0.0 108.86 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -52.23 -43.36 64.24 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.93 1.292 . . . . 0.0 113.096 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.13 -48.35 79.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.135 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -69.08 -33.91 74.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -56.07 -45.96 79.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -70.61 -38.98 74.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.953 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 92.5 mt -63.46 -44.04 95.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.36 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -58.87 -43.2 90.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.186 0.517 . . . . 0.0 110.346 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.8 mttt -62.89 -37.7 87.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -64.32 -37.57 87.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.582 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.1 mt -68.36 -45.28 73.26 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 28' ' ' LYS . 7.8 p -68.75 -36.21 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.799 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -68.75 -44.94 72.7 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 37' ' ' PRO . 3.7 p -62.93 -30.66 50.1 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.124 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.627 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 71.0 mt -53.91 -25.62 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 8.1 pt-20 -64.48 -28.85 69.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.084 0.856 . . . . 0.0 111.19 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -160.1 77.5 2.72 Favored Pre-proline 0 C--O 1.206 -1.207 0 C-N-CA 124.059 0.944 . . . . 0.0 108.493 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HA ' HG23 ' A' ' 33' ' ' VAL . 89.8 Cg_endo -85.25 -1.27 9.21 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.679 2.253 . . . . 0.0 113.537 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 40.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.549 0.69 . . . . 0.0 110.885 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.15 100.88 5.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.359 1.076 . . . . 0.0 110.352 -173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -55.42 -27.48 48.15 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.706 2.003 . . . . 0.0 112.509 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.23 61.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.064 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.73 1.47 17.88 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -80.25 135.63 36.28 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 121.07 0.462 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.8 mt -82.68 122.87 28.7 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.595 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -89.27 120.03 30.26 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.09 6.77 42.07 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.2 mmm -127.0 138.68 33.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -67.2 95.13 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.601 2.201 . . . . 0.0 112.971 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 52.5 39.02 27.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.041 1.337 . . . . 0.0 113.573 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.5 m -99.99 142.49 31.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.9 m-85 -132.4 156.24 47.04 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -133.37 141.97 48.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.27 0.557 . . . . 0.0 112.402 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.78 122.85 68.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.87 128.61 49.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.423 174.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.12 102.95 5.93 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -56.44 -39.58 73.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -88.26 20.38 3.28 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -156.05 -45.53 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.668 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.99 22.5 7.21 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.672 -1.251 . . . . 0.0 112.341 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -95.69 154.09 17.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 122.222 -0.575 . . . . 0.0 109.818 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -122.95 135.62 54.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.74 124.95 34.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -117.07 128.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.6 p90 -133.48 158.16 43.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.747 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -105.46 138.19 42.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.63 111.2 34.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.1 mt -97.35 101.75 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.01 -36.57 80.18 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.561 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.64 -40.31 96.59 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.17 -6.05 42.62 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.6 t 58.49 37.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.429 1.109 . . . . 0.0 109.711 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.1 140.31 40.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 121.365 -0.834 . . . . 0.0 110.902 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.83 124.99 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 124.461 1.104 . . . . 0.0 108.771 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.08 116.92 29.91 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.7 t -68.99 121.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.0 mt -96.28 -43.11 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.993 0.425 . . . . 0.0 110.638 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 p -141.3 143.5 34.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 120.877 0.37 . . . . 0.0 110.567 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.1 141.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.22 -140.24 7.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -116.71 155.44 28.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.351 0.575 . . . . 0.0 110.002 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.88 128.87 41.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -94.26 -38.17 11.16 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.42 -63.27 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.204 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -161.55 22.99 0.12 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 121.019 0.437 . . . . 0.0 110.924 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -58.41 -45.51 88.28 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.603 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.31 -25.49 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -79.75 -44.92 19.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -62.84 -43.15 99.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.853 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.1 -28.18 68.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.54 63.15 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.31 -23.28 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.124 0.488 . . . . 0.0 110.919 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -61.34 -26.23 67.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.183 0.993 . . . . 0.0 111.592 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -89.28 -12.07 41.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.595 0.712 . . . . 0.0 109.767 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.2 mt -94.62 -59.21 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.209 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.308 -1.23 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.727 177.551 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.35 152.95 50.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -118.33 168.57 10.5 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -99.03 163.17 12.69 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 123.062 0.226 . . . . 0.0 111.172 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.11 130.96 53.17 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.52 149.6 46.89 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.91 134.85 46.14 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 20.2 t70 -72.05 153.43 41.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 9.7 pt-20 -56.96 -32.53 66.13 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -68.27 -42.25 79.85 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.12 75.25 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.737 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.0 mt -69.84 -39.29 76.51 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.443 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 55.1 mttp -62.36 -44.29 96.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.068 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 32.5 mt-10 -70.01 -37.51 75.69 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.066 0.46 . . . . 0.0 111.4 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -62.37 -42.0 99.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 123.737 0.815 . . . . 0.0 110.33 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -75.24 -23.26 57.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 48.5 tttp -67.84 -45.4 74.75 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 14' ' ' GLU . 6.5 mp -58.69 151.15 21.6 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.623 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -75.42 152.12 42.7 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.5 t -52.44 -53.24 47.95 Favored 'General case' 0 C--O 1.201 -1.454 0 C-N-CA 123.058 0.543 . . . . 0.0 111.291 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.0 m -57.82 -38.0 74.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 123.507 0.723 . . . . 0.0 111.577 -176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -72.18 -47.87 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 109.944 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 9.2 ptt180 -68.45 -34.57 76.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.4 mt-10 -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.817 0.447 . . . . 0.0 111.599 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -66.01 -35.31 80.21 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.673 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.5 mt -67.24 -43.43 81.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.667 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -59.33 -44.37 92.63 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 110.5 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 90.5 mttt -62.49 -35.1 78.29 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.555 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.6 mptp? -65.71 -39.56 91.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.869 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.69 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.3 mt -61.63 -44.61 96.67 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 27' ' ' LYS . 87.9 t -61.67 -45.31 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.84 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -69.65 -42.49 74.18 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.746 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 30' ' ' LEU . 2.9 p -62.59 -29.67 47.44 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.7 mt -53.16 -25.77 14.73 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.5 pt-20 -66.24 -28.92 69.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.491 0.662 . . . . 0.0 110.966 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.4 m -158.42 76.66 3.47 Favored Pre-proline 0 C--N 1.315 -0.894 0 C-N-CA 124.227 1.011 . . . . 0.0 108.805 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HA ' HG21 ' A' ' 33' ' ' VAL . 61.1 Cg_endo -75.59 -24.43 11.93 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.472 1.448 . . . . 0.0 111.466 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 2.4 ppt_? -78.38 62.57 3.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.166 0.984 . . . . 0.0 112.907 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.84 124.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.25 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -35.94 67.37 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.16 0.984 . . . . 0.0 112.263 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.62 -15.98 61.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.549 0.69 . . . . 0.0 111.399 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.427 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.4 m-20 -104.68 -7.0 19.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 21.8 ttmt -85.9 138.59 31.92 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -172.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -86.45 129.09 34.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.948 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -74.87 116.52 15.68 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.847 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.49 49.66 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.862 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.1 mmm -101.93 137.18 19.45 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.07 95.16 0.14 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 123.205 2.604 . . . . 0.0 112.71 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 45.86 46.27 12.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 125.015 1.326 . . . . 0.0 113.012 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.38 141.61 33.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 43' ' ' LYS . 79.6 m-85 -131.66 145.84 51.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.424 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -115.86 141.15 48.48 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 123.618 0.573 . . . . 0.0 110.066 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.13 138.44 51.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.42 132.78 55.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.285 0.366 . . . . 0.0 110.389 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 tt -84.27 117.78 23.76 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -51.74 -57.28 9.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -76.12 -53.59 8.09 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.184 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -63.86 -34.84 78.84 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.67 26.68 49.63 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.327 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.54 150.33 20.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -123.5 141.53 51.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -126.3 131.89 51.77 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.18 122.72 67.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 CA-C-O 121.405 0.621 . . . . 0.0 110.494 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -131.78 157.97 42.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.055 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.16 139.77 48.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.5 t -88.63 112.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 mt -98.54 95.64 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.466 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.26 -35.76 76.25 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.28 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -104.8 -1.31 26.27 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.013 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t 59.14 33.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.378 0 CA-C-O 122.722 1.248 . . . . 0.0 110.267 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.04 141.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.528 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.6 m -98.17 128.07 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.112 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 87.1 t80 -103.09 110.04 21.83 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.401 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -75.52 120.79 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.4 mt -95.06 -42.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.341 0.591 . . . . 0.0 109.521 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.7 m -153.0 153.31 32.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.014 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.06 148.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.81 -111.86 0.72 Allowed Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.3 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -124.59 142.81 51.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.49 116.17 21.38 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -126.35 -35.04 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 123.517 0.51 . . . . 0.0 110.276 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.44 -69.29 0.75 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.495 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -159.96 24.18 0.17 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.821 0.819 . . . . 0.0 110.259 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 7.6 mp0 -61.46 -51.8 67.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.433 -175.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.2 m -74.06 -8.11 11.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.615 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -92.31 -52.08 4.85 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -61.46 -49.91 74.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.49 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.98 -29.55 67.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.457 ' O ' HG13 ' A' ' 94' ' ' ILE . . . -73.41 -51.04 18.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.298 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.41 -35.01 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.019 0.437 . . . . 0.0 110.768 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.14 -17.09 60.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.291 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -92.11 -18.97 22.8 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.241 0.543 . . . . 0.0 111.17 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 90' ' ' ALA . 83.4 mt -75.92 -46.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.45 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 tm? . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.666 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 CA--C 1.498 -1.039 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.85 135.9 17.55 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -87.47 164.91 15.9 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.652 0.595 . . . . 0.0 109.544 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.4 157.48 22.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -126.16 128.55 47.46 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -140.37 157.13 46.01 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.18 142.23 49.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 122.395 0.278 . . . . 0.0 110.433 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.69 155.02 40.19 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.49 -29.64 67.99 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 12.6 mmt85 -71.75 -43.02 66.52 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.32 81.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.04 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.6 mt -63.16 -43.26 98.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 110.774 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.212 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 37.3 mm-40 -68.36 -37.54 80.57 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 123.528 0.517 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.69 -45.11 94.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.064 0.945 . . . . 0.0 111.033 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.3 -22.71 57.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.858 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -77.09 -31.67 56.1 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.427 1.491 . . . . 0.0 110.732 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.71 152.2 27.35 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.932 0.893 . . . . 0.0 111.786 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -69.49 147.19 45.1 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 15.0 m -49.18 -54.6 15.73 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.289 1.035 . . . . 0.0 112.455 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -63.54 -34.55 78.04 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.277 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.83 -48.85 61.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 7.3 ptt180 -69.24 -35.58 76.29 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 43.2 mt-10 -57.15 -49.46 75.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 120.45 0.166 . . . . 0.0 110.6 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.486 ' CB ' HD13 ' A' ' 55' ' ' LEU . 2.9 mp0 -68.51 -34.98 76.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.1 mt -66.91 -42.77 84.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.56 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -59.05 -41.9 89.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.185 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.4 mttt -59.23 -41.29 88.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.1 mptp? -64.32 -34.79 78.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.158 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -68.92 -47.31 66.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.44 -38.63 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.886 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 10.5 pt-20 -68.31 -43.14 78.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.945 0.402 . . . . 0.0 110.563 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 37' ' ' PRO . 2.7 p -64.47 -30.56 50.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.838 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.8 mt -54.03 -25.46 21.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 14.6 pt-20 -75.17 -25.45 58.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.058 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.0 p -158.09 74.46 3.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.702 0.401 . . . . 0.0 110.125 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' HG21 ' A' ' 33' ' ' VAL . 94.3 Cg_endo -85.04 -1.34 9.37 Favored 'Trans proline' 0 C--O 1.206 -1.106 0 C-N-CA 122.057 1.838 . . . . 0.0 113.796 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 32.78 0.74 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.55 112.37 20.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -57.75 -29.04 64.46 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.82 -15.94 63.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.953 0.406 . . . . 0.0 111.725 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -102.41 -1.63 30.38 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.743 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 42.5 mtpt -74.03 144.67 45.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.084 0.469 . . . . 0.0 111.474 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 59.7 mt -74.41 133.46 42.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -73.26 107.61 5.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 32.41 9.23 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.736 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 77.2 mmm -133.98 142.72 44.45 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.64 93.47 0.6 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.765 2.31 . . . . 0.0 112.714 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 50.0 41.73 23.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 124.993 1.317 . . . . 0.0 113.986 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.412 ' SG ' ' HE1' ' A' ' 47' ' ' MET . 53.1 m -100.31 141.58 32.96 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.1 m-85 -130.01 146.24 51.68 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -115.14 140.4 49.11 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.28 0.562 . . . . 0.0 110.869 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.44 127.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -104.51 145.12 30.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.502 178.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.527 ' HB3' ' O ' ' A' ' 58' ' ' SER . 15.5 tp -85.59 143.32 28.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -89.83 -30.27 18.06 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.639 0.733 . . . . 0.0 109.219 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -65.47 -29.77 70.47 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.069 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 23.4 t -164.17 158.71 19.43 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.06 50.63 3.08 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -99.02 143.42 29.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -122.96 142.65 50.59 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -120.64 126.85 51.29 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.9 t -116.59 123.46 71.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.181 0.515 . . . . 0.0 109.947 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.5 p90 -135.58 158.96 43.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.188 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -112.08 139.53 47.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.5 t -97.74 111.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.622 0.725 . . . . 0.0 110.056 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 mt -100.08 95.06 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.37 -29.88 64.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.476 0.655 . . . . 0.0 109.76 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.73 -40.16 75.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.97 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -108.06 4.29 24.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.509 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p 51.86 40.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.704 1.602 . . . . 0.0 111.879 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.91 138.96 50.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.748 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.86 115.24 42.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -108.87 112.92 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.665 -173.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.52 121.48 27.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -95.42 -42.74 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.374 0.606 . . . . 0.0 109.624 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -149.43 149.97 31.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.315 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.21 131.97 6.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.02 -155.78 26.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -81.09 152.92 27.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.369 0.604 . . . . 0.0 110.839 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.17 33.15 3.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.994 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -46.52 -55.72 7.1 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.747 1.279 . . . . 0.0 110.335 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.27 53.97 1.13 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.695 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p 56.4 31.92 19.65 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.741 1.216 . . . . 0.0 113.261 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 9.1 tp10 -57.67 -52.13 66.67 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.999 0.519 . . . . 0.0 111.388 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.36 -11.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -81.56 -44.07 17.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.41 ' HA ' HG11 ' A' ' 91' ' ' VAL . 18.2 t -66.57 -34.68 78.44 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 39.7 mm-40 -60.88 -47.89 84.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.543 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -67.11 -55.97 11.96 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.178 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 88' ' ' SER . 13.7 p -60.29 -38.65 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.45 -12.75 59.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -93.45 -15.97 25.03 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 90' ' ' ALA . 39.7 mm -82.65 -49.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.019 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' O ' HD11 ' A' ' 95' ' ' LEU . 1.9 pp . . . . . 0 N--CA 1.438 -1.061 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.255 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 CA--C 1.505 -0.784 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.38 33.83 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.95 168.86 14.6 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.727 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -89.01 161.05 16.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.06 132.37 51.95 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.79 155.49 47.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -123.36 135.49 54.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 117.791 0.269 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.85 155.71 38.76 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 6.5 pt-20 -53.19 -40.82 64.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 117.809 0.277 . . . . 0.0 111.429 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 25.5 mmm180 -69.86 -38.06 76.3 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.99 93.32 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.925 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.45 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 44.7 mt -66.58 -42.85 86.34 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.164 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -61.32 -43.92 98.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -69.97 -39.57 75.89 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.765 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.11 -42.22 98.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.1 0.96 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 81.9 mtp180 -73.07 -26.63 61.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.041 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -71.84 -35.71 69.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.497 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -60.85 152.74 26.46 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.514 0.673 . . . . 0.0 112.528 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.0 155.77 49.67 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.778 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 3.0 p -55.73 -53.97 50.05 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 124.138 0.975 . . . . 0.0 112.801 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -57.62 -42.14 82.71 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 124.225 1.01 . . . . 0.0 110.899 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -68.58 -48.21 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.99 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.3 ptt-85 -68.72 -35.42 77.11 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 20' ' ' SER . 37.5 mt-10 -59.7 -45.41 92.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.399 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' HB3' HD12 ' A' ' 55' ' ' LEU . 2.6 mp0 -70.86 -34.74 71.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 85.1 mt -62.92 -44.06 97.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.397 174.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -56.38 -42.61 78.16 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.945 0.403 . . . . 0.0 110.498 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 98.9 mttt -60.24 -45.48 93.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.67 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.0 mptp? -59.95 -38.52 82.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.86 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.4 mt -65.96 -46.33 78.49 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.296 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.21 -37.73 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.737 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 8.2 pt-20 -68.6 -42.66 77.87 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.705 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.98 -29.37 47.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.49 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -52.85 -24.95 10.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.91 -30.37 70.95 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.683 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 t -161.72 75.81 2.32 Favored Pre-proline 0 C--O 1.2 -1.541 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 33' ' ' VAL . 85.3 Cg_endo -83.46 -9.68 10.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.0 1.8 . . . . 0.0 114.461 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 43.3 0.63 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.45 0.643 . . . . 0.0 111.881 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.14 101.32 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.793 0.806 . . . . 0.0 110.185 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.15 -25.2 65.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.629 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.75 -15.23 63.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.983 0.42 . . . . 0.0 110.81 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -113.87 11.12 17.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.383 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -80.49 144.69 32.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 120.98 0.419 . . . . 0.0 111.917 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.82 150.73 23.93 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.494 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -95.08 127.74 41.37 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.349 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.54 12.62 84.06 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.36 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.0 mmm -121.83 120.1 28.71 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.6 100.67 0.16 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.194 2.596 . . . . 0.0 113.598 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 65' ' ' GLN . 4.5 m-20 62.16 31.37 17.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 111.793 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.91 141.72 32.35 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.773 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.467 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 68.8 m-85 -136.5 156.54 48.45 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 140.46 47.11 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 112.536 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.26 141.28 34.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 1.1 mppt? -113.23 144.3 42.93 Favored 'General case' 0 N--CA 1.403 -2.813 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 25' ' ' GLN . 18.5 tp -98.51 118.47 35.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -70.78 -34.59 71.95 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.196 0.522 . . . . 0.0 110.346 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 m -61.9 -39.49 92.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -124.96 -12.37 7.02 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 21.36 57.3 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.493 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -93.52 156.64 16.62 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.096 -0.65 . . . . 0.0 110.938 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -121.8 143.73 49.23 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.69 0.796 . . . . 0.0 108.982 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.43 127.67 37.93 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.41 125.66 72.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 CA-C-O 121.035 0.445 . . . . 0.0 110.022 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.1 p90 -136.93 158.83 43.56 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.245 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 4.0 pt20 -111.44 133.72 53.54 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 173.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -98.0 110.88 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.7 mt -99.65 95.79 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.69 -25.03 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.055 0.455 . . . . 0.0 110.247 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.57 -36.28 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.636 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -107.68 -1.87 20.68 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.835 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t 58.5 32.52 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.234 1.414 . . . . 0.0 110.388 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 p -129.67 139.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.018 -1.051 . . . . 0.0 110.964 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -98.88 114.98 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -106.07 110.33 22.56 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.682 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.18 121.95 24.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.4 mt -94.89 -42.27 12.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.734 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.8 m -152.99 153.18 32.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.97 142.97 18.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.34 -131.72 3.18 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.176 -1.011 . . . . 0.0 111.797 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -124.03 167.06 14.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.468 -0.431 . . . . 0.0 110.641 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.57 55.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.481 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.39 126.53 28.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.15 18.51 10.99 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.262 1.025 . . . . 0.0 111.219 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 61.21 29.33 18.68 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.06 -50.86 71.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.55 0.74 . . . . 0.0 111.505 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -62.83 -25.9 39.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -80.92 -42.85 20.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.983 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -64.53 -41.49 96.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 12.2 tp10 -62.42 -46.8 86.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.076 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.37 56.58 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.819 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.73 -36.56 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.991 0.424 . . . . 0.0 111.164 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -71.36 -23.19 61.86 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 12.8 mmm180 -77.48 -15.26 59.4 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.671 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.3 mt -82.27 -31.18 9.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.917 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.309 -1.162 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.79 133.63 55.84 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -91.06 162.88 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.89 155.03 23.1 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.06 124.1 47.26 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -130.62 160.81 33.1 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.11 144.73 50.92 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 13.1 t70 -79.42 154.4 28.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 169.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -29.54 66.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 4.4 mmt85 -63.82 -45.0 91.56 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.07 93.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.386 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.99 -41.03 99.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 123.207 0.317 . . . . 0.0 111.749 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.67 -43.83 97.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.272 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 57.4 mm-40 -69.09 -39.5 78.97 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.272 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -61.3 -46.61 89.58 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.571 1.148 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -73.03 -28.58 62.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.529 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.4 -38.73 88.14 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.377 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.56 153.91 12.2 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.644 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.19 147.51 37.84 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.3 m -50.15 -48.04 53.96 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -67.27 -36.87 82.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.689 0.28 . . . . 0.0 110.966 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.16 -48.59 68.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 19.4 ptt180 -68.77 -35.43 77.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 24.0 mt-10 -57.93 -42.44 84.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.512 ' CB ' HD11 ' A' ' 55' ' ' LEU . 43.5 mt-30 -70.64 -35.11 72.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.128 0.489 . . . . 0.0 110.193 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.04 -41.87 85.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.956 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' O ' HG21 ' A' ' 31' ' ' VAL . 18.6 ptmt -63.18 -36.73 84.59 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.898 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -59.63 -39.02 82.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.9 mmtt -65.02 -36.21 83.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.689 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 71.7 mt -63.72 -43.62 96.0 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 27' ' ' LYS . 96.2 t -63.73 -45.46 97.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.717 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.2 pt-20 -69.09 -43.92 73.55 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.754 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.88 -29.76 47.9 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 81.5 mt -53.45 -25.32 15.71 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -75.09 -25.45 58.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.197 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -154.2 74.19 6.15 Favored Pre-proline 0 C--O 1.213 -0.829 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' HG23 ' A' ' 33' ' ' VAL . 84.4 Cg_endo -80.98 -7.31 13.23 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 121.515 1.476 . . . . 0.0 113.386 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 38.69 0.94 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.58 0.705 . . . . 0.0 112.074 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.52 108.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.4 -24.68 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.54 -8.19 44.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 87.0 m-20 -108.94 3.8 22.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 9.9 mtpm? -71.18 142.41 50.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.11 126.17 32.84 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 168.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -85.77 114.56 22.82 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 6.47 16.74 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -131.28 139.05 34.23 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.75 -71.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.323 2.682 . . . . 0.0 112.677 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -137.96 78.04 1.66 Allowed 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.9 m -126.88 141.38 51.83 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 40.4 m-85 -133.75 155.43 49.78 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -126.39 139.83 52.97 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.641 0.588 . . . . 0.0 110.033 177.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 mt -108.71 142.55 21.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -117.1 129.34 55.92 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.512 HD11 ' CB ' ' A' ' 25' ' ' GLN . 14.6 tp -81.71 143.52 31.8 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -73.66 -36.64 65.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.1 m -99.62 150.2 22.5 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 71.82 -43.88 0.58 Allowed 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.68 35.16 5.25 Favored Glycine 0 C--O 1.239 0.447 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.767 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.44 155.76 17.16 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 122.622 -0.34 . . . . 0.0 110.22 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.8 mpt_? -129.52 151.33 50.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -128.26 131.32 48.75 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.1 t -118.38 124.37 73.02 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-O 121.229 0.538 . . . . 0.0 110.943 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.4 p90 -137.48 158.88 43.44 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.977 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -112.23 141.28 46.12 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 m -101.37 123.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.561 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.83 94.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.168 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.2 -23.38 62.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.975 0.893 . . . . 0.0 109.51 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.99 -36.55 83.92 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.262 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HB2' HG13 ' A' ' 72' ' ' VAL . 99.5 mttt -107.31 -4.27 18.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.463 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t 63.35 34.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-O 122.678 1.228 . . . . 0.0 109.616 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' A' ' 70' ' ' LYS . 12.1 p -131.9 139.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.26 115.37 38.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 88.4 t80 -106.11 110.55 22.84 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.27 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.81 121.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.8 -42.61 12.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.881 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 m -151.39 153.92 35.65 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.3 139.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.85 -137.97 6.85 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -99.03 91.21 4.91 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.291 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.27 125.38 34.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -134.7 -37.31 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.742 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.69 -77.08 0.18 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 t -117.67 -12.74 10.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -58.38 -37.75 75.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -173.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.9 m -86.62 -30.97 6.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.428 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -67.64 -47.5 69.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 120.691 0.281 . . . . 0.0 110.621 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.657 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 51.1 m -59.21 -41.79 89.42 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 4.7 tp10 -70.37 -42.1 72.23 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.85 81.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.75 -32.36 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -77.85 -32.39 52.05 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.444 175.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 13.0 tpt180 -74.82 -45.87 40.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -174.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.64 83.86 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.993 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.24 154.38 45.75 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.42 175.68 5.85 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.87 159.35 15.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.1 130.84 51.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -145.35 158.35 43.85 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.24 144.17 45.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.006 0.431 . . . . 0.0 111.987 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.39 155.97 28.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.96 -38.23 64.77 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.911 0.323 . . . . 0.0 111.229 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.81 -45.36 93.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.79 98.02 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.835 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -63.4 -45.42 91.11 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -63.29 -44.12 95.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.776 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -70.05 -37.97 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.432 ' O ' ' HD3' ' A' ' 23' ' ' ARG . 61.9 t-105 -63.04 -45.01 94.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.789 1.236 . . . . 0.0 110.674 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -72.19 -27.14 62.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.298 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.65 -38.5 64.95 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.479 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.4 150.65 17.98 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 124.434 1.094 . . . . 0.0 111.923 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.54 144.32 48.22 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -50.03 -50.25 48.18 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.144 . . . . 0.0 111.972 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.8 m -68.99 -37.77 78.94 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.271 0.628 . . . . 0.0 111.148 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.37 -47.67 80.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 10.1 ptt-85 -68.75 -35.96 77.76 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.571 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 33.4 mt-10 -66.69 -31.69 72.52 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.568 ' N ' HE21 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -70.83 -34.37 71.61 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.649 175.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -65.48 -42.13 92.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.579 172.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.9 ttpt -55.3 -44.76 76.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.648 0.779 . . . . 0.0 109.585 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -58.42 -38.02 76.56 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.929 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.7 mptp? -69.99 -35.22 74.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.155 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 85.7 mt -65.78 -41.63 91.77 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.154 0.502 . . . . 0.0 109.698 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 27' ' ' LYS . 92.7 t -62.64 -44.47 99.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.374 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -68.85 -45.73 70.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.988 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.435 HG23 ' OH ' ' A' ' 64' ' ' TYR . 3.4 p -62.94 -30.27 49.18 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.805 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 72.4 mt -53.35 -25.53 15.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -76.71 -28.03 55.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.118 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 m -152.37 69.41 7.37 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.686 -0.633 . . . . 0.0 110.454 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' HG22 ' A' ' 33' ' ' VAL . 95.1 Cg_endo -87.63 -2.94 7.5 Favored 'Trans proline' 0 C--O 1.21 -0.887 0 C-N-CA 121.961 1.774 . . . . 0.0 112.828 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 37.94 0.94 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.949 0.881 . . . . 0.0 111.93 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.3 mt -82.7 100.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -57.48 -24.5 56.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.64 66.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.851 0.358 . . . . 0.0 111.143 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -99.5 3.89 45.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.437 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 43' ' ' LYS . 10.1 mtpm? -72.23 139.39 48.11 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.213 0.53 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 63.0 mt -80.14 138.25 36.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.398 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -72.31 106.61 4.53 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.56 32.46 10.23 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.103 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.402 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -135.75 132.68 19.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.65 99.08 0.37 Allowed 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.682 2.255 . . . . 0.0 113.319 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 60.36 31.92 20.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.637 1.175 . . . . 0.0 111.681 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -100.09 141.44 32.91 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.801 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.556 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 7.4 m-85 -132.0 160.4 35.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -130.51 146.95 52.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -124.93 139.6 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.3 131.01 56.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 25' ' ' GLN . 19.2 tp -77.61 96.59 4.84 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.421 0.629 . . . . 0.0 110.423 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -68.44 78.8 0.27 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.078 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t 172.63 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.279 1.432 . . . . 0.0 107.886 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 m -111.37 -23.44 10.79 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.82 49.32 Favored Glycine 0 C--O 1.241 0.544 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.585 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -88.01 150.21 23.55 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 122.61 -0.347 . . . . 0.0 110.16 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.13 147.88 46.31 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.181 0.515 . . . . 0.0 109.77 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -132.18 129.05 39.26 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.2 127.13 73.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 O-C-N 123.606 0.566 . . . . 0.0 110.102 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.2 p90 -138.08 158.78 43.63 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -108.92 130.37 55.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -99.52 110.5 26.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.0 mt -99.01 100.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.83 -34.48 78.02 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.039 0.536 . . . . 0.0 111.828 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.44 -36.74 85.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.321 0.388 . . . . 0.0 111.595 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -98.51 -6.97 29.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.05 0.453 . . . . 0.0 110.473 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 t 61.33 32.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 124.951 1.3 . . . . 0.0 109.936 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.42 138.78 53.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 111.148 -176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.3 114.88 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.03 110.69 21.34 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.94 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.77 121.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.14 -42.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.533 0.682 . . . . 0.0 110.218 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 m -145.87 149.91 35.14 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.17 145.91 17.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.65 -144.94 12.63 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -98.54 162.79 12.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 118.095 0.948 . . . . 0.0 109.388 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.04 109.1 9.78 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -68.0 0.82 Allowed 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.3 -59.82 1.08 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.916 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -125.87 10.95 7.71 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.781 -174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -57.98 -52.32 66.01 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 m -89.37 -6.12 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.03 0.443 . . . . 0.0 111.684 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -89.24 -44.53 10.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.931 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.619 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 68.5 m -64.99 -48.03 75.45 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.94 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -60.6 -31.6 70.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.804 0.335 . . . . 0.0 110.421 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.63 -54.75 6.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.344 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.6 -29.92 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 88' ' ' SER . 32.9 mmtp -71.12 -13.12 61.85 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 122.178 -0.326 . . . . 0.0 111.196 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.402 ' HE ' ' HA ' ' A' ' 93' ' ' ARG . 13.0 mmm-85 -86.09 -17.83 34.01 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.382 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 mp -89.67 -33.12 5.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--N 1.306 -1.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.095 179.057 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.09 135.02 44.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 124.022 0.827 . . . . 0.0 108.806 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -96.05 168.93 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.157 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.2 159.88 16.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.65 123.53 39.17 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -137.55 152.71 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.86 137.82 52.53 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -70.48 154.8 41.5 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.256 0.7 OUTLIER -59.75 -31.15 69.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.03 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -70.94 -38.11 72.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.205 0.526 . . . . 0.0 109.638 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.36 88.05 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.202 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 63.7 mt -61.28 -43.79 98.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.406 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -61.66 -44.76 96.35 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -69.76 -37.43 76.4 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.275 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -60.93 -37.24 81.63 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.997 0.919 . . . . 0.0 110.593 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 97.5 mtt180 -74.86 -28.98 60.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.597 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -77.04 -26.3 53.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.444 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.11 151.25 43.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.931 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.68 145.62 42.26 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -45.56 -53.02 9.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.623 1.169 . . . . 0.0 112.114 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -68.61 -36.29 78.47 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.372 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.0 -48.47 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.14 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -69.3 -35.59 76.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.6 mt-10 -57.41 -41.53 80.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.514 ' CB ' HD13 ' A' ' 55' ' ' LEU . 41.4 mt-30 -70.93 -35.75 72.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.012 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.2 mt -68.63 -39.81 80.62 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.268 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' O ' HG21 ' A' ' 31' ' ' VAL . 36.4 ttpt -60.11 -42.61 95.08 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.477 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.6 mttm -57.06 -41.6 79.05 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.7 mmtt -64.0 -37.6 88.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.298 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.1 mt -64.97 -41.19 95.66 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.333 0.587 . . . . 0.0 109.809 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 27' ' ' LYS . 95.8 t -65.37 -45.66 92.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.576 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.4 pt-20 -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.905 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' OH ' ' A' ' 64' ' ' TYR . 5.0 p -64.08 -31.3 52.76 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -55.21 -27.42 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.15 -8.01 34.33 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.097 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -154.81 63.72 4.05 Favored Pre-proline 0 C--O 1.211 -0.973 0 C-N-CA 122.62 0.368 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 33' ' ' VAL . 97.5 Cg_endo -80.54 -4.73 13.09 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.103 1.869 . . . . 0.0 114.902 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.02 40.2 1.04 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -82.34 113.68 22.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.832 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 41' ' ' ALA . 3.6 pt-20 -58.49 -33.2 69.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.715 0.806 . . . . 0.0 111.828 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 40' ' ' GLU . . . -70.0 -23.36 63.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.675 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 94.8 m-20 -103.04 -11.87 17.83 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.208 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -65.9 142.41 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 120.802 0.334 . . . . 0.0 111.772 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 mt -72.24 168.33 18.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -58.61 -46.36 87.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 111.161 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.19 86.77 0.09 OUTLIER Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 89.7 mmm -149.01 146.1 20.81 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.92 89.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.424 2.75 . . . . 0.0 113.998 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 48.46 44.9 20.83 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.923 1.289 . . . . 0.0 112.099 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 58.8 m -101.85 142.34 33.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.377 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.646 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 29.3 m-85 -130.48 161.47 31.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 15.3 ptpt -116.28 158.94 22.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.983 0.913 . . . . 0.0 109.165 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 70.6 mt -129.55 133.77 64.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.73 123.21 46.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD13 ' CB ' ' A' ' 25' ' ' GLN . 16.6 tp -73.79 136.16 43.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.074 0.464 . . . . 0.0 110.805 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.43 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -84.15 -63.48 1.34 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 18.3 m -104.96 160.77 14.76 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.48 64.95 3.73 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.504 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -114.05 139.59 49.16 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 98.0 mtt180 -128.13 137.91 52.3 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.823 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -122.23 136.65 54.94 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.3 t -124.66 128.06 73.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 17.1 p90 -137.69 158.3 44.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.8 pt20 -108.53 133.89 52.05 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.86 111.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.9 mt -91.62 95.38 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -22.96 63.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.764 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.65 -40.12 96.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.193 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -107.41 -1.97 20.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.1 t 62.96 41.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 122.48 1.134 . . . . 0.0 109.242 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.84 139.01 48.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.601 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.57 115.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.59 -1.634 . . . . 0.0 106.59 174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.03 111.72 23.26 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -173.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.76 121.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.22 -42.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.045 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -154.38 154.01 32.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.01 143.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.61 -139.83 7.86 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.581 -1.295 . . . . 0.0 112.435 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -107.44 91.22 3.56 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.545 0.688 . . . . 0.0 109.741 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.01 113.88 26.27 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.347 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -47.72 68.0 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.94 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.11 -51.33 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.531 0.732 . . . . 0.0 111.16 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -104.75 -15.15 15.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.77 -52.5 65.18 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.015 0.436 . . . . 0.0 111.765 -174.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.49 -30.33 22.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -63.71 -41.82 98.03 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.183 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 m -67.58 -43.09 81.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.517 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.02 -37.23 81.84 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 123.42 0.45 . . . . 0.0 110.773 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.83 -55.69 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.29 -32.92 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -77.06 -29.02 54.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.718 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -87.35 -34.81 18.69 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.23 113.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.719 0.771 . . . . 0.0 109.285 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.7 tp . . . . . 0 N--CA 1.414 -2.244 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -177.304 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -98.43 129.14 45.05 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -91.2 173.42 7.94 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.025 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.51 162.56 13.42 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.48 HD11 ' N ' ' A' ' 6' ' ' ASP . 1.5 tm? -126.77 136.59 52.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.48 ' N ' HD11 ' A' ' 5' ' ' LEU . 38.2 t70 -141.25 154.12 45.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 173.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.79 128.58 56.47 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.473 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.457 ' CG ' HH12 ' A' ' 93' ' ' ARG . 30.4 t70 -67.69 156.64 36.45 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 123.969 0.793 . . . . 0.0 111.247 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 8.7 pt-20 -52.89 -38.88 62.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.148 0.979 . . . . 0.0 111.359 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.423 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 74.3 mtt180 -72.31 -42.06 65.87 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.244 0.545 . . . . 0.0 110.104 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.16 78.55 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.511 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.3 mt -66.92 -37.79 84.99 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 53.9 mttm -62.28 -46.77 87.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.66 -38.74 73.84 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.968 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -60.81 -43.31 98.35 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.546 0.738 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.29 -20.79 58.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -81.51 -24.01 36.94 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 124.673 1.189 . . . . 0.0 109.812 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.45 157.75 35.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.987 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.12 141.86 28.62 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 1.9 p -53.39 -41.96 66.47 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -175.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -40.89 83.93 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.1 -47.25 85.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 120.835 0.35 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -65.48 -34.85 79.24 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.798 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 20' ' ' SER . 35.3 mt-10 -58.35 -38.54 77.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -70.12 -38.41 75.56 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 89.2 mt -64.25 -42.68 96.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.695 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' O ' HG21 ' A' ' 31' ' ' VAL . 31.5 ttpt -56.66 -44.46 81.4 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 123.302 0.641 . . . . 0.0 110.595 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.19 -42.11 90.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.833 0.349 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.5 mptp? -64.55 -34.68 78.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.182 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.3 mt -68.44 -43.7 76.53 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 27' ' ' LYS . 92.4 t -60.84 -45.5 97.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.988 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.6 pt-20 -69.29 -43.34 74.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.673 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 37' ' ' PRO . 2.3 p -64.0 -29.87 48.49 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.785 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.997 -175.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 90.2 mt -54.38 -25.94 27.3 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.7 pt-20 -77.11 -20.81 55.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.927 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 p -155.27 69.67 5.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' HG23 ' A' ' 33' ' ' VAL . 94.5 Cg_endo -80.13 -9.65 14.0 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 121.823 1.682 . . . . 0.0 112.484 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -89.04 38.7 0.9 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.767 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.19 109.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.505 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.949 0.404 . . . . 0.0 111.703 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -101.44 -2.94 29.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.095 -0.378 . . . . 0.0 112.002 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 21.1 mtpp -70.96 146.28 49.57 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.886 0.374 . . . . 0.0 110.985 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.29 164.09 15.08 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.165 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -91.81 131.08 37.42 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.13 0.572 . . . . 0.0 109.914 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.79 76.58 Favored Glycine 0 CA--C 1.506 -0.506 0 O-C-N 123.505 0.503 . . . . 0.0 113.198 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.427 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 95.9 mmm -126.17 129.99 24.07 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.25 98.9 0.34 Allowed 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.49 2.127 . . . . 0.0 112.859 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 52.51 42.03 31.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.204 1.002 . . . . 0.0 113.022 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 61.9 m -100.26 141.48 33.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.12 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.579 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 45.1 m-85 -134.0 159.6 40.26 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -134.39 140.54 46.37 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.858 177.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.56 144.06 29.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -127.13 140.26 52.38 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 120.907 0.384 . . . . 0.0 111.668 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.0 mt -85.62 115.65 23.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -66.13 -30.53 71.04 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -66.49 -65.1 0.72 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.93 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -89.98 -22.48 21.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.66 64.46 Favored Glycine 0 C--O 1.239 0.455 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.154 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -96.55 144.69 26.38 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.397 0.279 . . . . 0.0 110.403 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -122.2 147.57 46.02 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -131.4 134.36 46.18 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.23 128.55 75.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 C-N-CA 123.188 0.595 . . . . 0.0 110.262 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.579 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 7.5 p90 -138.84 158.78 43.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -112.03 137.47 50.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.85 112.81 29.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -95.79 95.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.84 -26.63 65.25 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 0.0 110.661 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.66 -30.26 69.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.424 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -105.47 -6.25 19.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.245 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.42 29.36 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 122.569 1.176 . . . . 0.0 109.089 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.87 139.09 52.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 O-C-N 121.206 -0.934 . . . . 0.0 111.197 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.8 120.85 46.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -109.08 110.6 21.9 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.834 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.3 t -76.56 121.72 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.6 mt -98.35 -42.04 10.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.565 0.698 . . . . 0.0 110.076 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.8 m -142.48 147.46 36.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.224 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.23 142.11 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.0 -115.36 0.71 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.295 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -137.54 149.57 46.84 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 110.577 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.35 91.13 3.53 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -42.76 57.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.62 -66.8 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.1 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 m -153.49 20.32 0.55 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.79 -42.4 84.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.282 0.947 . . . . 0.0 111.931 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.23 -19.73 24.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.226 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -91.72 -40.91 10.99 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 m -56.98 -51.18 70.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.963 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.14 -28.91 69.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.67 -47.97 13.28 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.058 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.09 -34.79 72.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 O-C-N 122.423 -0.173 . . . . 0.0 111.184 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.29 -10.69 59.0 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.285 0.564 . . . . 0.0 112.038 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.457 HH12 ' CG ' ' A' ' 8' ' ' ASP . 12.2 tpt180 -88.73 -26.45 21.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.73 -41.76 12.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.112 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 N--CA 1.435 -1.204 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.194 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 CA--C 1.489 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -98.24 146.81 25.26 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.029 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -124.64 173.99 8.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -86.72 159.55 19.12 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -124.8 125.9 44.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.69 167.1 22.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.31 141.05 51.55 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD2' ' HG3' ' A' ' 10' ' ' ARG . 19.5 t70 -80.23 154.87 27.63 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.14 -29.33 65.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 25.5 mtp-105 -68.37 -48.18 65.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.38 68.44 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.52 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -70.91 -37.46 72.96 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.931 0.396 . . . . 0.0 110.998 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.81 -42.87 90.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.44 -43.13 86.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.948 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -63.2 -41.4 99.16 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.329 1.052 . . . . 0.0 110.795 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.23 -24.61 57.73 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.491 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -67.57 -32.16 72.72 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.12 141.44 58.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.609 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.48 -83.43 0.05 OUTLIER Glycine 0 C--N 1.312 -0.8 0 O-C-N 124.837 1.336 . . . . 0.0 114.392 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 t -163.74 -60.85 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.516 HG21 ' OE1' ' A' ' 25' ' ' GLN . 4.9 m -63.07 -45.37 92.48 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.359 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.41 -47.52 90.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.899 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -68.42 -35.4 77.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.557 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.3 mt-10 -63.6 -42.17 98.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.555 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.0 mp0 -62.64 -45.24 93.77 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.131 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.514 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 88.9 mt -58.61 -43.15 89.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.422 0.451 . . . . 0.0 111.46 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' HG21 ' A' ' 31' ' ' VAL . 35.2 ttpt -58.16 -44.33 87.86 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.295 0.372 . . . . 0.0 110.254 175.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -64.93 -34.68 78.99 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.75 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 13.0 mmmm -67.38 -34.47 77.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.4 mt -68.96 -40.77 78.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.81 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 27' ' ' LYS . 76.6 t -61.11 -45.68 98.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -69.29 -38.17 78.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.036 0.446 . . . . 0.0 111.281 177.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -67.02 -30.34 49.23 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.791 -176.353 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 mt -53.86 -24.57 16.31 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.1 pt-20 -70.71 -24.96 62.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.318 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 39' ' ' ILE . 43.8 p -162.05 76.04 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 123.152 0.581 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HA ' HG23 ' A' ' 33' ' ' VAL . 73.7 Cg_endo -80.37 -4.97 13.33 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.722 1.615 . . . . 0.0 112.175 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 40.91 1.05 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.89 0.852 . . . . 0.0 111.624 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 36' ' ' SER . 85.0 mt -82.42 93.58 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 43' ' ' LYS . 9.7 pt-20 -55.57 -18.74 8.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.05 1.34 . . . . 0.0 113.993 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.72 74.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.975 0.417 . . . . 0.0 110.97 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -100.77 9.47 42.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.892 0.377 . . . . 0.0 110.625 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 56.9 tttt -80.96 144.33 31.94 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.0 mt -79.54 152.53 30.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.657 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -63.15 -74.28 0.1 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.44 43.28 1.7 Allowed Glycine 0 CA--C 1.502 -0.756 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.886 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.412 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 92.6 mmm -124.57 124.96 25.62 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.91 99.11 0.13 Allowed 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 123.139 2.559 . . . . 0.0 112.809 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 52.75 39.27 28.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.823 1.249 . . . . 0.0 113.395 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 56.0 m -100.09 141.55 32.77 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.484 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 47.3 m-85 -131.84 157.77 43.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.13 144.43 51.03 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.29 129.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.17 140.09 39.68 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.681 174.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.46 139.4 39.64 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -66.04 -48.7 70.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.24 123.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.8 m 69.51 -173.69 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.004 0.922 . . . . 0.0 111.585 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.35 42.31 1.99 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.46 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -91.38 136.96 32.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -133.99 141.89 47.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.789 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -123.75 138.18 54.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.7 t -123.85 129.59 74.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 18.9 p90 -138.84 159.26 42.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.164 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -119.74 138.08 53.54 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.2 m -95.81 121.26 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -99.29 95.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.18 -28.57 67.39 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.673 0.749 . . . . 0.0 109.046 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.21 -38.68 77.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.959 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.6 mttt -107.84 -4.17 18.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.615 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.4 t 61.9 29.46 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 CA-C-O 122.382 1.087 . . . . 0.0 109.868 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.1 p -131.32 141.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 121.008 -1.057 . . . . 0.0 111.214 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.46 121.14 53.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 124.146 0.978 . . . . 0.0 108.588 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -107.78 120.55 42.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -74.86 124.08 31.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -93.65 -42.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 123.464 0.477 . . . . 0.0 110.83 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 t -155.45 150.85 27.09 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.25 132.95 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.237 0.542 . . . . 0.0 110.551 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.14 -111.58 0.48 Allowed Glycine 0 N--CA 1.418 -2.548 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.425 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -132.9 158.07 43.51 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.58 -78.35 0.36 Allowed 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 58.35 -45.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 128.39 2.676 . . . . 0.0 113.671 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.61 18.18 6.86 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 125.827 1.651 . . . . 0.0 107.195 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.2 m 61.78 31.37 18.43 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.321 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 41.9 tt0 -57.96 -51.3 70.23 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.05 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 m -58.98 -24.76 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -84.67 -28.47 26.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 m -69.59 -43.73 72.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.7 mm-40 -61.15 -36.56 80.13 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.909 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.37 -49.47 55.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.478 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.33 -26.21 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.044 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -69.36 -11.96 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -79.69 -25.04 41.34 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.329 0.585 . . . . 0.0 109.678 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.83 -49.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.954 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.787 179.097 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.9 ptm . . . . . 0 CA--C 1.497 -1.096 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.45 152.65 50.81 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -108.84 167.63 9.94 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.73 151.59 35.99 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -125.83 122.17 35.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -132.83 157.04 46.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.78 140.84 52.56 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.79 155.59 40.26 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -53.56 -38.91 64.32 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.275 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.5 ptm180 -67.14 -38.75 86.07 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.37 -37.4 87.38 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.191 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 mt -67.73 -43.09 80.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.651 0.262 . . . . 0.0 110.852 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.35 -42.02 98.89 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 46.7 mt-10 -69.41 -39.59 77.84 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.833 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -60.69 -41.27 94.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 0.0 110.376 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -73.42 -31.16 63.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.401 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.8 -43.93 82.58 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.821 0.701 . . . . 0.0 109.818 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mp -53.08 153.05 3.76 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.464 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.37 142.06 41.98 Favored Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 1.8 p -54.17 -46.11 72.26 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.875 0.87 . . . . 0.0 113.085 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 m -68.51 -36.29 78.67 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.025 0.441 . . . . 0.0 110.88 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.73 -47.97 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.23 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.369 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -57.23 -43.61 83.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.695 0.225 . . . . 0.0 110.575 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.92 -38.64 86.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 -179.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.7 mt -67.25 -42.69 83.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 176.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -57.09 -43.38 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.036 0.534 . . . . 0.0 110.594 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -56.94 -43.21 81.29 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.397 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 75.3 mmtt -65.48 -38.47 89.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.912 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.4 mt -65.46 -46.94 77.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.57 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.26 -41.37 89.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.401 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.564 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -69.9 -37.72 76.08 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.694 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -64.45 -30.22 49.56 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.774 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.404 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.2 mt -54.47 -26.46 31.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 1.9 pp20? -80.41 -29.63 37.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.382 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -142.87 72.49 19.12 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' HG23 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -73.45 -27.94 12.65 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 121.547 1.498 . . . . 0.0 112.223 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.49 65.95 4.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -103.71 115.08 45.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 11.0 pt-20 -59.81 -28.67 67.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.21 65.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.41 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -107.1 -2.25 21.18 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.029 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 38.5 mtpt -75.42 139.57 42.4 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.7 mt -78.19 149.47 33.71 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.677 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.38 -65.07 0.75 Allowed 'General case' 0 C--N 1.311 -1.084 0 O-C-N 124.072 0.857 . . . . 0.0 111.945 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.83 61.43 0.36 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.475 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.439 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 94.3 mmm -141.2 140.97 21.96 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.4 95.76 0.53 Allowed 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.984 2.456 . . . . 0.0 112.787 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 48.21 44.64 19.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.764 1.226 . . . . 0.0 112.145 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 60.5 m -100.8 142.07 32.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.593 ' CE2' ' HG2' ' A' ' 43' ' ' LYS . 25.7 m-85 -130.91 156.47 45.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -126.02 139.51 53.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.426 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.2 mt -111.98 138.89 39.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.84 123.57 38.99 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 -178.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.7 91.37 6.99 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -62.88 -8.69 7.51 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.916 1.686 . . . . 0.0 113.279 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -100.13 -13.06 19.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.765 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -134.78 -36.03 0.86 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.249 -0.981 . . . . 0.0 113.083 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.44 28.92 6.17 Favored Glycine 0 C--O 1.247 0.932 0 C-N-CA 119.415 -1.374 . . . . 0.0 112.007 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.09 146.35 29.26 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -135.1 147.3 49.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.43 133.48 45.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.91 128.73 75.73 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 CA-C-O 121.015 0.436 . . . . 0.0 109.884 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 15.9 p90 -139.14 158.86 43.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.729 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 17.2 pt20 -110.27 138.89 46.04 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.0 t -103.15 112.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.81 94.68 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.35 -34.08 74.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.09 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.22 -35.42 71.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.141 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -103.81 -1.1 28.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.277 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p 54.81 40.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.405 1.882 . . . . 0.0 111.821 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.65 138.36 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.814 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -102.46 115.36 44.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -110.23 112.22 24.05 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.5 t -77.06 121.45 29.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.73 -42.32 12.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.133 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -151.01 148.07 27.91 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.042 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.07 141.25 21.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.04 -97.63 0.19 Allowed Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -137.61 144.18 41.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.41 77.81 3.39 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -97.49 106.49 18.82 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.086 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 72.87 -87.84 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 124.983 1.313 . . . . 0.0 111.128 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.4 m -153.24 7.24 0.38 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.94 -50.25 74.01 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.262 0.937 . . . . 0.0 113.374 -171.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m -62.91 -30.03 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.94 -43.6 13.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.428 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 91' ' ' VAL . 56.0 m -67.4 -29.27 68.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.17 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 9.5 tp10 -61.15 -50.08 74.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.34 23.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.017 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 88' ' ' SER . 12.3 p -66.67 -34.51 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -78.21 -13.39 59.88 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 50.5 ttt180 -84.14 -46.21 12.16 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.807 -175.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.21 85.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.422 -1.866 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -178.784 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.506 -0.714 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -122.3 153.23 39.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.376 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.84 171.29 7.96 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.03 156.89 18.58 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -126.18 130.09 50.3 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.63 158.11 44.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -119.21 133.83 55.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.67 155.95 39.1 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.167 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.506 ' OE1' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -56.43 -36.85 69.45 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.33 0.394 . . . . 0.0 110.783 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HG3' ' OE1' ' A' ' 9' ' ' GLU . 35.8 mtt180 -60.06 -48.93 79.66 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.65 77.23 Favored 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.861 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.9 mt -64.02 -38.66 91.89 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 120.988 0.423 . . . . 0.0 110.753 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -65.11 -43.49 91.85 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.5 mt-10 -69.39 -36.41 76.74 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.181 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.37 -38.41 90.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.021 0.928 . . . . 0.0 109.864 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -75.06 -26.4 59.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 61.4 tttm -72.36 -39.99 67.67 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.785 0.834 . . . . 0.0 109.102 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.36 151.53 43.73 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.54 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.95 147.8 40.34 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 23.2 m -51.05 -49.83 59.81 Favored 'General case' 0 C--O 1.205 -1.259 0 C-N-CA 123.994 0.918 . . . . 0.0 112.014 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -63.67 -38.55 91.55 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.244 0.545 . . . . 0.0 110.849 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.07 -47.48 81.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.399 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -68.42 -34.77 76.59 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.173 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 20' ' ' SER . 70.0 mt-10 -57.53 -42.25 82.52 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.052 0.387 . . . . 0.0 111.32 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.17 -39.35 89.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.549 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.7 mt -66.48 -40.92 89.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' HG22 ' A' ' 31' ' ' VAL . 32.0 ttpt -56.5 -44.62 80.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.137 0.575 . . . . 0.0 110.38 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.62 -39.64 88.95 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.262 0.553 . . . . 0.0 110.234 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 mptp? -65.29 -37.41 87.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.068 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.7 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -66.25 -41.44 89.95 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 27' ' ' LYS . 99.5 t -65.26 -44.74 94.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 9.5 pt-20 -68.75 -44.15 74.36 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.948 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.3 p -62.66 -29.92 48.08 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.228 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 89.9 mt -53.59 -25.56 17.89 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.6 pt-20 -71.46 -27.86 63.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 39' ' ' ILE . 48.2 m -152.6 73.95 7.28 Favored Pre-proline 0 C--O 1.209 -1.046 0 C-N-CA 123.558 0.743 . . . . 0.0 109.167 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' HG23 ' A' ' 33' ' ' VAL . 61.2 Cg_endo -74.72 -13.21 22.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.057 1.838 . . . . 0.0 112.622 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -87.51 41.45 0.98 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.427 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 36' ' ' SER . 91.9 mt -80.61 98.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.75 -19.32 10.75 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.738 1.615 . . . . 0.0 114.288 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.4 -25.86 65.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.594 0.711 . . . . 0.0 109.912 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.67 -1.75 39.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.811 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.9 142.07 49.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-O 121.201 0.524 . . . . 0.0 110.658 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.6 176.61 9.55 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.816 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -110.09 120.02 41.14 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.022 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.28 54.37 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.126 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.53 131.54 23.41 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -47.02 -59.06 1.39 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 124.401 3.401 . . . . 0.0 114.256 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.67 ' OD1' ' HB ' ' A' ' 66' ' ' VAL . 7.7 t70 -154.66 83.65 1.1 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.1 m -139.47 141.77 37.39 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.7 m-85 -138.23 153.78 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.3 pttt -126.18 139.43 53.36 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.2 mt -111.68 130.88 64.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 145.28 29.98 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.78 143.08 27.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -93.48 -42.56 9.18 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.217 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 m -89.32 5.08 46.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.7 m -152.89 138.3 17.6 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.39 73.04 2.07 Favored Glycine 0 C--N 1.314 -0.673 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.533 -175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -135.23 156.45 48.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.572 ' N ' ' HD2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -144.82 149.48 35.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -119.88 133.37 55.6 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.95 126.42 70.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.2 p90 -136.4 158.94 43.24 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -113.51 140.03 48.46 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.67 ' HB ' ' OD1' ' A' ' 49' ' ' ASP . 81.7 t -99.59 113.03 33.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.748 0.785 . . . . 0.0 109.849 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.69 94.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.25 -27.9 65.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.866 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.08 -37.34 76.86 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.037 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -107.78 -1.76 20.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.149 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t 62.32 35.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.638 1.209 . . . . 0.0 109.69 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -133.3 138.7 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.96 121.76 49.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.26 115.48 29.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.5 t -80.85 121.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.66 -42.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 123.585 0.553 . . . . 0.0 110.909 -174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 p -145.56 149.68 35.03 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.108 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.04 127.19 2.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.261 0.553 . . . . 0.0 112.112 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.78 -123.31 1.28 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 119.141 -1.504 . . . . 0.0 112.936 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -113.74 157.1 22.66 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.26 16.03 19.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.36 126.69 28.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.621 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.11 9.92 7.49 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 111.568 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.3 m 62.56 27.38 16.2 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.967 0.907 . . . . 0.0 112.508 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -57.93 -44.34 86.85 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -62.87 -26.66 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.95 -44.64 15.08 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.1 t -58.81 -49.44 77.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.52 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -62.04 -29.77 70.51 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 110.667 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.65 -44.47 28.03 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.93 -33.51 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 88' ' ' SER . 46.7 mmtm -65.48 -20.8 66.5 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.941 0.401 . . . . 0.0 110.172 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.795 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.79 128.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.741 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.424 -1.769 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.966 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.9 ttt . . . . . 0 CA--C 1.488 -1.44 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.19 152.73 37.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 123.521 0.513 . . . . 0.0 109.778 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -121.3 160.66 23.5 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -80.35 160.31 25.47 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.08 131.56 52.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.76 155.8 43.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -120.05 137.06 54.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.729 0.411 . . . . 0.0 111.19 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.54 154.8 31.39 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 170.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 6.8 pt-20 -53.55 -41.89 66.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.117 0.417 . . . . 0.0 111.934 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 90.0 mtt180 -72.25 -37.77 69.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.627 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.36 75.83 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.5 tp -73.47 -34.16 65.22 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.799 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 87.6 mttt -66.15 -44.41 84.2 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -67.43 -38.73 84.99 Favored 'General case' 0 C--O 1.199 -1.598 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.459 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -60.26 -40.25 89.65 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.604 0.762 . . . . 0.0 111.469 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -74.21 -33.94 63.55 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.601 0.715 . . . . 0.0 110.917 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.02 -19.41 58.68 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.29 162.5 29.38 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.317 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.08 152.58 43.96 Favored Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.897 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -53.58 -54.05 42.93 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 125.033 1.333 . . . . 0.0 112.248 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 m -63.1 -34.67 78.09 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.301 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.15 -48.18 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.756 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -63.35 -40.52 97.52 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.509 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.8 mt-10 -61.43 -43.6 98.59 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.667 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -69.84 -43.27 72.29 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.546 178.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.8 mt -58.81 -40.79 85.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 117.612 0.187 . . . . 0.0 110.92 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.3 ttpt -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 123.59 0.557 . . . . 0.0 110.07 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.1 mttt -63.09 -38.07 89.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 28.7 mmmt -66.82 -35.1 79.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 88.9 mt -68.87 -43.6 75.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 27' ' ' LYS . 53.9 t -60.54 -44.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.831 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 9.7 pt-20 -69.07 -44.76 71.9 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 37' ' ' PRO . 1.3 p -62.79 -29.64 47.53 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.343 -173.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.54 -26.65 22.12 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -79.09 -24.76 43.25 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.387 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -148.66 69.3 10.19 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' HG23 ' A' ' 33' ' ' VAL . 83.0 Cg_endo -83.2 -11.29 9.8 Favored 'Trans proline' 0 C--O 1.209 -0.939 0 C-N-CA 121.542 1.495 . . . . 0.0 111.799 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.48 39.22 0.72 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -82.94 107.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.33 -24.35 67.28 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.61 67.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.888 0.375 . . . . 0.0 111.677 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 90.6 m-20 -97.66 -0.4 45.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.553 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 43' ' ' LYS . 10.0 mtpm? -73.95 138.57 44.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.197 0.522 . . . . 0.0 111.402 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 67.6 mt -82.43 141.77 32.48 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -68.61 -42.53 77.99 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.03 18.56 57.3 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.435 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.482 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 83.8 mmm -130.71 145.68 58.65 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.88 -74.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.942 1.761 . . . . 0.0 114.722 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.14 36.8 4.21 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 40.0 m -100.32 141.24 33.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.507 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 29.6 m-85 -132.86 156.89 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.23 142.44 50.85 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.251 0.548 . . . . 0.0 111.025 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.91 144.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -120.17 126.43 50.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 2.1 tt -99.04 90.39 4.6 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -75.62 95.03 3.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.826 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.409 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . 35.9 t 171.61 -39.75 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.869 1.667 . . . . 0.0 107.298 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 p -125.37 -17.04 5.72 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.24 9.86 61.51 Favored Glycine 0 C--O 1.241 0.579 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.15 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.89 148.97 25.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.123 0.487 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -125.25 151.84 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.85 125.36 29.82 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.15 126.94 70.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.217 0.532 . . . . 0.0 109.955 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -139.22 159.71 41.51 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.952 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.405 ' NE2' HG12 ' A' ' 67' ' ' ILE . 11.0 pt20 -114.08 141.24 47.71 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 170.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -91.21 114.23 28.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.405 HG12 ' NE2' ' A' ' 65' ' ' GLN . 22.7 mt -99.95 95.15 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.84 -33.17 73.37 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.79 0.329 . . . . 0.0 110.581 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.54 -33.71 70.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.982 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB2' HG11 ' A' ' 72' ' ' VAL . 93.2 mttt -104.09 -6.7 20.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.204 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t 63.01 32.26 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.31 0 C-N-CA 124.449 1.1 . . . . 0.0 109.671 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' LYS . 13.6 p -131.58 138.83 52.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 111.065 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.1 t -96.37 115.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -106.07 111.78 24.55 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.981 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.33 121.9 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.6 mt -95.08 -40.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.258 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -155.75 151.95 27.93 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -149.44 147.03 16.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.6 -151.4 23.59 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.259 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -89.75 137.58 32.21 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.25 104.38 7.01 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -80.38 -40.49 26.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.19 -76.77 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.347 1.059 . . . . 0.0 110.783 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -65.76 -31.41 72.37 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.26 -51.82 67.83 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.25 -30.98 14.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.906 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -74.38 -45.3 47.73 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 m -64.82 -40.0 94.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 8.5 tp10 -65.14 -47.33 77.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.41 -49.63 71.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.37 -30.75 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 120.838 0.351 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -77.9 -11.27 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 20.8 mmm180 -87.69 -15.97 35.64 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.052 0.387 . . . . 0.0 111.482 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -128.3 99.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.68 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 C--N 1.304 -1.376 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 C--O 1.238 0.463 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.11 164.05 24.16 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -115.89 163.91 15.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.21 161.72 17.87 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.89 123.17 36.64 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.89 169.18 17.48 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.8 136.9 47.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.08 155.65 16.63 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 7.3 pt-20 -52.6 -41.93 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.317 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -63.87 -48.16 77.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.23 0.538 . . . . 0.0 111.055 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.6 71.55 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.051 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 9' ' ' GLU . 1.1 mptm? -65.06 -42.09 94.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.77 -35.74 77.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.672 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -60.56 -38.0 83.12 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 110.121 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.38 -35.03 65.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.666 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.38 -32.89 74.69 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.325 1.05 . . . . 0.0 110.71 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.25 147.61 52.04 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.272 0.558 . . . . 0.0 112.495 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.24 147.92 41.69 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 11.9 p -51.04 -54.93 20.26 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 124.334 1.053 . . . . 0.0 112.839 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -59.08 -40.39 85.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.039 0.535 . . . . 0.0 111.402 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.14 -47.06 80.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.016 0.436 . . . . 0.0 109.885 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -67.61 -34.96 78.05 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 46.8 mt-10 -58.57 -45.73 88.39 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 117.781 0.264 . . . . 0.0 111.435 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.89 -35.23 78.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.76 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 81.7 mt -65.34 -41.76 93.58 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.214 174.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -59.29 -43.18 92.6 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.1 mttm -59.24 -42.7 91.73 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.208 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -64.33 -41.06 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.166 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 91.8 mt -64.3 -47.18 80.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.24 -36.48 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.579 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -69.46 -45.72 68.37 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.877 175.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -62.37 -29.65 47.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 C-N-CA 123.229 0.612 . . . . 0.0 112.393 -174.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.41 -24.93 13.83 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.4 pt-20 -68.23 -31.44 70.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 111.049 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.2 m -157.57 77.58 3.73 Favored Pre-proline 0 C--O 1.208 -1.127 0 C-N-CA 123.356 0.663 . . . . 0.0 110.056 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.0 Cg_endo -80.96 -0.12 10.39 Favored 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 121.771 1.647 . . . . 0.0 112.08 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 27.63 1.08 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.517 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.89 103.55 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 12.0 pt-20 -66.02 -15.68 63.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.75 -26.21 68.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.232 0.539 . . . . 0.0 109.987 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -103.86 8.51 37.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.848 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.667 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 2.6 tttm -72.25 148.29 45.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.465 0.65 . . . . 0.0 112.522 -177.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 81.2 mt -91.47 127.25 36.84 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.74 -1.118 . . . . 0.0 107.993 171.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -81.11 128.76 34.09 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 122.953 0.501 . . . . 0.0 110.591 -177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.52 11.26 66.55 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.4 mmm -123.61 140.91 35.19 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.87 101.62 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.496 1.464 . . . . 0.0 111.911 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 47.54 54.99 8.93 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.169 1.387 . . . . 0.0 113.911 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -113.24 141.7 46.67 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.667 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 38.0 m-85 -136.61 160.22 39.45 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HD2' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.76 140.27 47.97 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.789 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -110.57 140.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -126.74 133.36 50.89 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.022 0.439 . . . . 0.0 109.917 -177.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.09 135.79 33.69 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -106.76 -15.6 14.7 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.811 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -78.07 -27.93 48.69 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.346 0.593 . . . . 0.0 109.632 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -144.11 140.35 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.62 74.62 0.9 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.815 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -124.14 141.27 52.2 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.883 0.473 . . . . 0.0 110.333 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -126.43 149.38 49.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 tt -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.8 t -116.27 129.14 73.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.537 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.5 p90 -138.64 158.77 43.62 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.59 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -109.24 140.92 42.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.21 112.18 29.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 mt -91.3 95.87 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.61 -30.5 71.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.817 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.77 -39.91 90.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.394 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.6 mttt -107.46 -5.0 17.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.2 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.2 t 60.54 41.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 123.067 1.413 . . . . 0.0 109.537 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -135.79 138.93 47.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.359 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -94.22 115.35 32.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -107.19 110.42 22.48 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.197 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.1 123.41 27.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.0 mt -89.99 -42.26 14.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.57 0.7 . . . . 0.0 109.664 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -154.68 149.91 27.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.93 134.44 18.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.59 -147.75 18.38 Favored Glycine 0 C--N 1.3 -1.419 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.21 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -93.1 141.54 28.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 117.226 0.513 . . . . 0.0 110.315 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.41 116.77 13.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.15 -45.66 5.31 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.396 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.68 -54.55 0.67 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.6 p -145.2 9.33 1.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.207 -0.997 . . . . 0.0 113.2 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -56.99 -48.88 77.37 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 112.005 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.83 -3.46 10.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.003 0.43 . . . . 0.0 111.016 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.33 -40.63 11.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.41 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 p -63.04 -42.15 99.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.591 0.71 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 6.1 mm-40 -65.24 -34.24 77.9 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.678 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.46 -44.61 50.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.374 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.4 p -69.92 -30.85 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.203 0.525 . . . . 0.0 110.798 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.49 -9.88 59.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 11.7 mmm180 -69.85 -22.69 63.24 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.88 75.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 C--N 1.31 -1.146 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.242 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.094 0 CA-C-O 121.048 0.452 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.17 172.47 6.79 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -94.87 164.84 12.75 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -125.72 132.29 52.4 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -135.7 160.43 38.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.01 141.86 49.39 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.776 0.43 . . . . 0.0 110.604 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -76.86 150.22 36.08 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.95 -28.92 70.15 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.32 -41.62 66.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.33 85.52 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.713 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.56 -37.77 87.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.9 -44.31 90.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.51 -38.76 77.74 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.16 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -60.47 -46.72 89.05 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.136 0.974 . . . . 0.0 110.951 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.86 -21.17 59.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.229 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -77.31 -34.88 55.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.4 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.53 150.52 18.78 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.09 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 140.36 48.04 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -50.01 -52.33 34.91 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.175 0.99 . . . . 0.0 112.083 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.0 m -68.7 -29.99 68.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 HD12 ' A' ' 55' ' ' LEU . 97.2 t -72.32 -49.1 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -68.84 -35.11 76.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.946 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 9.6 mm-40 -57.14 -46.8 82.38 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 116.858 -0.156 . . . . 0.0 111.346 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -70.33 -37.09 74.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.791 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 79.4 mt -63.99 -41.33 97.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 31' ' ' VAL . 34.3 ttpt -60.09 -44.32 94.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 92.9 mttt -64.06 -35.45 80.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.632 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.4 mmtt -64.06 -39.61 94.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.592 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -63.65 -42.87 98.05 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 123.653 0.596 . . . . 0.0 109.558 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 27' ' ' LYS . 69.9 t -63.45 -45.96 96.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.537 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.7 pt-20 -69.76 -39.37 76.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.98 -29.89 48.3 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.73 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.724 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.2 mt -53.32 -24.44 11.82 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.6 pt-20 -66.07 -27.36 68.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.149 0.5 . . . . 0.0 110.699 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.545 ' O ' HG13 ' A' ' 39' ' ' ILE . 12.3 t -160.16 77.92 2.66 Favored Pre-proline 0 C--O 1.205 -1.253 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.32 -25.41 49.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.988 1.792 . . . . 0.0 112.785 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -87.3 60.74 6.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.284 1.04 . . . . 0.0 113.122 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 36' ' ' SER . 85.5 mt -89.96 115.93 30.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.606 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.59 -30.88 61.64 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 123.732 0.813 . . . . 0.0 112.493 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -18.33 61.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.967 0.413 . . . . 0.0 111.59 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.554 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.3 m-20 -103.16 -16.02 15.85 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -63.19 145.75 54.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.603 0.761 . . . . 0.0 112.559 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 91.9 mt -96.75 123.78 40.54 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 169.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -87.25 130.87 34.41 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.18 -34.01 6.06 Favored Glycine 0 C--N 1.306 -1.12 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 94.5 mmm -86.37 125.5 67.52 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -35.84 -66.56 0.11 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 124.733 3.622 . . . . 0.0 114.029 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 55.54 0.98 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.75 142.3 34.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 21.2 m-85 -135.04 152.19 51.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.29 139.96 53.25 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.103 178.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.6 mt -122.89 132.69 70.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -113.37 149.98 33.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.907 0.384 . . . . 0.0 111.961 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.49 HD12 HG13 ' A' ' 22' ' ' VAL . 15.4 mt -94.47 136.66 34.52 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -62.09 -32.21 72.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.462 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -71.68 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p -102.45 2.21 36.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.56 46.04 9.11 Favored Glycine 0 C--N 1.32 -0.319 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.86 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -97.25 145.45 26.07 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 54' ' ' LYS . 5.6 mpt_? -120.98 149.59 42.42 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.88 130.88 45.75 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.12 122.84 70.24 Favored 'Isoleucine or valine' 0 C--O 1.251 1.155 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 25.9 p90 -132.75 159.35 39.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.668 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -111.6 138.43 48.15 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.31 111.62 25.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.24 95.81 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.22 -31.0 71.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.133 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.0 -40.27 76.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.377 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HB2' HG12 ' A' ' 72' ' ' VAL . 53.1 mttm -107.65 -6.74 16.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.714 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t 65.83 33.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 122.881 1.324 . . . . 0.0 110.066 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.2 p -133.8 140.22 46.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 O-C-N 121.35 -0.844 . . . . 0.0 110.353 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.451 ' HB ' HD22 ' A' ' 5' ' ' LEU . 91.2 t -96.69 117.98 42.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -108.22 117.94 35.46 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.501 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -77.45 121.08 29.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.72 -41.89 13.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.573 0.701 . . . . 0.0 109.119 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -148.79 153.37 38.04 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.0 p -148.85 138.99 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.88 -114.8 0.64 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.38 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -127.82 155.73 43.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.516 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.227 0.537 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -81.17 -24.34 37.61 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.55 -35.49 80.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.958 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -72.04 -50.44 28.4 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.158 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.782 . . . . 0.0 113.05 -177.206 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.987 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.15 172.93 6.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.43 160.57 17.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.3 128.9 47.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -142.59 169.11 18.19 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -129.63 141.68 50.89 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.083 0.553 . . . . 0.0 110.178 -175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.59 154.9 41.1 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 4.6 pt-20 -61.31 -31.91 71.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.424 0.556 . . . . 0.0 110.634 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 75.3 mtt180 -63.81 -42.59 97.65 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.6 82.27 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.89 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.4 mt -63.8 -43.13 97.19 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.657 0.265 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -61.25 -43.73 98.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.368 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.21 -39.71 78.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.923 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -62.55 -43.73 98.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -75.58 -20.93 58.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.341 0.591 . . . . 0.0 110.893 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -74.54 -35.47 63.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.405 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD11 ' HA2' ' A' ' 79' ' ' GLY . 3.3 mp -62.59 156.95 21.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.376 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.33 149.85 47.71 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 22.8 t -57.86 -49.05 78.01 Favored 'General case' 0 C--O 1.205 -1.251 0 C-N-CA 122.555 0.342 . . . . 0.0 111.812 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.462 HG22 ' OE1' ' A' ' 25' ' ' GLN . 15.6 m -68.53 -38.19 80.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.38 -47.13 94.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.274 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.37 -35.29 79.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.333 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 20' ' ' SER . 44.5 mt-10 -63.51 -39.51 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.462 ' OE1' HG22 ' A' ' 21' ' ' THR . 2.0 mp0 -63.75 -41.29 98.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.401 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 93.0 mt -62.44 -41.98 99.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.06 -42.28 89.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 99.5 mttt -59.54 -36.98 77.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.678 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 53' ' ' ILE . 5.6 mptp? -69.0 -37.89 78.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.32 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.6 mt -62.51 -47.53 83.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.573 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.44 -41.08 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.319 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 13.1 pt-20 -69.65 -44.0 71.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.708 0.29 . . . . 0.0 111.709 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.7 -29.67 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.5 mt -53.05 -25.3 12.07 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.7 pt-20 -68.77 -26.81 65.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.122 0.419 . . . . 0.0 110.924 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -162.55 80.21 1.78 Allowed Pre-proline 0 C--O 1.212 -0.884 0 C-N-CA 123.138 0.575 . . . . 0.0 109.504 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -82.62 5.75 6.2 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.139 1.893 . . . . 0.0 112.662 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 36.15 0.87 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.328 0.585 . . . . 0.0 111.614 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.8 mt -81.89 105.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.33 -32.12 62.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.833 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.99 72.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.382 0.61 . . . . 0.0 110.929 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -94.17 -2.5 52.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.016 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -78.22 138.35 38.6 Favored 'General case' 0 N--CA 1.4 -2.948 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.09 155.55 21.45 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.666 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -87.12 122.66 31.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.4 83.68 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.58 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.6 mmm -111.15 131.44 22.2 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.18 95.13 0.17 Allowed 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 122.804 2.336 . . . . 0.0 112.362 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 48.16 45.99 19.7 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.696 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -102.58 141.29 35.64 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 58.4 m-85 -133.66 150.98 51.56 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 55.2 pttt -118.98 144.86 46.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.134 0.492 . . . . 0.0 110.569 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 29' ' ' LYS . 82.0 mt -109.39 132.9 56.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.93 137.75 40.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 124.06 0.85 . . . . 0.0 109.255 173.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.2 tt -88.9 -11.75 43.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 74.27 -62.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.502 1.521 . . . . 0.0 111.29 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -75.59 -59.77 2.6 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -68.61 -25.9 65.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.55 49.16 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.197 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -98.75 149.19 23.1 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 120.837 0.351 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 mpt_? -131.51 144.22 50.96 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.812 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -127.01 127.72 45.23 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.33 123.17 69.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-O 121.073 0.463 . . . . 0.0 110.009 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.1 p90 -133.57 159.51 40.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 30.2 pt20 -111.89 140.82 46.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.47 111.46 25.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.1 mt -97.8 95.45 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.07 -29.23 63.92 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.416 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.58 -40.55 87.75 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.5 mttm -98.37 -7.15 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.334 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.87 36.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.775 1.274 . . . . 0.0 109.237 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 70' ' ' LYS . 11.3 p -134.22 138.72 49.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.71 115.34 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -111.34 112.82 24.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.03 124.96 33.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.1 mt -98.03 -41.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.461 0.648 . . . . 0.0 110.095 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.1 m -148.11 151.55 35.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.219 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.43 147.57 16.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' HD11 ' A' ' 18' ' ' LEU . . . 146.92 -124.23 1.93 Allowed Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -123.09 167.67 13.36 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 121.495 0.664 . . . . 0.0 109.306 -175.352 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -82.87 -41.57 18.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -58.79 -43.67 90.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.834 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.21 -49.86 70.32 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.861 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.275 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -134.43 167.23 21.14 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.45 157.77 24.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -125.69 122.56 36.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -140.41 169.34 17.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -129.89 147.9 51.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.69 154.46 38.83 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -32.53 72.51 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.452 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 57.5 mtp180 -72.8 -34.21 66.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.716 0.293 . . . . 0.0 111.034 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.04 79.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 mt -66.99 -43.54 82.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.924 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 89.2 mttt -59.49 -44.59 93.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.269 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 16.7 mm-40 -69.5 -37.67 77.29 Favored 'General case' 0 C--O 1.202 -1.406 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.5 -42.5 96.47 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 110.132 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.86 -24.11 58.52 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.096 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -78.3 -29.64 47.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.375 1.07 . . . . 0.0 111.175 177.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mp -63.67 161.11 15.55 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.71 0.804 . . . . 0.0 111.322 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.77 145.37 33.83 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -46.6 64.95 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.149 0.98 . . . . 0.0 111.287 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 m -62.43 -46.54 88.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.173 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -47.29 85.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.713 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.5 ptt180 -67.01 -35.04 79.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.077 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 35.4 mt-10 -59.71 -39.12 83.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.072 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.07 -39.32 79.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.831 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.3 mt -63.04 -43.83 97.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.684 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 27' ' ' LYS . 19.4 ptmt -64.22 -34.04 77.18 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.1 mttm -58.79 -43.87 90.58 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.8 mptp? -66.62 -34.69 78.44 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.8 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 82.1 mt -61.82 -47.96 82.75 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.576 0.547 . . . . 0.0 110.491 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.22 -40.92 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -68.76 -42.91 76.84 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.99 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 65.4 mt -54.78 -26.35 33.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 pt-20 -79.16 -18.76 52.53 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.492 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.9 m -157.47 67.47 3.92 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 123.027 0.531 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.82 -0.34 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.847 0 C-N-CA 122.112 1.875 . . . . 0.0 114.218 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 25.75 0.23 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -82.31 100.33 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.642 0.734 . . . . 0.0 110.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.93 -20.42 57.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.626 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.76 64.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.431 0.634 . . . . 0.0 110.813 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -104.27 -1.22 27.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.364 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -84.22 138.88 32.72 Favored 'General case' 0 N--CA 1.404 -2.73 0 CA-C-O 121.357 0.598 . . . . 0.0 112.009 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -91.49 124.55 35.75 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.869 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.93 120.41 28.17 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.859 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.92 46.37 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.9 mmm -117.58 131.42 24.09 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.03 94.4 0.16 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.773 2.316 . . . . 0.0 112.937 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 45.57 50.05 10.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 125.117 1.367 . . . . 0.0 113.532 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 59.2 m -100.28 142.01 32.34 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.428 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 59.3 m-85 -133.28 154.99 50.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -126.15 147.44 49.62 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.893 0.854 . . . . 0.0 112.653 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 78.5 mt -109.19 141.57 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 138.41 41.6 Favored 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 123.213 0.32 . . . . 0.0 110.3 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 55' ' ' LEU . 13.0 mt -79.73 161.94 25.47 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.967 0.413 . . . . 0.0 111.139 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 -99.46 -40.91 7.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -88.78 0.22 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -152.57 163.7 39.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.21 29.82 10.62 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.022 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -83.02 136.56 34.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.088 0.471 . . . . 0.0 110.99 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.3 mpt_? -128.31 149.63 50.42 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.112 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -129.9 125.15 34.88 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.07 127.65 72.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 16.8 p90 -136.01 158.62 43.97 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.271 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HB3' HD11 ' A' ' 76' ' ' ILE . 28.7 pt20 -112.81 139.6 48.3 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.4 t -93.22 111.7 25.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.69 95.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.13 -30.95 65.55 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.074 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.65 -32.51 71.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.114 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -100.02 -3.26 32.47 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.334 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.24 25.1 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 CA-C-O 122.451 1.119 . . . . 0.0 110.403 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.55 138.83 52.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.985 -1.072 . . . . 0.0 111.281 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.2 t -97.96 117.37 42.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -107.57 114.56 28.63 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.351 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.96 121.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 65' ' ' GLN . 57.8 mt -95.84 -42.86 12.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.406 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 m -150.41 150.34 31.24 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.116 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.2 136.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -130.6 2.36 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -113.55 165.9 12.04 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 117.505 0.652 . . . . 0.0 111.01 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.656 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.214 -0.765 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -85.22 -47.33 10.2 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.056 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 p -66.57 -36.44 82.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.438 0.637 . . . . 0.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.57 -44.64 86.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.461 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.589 -179.235 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.11 169.87 9.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.687 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -92.88 162.1 14.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -126.53 125.12 41.49 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -130.27 151.61 50.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.21 135.48 54.66 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.642 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 18.0 t70 -71.45 154.09 41.77 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.83 -32.48 69.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.304 0.502 . . . . 0.0 112.164 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.642 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 7.7 ptm180 -62.64 -39.22 93.18 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.194 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 -38.61 84.23 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.079 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.25 -43.5 97.83 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 122.579 0.351 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -63.01 -43.99 97.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.989 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.4 mm-40 -69.38 -37.17 77.44 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.05 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -60.62 -42.72 97.43 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 124.419 1.088 . . . . 0.0 110.224 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -74.63 -23.68 58.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.693 0.759 . . . . 0.0 110.194 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 85.4 tttt -74.44 -21.57 59.54 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.9 1.28 . . . . 0.0 109.864 177.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -76.75 165.26 24.96 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.386 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.13 154.16 40.58 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 p -55.21 -46.72 75.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 12.0 m -69.52 -42.45 74.65 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.39 -47.89 91.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.355 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 24' ' ' GLU . 9.8 ptt180 -63.29 -41.44 98.97 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 23' ' ' ARG 0.324 42.6 mt-10 -67.84 -33.63 75.15 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 21' ' ' THR . 30.4 mm-40 -60.05 -44.43 94.69 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -66.93 -41.51 86.9 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.323 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 33.3 ttpt -56.99 -43.59 81.87 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -58.95 -41.82 88.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.565 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.18 -38.31 87.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.545 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.5 mt -64.7 -47.31 78.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.534 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.42 -40.87 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.377 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.5 pt-20 -69.73 -42.88 73.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.78 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.43 -30.99 51.2 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 C-N-CA 122.392 0.277 . . . . 0.0 111.201 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 73.4 mt -54.5 -26.36 31.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.9 pt-20 -67.58 -26.52 66.32 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.658 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p -162.9 77.66 1.85 Allowed Pre-proline 0 N--CA 1.436 -1.132 0 C-N-CA 122.685 0.394 . . . . 0.0 111.483 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.11 12.12 1.59 Allowed 'Trans proline' 0 C--O 1.209 -0.937 0 C-N-CA 122.891 2.394 . . . . 0.0 113.554 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.52 28.16 0.78 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 111.836 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.7 94.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.771 0.796 . . . . 0.0 110.119 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.25 -23.29 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.041 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.97 66.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.129 0.49 . . . . 0.0 110.772 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.17 -8.09 18.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -75.71 136.53 40.35 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.482 0.658 . . . . 0.0 112.658 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.508 HD21 ' HD3' ' A' ' 52' ' ' LYS . 92.1 mt -81.44 139.45 35.23 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.793 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -92.03 121.31 33.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.35 58.4 Favored Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.991 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 81.3 mmm -126.26 131.32 23.91 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.43 90.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.228 2.618 . . . . 0.0 113.419 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 49.55 44.61 24.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.911 1.684 . . . . 0.0 112.629 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -100.18 142.74 31.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.571 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 22.4 m-85 -129.74 152.85 48.79 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HD3' HD21 ' A' ' 44' ' ' LEU . 55.6 pttt -125.93 139.82 53.14 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.574 0.546 . . . . 0.0 109.569 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.18 144.71 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -123.26 140.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.0 tt -83.08 137.22 34.18 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -74.34 -57.35 4.0 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -61.37 -63.84 1.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.592 0.557 . . . . 0.0 110.709 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 5.5 p -103.86 122.94 46.18 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.5 73.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.67 0 O-C-N 123.837 0.71 . . . . 0.0 114.537 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.67 144.53 36.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -125.52 150.68 47.2 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.75 133.15 39.59 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.01 127.66 75.97 Favored 'Isoleucine or valine' 0 C--O 1.255 1.362 0 C-N-CA 123.169 0.588 . . . . 0.0 109.431 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 12.9 p90 -138.32 158.63 43.91 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 28.3 pt20 -109.55 141.0 42.67 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.7 112.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.47 94.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.38 -25.22 62.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.617 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.09 -41.25 92.09 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.134 0.897 . . . . 0.0 110.142 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -105.72 -3.43 22.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.155 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t 65.19 34.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 122.66 1.219 . . . . 0.0 109.437 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.91 138.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.37 122.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -110.23 110.58 21.47 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.353 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.15 127.74 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.509 HG21 ' HA ' ' A' ' 90' ' ' ALA . 19.6 mt -110.73 -42.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.954 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -133.75 140.38 46.94 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.72 135.89 12.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.38 -146.5 18.12 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -95.25 140.17 30.53 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.532 0.666 . . . . 0.0 109.358 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -77.42 -50.45 12.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -62.34 -42.91 99.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.294 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.09 -30.49 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 110.381 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.509 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.913 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.909 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.05 159.64 15.34 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -81.13 160.58 24.38 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 34' ' ' LEU . 1.1 tm? -125.68 127.95 47.04 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -138.92 155.16 48.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.6 143.15 45.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.73 156.36 32.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.6 pt-20 -53.51 -37.14 62.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.913 0.485 . . . . 0.0 110.975 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -70.43 -44.79 67.15 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.79 70.25 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.613 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.08 -36.92 75.29 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.787 0.327 . . . . 0.0 111.681 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 57.3 mttm -67.98 -43.86 77.98 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -67.56 -39.32 84.94 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -60.9 -38.5 85.93 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.842 0.857 . . . . 0.0 109.999 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -73.15 -37.81 66.46 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.655 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -74.88 -16.34 60.68 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.721 0.772 . . . . 0.0 111.131 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 149.63 38.27 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.486 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.14 139.35 42.26 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 16.4 m -50.97 -46.48 61.24 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.918 0.887 . . . . 0.0 111.227 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 43.2 m -62.88 -43.22 99.37 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.06 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.21 -47.09 79.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.731 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.9 ptt180 -66.41 -33.92 76.79 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.016 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 26.5 mm-40 -60.24 -41.08 92.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 118.111 0.414 . . . . 0.0 111.136 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 21' ' ' THR . 73.9 mm-40 -65.76 -46.56 78.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.6 mt -61.47 -40.67 95.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.065 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.7 ttpt -57.25 -44.63 84.06 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.174 0.59 . . . . 0.0 110.245 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.3 mttt -57.7 -43.39 85.15 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.4 mptp? -62.34 -40.54 96.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.703 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -62.94 -45.73 91.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 123.516 0.51 . . . . 0.0 109.767 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 27' ' ' LYS . 62.5 t -64.49 -45.1 96.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.451 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.4 pt-20 -68.86 -44.06 74.11 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.621 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 37' ' ' PRO . 3.4 p -62.22 -29.78 47.37 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 123.327 0.651 . . . . 0.0 112.099 -173.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 87.9 mt -53.03 -25.36 12.14 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.37 -22.09 59.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.723 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -164.52 78.78 1.42 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 121.308 0.575 . . . . 0.0 111.683 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.5 Cg_endo -85.89 -9.73 7.46 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.384 2.056 . . . . 0.0 112.764 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.62 34.16 0.48 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.623 0.725 . . . . 0.0 112.956 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -83.25 110.57 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.819 0.818 . . . . 0.0 109.16 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -55.02 -29.34 57.18 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 126.246 1.818 . . . . 0.0 113.303 -175.084 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.23 -13.81 62.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -111.44 8.25 21.11 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.986 -0.446 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 17.2 ptmt -89.58 147.47 23.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.072 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 96.3 mt -69.91 155.69 40.19 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.46 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.64 -55.29 36.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.68 23.22 7.12 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.011 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.471 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -102.12 132.37 21.6 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 122.548 -0.384 . . . . 0.0 110.632 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.87 95.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.273 2.649 . . . . 0.0 112.642 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 50.83 47.06 25.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 113.015 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.0 m -106.64 141.09 38.48 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 38.5 m-85 -128.7 153.33 47.44 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 139.69 43.91 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.168 0.509 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.36 131.26 61.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.86 140.86 36.59 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -94.76 112.77 24.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -78.71 81.81 4.98 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.184 0.516 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 m -165.57 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.116 1.366 . . . . 0.0 109.137 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -161.17 179.17 8.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.04 51.78 4.15 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 121.108 -0.568 . . . . 0.0 114.397 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -108.14 142.64 38.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 151.05 38.27 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 123.689 0.796 . . . . 0.0 109.17 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.62 128.13 50.27 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.08 124.79 70.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.061 0 O-C-N 123.619 0.574 . . . . 0.0 110.248 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.3 p90 -136.67 158.83 43.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.4 pt20 -108.86 137.99 45.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.92 114.77 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.01 95.6 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.58 -36.61 84.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.722 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -60.93 -30.14 70.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.5 mttm -108.28 -5.32 16.86 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.627 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t 60.79 39.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.707 1.241 . . . . 0.0 109.624 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.5 p -132.31 139.01 51.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 121.335 -0.853 . . . . 0.0 111.173 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.63 115.39 42.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -110.63 111.62 22.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 61.1 t -75.45 122.49 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.528 HG21 ' HA ' ' A' ' 90' ' ' ALA . 48.4 mt -100.17 -42.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.204 0.526 . . . . 0.0 110.409 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m -147.98 149.85 32.92 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 122.152 -0.342 . . . . 0.0 110.43 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.14 139.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.97 -144.03 12.98 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.7 155.31 16.83 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.016 0.408 . . . . 0.0 110.022 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--O 1.214 -0.779 0 CA-C-O 120.724 0.297 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.94 -41.48 67.75 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -59.27 -51.15 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.981 0.8 . . . . 0.0 110.833 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.41 -35.67 73.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.539 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.04 168.85 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.11 160.13 14.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.86 132.36 52.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -141.79 156.86 45.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.67 147.59 41.81 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.035 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.04 154.77 40.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -32.42 72.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.626 0.25 . . . . 0.0 110.863 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -66.99 -46.53 74.3 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.552 0.691 . . . . 0.0 109.598 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.15 75.42 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.219 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.57 -40.83 96.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.024 0.44 . . . . 0.0 111.326 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.48 -43.4 85.53 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.58 -37.29 76.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.274 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.49 1.116 . . . . 0.0 110.824 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -74.69 -23.14 58.58 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.915 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.82 -40.32 61.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.128 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mp -58.95 147.11 35.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 124.541 1.136 . . . . 0.0 112.725 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -70.49 146.49 42.32 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.666 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 m -52.75 -45.88 67.24 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.058 0.943 . . . . 0.0 112.213 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 m -68.4 -36.7 79.5 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.893 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.14 -47.18 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.277 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.8 ptt180 -67.38 -33.83 76.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.186 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.07 -48.68 75.61 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.615 0.189 . . . . 0.0 110.702 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HB2' HD11 ' A' ' 55' ' ' LEU . 36.7 mt-30 -57.85 -41.97 83.47 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.014 0.821 . . . . 0.0 110.546 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.575 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 96.6 mt -66.65 -45.15 79.9 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.186 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.8 -44.2 94.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.515 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 94.9 mttt -62.97 -35.14 79.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.198 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.74 -35.03 72.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.81 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 mt -68.61 -46.12 70.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.04 -39.91 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.245 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.1 pt-20 -69.19 -42.8 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.2 p -63.87 -29.71 48.02 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.207 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 94.4 mt -53.73 -25.04 16.78 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.4 pt-20 -80.39 -19.71 45.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.078 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -155.2 70.99 5.66 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.839 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HB2' HG21 ' A' ' 66' ' ' VAL . 79.0 Cg_endo -77.3 -14.3 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.528 1.485 . . . . 0.0 111.606 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -83.11 61.08 5.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.71 0.767 . . . . 0.0 112.833 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -101.95 110.59 29.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.025 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.48 -22.04 66.84 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.51 -19.89 60.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 111.536 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -107.04 -7.6 16.86 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.013 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -70.35 133.64 47.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 123.568 0.747 . . . . 0.0 110.269 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.3 121.61 28.28 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -64.04 123.38 18.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.254 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.26 -29.4 8.91 Favored Glycine 0 C--N 1.324 -0.129 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.698 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.9 mmm -75.8 139.53 70.18 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 122.817 0.447 . . . . 0.0 110.053 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.92 90.88 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.869 2.379 . . . . 0.0 112.603 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 46.54 46.09 14.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 125.159 1.384 . . . . 0.0 113.014 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.5 m -99.88 142.34 31.5 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.569 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.3 m-85 -133.92 151.55 51.54 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -120.47 140.41 51.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 123.447 0.467 . . . . 0.0 110.62 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.01 134.94 61.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 157.86 17.68 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.479 0.487 . . . . 0.0 111.9 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 58' ' ' SER . 9.0 tp -94.11 166.06 12.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.501 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 37.9 mmt180 -90.22 -55.15 3.72 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.259 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 m -58.03 -59.86 4.63 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.539 ' H ' HD23 ' A' ' 55' ' ' LEU . 66.7 m -133.59 -177.42 4.54 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 122.069 -0.394 . . . . 0.0 110.692 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.75 62.83 4.46 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -103.32 139.66 38.45 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.522 HH11 ' HB3' ' A' ' 81' ' ' ALA . 2.9 mpt_? -136.26 142.93 44.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.15 0.5 . . . . 0.0 109.775 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -119.98 129.02 54.09 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.27 126.49 73.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.9 p90 -135.44 159.23 42.24 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.617 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 28.2 pt20 -109.09 140.66 42.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 37' ' ' PRO . 90.2 t -100.45 111.89 31.48 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mt -97.11 94.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.31 -29.84 68.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.168 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.2 -38.9 74.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.779 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -108.65 2.61 22.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.195 0.522 . . . . 0.0 111.374 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 t 61.54 34.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.824 1.249 . . . . 0.0 109.957 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.93 138.83 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.292 -0.88 . . . . 0.0 111.513 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -98.27 115.75 39.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -110.86 114.75 28.33 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.623 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.09 123.94 29.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.5 -42.49 11.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.096 0.474 . . . . 0.0 110.485 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 m -146.83 145.78 29.99 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.096 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.1 141.38 17.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.73 -152.93 24.6 Favored Glycine 0 CA--C 1.497 -1.05 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -91.44 149.04 21.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.522 ' HB3' HH11 ' A' ' 61' ' ' ARG . . . . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.292 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.08 -42.09 10.14 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.233 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 m -68.09 -45.22 74.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.152 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -29.66 63.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.591 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.733 179.06 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -116.47 172.31 7.29 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -87.23 156.92 19.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.25 127.92 50.51 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.87 155.17 50.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.61 133.58 54.99 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 33.9 t70 -71.99 151.94 42.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pp20? -58.55 -34.34 70.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.0 mtt180 -69.69 -44.91 69.46 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.17 73.38 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 17.0 tp -72.3 -34.84 68.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.9 mttm -66.41 -42.09 88.3 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 36.0 mm-40 -63.65 -39.15 93.63 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -60.87 -39.56 89.65 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.09 1.356 . . . . 0.0 110.754 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 88.3 mtt180 -74.55 -32.75 62.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -72.81 -28.12 62.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 110.842 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -63.77 152.76 38.49 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.33 0.652 . . . . 0.0 112.103 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -68.78 143.37 39.97 Favored Glycine 0 N--CA 1.424 -2.119 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.602 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 8.1 m -48.99 -54.55 15.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.584 1.154 . . . . 0.0 112.411 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.8 m -64.66 -34.77 79.07 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.879 0.472 . . . . 0.0 110.713 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.83 -48.18 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 6.1 ptt180 -68.57 -35.54 77.54 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 20' ' ' SER . 54.1 mt-10 -58.03 -50.06 74.72 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.992 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -63.28 -35.3 79.91 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.213 0.32 . . . . 0.0 111.691 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.4 mt -66.77 -44.94 80.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.987 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.82 -41.98 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.5 mttt -59.47 -35.44 74.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.146 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.5 mptp? -70.96 -35.81 72.3 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.144 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.6 mt -66.32 -46.27 77.44 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.754 0.312 . . . . 0.0 110.897 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.83 -38.54 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.43 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 pt-20 -69.99 -43.43 71.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.85 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -63.08 -30.12 48.9 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.478 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 77.2 mt -54.18 -25.38 22.36 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -84.0 -8.54 59.11 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.022 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 39' ' ' ILE . 26.8 p -159.29 62.19 1.99 Allowed Pre-proline 0 C--O 1.206 -1.185 0 C-N-CA 124.038 0.935 . . . . 0.0 110.576 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 33' ' ' VAL . 73.0 Cg_endo -75.01 -20.6 16.69 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.777 1.651 . . . . 0.0 113.752 -172.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -89.69 54.76 2.97 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.148 0.975 . . . . 0.0 113.247 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 36' ' ' SER . 98.1 mt -83.19 110.86 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.732 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.15 -27.18 68.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.74 68.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.088 0.471 . . . . 0.0 111.067 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.02 -1.44 57.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.987 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 8.3 mtpm? -62.74 146.55 52.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.62 173.02 12.75 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.459 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -85.75 -55.02 4.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.33 52.51 0.82 Allowed Glycine 0 CA--C 1.5 -0.887 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.299 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.407 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 96.9 mmm -135.78 132.34 19.47 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.53 102.25 0.34 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.906 2.404 . . . . 0.0 113.309 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.8 35.3 24.22 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 124.347 1.059 . . . . 0.0 111.952 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 63.5 m -101.65 141.23 34.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.245 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.621 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 18.4 m-85 -131.75 153.66 49.84 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 47.9 pttt -126.5 140.35 52.53 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.41 0.624 . . . . 0.0 111.246 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.48 129.26 65.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -110.39 133.51 53.2 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.44 96.32 10.33 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -44.82 -41.77 7.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 126.598 1.959 . . . . 0.0 113.963 -172.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -82.38 -44.36 16.23 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 m -77.31 -36.0 54.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.7 14.63 49.25 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.354 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.99 158.26 15.54 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.75 147.59 33.14 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.461 0.648 . . . . 0.0 111.843 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -119.59 126.98 52.5 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.63 123.34 66.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 121.032 0.444 . . . . 0.0 110.297 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -133.82 157.63 45.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.677 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HB3' HD11 ' A' ' 76' ' ' ILE . 20.6 pt20 -107.71 131.67 54.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.53 111.05 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 70' ' ' LYS . 31.8 mt -99.04 96.01 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.32 -32.77 73.96 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.34 -35.52 74.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.082 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.423 ' H ' HG22 ' A' ' 67' ' ' ILE . 99.3 mttt -104.46 -2.41 25.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.53 33.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.525 1.13 . . . . 0.0 109.754 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.15 138.99 50.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 O-C-N 121.161 -0.962 . . . . 0.0 111.304 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -99.14 114.81 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 81.8 t80 -107.94 111.21 23.19 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.469 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -73.15 121.43 23.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.455 HG21 ' HA ' ' A' ' 90' ' ' ALA . 29.8 mt -98.09 -42.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.613 0.571 . . . . 0.0 110.373 -174.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 t -153.38 151.85 30.4 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.11 138.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.15 -139.86 8.43 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.394 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -101.83 158.7 15.93 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.999 0.428 . . . . 0.0 109.921 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.845 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.77 -48.59 16.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.272 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.7 m -60.95 -42.93 99.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.557 0.536 . . . . 0.0 110.828 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -68.35 -35.83 78.33 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.91 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 CA--C 1.503 -0.865 0 CA-C-O 121.169 0.509 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.35 167.09 9.97 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.738 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.51 153.39 24.43 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 30' ' ' LEU . 1.9 tm? -125.56 124.39 41.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.65 156.05 49.46 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.413 0.625 . . . . 0.0 110.385 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.88 134.95 47.14 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.27 142.34 57.78 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 10.1 pt-20 -56.27 -31.32 63.5 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -72.34 -40.11 67.63 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.274 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.27 -31.19 70.48 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.869 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -68.16 -34.91 77.2 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.3 mttm -63.61 -42.8 98.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.893 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 42.0 mm-40 -68.69 -37.47 79.59 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.088 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -60.68 -45.01 95.77 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.83 0.852 . . . . 0.0 110.643 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -74.78 -21.18 59.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.587 0.708 . . . . 0.0 110.175 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 80.2 tttt -74.86 -25.43 58.96 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.79 1.236 . . . . 0.0 110.154 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 14' ' ' GLU . 5.5 mp -68.06 168.07 12.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.253 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.03 -138.68 1.56 Allowed Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.056 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -106.5 -60.47 1.65 Allowed 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.585 -0.95 . . . . 0.0 108.86 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -52.23 -43.36 64.24 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.93 1.292 . . . . 0.0 113.096 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.13 -48.35 79.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.135 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -69.08 -33.91 74.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -56.07 -45.96 79.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.444 ' HB3' HD21 ' A' ' 55' ' ' LEU . 45.8 mt-30 -70.61 -38.98 74.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.953 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 92.5 mt -63.46 -44.04 95.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.36 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -58.87 -43.2 90.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.186 0.517 . . . . 0.0 110.346 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.512 ' HA ' HG12 ' A' ' 31' ' ' VAL . 97.8 mttt -62.89 -37.7 87.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.9 mptp? -64.32 -37.57 87.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.582 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.1 mt -68.36 -45.28 73.26 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 28' ' ' LYS . 7.8 p -68.75 -36.21 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.799 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -68.75 -44.94 72.7 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 37' ' ' PRO . 3.7 p -62.93 -30.66 50.1 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.124 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.627 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 71.0 mt -53.91 -25.62 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 8.1 pt-20 -64.48 -28.85 69.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.084 0.856 . . . . 0.0 111.19 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -160.1 77.5 2.72 Favored Pre-proline 0 C--O 1.206 -1.207 0 C-N-CA 124.059 0.944 . . . . 0.0 108.493 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 33' ' ' VAL . 89.8 Cg_endo -85.25 -1.27 9.21 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.679 2.253 . . . . 0.0 113.537 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 40.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.549 0.69 . . . . 0.0 110.885 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.15 100.88 5.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.359 1.076 . . . . 0.0 110.352 -173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -55.42 -27.48 48.15 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.706 2.003 . . . . 0.0 112.509 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.23 61.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.064 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.73 1.47 17.88 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -80.25 135.63 36.28 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 121.07 0.462 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.8 mt -82.68 122.87 28.7 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.595 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -89.27 120.03 30.26 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.09 6.77 42.07 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 95.2 mmm -127.0 138.68 33.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' MET . 14.1 Cg_exo -67.2 95.13 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.601 2.201 . . . . 0.0 112.971 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 52.5 39.02 27.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.041 1.337 . . . . 0.0 113.573 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.5 m -99.99 142.49 31.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.9 m-85 -132.4 156.24 47.04 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -133.37 141.97 48.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.27 0.557 . . . . 0.0 112.402 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.78 122.85 68.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 128.61 49.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.423 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 25' ' ' GLN . 1.3 tm? -76.12 102.95 5.93 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 -173.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -56.44 -39.58 73.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -88.26 20.38 3.28 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -156.05 -45.53 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.668 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.99 22.5 7.21 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.672 -1.251 . . . . 0.0 112.341 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -95.69 154.09 17.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 122.222 -0.575 . . . . 0.0 109.818 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -122.95 135.62 54.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.74 124.95 34.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -117.07 128.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.6 p90 -133.48 158.16 43.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.747 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HB3' HD11 ' A' ' 76' ' ' ILE . 20.5 pt20 -105.46 138.19 42.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.63 111.2 34.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.1 mt -97.35 101.75 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.01 -36.57 80.18 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.561 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.64 -40.31 96.59 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.17 -6.05 42.62 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.6 t 58.49 37.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.429 1.109 . . . . 0.0 109.711 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.1 140.31 40.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 121.365 -0.834 . . . . 0.0 110.902 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.83 124.99 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 124.461 1.104 . . . . 0.0 108.771 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.08 116.92 29.91 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.7 t -68.99 121.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 65' ' ' GLN . 59.0 mt -96.28 -43.11 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.993 0.425 . . . . 0.0 110.638 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 p -141.3 143.5 34.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 120.877 0.37 . . . . 0.0 110.567 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.1 141.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.22 -140.24 7.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -116.71 155.44 28.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.351 0.575 . . . . 0.0 110.002 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.768 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -79.75 -44.92 19.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -62.84 -43.15 99.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.853 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.1 -28.18 68.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.847 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.158 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -118.33 168.57 10.5 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -99.03 163.17 12.69 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 123.062 0.226 . . . . 0.0 111.172 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.11 130.96 53.17 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.52 149.6 46.89 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.91 134.85 46.14 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 20.2 t70 -72.05 153.43 41.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.96 -32.53 66.13 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -68.27 -42.25 79.85 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.12 75.25 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.737 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.0 mt -69.84 -39.29 76.51 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.443 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -62.36 -44.29 96.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.068 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 32.5 mt-10 -70.01 -37.51 75.69 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.066 0.46 . . . . 0.0 111.4 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -62.37 -42.0 99.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 123.737 0.815 . . . . 0.0 110.33 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -75.24 -23.26 57.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 48.5 tttp -67.84 -45.4 74.75 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 14' ' ' GLU . 6.5 mp -58.69 151.15 21.6 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.623 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -75.42 152.12 42.7 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.5 t -52.44 -53.24 47.95 Favored 'General case' 0 C--O 1.201 -1.454 0 C-N-CA 123.058 0.543 . . . . 0.0 111.291 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.0 m -57.82 -38.0 74.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 123.507 0.723 . . . . 0.0 111.577 -176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -72.18 -47.87 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 109.944 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 9.2 ptt180 -68.45 -34.57 76.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.4 mt-10 -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.817 0.447 . . . . 0.0 111.599 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -66.01 -35.31 80.21 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.673 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.5 mt -67.24 -43.43 81.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.667 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -59.33 -44.37 92.63 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 110.5 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 90.5 mttt -62.49 -35.1 78.29 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.555 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.6 mptp? -65.71 -39.56 91.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.869 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.3 mt -61.63 -44.61 96.67 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 27' ' ' LYS . 87.9 t -61.67 -45.31 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.84 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -69.65 -42.49 74.18 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.746 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.9 p -62.59 -29.67 47.44 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.7 mt -53.16 -25.77 14.73 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.5 pt-20 -66.24 -28.92 69.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.491 0.662 . . . . 0.0 110.966 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.4 m -158.42 76.66 3.47 Favored Pre-proline 0 C--N 1.315 -0.894 0 C-N-CA 124.227 1.011 . . . . 0.0 108.805 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 33' ' ' VAL . 61.1 Cg_endo -75.59 -24.43 11.93 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.472 1.448 . . . . 0.0 111.466 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 2.4 ppt_? -78.38 62.57 3.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.166 0.984 . . . . 0.0 112.907 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.84 124.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.25 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -35.94 67.37 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.16 0.984 . . . . 0.0 112.263 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.62 -15.98 61.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.549 0.69 . . . . 0.0 111.399 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.4 m-20 -104.68 -7.0 19.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 21.8 ttmt -85.9 138.59 31.92 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -172.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -86.45 129.09 34.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.948 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -74.87 116.52 15.68 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.847 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.49 49.66 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.862 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.1 mmm -101.93 137.18 19.45 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.07 95.16 0.14 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 123.205 2.604 . . . . 0.0 112.71 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 45.86 46.27 12.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 125.015 1.326 . . . . 0.0 113.012 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.38 141.61 33.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 43' ' ' LYS . 79.6 m-85 -131.66 145.84 51.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.424 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -115.86 141.15 48.48 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 123.618 0.573 . . . . 0.0 110.066 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.13 138.44 51.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -119.42 132.78 55.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.285 0.366 . . . . 0.0 110.389 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 tt -84.27 117.78 23.76 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -51.74 -57.28 9.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -76.12 -53.59 8.09 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.184 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -63.86 -34.84 78.84 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.67 26.68 49.63 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.327 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.54 150.33 20.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -123.5 141.53 51.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -126.3 131.89 51.77 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.18 122.72 67.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 CA-C-O 121.405 0.621 . . . . 0.0 110.494 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -131.78 157.97 42.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.055 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.16 139.77 48.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 73' ' ' VAL . 77.5 t -88.63 112.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 mt -98.54 95.64 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.466 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.26 -35.76 76.25 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.28 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -104.8 -1.31 26.27 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.013 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t 59.14 33.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.378 0 CA-C-O 122.722 1.248 . . . . 0.0 110.267 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.04 141.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.528 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 66' ' ' VAL . 17.6 m -98.17 128.07 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.112 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 87.1 t80 -103.09 110.04 21.83 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.401 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -75.52 120.79 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.4 mt -95.06 -42.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.341 0.591 . . . . 0.0 109.521 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.7 m -153.0 153.31 32.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.014 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.06 148.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.81 -111.86 0.72 Allowed Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.3 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -124.59 142.81 51.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.533 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.204 -1.292 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -92.31 -52.08 4.85 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -61.46 -49.91 74.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.49 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.98 -29.55 67.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.298 -179.102 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -87.47 164.91 15.9 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.652 0.595 . . . . 0.0 109.544 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.4 157.48 22.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.449 HD23 HD21 ' A' ' 34' ' ' LEU . 1.3 tm? -126.16 128.55 47.46 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -140.37 157.13 46.01 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.18 142.23 49.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 122.395 0.278 . . . . 0.0 110.433 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.69 155.02 40.19 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.49 -29.64 67.99 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 12.6 mmt85 -71.75 -43.02 66.52 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.32 81.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.04 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.6 mt -63.16 -43.26 98.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 110.774 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.212 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 37.3 mm-40 -68.36 -37.54 80.57 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 123.528 0.517 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.69 -45.11 94.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.064 0.945 . . . . 0.0 111.033 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.3 -22.71 57.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.858 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -77.09 -31.67 56.1 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.427 1.491 . . . . 0.0 110.732 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.71 152.2 27.35 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.932 0.893 . . . . 0.0 111.786 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -69.49 147.19 45.1 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 15.0 m -49.18 -54.6 15.73 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.289 1.035 . . . . 0.0 112.455 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -63.54 -34.55 78.04 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.277 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.83 -48.85 61.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 7.3 ptt180 -69.24 -35.58 76.29 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 43.2 mt-10 -57.15 -49.46 75.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 120.45 0.166 . . . . 0.0 110.6 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.59 ' HB3' HD11 ' A' ' 55' ' ' LEU . 2.9 mp0 -68.51 -34.98 76.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.1 mt -66.91 -42.77 84.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.56 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -59.05 -41.9 89.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.185 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.4 mttt -59.23 -41.29 88.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.1 mptp? -64.32 -34.79 78.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.158 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -68.92 -47.31 66.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.44 -38.63 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.886 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 10.5 pt-20 -68.31 -43.14 78.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.945 0.402 . . . . 0.0 110.563 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.7 p -64.47 -30.56 50.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.838 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.8 mt -54.03 -25.46 21.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 14.6 pt-20 -75.17 -25.45 58.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.058 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.0 p -158.09 74.46 3.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.702 0.401 . . . . 0.0 110.125 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' HG22 ' A' ' 33' ' ' VAL . 94.3 Cg_endo -85.04 -1.34 9.37 Favored 'Trans proline' 0 C--O 1.206 -1.106 0 C-N-CA 122.057 1.838 . . . . 0.0 113.796 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 32.78 0.74 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.55 112.37 20.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -57.75 -29.04 64.46 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.82 -15.94 63.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.953 0.406 . . . . 0.0 111.725 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -102.41 -1.63 30.38 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.743 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.499 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 42.5 mtpt -74.03 144.67 45.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.084 0.469 . . . . 0.0 111.474 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 59.7 mt -74.41 133.46 42.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -73.26 107.61 5.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 32.41 9.23 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.736 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.551 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 77.2 mmm -133.98 142.72 44.45 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 47' ' ' MET . 9.5 Cg_exo -70.64 93.47 0.6 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.765 2.31 . . . . 0.0 112.714 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 50.0 41.73 23.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 124.993 1.317 . . . . 0.0 113.986 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 m -100.31 141.58 32.96 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.1 m-85 -130.01 146.24 51.68 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -115.14 140.4 49.11 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.28 0.562 . . . . 0.0 110.869 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.44 127.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -104.51 145.12 30.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.502 178.469 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 25' ' ' GLN . 15.5 tp -85.59 143.32 28.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -89.83 -30.27 18.06 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.639 0.733 . . . . 0.0 109.219 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -65.47 -29.77 70.47 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.069 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 23.4 t -164.17 158.71 19.43 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.06 50.63 3.08 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -99.02 143.42 29.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -122.96 142.65 50.59 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -120.64 126.85 51.29 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.9 t -116.59 123.46 71.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.181 0.515 . . . . 0.0 109.947 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.58 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.5 p90 -135.58 158.96 43.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.188 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -112.08 139.53 47.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.5 t -97.74 111.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.622 0.725 . . . . 0.0 110.056 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 70' ' ' LYS . 38.4 mt -100.08 95.06 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.37 -29.88 64.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.476 0.655 . . . . 0.0 109.76 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.73 -40.16 75.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.97 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 67' ' ' ILE . 95.3 mttt -108.06 4.29 24.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.509 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p 51.86 40.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.704 1.602 . . . . 0.0 111.879 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.91 138.96 50.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.748 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.86 115.24 42.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -108.87 112.92 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.665 -173.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.52 121.48 27.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -95.42 -42.74 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.374 0.606 . . . . 0.0 109.624 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -149.43 149.97 31.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.315 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.21 131.97 6.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.02 -155.78 26.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -81.09 152.92 27.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.369 0.604 . . . . 0.0 110.839 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.994 -176.827 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -81.56 -44.07 17.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 t -66.57 -34.68 78.44 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -60.88 -47.89 84.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.543 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.913 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.178 -178.217 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.95 168.86 14.6 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.727 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -89.01 161.05 16.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -126.06 132.37 51.95 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.79 155.49 47.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -123.36 135.49 54.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 117.791 0.269 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.85 155.71 38.76 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 6.5 pt-20 -53.19 -40.82 64.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 117.809 0.277 . . . . 0.0 111.429 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 25.5 mmm180 -69.86 -38.06 76.3 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.99 93.32 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.925 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 44.7 mt -66.58 -42.85 86.34 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.164 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -61.32 -43.92 98.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -69.97 -39.57 75.89 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.765 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.11 -42.22 98.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.1 0.96 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 81.9 mtp180 -73.07 -26.63 61.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.041 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -71.84 -35.71 69.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.497 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -60.85 152.74 26.46 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.514 0.673 . . . . 0.0 112.528 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.0 155.77 49.67 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.778 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 3.0 p -55.73 -53.97 50.05 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 124.138 0.975 . . . . 0.0 112.801 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -57.62 -42.14 82.71 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 124.225 1.01 . . . . 0.0 110.899 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 93.7 t -68.58 -48.21 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.99 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.3 ptt-85 -68.72 -35.42 77.11 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 20' ' ' SER . 37.5 mt-10 -59.7 -45.41 92.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.399 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.639 ' HB3' HD11 ' A' ' 55' ' ' LEU . 2.6 mp0 -70.86 -34.74 71.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 85.1 mt -62.92 -44.06 97.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.397 174.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -56.38 -42.61 78.16 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.945 0.403 . . . . 0.0 110.498 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 98.9 mttt -60.24 -45.48 93.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.67 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.0 mptp? -59.95 -38.52 82.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.86 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.4 mt -65.96 -46.33 78.49 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.296 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.21 -37.73 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.737 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 8.2 pt-20 -68.6 -42.66 77.87 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.705 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.98 -29.37 47.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.49 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -52.85 -24.95 10.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.91 -30.37 70.95 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.683 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 t -161.72 75.81 2.32 Favored Pre-proline 0 C--O 1.2 -1.541 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 33' ' ' VAL . 85.3 Cg_endo -83.46 -9.68 10.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.0 1.8 . . . . 0.0 114.461 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 43.3 0.63 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.45 0.643 . . . . 0.0 111.881 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.14 101.32 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.793 0.806 . . . . 0.0 110.185 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.15 -25.2 65.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.629 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.75 -15.23 63.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.983 0.42 . . . . 0.0 110.81 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -113.87 11.12 17.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.383 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -80.49 144.69 32.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 120.98 0.419 . . . . 0.0 111.917 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.82 150.73 23.93 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.494 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -95.08 127.74 41.37 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.349 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.54 12.62 84.06 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.36 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.0 mmm -121.83 120.1 28.71 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.6 100.67 0.16 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.194 2.596 . . . . 0.0 113.598 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' GLN . 4.5 m-20 62.16 31.37 17.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 111.793 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.91 141.72 32.35 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.773 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.48 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 68.8 m-85 -136.5 156.54 48.45 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 140.46 47.11 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 112.536 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.26 141.28 34.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -113.23 144.3 42.93 Favored 'General case' 0 N--CA 1.403 -2.813 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 25' ' ' GLN . 18.5 tp -98.51 118.47 35.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -70.78 -34.59 71.95 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.196 0.522 . . . . 0.0 110.346 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 m -61.9 -39.49 92.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -124.96 -12.37 7.02 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 21.36 57.3 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.493 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -93.52 156.64 16.62 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.096 -0.65 . . . . 0.0 110.938 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -121.8 143.73 49.23 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.69 0.796 . . . . 0.0 108.982 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.43 127.67 37.93 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.41 125.66 72.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 CA-C-O 121.035 0.445 . . . . 0.0 110.022 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.1 p90 -136.93 158.83 43.56 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.245 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 4.0 pt20 -111.44 133.72 53.54 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 173.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -98.0 110.88 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.7 mt -99.65 95.79 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.69 -25.03 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.055 0.455 . . . . 0.0 110.247 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.57 -36.28 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.636 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HB2' HG12 ' A' ' 72' ' ' VAL . 96.7 mttt -107.68 -1.87 20.68 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.835 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t 58.5 32.52 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.234 1.414 . . . . 0.0 110.388 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -129.67 139.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.018 -1.051 . . . . 0.0 110.964 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -98.88 114.98 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -106.07 110.33 22.56 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.682 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.18 121.95 24.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.4 mt -94.89 -42.27 12.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.734 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.8 m -152.99 153.18 32.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.97 142.97 18.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.34 -131.72 3.18 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.176 -1.011 . . . . 0.0 111.797 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -124.03 167.06 14.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.468 -0.431 . . . . 0.0 110.641 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.943 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.481 -176.587 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.213 -0.848 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -80.92 -42.85 20.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.983 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -64.53 -41.49 96.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -62.42 -46.8 86.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.076 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.535 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.819 -176.415 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -91.06 162.88 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.89 155.03 23.1 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.403 HD23 HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -118.06 124.1 47.26 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -130.62 160.81 33.1 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.11 144.73 50.92 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 13.1 t70 -79.42 154.4 28.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 169.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -29.54 66.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 4.4 mmt85 -63.82 -45.0 91.56 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.07 93.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.386 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.99 -41.03 99.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 123.207 0.317 . . . . 0.0 111.749 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.67 -43.83 97.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.272 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 57.4 mm-40 -69.09 -39.5 78.97 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.272 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -61.3 -46.61 89.58 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.571 1.148 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -73.03 -28.58 62.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.529 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.4 -38.73 88.14 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.377 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.56 153.91 12.2 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.644 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.19 147.51 37.84 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.3 m -50.15 -48.04 53.96 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -67.27 -36.87 82.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.689 0.28 . . . . 0.0 110.966 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.16 -48.59 68.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 19.4 ptt180 -68.77 -35.43 77.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 24.0 mt-10 -57.93 -42.44 84.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.529 ' CB ' HD11 ' A' ' 55' ' ' LEU . 43.5 mt-30 -70.64 -35.11 72.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.128 0.489 . . . . 0.0 110.193 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.04 -41.87 85.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.956 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 18.6 ptmt -63.18 -36.73 84.59 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.898 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -59.63 -39.02 82.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 29' ' ' LYS . 72.9 mmtt -65.02 -36.21 83.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.689 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.661 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 71.7 mt -63.72 -43.62 96.0 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 27' ' ' LYS . 96.2 t -63.73 -45.46 97.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.717 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.2 pt-20 -69.09 -43.92 73.55 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.754 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.88 -29.76 47.9 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 81.5 mt -53.45 -25.32 15.71 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -75.09 -25.45 58.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.197 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -154.2 74.19 6.15 Favored Pre-proline 0 C--O 1.213 -0.829 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 33' ' ' VAL . 84.4 Cg_endo -80.98 -7.31 13.23 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 121.515 1.476 . . . . 0.0 113.386 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 38.69 0.94 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.58 0.705 . . . . 0.0 112.074 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.52 108.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.4 -24.68 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.54 -8.19 44.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 87.0 m-20 -108.94 3.8 22.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 9.9 mtpm? -71.18 142.41 50.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.11 126.17 32.84 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 168.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -85.77 114.56 22.82 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 6.47 16.74 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -131.28 139.05 34.23 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.75 -71.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.323 2.682 . . . . 0.0 112.677 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -137.96 78.04 1.66 Allowed 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.9 m -126.88 141.38 51.83 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 40.4 m-85 -133.75 155.43 49.78 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -126.39 139.83 52.97 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.641 0.588 . . . . 0.0 110.033 177.667 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 mt -108.71 142.55 21.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -117.1 129.34 55.92 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' A' ' 25' ' ' GLN . 14.6 tp -81.71 143.52 31.8 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -73.66 -36.64 65.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.1 m -99.62 150.2 22.5 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 71.82 -43.88 0.58 Allowed 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.68 35.16 5.25 Favored Glycine 0 C--O 1.239 0.447 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.767 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.44 155.76 17.16 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 122.622 -0.34 . . . . 0.0 110.22 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.8 mpt_? -129.52 151.33 50.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -128.26 131.32 48.75 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 86' ' ' VAL . 84.1 t -118.38 124.37 73.02 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-O 121.229 0.538 . . . . 0.0 110.943 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.4 p90 -137.48 158.88 43.44 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.977 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -112.23 141.28 46.12 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG22 ' HE1' ' A' ' 51' ' ' TYR . 12.0 m -101.37 123.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.561 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.83 94.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.168 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.2 -23.38 62.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.975 0.893 . . . . 0.0 109.51 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.99 -36.55 83.92 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.262 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 72' ' ' VAL . 99.5 mttt -107.31 -4.27 18.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.463 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t 63.35 34.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-O 122.678 1.228 . . . . 0.0 109.616 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.1 p -131.9 139.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.26 115.37 38.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 88.4 t80 -106.11 110.55 22.84 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.27 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.81 121.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.8 -42.61 12.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.881 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 m -151.39 153.92 35.65 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.3 139.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.85 -137.97 6.85 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -99.03 91.21 4.91 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.291 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.773 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 63' ' ' VAL . 29.9 m . . . . . 0 N--CA 1.446 -0.625 0 CA-C-O 120.567 0.223 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -67.64 -47.5 69.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 120.691 0.281 . . . . 0.0 110.621 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.1 m -59.21 -41.79 89.42 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.37 -42.1 72.23 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.423 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.42 175.68 5.85 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.87 159.35 15.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.1 130.84 51.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -145.35 158.35 43.85 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.24 144.17 45.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.006 0.431 . . . . 0.0 111.987 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.39 155.97 28.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.96 -38.23 64.77 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.911 0.323 . . . . 0.0 111.229 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.81 -45.36 93.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.79 98.02 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.835 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -63.4 -45.42 91.11 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -63.29 -44.12 95.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.776 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -70.05 -37.97 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.442 ' O ' ' HD3' ' A' ' 23' ' ' ARG . 61.9 t-105 -63.04 -45.01 94.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.789 1.236 . . . . 0.0 110.674 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -72.19 -27.14 62.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.298 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.65 -38.5 64.95 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.479 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.4 150.65 17.98 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 124.434 1.094 . . . . 0.0 111.923 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.54 144.32 48.22 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -50.03 -50.25 48.18 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.144 . . . . 0.0 111.972 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.8 m -68.99 -37.77 78.94 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.271 0.628 . . . . 0.0 111.148 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.37 -47.67 80.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 10.1 ptt-85 -68.75 -35.96 77.76 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.571 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 33.4 mt-10 -66.69 -31.69 72.52 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.638 ' HB3' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.83 -34.37 71.61 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.649 175.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -65.48 -42.13 92.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.579 172.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' O ' HG23 ' A' ' 31' ' ' VAL . 30.9 ttpt -55.3 -44.76 76.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.648 0.779 . . . . 0.0 109.585 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -58.42 -38.02 76.56 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.929 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.7 mptp? -69.99 -35.22 74.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.155 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 85.7 mt -65.78 -41.63 91.77 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.154 0.502 . . . . 0.0 109.698 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' LYS . 92.7 t -62.64 -44.47 99.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.374 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -68.85 -45.73 70.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.988 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.424 HG21 ' OH ' ' A' ' 64' ' ' TYR . 3.4 p -62.94 -30.27 49.18 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.805 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 72.4 mt -53.35 -25.53 15.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.4 pt-20 -76.71 -28.03 55.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.118 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 m -152.37 69.41 7.37 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.686 -0.633 . . . . 0.0 110.454 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 33' ' ' VAL . 95.1 Cg_endo -87.63 -2.94 7.5 Favored 'Trans proline' 0 C--O 1.21 -0.887 0 C-N-CA 121.961 1.774 . . . . 0.0 112.828 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 37.94 0.94 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.949 0.881 . . . . 0.0 111.93 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.3 mt -82.7 100.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 12.6 pt-20 -57.48 -24.5 56.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.64 66.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.851 0.358 . . . . 0.0 111.143 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -99.5 3.89 45.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.437 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 10.1 mtpm? -72.23 139.39 48.11 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.213 0.53 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 63.0 mt -80.14 138.25 36.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.398 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -72.31 106.61 4.53 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.56 32.46 10.23 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.103 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -135.75 132.68 19.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.65 99.08 0.37 Allowed 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.682 2.255 . . . . 0.0 113.319 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 60.36 31.92 20.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.637 1.175 . . . . 0.0 111.681 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.3 m -100.09 141.44 32.91 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.801 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 7.4 m-85 -132.0 160.4 35.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -130.51 146.95 52.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -124.93 139.6 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.3 131.01 56.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.638 HD11 ' HB3' ' A' ' 25' ' ' GLN . 19.2 tp -77.61 96.59 4.84 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.421 0.629 . . . . 0.0 110.423 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -68.44 78.8 0.27 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.078 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t 172.63 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.279 1.432 . . . . 0.0 107.886 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 m -111.37 -23.44 10.79 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.82 49.32 Favored Glycine 0 C--O 1.241 0.544 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.585 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -88.01 150.21 23.55 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 122.61 -0.347 . . . . 0.0 110.16 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.13 147.88 46.31 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.181 0.515 . . . . 0.0 109.77 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -132.18 129.05 39.26 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.2 127.13 73.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 O-C-N 123.606 0.566 . . . . 0.0 110.102 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.2 p90 -138.08 158.78 43.63 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.9 pt20 -108.92 130.37 55.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -99.52 110.5 26.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.0 mt -99.01 100.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.83 -34.48 78.02 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.039 0.536 . . . . 0.0 111.828 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.44 -36.74 85.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.321 0.388 . . . . 0.0 111.595 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HB2' HG12 ' A' ' 72' ' ' VAL . 96.7 mttt -98.51 -6.97 29.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.05 0.453 . . . . 0.0 110.473 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 t 61.33 32.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 124.951 1.3 . . . . 0.0 109.936 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.3 p -129.42 138.78 53.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 111.148 -176.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.3 114.88 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.03 110.69 21.34 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.94 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 59.6 t -74.77 121.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.14 -42.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.533 0.682 . . . . 0.0 110.218 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 m -145.87 149.91 35.14 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.17 145.91 17.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.65 -144.94 12.63 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -98.54 162.79 12.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 118.095 0.948 . . . . 0.0 109.388 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.682 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 121.03 0.443 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -89.24 -44.53 10.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.931 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -64.99 -48.03 75.45 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.94 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -60.6 -31.6 70.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.804 0.335 . . . . 0.0 110.421 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.344 179.785 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -96.05 168.93 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.157 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.2 159.88 16.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD23 HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -125.65 123.53 39.17 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -137.55 152.71 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.86 137.82 52.53 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -70.48 154.8 41.5 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.256 0.7 OUTLIER -59.75 -31.15 69.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.03 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -70.94 -38.11 72.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.205 0.526 . . . . 0.0 109.638 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.36 88.05 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.202 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 63.7 mt -61.28 -43.79 98.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.406 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -61.66 -44.76 96.35 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -69.76 -37.43 76.4 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.275 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -60.93 -37.24 81.63 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.997 0.919 . . . . 0.0 110.593 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 97.5 mtt180 -74.86 -28.98 60.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.597 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -77.04 -26.3 53.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.444 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.11 151.25 43.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.931 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.68 145.62 42.26 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -45.56 -53.02 9.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.623 1.169 . . . . 0.0 112.114 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -68.61 -36.29 78.47 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.372 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.0 -48.47 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.14 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -69.3 -35.59 76.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.6 mt-10 -57.41 -41.53 80.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.536 ' CB ' HD11 ' A' ' 55' ' ' LEU . 41.4 mt-30 -70.93 -35.75 72.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.012 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.2 mt -68.63 -39.81 80.62 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.268 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 31' ' ' VAL . 36.4 ttpt -60.11 -42.61 95.08 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.477 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.6 mttm -57.06 -41.6 79.05 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.7 mmtt -64.0 -37.6 88.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.298 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.1 mt -64.97 -41.19 95.66 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.333 0.587 . . . . 0.0 109.809 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 27' ' ' LYS . 95.8 t -65.37 -45.66 92.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.576 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.4 pt-20 -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.905 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' OH ' ' A' ' 64' ' ' TYR . 5.0 p -64.08 -31.3 52.76 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -55.21 -27.42 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.15 -8.01 34.33 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.097 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -154.81 63.72 4.05 Favored Pre-proline 0 C--O 1.211 -0.973 0 C-N-CA 122.62 0.368 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HA ' HG22 ' A' ' 33' ' ' VAL . 97.5 Cg_endo -80.54 -4.73 13.09 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.103 1.869 . . . . 0.0 114.902 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.02 40.2 1.04 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -82.34 113.68 22.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.832 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 41' ' ' ALA . 3.6 pt-20 -58.49 -33.2 69.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.715 0.806 . . . . 0.0 111.828 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 40' ' ' GLU . . . -70.0 -23.36 63.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.675 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 94.8 m-20 -103.04 -11.87 17.83 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.208 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -65.9 142.41 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 120.802 0.334 . . . . 0.0 111.772 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HE2' ' A' ' 52' ' ' LYS . 60.7 mt -72.24 168.33 18.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -58.61 -46.36 87.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 111.161 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.19 86.77 0.09 OUTLIER Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 89.7 mmm -149.01 146.1 20.81 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.92 89.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.424 2.75 . . . . 0.0 113.998 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 48.46 44.9 20.83 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.923 1.289 . . . . 0.0 112.099 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 58.8 m -101.85 142.34 33.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.377 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.653 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 29.3 m-85 -130.48 161.47 31.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' HD23 ' A' ' 44' ' ' LEU . 15.3 ptpt -116.28 158.94 22.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.983 0.913 . . . . 0.0 109.165 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 70.6 mt -129.55 133.77 64.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -116.73 123.21 46.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.333 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 25' ' ' GLN . 16.6 tp -73.79 136.16 43.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.074 0.464 . . . . 0.0 110.805 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.43 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -84.15 -63.48 1.34 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 18.3 m -104.96 160.77 14.76 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.48 64.95 3.73 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.504 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -114.05 139.59 49.16 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 98.0 mtt180 -128.13 137.91 52.3 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.823 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -122.23 136.65 54.94 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.3 t -124.66 128.06 73.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.653 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 17.1 p90 -137.69 158.3 44.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 27.0 pt20 -108.53 133.89 52.05 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.86 111.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 70' ' ' LYS . 55.9 mt -91.62 95.38 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -22.96 63.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.764 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.65 -40.12 96.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.193 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.499 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.1 mttm -107.41 -1.97 20.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.1 t 62.96 41.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 122.48 1.134 . . . . 0.0 109.242 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 70' ' ' LYS . 9.9 p -134.84 139.01 48.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.601 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 5' ' ' LEU . 93.9 t -95.57 115.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.59 -1.634 . . . . 0.0 106.59 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.03 111.72 23.26 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -173.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.76 121.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.22 -42.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.045 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -154.38 154.01 32.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.01 143.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.61 -139.83 7.86 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.581 -1.295 . . . . 0.0 112.435 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -107.44 91.22 3.56 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.545 0.688 . . . . 0.0 109.741 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.643 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.347 -179.382 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -63.71 -41.82 98.03 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.183 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 m -67.58 -43.09 81.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.517 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.02 -37.23 81.84 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 123.42 0.45 . . . . 0.0 110.773 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.281 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -91.2 173.42 7.94 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.025 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.51 162.56 13.42 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 6' ' ' ASP . 1.5 tm? -126.77 136.59 52.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 5' ' ' LEU . 38.2 t70 -141.25 154.12 45.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 173.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.79 128.58 56.47 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.473 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.69 156.64 36.45 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 123.969 0.793 . . . . 0.0 111.247 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 8.7 pt-20 -52.89 -38.88 62.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.148 0.979 . . . . 0.0 111.359 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 74.3 mtt180 -72.31 -42.06 65.87 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.244 0.545 . . . . 0.0 110.104 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.16 78.55 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.511 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.3 mt -66.92 -37.79 84.99 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 53.9 mttm -62.28 -46.77 87.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.66 -38.74 73.84 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.968 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -60.81 -43.31 98.35 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.546 0.738 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.29 -20.79 58.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -81.51 -24.01 36.94 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 124.673 1.189 . . . . 0.0 109.812 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.45 157.75 35.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.987 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.12 141.86 28.62 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 1.9 p -53.39 -41.96 66.47 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -175.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -40.89 83.93 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.1 -47.25 85.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 120.835 0.35 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -65.48 -34.85 79.24 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.798 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 20' ' ' SER . 35.3 mt-10 -58.35 -38.54 77.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -70.12 -38.41 75.56 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 89.2 mt -64.25 -42.68 96.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.695 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 31' ' ' VAL . 31.5 ttpt -56.66 -44.46 81.4 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 123.302 0.641 . . . . 0.0 110.595 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.19 -42.11 90.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.833 0.349 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.5 mptp? -64.55 -34.68 78.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.182 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.687 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.3 mt -68.44 -43.7 76.53 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 27' ' ' LYS . 92.4 t -60.84 -45.5 97.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.988 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.6 pt-20 -69.29 -43.34 74.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.673 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.3 p -64.0 -29.87 48.49 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.785 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.997 -175.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 90.2 mt -54.38 -25.94 27.3 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.7 pt-20 -77.11 -20.81 55.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.927 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 p -155.27 69.67 5.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HA ' HG22 ' A' ' 33' ' ' VAL . 94.5 Cg_endo -80.13 -9.65 14.0 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 121.823 1.682 . . . . 0.0 112.484 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -89.04 38.7 0.9 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.767 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.19 109.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.557 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.949 0.404 . . . . 0.0 111.703 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -101.44 -2.94 29.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.095 -0.378 . . . . 0.0 112.002 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 21.1 mtpp -70.96 146.28 49.57 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.886 0.374 . . . . 0.0 110.985 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.29 164.09 15.08 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.165 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -91.81 131.08 37.42 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.13 0.572 . . . . 0.0 109.914 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.79 76.58 Favored Glycine 0 CA--C 1.506 -0.506 0 O-C-N 123.505 0.503 . . . . 0.0 113.198 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.437 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 95.9 mmm -126.17 129.99 24.07 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.25 98.9 0.34 Allowed 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.49 2.127 . . . . 0.0 112.859 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 52.51 42.03 31.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.204 1.002 . . . . 0.0 113.022 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 61.9 m -100.26 141.48 33.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.12 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.582 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 45.1 m-85 -134.0 159.6 40.26 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -134.39 140.54 46.37 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.858 177.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.56 144.06 29.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -127.13 140.26 52.38 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 120.907 0.384 . . . . 0.0 111.668 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.0 mt -85.62 115.65 23.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -66.13 -30.53 71.04 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -66.49 -65.1 0.72 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.93 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -89.98 -22.48 21.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.66 64.46 Favored Glycine 0 C--O 1.239 0.455 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.154 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -96.55 144.69 26.38 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.397 0.279 . . . . 0.0 110.403 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -122.2 147.57 46.02 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -131.4 134.36 46.18 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.23 128.55 75.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 C-N-CA 123.188 0.595 . . . . 0.0 110.262 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 7.5 p90 -138.84 158.78 43.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -112.03 137.47 50.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.85 112.81 29.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -95.79 95.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.84 -26.63 65.25 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 0.0 110.661 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.66 -30.26 69.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.424 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.7 mttm -105.47 -6.25 19.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.245 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.42 29.36 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 122.569 1.176 . . . . 0.0 109.089 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.0 p -130.87 139.09 52.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 O-C-N 121.206 -0.934 . . . . 0.0 111.197 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.8 120.85 46.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -109.08 110.6 21.9 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.834 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.3 t -76.56 121.72 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.6 mt -98.35 -42.04 10.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.565 0.698 . . . . 0.0 110.076 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.8 m -142.48 147.46 36.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.224 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.23 142.11 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.0 -115.36 0.71 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.295 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -137.54 149.57 46.84 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 110.577 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.178 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.217 -0.637 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -91.72 -40.91 10.99 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 m -56.98 -51.18 70.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.963 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.14 -28.91 69.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.107 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.058 -179.313 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.192 0 CA-C-O 121.107 0.479 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -124.64 173.99 8.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -86.72 159.55 19.12 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -124.8 125.9 44.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.69 167.1 22.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.31 141.05 51.55 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' OD2' ' HG3' ' A' ' 10' ' ' ARG . 19.5 t70 -80.23 154.87 27.63 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.14 -29.33 65.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 25.5 mtp-105 -68.37 -48.18 65.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.38 68.44 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.52 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -70.91 -37.46 72.96 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.931 0.396 . . . . 0.0 110.998 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.81 -42.87 90.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.44 -43.13 86.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.948 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -63.2 -41.4 99.16 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.329 1.052 . . . . 0.0 110.795 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.23 -24.61 57.73 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.491 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -67.57 -32.16 72.72 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.12 141.44 58.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.609 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.48 -83.43 0.05 OUTLIER Glycine 0 C--N 1.312 -0.8 0 O-C-N 124.837 1.336 . . . . 0.0 114.392 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 t -163.74 -60.85 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 ' OE1' ' A' ' 25' ' ' GLN . 4.9 m -63.07 -45.37 92.48 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.359 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.41 -47.52 90.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.899 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -68.42 -35.4 77.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.557 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.3 mt-10 -63.6 -42.17 98.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.0 mp0 -62.64 -45.24 93.77 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.131 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 88.9 mt -58.61 -43.15 89.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.422 0.451 . . . . 0.0 111.46 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -58.16 -44.33 87.86 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.295 0.372 . . . . 0.0 110.254 175.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -64.93 -34.68 78.99 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.75 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 13.0 mmmm -67.38 -34.47 77.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.4 mt -68.96 -40.77 78.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.81 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 27' ' ' LYS . 76.6 t -61.11 -45.68 98.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -69.29 -38.17 78.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.036 0.446 . . . . 0.0 111.281 177.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -67.02 -30.34 49.23 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.791 -176.353 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 mt -53.86 -24.57 16.31 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.1 pt-20 -70.71 -24.96 62.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.318 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 39' ' ' ILE . 43.8 p -162.05 76.04 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 123.152 0.581 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HA ' HG22 ' A' ' 33' ' ' VAL . 73.7 Cg_endo -80.37 -4.97 13.33 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.722 1.615 . . . . 0.0 112.175 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 40.91 1.05 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.89 0.852 . . . . 0.0 111.624 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' SER . 85.0 mt -82.42 93.58 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 43' ' ' LYS . 9.7 pt-20 -55.57 -18.74 8.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.05 1.34 . . . . 0.0 113.993 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.72 74.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.975 0.417 . . . . 0.0 110.97 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -100.77 9.47 42.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.892 0.377 . . . . 0.0 110.625 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 56.9 tttt -80.96 144.33 31.94 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 86.0 mt -79.54 152.53 30.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -63.15 -74.28 0.1 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.44 43.28 1.7 Allowed Glycine 0 CA--C 1.502 -0.756 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.886 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 92.6 mmm -124.57 124.96 25.62 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.91 99.11 0.13 Allowed 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 123.139 2.559 . . . . 0.0 112.809 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.452 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 17.7 m-20 52.75 39.27 28.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.823 1.249 . . . . 0.0 113.395 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 56.0 m -100.09 141.55 32.77 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 47.3 m-85 -131.84 157.77 43.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.13 144.43 51.03 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.29 129.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -106.17 140.09 39.68 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.681 174.446 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.46 139.4 39.64 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -66.04 -48.7 70.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.24 123.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.8 m 69.51 -173.69 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.004 0.922 . . . . 0.0 111.585 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.35 42.31 1.99 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.46 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -91.38 136.96 32.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -133.99 141.89 47.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.789 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -123.75 138.18 54.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.7 t -123.85 129.59 74.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 18.9 p90 -138.84 159.26 42.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.164 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.5 pt20 -119.74 138.08 53.54 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.418 HG22 ' HE1' ' A' ' 51' ' ' TYR . 10.2 m -95.81 121.26 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -99.29 95.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.18 -28.57 67.39 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.673 0.749 . . . . 0.0 109.046 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.21 -38.68 77.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.959 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.6 mttt -107.84 -4.17 18.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.615 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.4 t 61.9 29.46 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 CA-C-O 122.382 1.087 . . . . 0.0 109.868 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.1 p -131.32 141.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 121.008 -1.057 . . . . 0.0 111.214 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.46 121.14 53.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 124.146 0.978 . . . . 0.0 108.588 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -107.78 120.55 42.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -74.86 124.08 31.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -93.65 -42.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 123.464 0.477 . . . . 0.0 110.83 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 t -155.45 150.85 27.09 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.25 132.95 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.237 0.542 . . . . 0.0 110.551 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.14 -111.58 0.48 Allowed Glycine 0 N--CA 1.418 -2.548 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.425 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -132.9 158.07 43.51 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -2.547 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.022 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -84.67 -28.47 26.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 m -69.59 -43.73 72.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.15 -36.56 80.13 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.909 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.478 179.178 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -108.84 167.63 9.94 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.73 151.59 35.99 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 34' ' ' LEU . 1.1 tm? -125.83 122.17 35.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -132.83 157.04 46.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.78 140.84 52.56 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.79 155.59 40.26 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -53.56 -38.91 64.32 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.275 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.5 ptm180 -67.14 -38.75 86.07 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.37 -37.4 87.38 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.191 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 mt -67.73 -43.09 80.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.651 0.262 . . . . 0.0 110.852 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.35 -42.02 98.89 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 46.7 mt-10 -69.41 -39.59 77.84 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.833 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -60.69 -41.27 94.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 0.0 110.376 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -73.42 -31.16 63.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.401 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.8 -43.93 82.58 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.821 0.701 . . . . 0.0 109.818 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mp -53.08 153.05 3.76 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.464 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.37 142.06 41.98 Favored Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -54.17 -46.11 72.26 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.875 0.87 . . . . 0.0 113.085 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 m -68.51 -36.29 78.67 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.025 0.441 . . . . 0.0 110.88 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.73 -47.97 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.23 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.369 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -57.23 -43.61 83.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.695 0.225 . . . . 0.0 110.575 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.92 -38.64 86.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 -179.302 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.7 mt -67.25 -42.69 83.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 176.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -57.09 -43.38 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.036 0.534 . . . . 0.0 110.594 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -56.94 -43.21 81.29 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.397 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 75.3 mmtt -65.48 -38.47 89.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.912 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.4 mt -65.46 -46.94 77.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.57 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.26 -41.37 89.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.401 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -69.9 -37.72 76.08 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.694 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -64.45 -30.22 49.56 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.774 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.404 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.2 mt -54.47 -26.46 31.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.569 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 1.9 pp20? -80.41 -29.63 37.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.382 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -142.87 72.49 19.12 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' HG22 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -73.45 -27.94 12.65 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 121.547 1.498 . . . . 0.0 112.223 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.49 65.95 4.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -103.71 115.08 45.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 11.0 pt-20 -59.81 -28.67 67.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.21 65.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.41 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -107.1 -2.25 21.18 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.029 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 38.5 mtpt -75.42 139.57 42.4 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 92.7 mt -78.19 149.47 33.71 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.677 174.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.38 -65.07 0.75 Allowed 'General case' 0 C--N 1.311 -1.084 0 O-C-N 124.072 0.857 . . . . 0.0 111.945 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.83 61.43 0.36 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.475 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.3 mmm -141.2 140.97 21.96 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.4 95.76 0.53 Allowed 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.984 2.456 . . . . 0.0 112.787 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 48.21 44.64 19.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.764 1.226 . . . . 0.0 112.145 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.5 m -100.8 142.07 32.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.644 ' CE2' ' HG2' ' A' ' 43' ' ' LYS . 25.7 m-85 -130.91 156.47 45.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -126.02 139.51 53.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.426 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.2 mt -111.98 138.89 39.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.84 123.57 38.99 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 -178.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.7 91.37 6.99 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -62.88 -8.69 7.51 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.916 1.686 . . . . 0.0 113.279 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -100.13 -13.06 19.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.765 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -134.78 -36.03 0.86 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.249 -0.981 . . . . 0.0 113.083 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.44 28.92 6.17 Favored Glycine 0 C--O 1.247 0.932 0 C-N-CA 119.415 -1.374 . . . . 0.0 112.007 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.09 146.35 29.26 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -135.1 147.3 49.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.43 133.48 45.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.91 128.73 75.73 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 CA-C-O 121.015 0.436 . . . . 0.0 109.884 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 15.9 p90 -139.14 158.86 43.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.729 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 17.2 pt20 -110.27 138.89 46.04 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.0 t -103.15 112.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.81 94.68 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.35 -34.08 74.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.09 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.22 -35.42 71.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.141 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 98.4 mttt -103.81 -1.1 28.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.277 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p 54.81 40.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.405 1.882 . . . . 0.0 111.821 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.6 p -128.65 138.36 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.814 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -102.46 115.36 44.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -110.23 112.22 24.05 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.5 t -77.06 121.45 29.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.73 -42.32 12.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.133 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -151.01 148.07 27.91 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.042 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.07 141.25 21.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.04 -97.63 0.19 Allowed Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -137.61 144.18 41.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.095 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.94 -43.6 13.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.428 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.0 m -67.4 -29.27 68.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.17 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.15 -50.08 74.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.017 -176.935 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 120.605 0.24 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.84 171.29 7.96 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.03 156.89 18.58 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -126.18 130.09 50.3 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.63 158.11 44.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -119.21 133.83 55.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.67 155.95 39.1 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.167 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.517 ' OE1' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -56.43 -36.85 69.45 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.33 0.394 . . . . 0.0 110.783 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG3' ' OE1' ' A' ' 9' ' ' GLU . 35.8 mtt180 -60.06 -48.93 79.66 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.65 77.23 Favored 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.861 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.9 mt -64.02 -38.66 91.89 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 120.988 0.423 . . . . 0.0 110.753 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -65.11 -43.49 91.85 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.5 mt-10 -69.39 -36.41 76.74 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.181 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.37 -38.41 90.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.021 0.928 . . . . 0.0 109.864 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -75.06 -26.4 59.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 61.4 tttm -72.36 -39.99 67.67 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.785 0.834 . . . . 0.0 109.102 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.36 151.53 43.73 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.54 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.95 147.8 40.34 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.658 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 23.2 m -51.05 -49.83 59.81 Favored 'General case' 0 C--O 1.205 -1.259 0 C-N-CA 123.994 0.918 . . . . 0.0 112.014 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -63.67 -38.55 91.55 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.244 0.545 . . . . 0.0 110.849 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.07 -47.48 81.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.399 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -68.42 -34.77 76.59 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.173 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.658 ' HG3' ' O ' ' A' ' 20' ' ' SER . 70.0 mt-10 -57.53 -42.25 82.52 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.052 0.387 . . . . 0.0 111.32 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.17 -39.35 89.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.7 mt -66.48 -40.92 89.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 31' ' ' VAL . 32.0 ttpt -56.5 -44.62 80.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.137 0.575 . . . . 0.0 110.38 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.62 -39.64 88.95 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.262 0.553 . . . . 0.0 110.234 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 mptp? -65.29 -37.41 87.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.068 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -66.25 -41.44 89.95 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 27' ' ' LYS . 99.5 t -65.26 -44.74 94.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.5 pt-20 -68.75 -44.15 74.36 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.948 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.3 p -62.66 -29.92 48.08 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.228 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 89.9 mt -53.59 -25.56 17.89 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.6 pt-20 -71.46 -27.86 63.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.473 ' O ' HG13 ' A' ' 39' ' ' ILE . 48.2 m -152.6 73.95 7.28 Favored Pre-proline 0 C--O 1.209 -1.046 0 C-N-CA 123.558 0.743 . . . . 0.0 109.167 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.51 ' HA ' HG22 ' A' ' 33' ' ' VAL . 61.2 Cg_endo -74.72 -13.21 22.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.057 1.838 . . . . 0.0 112.622 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -87.51 41.45 0.98 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.427 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' SER . 91.9 mt -80.61 98.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.75 -19.32 10.75 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.738 1.615 . . . . 0.0 114.288 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.4 -25.86 65.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.594 0.711 . . . . 0.0 109.912 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.67 -1.75 39.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.811 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.9 142.07 49.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-O 121.201 0.524 . . . . 0.0 110.658 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.6 176.61 9.55 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.816 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -110.09 120.02 41.14 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.022 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.28 54.37 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.126 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.53 131.54 23.41 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -47.02 -59.06 1.39 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 124.401 3.401 . . . . 0.0 114.256 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.679 ' OD1' ' HB ' ' A' ' 66' ' ' VAL . 7.7 t70 -154.66 83.65 1.1 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.1 m -139.47 141.77 37.39 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.7 m-85 -138.23 153.78 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.3 pttt -126.18 139.43 53.36 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.2 mt -111.68 130.88 64.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 145.28 29.98 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 58' ' ' SER . 3.0 tt -88.78 143.08 27.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -93.48 -42.56 9.18 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.217 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 m -89.32 5.08 46.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' ' 55' ' ' LEU . 20.7 m -152.89 138.3 17.6 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.39 73.04 2.07 Favored Glycine 0 C--N 1.314 -0.673 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.533 -175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -135.23 156.45 48.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HD2' ' N ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -144.82 149.48 35.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -119.88 133.37 55.6 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.95 126.42 70.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.2 p90 -136.4 158.94 43.24 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -113.51 140.03 48.46 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.679 ' HB ' ' OD1' ' A' ' 49' ' ' ASP . 81.7 t -99.59 113.03 33.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.748 0.785 . . . . 0.0 109.849 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.69 94.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.25 -27.9 65.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.866 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.08 -37.34 76.86 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.037 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.3 mttt -107.78 -1.76 20.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.149 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t 62.32 35.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.638 1.209 . . . . 0.0 109.69 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 70' ' ' LYS . 11.3 p -133.3 138.7 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.96 121.76 49.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.26 115.48 29.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -173.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.5 t -80.85 121.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 90' ' ' ALA . 21.7 mt -97.66 -42.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 123.585 0.553 . . . . 0.0 110.909 -174.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 p -145.56 149.68 35.03 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.108 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.04 127.19 2.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.261 0.553 . . . . 0.0 112.112 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.78 -123.31 1.28 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 119.141 -1.504 . . . . 0.0 112.936 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -113.74 157.1 22.66 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 -175.593 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.95 -44.64 15.08 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.1 t -58.81 -49.44 77.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.52 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 10' ' ' ARG . 14.3 tp10 -62.04 -29.77 70.51 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 110.667 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.898 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -121.3 160.66 23.5 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -80.35 160.31 25.47 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.08 131.56 52.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.76 155.8 43.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -120.05 137.06 54.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.729 0.411 . . . . 0.0 111.19 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.54 154.8 31.39 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 170.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 6.8 pt-20 -53.55 -41.89 66.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.117 0.417 . . . . 0.0 111.934 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 90.0 mtt180 -72.25 -37.77 69.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.627 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.36 75.83 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.5 tp -73.47 -34.16 65.22 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.799 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 87.6 mttt -66.15 -44.41 84.2 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -67.43 -38.73 84.99 Favored 'General case' 0 C--O 1.199 -1.598 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.459 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -60.26 -40.25 89.65 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.604 0.762 . . . . 0.0 111.469 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -74.21 -33.94 63.55 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.601 0.715 . . . . 0.0 110.917 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.02 -19.41 58.68 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.29 162.5 29.38 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.317 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.08 152.58 43.96 Favored Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.897 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -53.58 -54.05 42.93 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 125.033 1.333 . . . . 0.0 112.248 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 m -63.1 -34.67 78.09 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.301 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.15 -48.18 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.756 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -63.35 -40.52 97.52 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.509 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.8 mt-10 -61.43 -43.6 98.59 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -69.84 -43.27 72.29 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.546 178.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.8 mt -58.81 -40.79 85.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 117.612 0.187 . . . . 0.0 110.92 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.3 ttpt -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 123.59 0.557 . . . . 0.0 110.07 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.1 mttt -63.09 -38.07 89.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 28.7 mmmt -66.82 -35.1 79.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.668 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 88.9 mt -68.87 -43.6 75.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 27' ' ' LYS . 53.9 t -60.54 -44.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.831 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 9.7 pt-20 -69.07 -44.76 71.9 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.79 -29.64 47.53 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.343 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.54 -26.65 22.12 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.5 pt-20 -79.09 -24.76 43.25 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.387 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -148.66 69.3 10.19 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.2 -11.29 9.8 Favored 'Trans proline' 0 C--O 1.209 -0.939 0 C-N-CA 121.542 1.495 . . . . 0.0 111.799 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.48 39.22 0.72 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -82.94 107.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.33 -24.35 67.28 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.61 67.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.888 0.375 . . . . 0.0 111.677 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 90.6 m-20 -97.66 -0.4 45.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.553 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 50' ' ' CYS . 10.0 mtpm? -73.95 138.57 44.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.197 0.522 . . . . 0.0 111.402 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 67.6 mt -82.43 141.77 32.48 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -68.61 -42.53 77.99 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.03 18.56 57.3 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.435 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.518 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 83.8 mmm -130.71 145.68 58.65 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.88 -74.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.942 1.761 . . . . 0.0 114.722 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.14 36.8 4.21 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 40.0 m -100.32 141.24 33.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.507 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 29.6 m-85 -132.86 156.89 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.23 142.44 50.85 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.251 0.548 . . . . 0.0 111.025 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.91 144.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -120.17 126.43 50.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.432 HD12 ' HG ' ' A' ' 26' ' ' LEU . 2.1 tt -99.04 90.39 4.6 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -75.62 95.03 3.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.826 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . 35.9 t 171.61 -39.75 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.869 1.667 . . . . 0.0 107.298 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 p -125.37 -17.04 5.72 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.24 9.86 61.51 Favored Glycine 0 C--O 1.241 0.579 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.15 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.89 148.97 25.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.123 0.487 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -125.25 151.84 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.85 125.36 29.82 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.15 126.94 70.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.217 0.532 . . . . 0.0 109.955 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -139.22 159.71 41.51 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.952 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -114.08 141.24 47.71 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 170.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -91.21 114.23 28.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -99.95 95.15 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.84 -33.17 73.37 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.79 0.329 . . . . 0.0 110.581 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.54 -33.71 70.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.982 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.2 mttt -104.09 -6.7 20.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.204 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t 63.01 32.26 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.31 0 C-N-CA 124.449 1.1 . . . . 0.0 109.671 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.6 p -131.58 138.83 52.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 111.065 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.1 t -96.37 115.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -106.07 111.78 24.55 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.981 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.33 121.9 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.6 mt -95.08 -40.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.258 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -155.75 151.95 27.93 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -149.44 147.03 16.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.6 -151.4 23.59 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.259 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -89.75 137.58 32.21 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.506 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.088 -175.207 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -74.38 -45.3 47.73 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 m -64.82 -40.0 94.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.14 -47.33 77.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.996 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -115.89 163.91 15.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.21 161.72 17.87 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.89 123.17 36.64 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.89 169.18 17.48 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.8 136.9 47.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.08 155.65 16.63 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 7.3 pt-20 -52.6 -41.93 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.317 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -63.87 -48.16 77.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.23 0.538 . . . . 0.0 111.055 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.6 71.55 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.051 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 9' ' ' GLU . 1.1 mptm? -65.06 -42.09 94.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.77 -35.74 77.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.672 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -60.56 -38.0 83.12 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 110.121 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.38 -35.03 65.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.666 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.38 -32.89 74.69 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.325 1.05 . . . . 0.0 110.71 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.25 147.61 52.04 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.272 0.558 . . . . 0.0 112.495 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.24 147.92 41.69 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.505 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 11.9 p -51.04 -54.93 20.26 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 124.334 1.053 . . . . 0.0 112.839 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -59.08 -40.39 85.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.039 0.535 . . . . 0.0 111.402 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.14 -47.06 80.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.016 0.436 . . . . 0.0 109.885 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -67.61 -34.96 78.05 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 46.8 mt-10 -58.57 -45.73 88.39 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 117.781 0.264 . . . . 0.0 111.435 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.89 -35.23 78.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.76 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 81.7 mt -65.34 -41.76 93.58 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.214 174.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -59.29 -43.18 92.6 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.1 mttm -59.24 -42.7 91.73 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.208 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -64.33 -41.06 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.166 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 91.8 mt -64.3 -47.18 80.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 28' ' ' LYS . 9.1 p -67.24 -36.48 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.579 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -69.46 -45.72 68.37 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.877 175.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -62.37 -29.65 47.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 C-N-CA 123.229 0.612 . . . . 0.0 112.393 -174.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.41 -24.93 13.83 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.4 pt-20 -68.23 -31.44 70.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 111.049 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.2 m -157.57 77.58 3.73 Favored Pre-proline 0 C--O 1.208 -1.127 0 C-N-CA 123.356 0.663 . . . . 0.0 110.056 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.0 Cg_endo -80.96 -0.12 10.39 Favored 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 121.771 1.647 . . . . 0.0 112.08 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 27.63 1.08 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.517 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.89 103.55 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 12.0 pt-20 -66.02 -15.68 63.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.75 -26.21 68.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.232 0.539 . . . . 0.0 109.987 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -103.86 8.51 37.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.848 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.684 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 2.6 tttm -72.25 148.29 45.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.465 0.65 . . . . 0.0 112.522 -177.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 81.2 mt -91.47 127.25 36.84 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.74 -1.118 . . . . 0.0 107.993 171.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -81.11 128.76 34.09 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 122.953 0.501 . . . . 0.0 110.591 -177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.52 11.26 66.55 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.4 mmm -123.61 140.91 35.19 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.87 101.62 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.496 1.464 . . . . 0.0 111.911 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 47.54 54.99 8.93 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.169 1.387 . . . . 0.0 113.911 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -113.24 141.7 46.67 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 38.0 m-85 -136.61 160.22 39.45 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HD2' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.76 140.27 47.97 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.789 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -110.57 140.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.504 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -126.74 133.36 50.89 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.022 0.439 . . . . 0.0 109.917 -177.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.09 135.79 33.69 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -106.76 -15.6 14.7 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.811 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -78.07 -27.93 48.69 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.346 0.593 . . . . 0.0 109.632 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -144.11 140.35 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.62 74.62 0.9 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.815 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -124.14 141.27 52.2 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.883 0.473 . . . . 0.0 110.333 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -126.43 149.38 49.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 tt -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.8 t -116.27 129.14 73.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.5 p90 -138.64 158.77 43.62 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.59 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -109.24 140.92 42.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.21 112.18 29.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 mt -91.3 95.87 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.61 -30.5 71.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.817 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.77 -39.91 90.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.394 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.6 mttt -107.46 -5.0 17.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.2 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.2 t 60.54 41.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 123.067 1.413 . . . . 0.0 109.537 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -135.79 138.93 47.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.359 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -94.22 115.35 32.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -107.19 110.42 22.48 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.197 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.1 123.41 27.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.0 mt -89.99 -42.26 14.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.57 0.7 . . . . 0.0 109.664 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -154.68 149.91 27.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.93 134.44 18.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.59 -147.75 18.38 Favored Glycine 0 C--N 1.3 -1.419 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.21 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -93.1 141.54 28.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 117.226 0.513 . . . . 0.0 110.315 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.376 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 121.003 0.43 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.33 -40.63 11.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.41 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 p -63.04 -42.15 99.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.591 0.71 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.24 -34.24 77.9 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.678 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.374 -178.679 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.71 141.44 51.16 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.048 0.452 . . . . 0.0 110.002 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.17 172.47 6.79 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -94.87 164.84 12.75 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -125.72 132.29 52.4 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -135.7 160.43 38.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.01 141.86 49.39 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.776 0.43 . . . . 0.0 110.604 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -76.86 150.22 36.08 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.95 -28.92 70.15 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.32 -41.62 66.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.33 85.52 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.713 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.56 -37.77 87.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.9 -44.31 90.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.51 -38.76 77.74 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.16 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -60.47 -46.72 89.05 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.136 0.974 . . . . 0.0 110.951 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.86 -21.17 59.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.229 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -77.31 -34.88 55.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.4 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.53 150.52 18.78 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.09 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 140.36 48.04 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -50.01 -52.33 34.91 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.175 0.99 . . . . 0.0 112.083 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.0 m -68.7 -29.99 68.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 HD12 ' A' ' 55' ' ' LEU . 97.2 t -72.32 -49.1 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -68.84 -35.11 76.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.946 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 9.6 mm-40 -57.14 -46.8 82.38 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 116.858 -0.156 . . . . 0.0 111.346 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -70.33 -37.09 74.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.791 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 79.4 mt -63.99 -41.33 97.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 31' ' ' VAL . 34.3 ttpt -60.09 -44.32 94.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 92.9 mttt -64.06 -35.45 80.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.632 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.4 mmtt -64.06 -39.61 94.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.592 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -63.65 -42.87 98.05 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 123.653 0.596 . . . . 0.0 109.558 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 27' ' ' LYS . 69.9 t -63.45 -45.96 96.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.537 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.7 pt-20 -69.76 -39.37 76.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.98 -29.89 48.3 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.73 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.724 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.2 mt -53.32 -24.44 11.82 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.6 pt-20 -66.07 -27.36 68.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.149 0.5 . . . . 0.0 110.699 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.545 ' O ' HG13 ' A' ' 39' ' ' ILE . 12.3 t -160.16 77.92 2.66 Favored Pre-proline 0 C--O 1.205 -1.253 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.32 -25.41 49.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.988 1.792 . . . . 0.0 112.785 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -87.3 60.74 6.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.284 1.04 . . . . 0.0 113.122 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 36' ' ' SER . 85.5 mt -89.96 115.93 30.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.606 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.59 -30.88 61.64 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 123.732 0.813 . . . . 0.0 112.493 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -18.33 61.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.967 0.413 . . . . 0.0 111.59 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.554 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.3 m-20 -103.16 -16.02 15.85 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -63.19 145.75 54.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.603 0.761 . . . . 0.0 112.559 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 91.9 mt -96.75 123.78 40.54 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 169.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -87.25 130.87 34.41 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.18 -34.01 6.06 Favored Glycine 0 C--N 1.306 -1.12 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 94.5 mmm -86.37 125.5 67.52 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -35.84 -66.56 0.11 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 124.733 3.622 . . . . 0.0 114.029 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 55.54 0.98 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.75 142.3 34.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 21.2 m-85 -135.04 152.19 51.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.29 139.96 53.25 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.103 178.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.6 mt -122.89 132.69 70.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -113.37 149.98 33.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.907 0.384 . . . . 0.0 111.961 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.49 HD12 HG13 ' A' ' 22' ' ' VAL . 15.4 mt -94.47 136.66 34.52 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -62.09 -32.21 72.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.462 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -71.68 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p -102.45 2.21 36.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.56 46.04 9.11 Favored Glycine 0 C--N 1.32 -0.319 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.86 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -97.25 145.45 26.07 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 54' ' ' LYS . 5.6 mpt_? -120.98 149.59 42.42 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.88 130.88 45.75 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.12 122.84 70.24 Favored 'Isoleucine or valine' 0 C--O 1.251 1.155 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 25.9 p90 -132.75 159.35 39.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.668 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -111.6 138.43 48.15 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.31 111.62 25.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.24 95.81 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.22 -31.0 71.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.133 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.0 -40.27 76.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.377 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HB2' HG12 ' A' ' 72' ' ' VAL . 53.1 mttm -107.65 -6.74 16.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.714 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t 65.83 33.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 122.881 1.324 . . . . 0.0 110.066 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.2 p -133.8 140.22 46.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 O-C-N 121.35 -0.844 . . . . 0.0 110.353 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.451 ' HB ' HD22 ' A' ' 5' ' ' LEU . 91.2 t -96.69 117.98 42.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -108.22 117.94 35.46 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.501 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -77.45 121.08 29.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.72 -41.89 13.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.573 0.701 . . . . 0.0 109.119 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -148.79 153.37 38.04 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.0 p -148.85 138.99 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.88 -114.8 0.64 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.38 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.572 ' HB3' ' OE1' ' A' ' 82' ' ' GLU . 63.0 mtpt -127.82 155.73 43.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.6 6.07 4.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' OE1' ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -78.81 -15.54 58.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 122.064 -0.398 . . . . 0.0 111.917 -177.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.17 -2.79 30.45 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.314 0.578 . . . . 0.0 109.502 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m 63.73 15.19 8.81 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.844 1.258 . . . . 0.0 113.813 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.79 -28.7 68.6 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.162 0.585 . . . . 0.0 112.22 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.0 m -72.72 -21.26 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.227 0.537 . . . . 0.0 111.303 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -81.17 -24.34 37.61 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.55 -35.49 80.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.958 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -72.04 -50.44 28.4 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.158 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -55.35 -51.5 66.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.782 . . . . 0.0 113.05 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 -37.91 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -77.06 -24.53 51.96 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -77.71 -28.45 50.91 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.66 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 90' ' ' ALA . 43.7 mm -80.38 79.35 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.166 0.507 . . . . 0.0 111.682 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.425 -1.713 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 172.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.78 163.51 32.0 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.15 172.93 6.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.43 160.57 17.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.3 128.9 47.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -142.59 169.11 18.19 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -129.63 141.68 50.89 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.083 0.553 . . . . 0.0 110.178 -175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.59 154.9 41.1 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 4.6 pt-20 -61.31 -31.91 71.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.424 0.556 . . . . 0.0 110.634 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 75.3 mtt180 -63.81 -42.59 97.65 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.6 82.27 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.89 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.4 mt -63.8 -43.13 97.19 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.657 0.265 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -61.25 -43.73 98.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.368 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.21 -39.71 78.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.923 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -62.55 -43.73 98.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -75.58 -20.93 58.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.341 0.591 . . . . 0.0 110.893 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -74.54 -35.47 63.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.405 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD11 ' HA2' ' A' ' 79' ' ' GLY . 3.3 mp -62.59 156.95 21.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.376 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.33 149.85 47.71 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 22.8 t -57.86 -49.05 78.01 Favored 'General case' 0 C--O 1.205 -1.251 0 C-N-CA 122.555 0.342 . . . . 0.0 111.812 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.462 HG22 ' OE1' ' A' ' 25' ' ' GLN . 15.6 m -68.53 -38.19 80.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.38 -47.13 94.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.274 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.37 -35.29 79.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.333 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 20' ' ' SER . 44.5 mt-10 -63.51 -39.51 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' OE1' HG22 ' A' ' 21' ' ' THR . 2.0 mp0 -63.75 -41.29 98.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.401 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 93.0 mt -62.44 -41.98 99.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.06 -42.28 89.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 99.5 mttt -59.54 -36.98 77.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.678 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 53' ' ' ILE . 5.6 mptp? -69.0 -37.89 78.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.32 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.6 mt -62.51 -47.53 83.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.573 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.44 -41.08 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.319 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 13.1 pt-20 -69.65 -44.0 71.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.708 0.29 . . . . 0.0 111.709 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.7 -29.67 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.5 mt -53.05 -25.3 12.07 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.7 pt-20 -68.77 -26.81 65.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.122 0.419 . . . . 0.0 110.924 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -162.55 80.21 1.78 Allowed Pre-proline 0 C--O 1.212 -0.884 0 C-N-CA 123.138 0.575 . . . . 0.0 109.504 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -82.62 5.75 6.2 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.139 1.893 . . . . 0.0 112.662 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 36.15 0.87 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.328 0.585 . . . . 0.0 111.614 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.8 mt -81.89 105.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.33 -32.12 62.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.833 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.99 72.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.382 0.61 . . . . 0.0 110.929 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -94.17 -2.5 52.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.016 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -78.22 138.35 38.6 Favored 'General case' 0 N--CA 1.4 -2.948 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.09 155.55 21.45 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.666 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -87.12 122.66 31.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.4 83.68 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.58 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.6 mmm -111.15 131.44 22.2 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.18 95.13 0.17 Allowed 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 122.804 2.336 . . . . 0.0 112.362 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 48.16 45.99 19.7 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.696 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -102.58 141.29 35.64 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 58.4 m-85 -133.66 150.98 51.56 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 55.2 pttt -118.98 144.86 46.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.134 0.492 . . . . 0.0 110.569 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 29' ' ' LYS . 82.0 mt -109.39 132.9 56.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.93 137.75 40.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 124.06 0.85 . . . . 0.0 109.255 173.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.2 tt -88.9 -11.75 43.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 74.27 -62.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.502 1.521 . . . . 0.0 111.29 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -75.59 -59.77 2.6 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -68.61 -25.9 65.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.55 49.16 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.197 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -98.75 149.19 23.1 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 120.837 0.351 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 mpt_? -131.51 144.22 50.96 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.812 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -127.01 127.72 45.23 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.33 123.17 69.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-O 121.073 0.463 . . . . 0.0 110.009 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.1 p90 -133.57 159.51 40.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 4.2 pt20 -111.89 140.82 46.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.47 111.46 25.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.1 mt -97.8 95.45 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.07 -29.23 63.92 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.416 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.58 -40.55 87.75 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.5 mttm -98.37 -7.15 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.334 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.87 36.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.775 1.274 . . . . 0.0 109.237 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 70' ' ' LYS . 11.3 p -134.22 138.72 49.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.71 115.34 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -111.34 112.82 24.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.03 124.96 33.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.1 mt -98.03 -41.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.461 0.648 . . . . 0.0 110.095 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.1 m -148.11 151.55 35.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.219 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.43 147.57 16.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' HD11 ' A' ' 18' ' ' LEU . . . 146.92 -124.23 1.93 Allowed Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -123.09 167.67 13.36 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.58 31.78 5.63 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.495 0.664 . . . . 0.0 109.306 -175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.73 -40.61 95.62 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.695 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.22 15.63 15.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.6 m 66.1 22.6 11.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.508 1.123 . . . . 0.0 110.76 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -58.86 -41.45 87.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.92 0.888 . . . . 0.0 112.672 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.01 -24.3 32.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.402 ' O ' HG12 ' A' ' 91' ' ' VAL . 57.2 m-85 -82.87 -41.57 18.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -58.79 -43.67 90.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.834 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.21 -49.86 70.32 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.861 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -51.19 68.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.275 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 87' ' ' TYR . 11.3 p -66.65 -32.32 57.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 7.5 mmpt? -77.41 -15.37 59.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -79.9 -34.92 38.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.31 -34.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.081 -176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.464 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.504 -0.798 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.3 165.5 13.76 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -134.43 167.23 21.14 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.45 157.77 24.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -125.69 122.56 36.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -140.41 169.34 17.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -129.89 147.9 51.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.69 154.46 38.83 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -32.53 72.51 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.452 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 57.5 mtp180 -72.8 -34.21 66.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.716 0.293 . . . . 0.0 111.034 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.04 79.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 mt -66.99 -43.54 82.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.924 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 89.2 mttt -59.49 -44.59 93.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.269 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 16.7 mm-40 -69.5 -37.67 77.29 Favored 'General case' 0 C--O 1.202 -1.406 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.5 -42.5 96.47 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 110.132 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.86 -24.11 58.52 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.096 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -78.3 -29.64 47.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.375 1.07 . . . . 0.0 111.175 177.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mp -63.67 161.11 15.55 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.71 0.804 . . . . 0.0 111.322 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.77 145.37 33.83 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -46.6 64.95 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.149 0.98 . . . . 0.0 111.287 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 m -62.43 -46.54 88.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.173 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -47.29 85.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.713 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.5 ptt180 -67.01 -35.04 79.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.077 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 35.4 mt-10 -59.71 -39.12 83.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.072 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.07 -39.32 79.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.831 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.3 mt -63.04 -43.83 97.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.684 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 27' ' ' LYS . 19.4 ptmt -64.22 -34.04 77.18 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.1 mttm -58.79 -43.87 90.58 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.8 mptp? -66.62 -34.69 78.44 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.8 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 82.1 mt -61.82 -47.96 82.75 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.576 0.547 . . . . 0.0 110.491 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.22 -40.92 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -68.76 -42.91 76.84 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.99 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 65.4 mt -54.78 -26.35 33.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 pt-20 -79.16 -18.76 52.53 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.492 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.9 m -157.47 67.47 3.92 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 123.027 0.531 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.82 -0.34 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.847 0 C-N-CA 122.112 1.875 . . . . 0.0 114.218 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 25.75 0.23 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -82.31 100.33 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.642 0.734 . . . . 0.0 110.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.93 -20.42 57.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.626 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.76 64.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.431 0.634 . . . . 0.0 110.813 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -104.27 -1.22 27.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.364 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -84.22 138.88 32.72 Favored 'General case' 0 N--CA 1.404 -2.73 0 CA-C-O 121.357 0.598 . . . . 0.0 112.009 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -91.49 124.55 35.75 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.869 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.93 120.41 28.17 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.859 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.92 46.37 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.9 mmm -117.58 131.42 24.09 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.03 94.4 0.16 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.773 2.316 . . . . 0.0 112.937 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 45.57 50.05 10.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 125.117 1.367 . . . . 0.0 113.532 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 59.2 m -100.28 142.01 32.34 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.428 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 59.3 m-85 -133.28 154.99 50.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -126.15 147.44 49.62 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.893 0.854 . . . . 0.0 112.653 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 78.5 mt -109.19 141.57 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 138.41 41.6 Favored 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 123.213 0.32 . . . . 0.0 110.3 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 55' ' ' LEU . 13.0 mt -79.73 161.94 25.47 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.967 0.413 . . . . 0.0 111.139 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 -99.46 -40.91 7.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -88.78 0.22 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -152.57 163.7 39.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.21 29.82 10.62 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.022 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -83.02 136.56 34.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.088 0.471 . . . . 0.0 110.99 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.3 mpt_? -128.31 149.63 50.42 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.112 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -129.9 125.15 34.88 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.07 127.65 72.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 16.8 p90 -136.01 158.62 43.97 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.271 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HB3' HD11 ' A' ' 76' ' ' ILE . 28.7 pt20 -112.81 139.6 48.3 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.4 t -93.22 111.7 25.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.69 95.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.13 -30.95 65.55 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.074 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.65 -32.51 71.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.114 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -100.02 -3.26 32.47 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.334 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.24 25.1 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 CA-C-O 122.451 1.119 . . . . 0.0 110.403 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.55 138.83 52.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.985 -1.072 . . . . 0.0 111.281 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.2 t -97.96 117.37 42.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -107.57 114.56 28.63 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.351 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.96 121.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 65' ' ' GLN . 57.8 mt -95.84 -42.86 12.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.406 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 m -150.41 150.34 31.24 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.116 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.2 136.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -130.6 2.36 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 85' ' ' GLU . 32.6 mtmm -113.55 165.9 12.04 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 117.505 0.652 . . . . 0.0 111.01 -176.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.17 70.55 1.41 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -40.18 64.23 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.753 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.77 -67.13 0.32 Allowed 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.5 m -151.53 26.32 0.67 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 29.2 tt0 -56.27 -51.91 66.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -82.37 -9.94 11.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -85.22 -47.33 10.2 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.056 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 p -66.57 -36.44 82.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.438 0.637 . . . . 0.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.57 -44.64 86.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.461 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 94' ' ' ILE . . . -63.02 -56.24 18.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.589 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.446 HG13 ' HD2' ' A' ' 92' ' ' LYS . 9.4 p -60.95 -35.82 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.446 ' HD2' HG13 ' A' ' 91' ' ' VAL . 13.5 mptt -76.56 -15.25 59.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.914 -0.491 . . . . 0.0 112.105 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -89.03 -28.29 20.27 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.059 -0.401 . . . . 0.0 110.248 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 90' ' ' ALA . 57.0 mt -82.67 -52.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.834 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--O 1.252 1.192 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.746 -179.395 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.31 135.54 33.41 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.146 0.498 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.11 169.87 9.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.687 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -92.88 162.1 14.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -126.53 125.12 41.49 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -130.27 151.61 50.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.21 135.48 54.66 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.642 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 18.0 t70 -71.45 154.09 41.77 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.83 -32.48 69.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.304 0.502 . . . . 0.0 112.164 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.642 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 7.7 ptm180 -62.64 -39.22 93.18 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.194 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 -38.61 84.23 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.079 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.25 -43.5 97.83 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 122.579 0.351 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -63.01 -43.99 97.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.989 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.4 mm-40 -69.38 -37.17 77.44 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.05 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -60.62 -42.72 97.43 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 124.419 1.088 . . . . 0.0 110.224 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -74.63 -23.68 58.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.693 0.759 . . . . 0.0 110.194 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 85.4 tttt -74.44 -21.57 59.54 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.9 1.28 . . . . 0.0 109.864 177.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -76.75 165.26 24.96 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.386 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.13 154.16 40.58 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 p -55.21 -46.72 75.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 12.0 m -69.52 -42.45 74.65 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.39 -47.89 91.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.355 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 24' ' ' GLU . 9.8 ptt180 -63.29 -41.44 98.97 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 23' ' ' ARG 0.324 42.6 mt-10 -67.84 -33.63 75.15 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 21' ' ' THR . 30.4 mm-40 -60.05 -44.43 94.69 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -66.93 -41.51 86.9 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.323 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 33.3 ttpt -56.99 -43.59 81.87 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -58.95 -41.82 88.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.565 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.18 -38.31 87.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.545 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.5 mt -64.7 -47.31 78.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.534 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.42 -40.87 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.377 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.5 pt-20 -69.73 -42.88 73.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.78 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.43 -30.99 51.2 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 C-N-CA 122.392 0.277 . . . . 0.0 111.201 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 73.4 mt -54.5 -26.36 31.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.9 pt-20 -67.58 -26.52 66.32 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.658 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p -162.9 77.66 1.85 Allowed Pre-proline 0 N--CA 1.436 -1.132 0 C-N-CA 122.685 0.394 . . . . 0.0 111.483 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.11 12.12 1.59 Allowed 'Trans proline' 0 C--O 1.209 -0.937 0 C-N-CA 122.891 2.394 . . . . 0.0 113.554 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.52 28.16 0.78 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 111.836 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.7 94.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.771 0.796 . . . . 0.0 110.119 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.25 -23.29 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.041 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.97 66.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.129 0.49 . . . . 0.0 110.772 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.17 -8.09 18.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -75.71 136.53 40.35 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.482 0.658 . . . . 0.0 112.658 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.508 HD21 ' HD3' ' A' ' 52' ' ' LYS . 92.1 mt -81.44 139.45 35.23 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.793 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -92.03 121.31 33.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.35 58.4 Favored Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.991 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 81.3 mmm -126.26 131.32 23.91 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.43 90.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.228 2.618 . . . . 0.0 113.419 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 49.55 44.61 24.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.911 1.684 . . . . 0.0 112.629 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -100.18 142.74 31.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.571 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 22.4 m-85 -129.74 152.85 48.79 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HD3' HD21 ' A' ' 44' ' ' LEU . 55.6 pttt -125.93 139.82 53.14 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.574 0.546 . . . . 0.0 109.569 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.18 144.71 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -123.26 140.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.0 tt -83.08 137.22 34.18 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -74.34 -57.35 4.0 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -61.37 -63.84 1.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.592 0.557 . . . . 0.0 110.709 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 5.5 p -103.86 122.94 46.18 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.5 73.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.67 0 O-C-N 123.837 0.71 . . . . 0.0 114.537 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.67 144.53 36.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -125.52 150.68 47.2 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.75 133.15 39.59 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.01 127.66 75.97 Favored 'Isoleucine or valine' 0 C--O 1.255 1.362 0 C-N-CA 123.169 0.588 . . . . 0.0 109.431 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 12.9 p90 -138.32 158.63 43.91 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 28.3 pt20 -109.55 141.0 42.67 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.7 112.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.47 94.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.38 -25.22 62.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.617 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.09 -41.25 92.09 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.134 0.897 . . . . 0.0 110.142 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -105.72 -3.43 22.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.155 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t 65.19 34.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 122.66 1.219 . . . . 0.0 109.437 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.91 138.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.37 122.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -110.23 110.58 21.47 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.353 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.15 127.74 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.509 HG21 ' HA ' ' A' ' 90' ' ' ALA . 19.6 mt -110.73 -42.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.954 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -133.75 140.38 46.94 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.72 135.89 12.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.38 -146.5 18.12 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -95.25 140.17 30.53 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.532 0.666 . . . . 0.0 109.358 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.71 101.3 9.94 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -113.3 -34.19 5.71 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.368 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.08 8.84 32.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.5 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 66.49 25.39 10.16 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.967 1.365 . . . . 0.0 109.847 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -69.04 -37.4 78.57 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.791 -176.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m -58.37 -26.56 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -77.42 -50.45 12.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -62.34 -42.91 99.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.294 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 51.1 mt-10 -66.09 -30.49 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 110.381 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.509 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . -71.88 -53.34 13.48 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.909 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.13 -36.59 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.879 0.371 . . . . 0.0 111.407 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -76.59 -10.85 59.68 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -86.26 -32.64 21.01 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.42 -49.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.817 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.488 -179.109 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 CA--C 1.505 -0.784 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.97 151.08 20.67 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.05 159.64 15.34 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -81.13 160.58 24.38 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 34' ' ' LEU . 1.1 tm? -125.68 127.95 47.04 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -138.92 155.16 48.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.6 143.15 45.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.73 156.36 32.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.6 pt-20 -53.51 -37.14 62.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.913 0.485 . . . . 0.0 110.975 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -70.43 -44.79 67.15 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.79 70.25 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.613 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.08 -36.92 75.29 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.787 0.327 . . . . 0.0 111.681 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 57.3 mttm -67.98 -43.86 77.98 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -67.56 -39.32 84.94 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -60.9 -38.5 85.93 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.842 0.857 . . . . 0.0 109.999 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -73.15 -37.81 66.46 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.655 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -74.88 -16.34 60.68 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.721 0.772 . . . . 0.0 111.131 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 149.63 38.27 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.486 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.14 139.35 42.26 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 16.4 m -50.97 -46.48 61.24 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.918 0.887 . . . . 0.0 111.227 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 43.2 m -62.88 -43.22 99.37 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.06 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.21 -47.09 79.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.731 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.9 ptt180 -66.41 -33.92 76.79 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.016 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 26.5 mm-40 -60.24 -41.08 92.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 118.111 0.414 . . . . 0.0 111.136 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 21' ' ' THR . 73.9 mm-40 -65.76 -46.56 78.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.6 mt -61.47 -40.67 95.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.065 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.7 ttpt -57.25 -44.63 84.06 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.174 0.59 . . . . 0.0 110.245 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.3 mttt -57.7 -43.39 85.15 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.4 mptp? -62.34 -40.54 96.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.703 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -62.94 -45.73 91.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 123.516 0.51 . . . . 0.0 109.767 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 27' ' ' LYS . 62.5 t -64.49 -45.1 96.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.451 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.4 pt-20 -68.86 -44.06 74.11 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.621 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 37' ' ' PRO . 3.4 p -62.22 -29.78 47.37 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 123.327 0.651 . . . . 0.0 112.099 -173.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 87.9 mt -53.03 -25.36 12.14 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.37 -22.09 59.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.723 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -164.52 78.78 1.42 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 121.308 0.575 . . . . 0.0 111.683 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.5 Cg_endo -85.89 -9.73 7.46 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.384 2.056 . . . . 0.0 112.764 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.62 34.16 0.48 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.623 0.725 . . . . 0.0 112.956 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -83.25 110.57 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.819 0.818 . . . . 0.0 109.16 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -55.02 -29.34 57.18 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 126.246 1.818 . . . . 0.0 113.303 -175.084 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.23 -13.81 62.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -111.44 8.25 21.11 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.986 -0.446 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 17.2 ptmt -89.58 147.47 23.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.072 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 96.3 mt -69.91 155.69 40.19 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.46 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.64 -55.29 36.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.68 23.22 7.12 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.011 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.471 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -102.12 132.37 21.6 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 122.548 -0.384 . . . . 0.0 110.632 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.87 95.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.273 2.649 . . . . 0.0 112.642 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 50.83 47.06 25.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 113.015 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.0 m -106.64 141.09 38.48 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 38.5 m-85 -128.7 153.33 47.44 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 139.69 43.91 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.168 0.509 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.36 131.26 61.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.86 140.86 36.59 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -94.76 112.77 24.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -78.71 81.81 4.98 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.184 0.516 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 m -165.57 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.116 1.366 . . . . 0.0 109.137 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -161.17 179.17 8.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.04 51.78 4.15 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 121.108 -0.568 . . . . 0.0 114.397 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -108.14 142.64 38.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 151.05 38.27 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 123.689 0.796 . . . . 0.0 109.17 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.62 128.13 50.27 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.08 124.79 70.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.061 0 O-C-N 123.619 0.574 . . . . 0.0 110.248 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.3 p90 -136.67 158.83 43.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.4 pt20 -108.86 137.99 45.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.92 114.77 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.01 95.6 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.58 -36.61 84.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.722 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -60.93 -30.14 70.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.5 mttm -108.28 -5.32 16.86 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.627 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t 60.79 39.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.707 1.241 . . . . 0.0 109.624 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.5 p -132.31 139.01 51.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 121.335 -0.853 . . . . 0.0 111.173 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.63 115.39 42.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -110.63 111.62 22.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 61.1 t -75.45 122.49 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.528 HG21 ' HA ' ' A' ' 90' ' ' ALA . 48.4 mt -100.17 -42.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.204 0.526 . . . . 0.0 110.409 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m -147.98 149.85 32.92 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 122.152 -0.342 . . . . 0.0 110.43 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.14 139.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.97 -144.03 12.98 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.7 155.31 16.83 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.016 0.408 . . . . 0.0 110.022 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.97 101.79 4.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -68.2 -45.87 72.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.049 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -149.44 -61.62 0.22 Allowed 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.828 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -129.05 10.53 5.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -58.12 -52.48 65.36 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.328 0.585 . . . . 0.0 111.688 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.16 -25.61 16.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.518 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.94 -41.48 67.75 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -59.27 -51.15 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.981 0.8 . . . . 0.0 110.833 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.41 -35.67 73.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . -65.51 -49.35 69.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.539 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.57 -36.86 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.039 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.29 -11.01 59.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.134 0.492 . . . . 0.0 111.993 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -82.67 -34.65 27.36 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.4 mt -79.2 -48.71 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.739 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.411 -0.805 . . . . 0.0 110.799 -179.565 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.2 ttt . . . . . 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.92 143.41 46.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.04 168.85 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.11 160.13 14.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.86 132.36 52.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -141.79 156.86 45.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.67 147.59 41.81 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.035 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.04 154.77 40.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -32.42 72.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.626 0.25 . . . . 0.0 110.863 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -66.99 -46.53 74.3 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.552 0.691 . . . . 0.0 109.598 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.15 75.42 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.219 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.57 -40.83 96.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.024 0.44 . . . . 0.0 111.326 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.48 -43.4 85.53 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.58 -37.29 76.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.274 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.49 1.116 . . . . 0.0 110.824 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -74.69 -23.14 58.58 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.915 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.82 -40.32 61.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.128 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mp -58.95 147.11 35.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 124.541 1.136 . . . . 0.0 112.725 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -70.49 146.49 42.32 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.666 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 m -52.75 -45.88 67.24 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.058 0.943 . . . . 0.0 112.213 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 m -68.4 -36.7 79.5 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.893 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.14 -47.18 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.277 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.8 ptt180 -67.38 -33.83 76.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.186 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.07 -48.68 75.61 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.615 0.189 . . . . 0.0 110.702 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HB2' HD11 ' A' ' 55' ' ' LEU . 36.7 mt-30 -57.85 -41.97 83.47 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.014 0.821 . . . . 0.0 110.546 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.575 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 96.6 mt -66.65 -45.15 79.9 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.186 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.8 -44.2 94.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.515 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 94.9 mttt -62.97 -35.14 79.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.198 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.74 -35.03 72.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.81 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 mt -68.61 -46.12 70.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.04 -39.91 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.245 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.1 pt-20 -69.19 -42.8 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.2 p -63.87 -29.71 48.02 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.207 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 94.4 mt -53.73 -25.04 16.78 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -80.39 -19.71 45.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.078 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -155.2 70.99 5.66 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.839 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HB2' HG21 ' A' ' 66' ' ' VAL . 79.0 Cg_endo -77.3 -14.3 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.528 1.485 . . . . 0.0 111.606 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -83.11 61.08 5.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.71 0.767 . . . . 0.0 112.833 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -101.95 110.59 29.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.025 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.48 -22.04 66.84 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.51 -19.89 60.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 111.536 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -107.04 -7.6 16.86 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.013 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -70.35 133.64 47.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 123.568 0.747 . . . . 0.0 110.269 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.3 121.61 28.28 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -64.04 123.38 18.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.254 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.26 -29.4 8.91 Favored Glycine 0 C--N 1.324 -0.129 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.698 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.9 mmm -75.8 139.53 70.18 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 122.817 0.447 . . . . 0.0 110.053 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.92 90.88 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.869 2.379 . . . . 0.0 112.603 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 46.54 46.09 14.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 125.159 1.384 . . . . 0.0 113.014 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.5 m -99.88 142.34 31.5 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.569 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.3 m-85 -133.92 151.55 51.54 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -120.47 140.41 51.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 123.447 0.467 . . . . 0.0 110.62 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.01 134.94 61.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 157.86 17.68 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.479 0.487 . . . . 0.0 111.9 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 58' ' ' SER . 9.0 tp -94.11 166.06 12.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.501 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 37.9 mmt180 -90.22 -55.15 3.72 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.259 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 m -58.03 -59.86 4.63 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.539 ' H ' HD23 ' A' ' 55' ' ' LEU . 66.7 m -133.59 -177.42 4.54 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 122.069 -0.394 . . . . 0.0 110.692 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.75 62.83 4.46 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -103.32 139.66 38.45 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.522 HH11 ' HB3' ' A' ' 81' ' ' ALA . 2.9 mpt_? -136.26 142.93 44.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.15 0.5 . . . . 0.0 109.775 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -119.98 129.02 54.09 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.27 126.49 73.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.9 p90 -135.44 159.23 42.24 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.617 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.7 pt20 -109.09 140.66 42.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 37' ' ' PRO . 90.2 t -100.45 111.89 31.48 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mt -97.11 94.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.31 -29.84 68.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.168 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.2 -38.9 74.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.779 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -108.65 2.61 22.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.195 0.522 . . . . 0.0 111.374 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 t 61.54 34.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.824 1.249 . . . . 0.0 109.957 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.93 138.83 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.292 -0.88 . . . . 0.0 111.513 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -98.27 115.75 39.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -110.86 114.75 28.33 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.623 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.09 123.94 29.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.5 -42.49 11.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.096 0.474 . . . . 0.0 110.485 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 m -146.83 145.78 29.99 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.096 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.1 141.38 17.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.73 -152.93 24.6 Favored Glycine 0 CA--C 1.497 -1.05 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -91.44 149.04 21.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.522 ' HB3' HH11 ' A' ' 61' ' ' ARG . . . -85.79 71.48 10.66 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.292 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.76 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 60.2 18.09 7.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 112.385 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.7 m 60.89 32.67 20.04 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.164 0.986 . . . . 0.0 111.811 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.391 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 m -66.65 -17.25 22.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.338 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.08 -42.09 10.14 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.233 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 m -68.09 -45.22 74.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.152 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -29.66 63.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.591 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.07 -52.31 65.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.733 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.41 -40.75 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.966 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -68.68 -17.59 64.11 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -79.52 -28.04 41.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.28 -62.99 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.443 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 N--CA 1.429 -1.506 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.765 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 CA--C 1.5 -0.961 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 158.78 37.82 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -116.47 172.31 7.29 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -87.23 156.92 19.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.25 127.92 50.51 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.87 155.17 50.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.61 133.58 54.99 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 33.9 t70 -71.99 151.94 42.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pp20? -58.55 -34.34 70.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.0 mtt180 -69.69 -44.91 69.46 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.17 73.38 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 17.0 tp -72.3 -34.84 68.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.9 mttm -66.41 -42.09 88.3 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 36.0 mm-40 -63.65 -39.15 93.63 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -60.87 -39.56 89.65 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.09 1.356 . . . . 0.0 110.754 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 88.3 mtt180 -74.55 -32.75 62.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -72.81 -28.12 62.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 110.842 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -63.77 152.76 38.49 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.33 0.652 . . . . 0.0 112.103 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -68.78 143.37 39.97 Favored Glycine 0 N--CA 1.424 -2.119 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.602 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 8.1 m -48.99 -54.55 15.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.584 1.154 . . . . 0.0 112.411 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.8 m -64.66 -34.77 79.07 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.879 0.472 . . . . 0.0 110.713 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.83 -48.18 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 6.1 ptt180 -68.57 -35.54 77.54 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 20' ' ' SER . 54.1 mt-10 -58.03 -50.06 74.72 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.992 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -63.28 -35.3 79.91 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.213 0.32 . . . . 0.0 111.691 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.4 mt -66.77 -44.94 80.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.987 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.82 -41.98 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.5 mttt -59.47 -35.44 74.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.146 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.5 mptp? -70.96 -35.81 72.3 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.144 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.6 mt -66.32 -46.27 77.44 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.754 0.312 . . . . 0.0 110.897 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.83 -38.54 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.43 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 pt-20 -69.99 -43.43 71.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.85 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -63.08 -30.12 48.9 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.478 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 77.2 mt -54.18 -25.38 22.36 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -84.0 -8.54 59.11 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.022 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 39' ' ' ILE . 26.8 p -159.29 62.19 1.99 Allowed Pre-proline 0 C--O 1.206 -1.185 0 C-N-CA 124.038 0.935 . . . . 0.0 110.576 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 33' ' ' VAL . 73.0 Cg_endo -75.01 -20.6 16.69 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.777 1.651 . . . . 0.0 113.752 -172.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -89.69 54.76 2.97 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.148 0.975 . . . . 0.0 113.247 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 36' ' ' SER . 98.1 mt -83.19 110.86 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.732 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.15 -27.18 68.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.74 68.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.088 0.471 . . . . 0.0 111.067 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.02 -1.44 57.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.987 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 8.3 mtpm? -62.74 146.55 52.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.62 173.02 12.75 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.459 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -85.75 -55.02 4.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.33 52.51 0.82 Allowed Glycine 0 CA--C 1.5 -0.887 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.299 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.407 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 96.9 mmm -135.78 132.34 19.47 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.53 102.25 0.34 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.906 2.404 . . . . 0.0 113.309 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.8 35.3 24.22 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 124.347 1.059 . . . . 0.0 111.952 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 63.5 m -101.65 141.23 34.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.245 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.621 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 18.4 m-85 -131.75 153.66 49.84 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 47.9 pttt -126.5 140.35 52.53 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.41 0.624 . . . . 0.0 111.246 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.48 129.26 65.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -110.39 133.51 53.2 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.44 96.32 10.33 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -44.82 -41.77 7.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 126.598 1.959 . . . . 0.0 113.963 -172.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -82.38 -44.36 16.23 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 m -77.31 -36.0 54.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.7 14.63 49.25 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.354 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.99 158.26 15.54 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.75 147.59 33.14 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.461 0.648 . . . . 0.0 111.843 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -119.59 126.98 52.5 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.63 123.34 66.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 121.032 0.444 . . . . 0.0 110.297 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -133.82 157.63 45.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.677 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HB3' HD11 ' A' ' 76' ' ' ILE . 20.6 pt20 -107.71 131.67 54.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.53 111.05 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 70' ' ' LYS . 31.8 mt -99.04 96.01 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.32 -32.77 73.96 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.34 -35.52 74.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.082 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.423 ' H ' HG22 ' A' ' 67' ' ' ILE . 99.3 mttt -104.46 -2.41 25.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.53 33.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.525 1.13 . . . . 0.0 109.754 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.15 138.99 50.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 O-C-N 121.161 -0.962 . . . . 0.0 111.304 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -99.14 114.81 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 81.8 t80 -107.94 111.21 23.19 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.469 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -73.15 121.43 23.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.455 HG21 ' HA ' ' A' ' 90' ' ' ALA . 29.8 mt -98.09 -42.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.613 0.571 . . . . 0.0 110.373 -174.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 t -153.38 151.85 30.4 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.11 138.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.15 -139.86 8.43 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.394 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -101.83 158.7 15.93 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.999 0.428 . . . . 0.0 109.921 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.04 95.78 4.52 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.85 -41.91 2.33 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.278 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' HB3' ' OE2' ' A' ' 85' ' ' GLU . . . -123.86 29.48 6.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m 72.89 35.92 0.95 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.858 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.464 ' OE2' ' HB3' ' A' ' 83' ' ' ALA . 18.3 mp0 -57.58 -51.93 67.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.28 -27.51 26.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.514 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.77 -48.59 16.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.272 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.7 m -60.95 -42.93 99.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.557 0.536 . . . . 0.0 110.828 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -68.35 -35.83 78.33 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.91 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -65.84 -54.84 21.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.0 -35.68 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.905 0.383 . . . . 0.0 111.75 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -77.12 -19.28 57.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.425 ' HE ' ' CG ' ' A' ' 8' ' ' ASP . 21.8 tpt180 -93.97 -6.71 44.81 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.528 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 90' ' ' ALA . 48.5 mm -74.42 102.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 170.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -174.006 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -92.66 128.12 38.41 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.595 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.35 167.09 9.97 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.738 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.51 153.39 24.43 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 30' ' ' LEU . 1.9 tm? -125.56 124.39 41.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.65 156.05 49.46 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.413 0.625 . . . . 0.0 110.385 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.88 134.95 47.14 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.27 142.34 57.78 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 10.1 pt-20 -56.27 -31.32 63.5 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -72.34 -40.11 67.63 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.274 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.27 -31.19 70.48 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.869 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -68.16 -34.91 77.2 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.3 mttm -63.61 -42.8 98.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.893 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 42.0 mm-40 -68.69 -37.47 79.59 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.088 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -60.68 -45.01 95.77 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.83 0.852 . . . . 0.0 110.643 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -74.78 -21.18 59.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.587 0.708 . . . . 0.0 110.175 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 80.2 tttt -74.86 -25.43 58.96 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.79 1.236 . . . . 0.0 110.154 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 14' ' ' GLU . 5.5 mp -68.06 168.07 12.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.253 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.03 -138.68 1.56 Allowed Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.056 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -106.5 -60.47 1.65 Allowed 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.585 -0.95 . . . . 0.0 108.86 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -52.23 -43.36 64.24 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.93 1.292 . . . . 0.0 113.096 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.13 -48.35 79.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.135 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -69.08 -33.91 74.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -56.07 -45.96 79.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.444 ' HB3' HD21 ' A' ' 55' ' ' LEU . 45.8 mt-30 -70.61 -38.98 74.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.953 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 92.5 mt -63.46 -44.04 95.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.36 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -58.87 -43.2 90.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.186 0.517 . . . . 0.0 110.346 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' HA ' HG12 ' A' ' 31' ' ' VAL . 97.8 mttt -62.89 -37.7 87.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.9 mptp? -64.32 -37.57 87.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.582 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.1 mt -68.36 -45.28 73.26 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 28' ' ' LYS . 7.8 p -68.75 -36.21 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.799 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -68.75 -44.94 72.7 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 37' ' ' PRO . 3.7 p -62.93 -30.66 50.1 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.124 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.627 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 71.0 mt -53.91 -25.62 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 8.1 pt-20 -64.48 -28.85 69.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.084 0.856 . . . . 0.0 111.19 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -160.1 77.5 2.72 Favored Pre-proline 0 C--O 1.206 -1.207 0 C-N-CA 124.059 0.944 . . . . 0.0 108.493 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 33' ' ' VAL . 89.8 Cg_endo -85.25 -1.27 9.21 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.679 2.253 . . . . 0.0 113.537 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 40.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.549 0.69 . . . . 0.0 110.885 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.15 100.88 5.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.359 1.076 . . . . 0.0 110.352 -173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -55.42 -27.48 48.15 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.706 2.003 . . . . 0.0 112.509 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.23 61.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.064 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.73 1.47 17.88 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -80.25 135.63 36.28 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 121.07 0.462 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.8 mt -82.68 122.87 28.7 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.595 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -89.27 120.03 30.26 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.09 6.77 42.07 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 95.2 mmm -127.0 138.68 33.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' MET . 14.1 Cg_exo -67.2 95.13 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.601 2.201 . . . . 0.0 112.971 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 52.5 39.02 27.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.041 1.337 . . . . 0.0 113.573 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.5 m -99.99 142.49 31.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.9 m-85 -132.4 156.24 47.04 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -133.37 141.97 48.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.27 0.557 . . . . 0.0 112.402 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.78 122.85 68.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 128.61 49.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.423 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 25' ' ' GLN . 1.3 tm? -76.12 102.95 5.93 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 -173.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -56.44 -39.58 73.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -88.26 20.38 3.28 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -156.05 -45.53 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.668 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.99 22.5 7.21 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.672 -1.251 . . . . 0.0 112.341 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -95.69 154.09 17.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 122.222 -0.575 . . . . 0.0 109.818 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -122.95 135.62 54.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.74 124.95 34.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -117.07 128.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.6 p90 -133.48 158.16 43.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.747 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HB3' HD11 ' A' ' 76' ' ' ILE . 20.5 pt20 -105.46 138.19 42.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.63 111.2 34.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.1 mt -97.35 101.75 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.01 -36.57 80.18 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.561 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.64 -40.31 96.59 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.17 -6.05 42.62 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.6 t 58.49 37.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.429 1.109 . . . . 0.0 109.711 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.1 140.31 40.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 121.365 -0.834 . . . . 0.0 110.902 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.83 124.99 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 124.461 1.104 . . . . 0.0 108.771 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.08 116.92 29.91 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.7 t -68.99 121.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 65' ' ' GLN . 59.0 mt -96.28 -43.11 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.993 0.425 . . . . 0.0 110.638 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 p -141.3 143.5 34.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 120.877 0.37 . . . . 0.0 110.567 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.1 141.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.22 -140.24 7.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -116.71 155.44 28.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.351 0.575 . . . . 0.0 110.002 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.88 128.87 41.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -94.26 -38.17 11.16 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.42 -63.27 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.204 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -161.55 22.99 0.12 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 121.019 0.437 . . . . 0.0 110.924 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -58.41 -45.51 88.28 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.603 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.31 -25.49 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -79.75 -44.92 19.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -62.84 -43.15 99.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.853 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.1 -28.18 68.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.54 63.15 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.31 -23.28 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.124 0.488 . . . . 0.0 110.919 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -61.34 -26.23 67.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.183 0.993 . . . . 0.0 111.592 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -89.28 -12.07 41.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.595 0.712 . . . . 0.0 109.767 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.2 mt -94.62 -59.21 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.209 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.308 -1.23 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.727 177.551 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.35 152.95 50.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -118.33 168.57 10.5 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -99.03 163.17 12.69 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 123.062 0.226 . . . . 0.0 111.172 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.11 130.96 53.17 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.52 149.6 46.89 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.91 134.85 46.14 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 20.2 t70 -72.05 153.43 41.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.96 -32.53 66.13 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -68.27 -42.25 79.85 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.12 75.25 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.737 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.0 mt -69.84 -39.29 76.51 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.443 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -62.36 -44.29 96.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.068 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 32.5 mt-10 -70.01 -37.51 75.69 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.066 0.46 . . . . 0.0 111.4 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -62.37 -42.0 99.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 123.737 0.815 . . . . 0.0 110.33 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -75.24 -23.26 57.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 48.5 tttp -67.84 -45.4 74.75 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 14' ' ' GLU . 6.5 mp -58.69 151.15 21.6 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.623 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -75.42 152.12 42.7 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.5 t -52.44 -53.24 47.95 Favored 'General case' 0 C--O 1.201 -1.454 0 C-N-CA 123.058 0.543 . . . . 0.0 111.291 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.0 m -57.82 -38.0 74.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 123.507 0.723 . . . . 0.0 111.577 -176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -72.18 -47.87 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 109.944 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 9.2 ptt180 -68.45 -34.57 76.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.4 mt-10 -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.817 0.447 . . . . 0.0 111.599 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -66.01 -35.31 80.21 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.673 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.5 mt -67.24 -43.43 81.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.667 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -59.33 -44.37 92.63 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 110.5 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 90.5 mttt -62.49 -35.1 78.29 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.555 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.6 mptp? -65.71 -39.56 91.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.869 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.3 mt -61.63 -44.61 96.67 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 27' ' ' LYS . 87.9 t -61.67 -45.31 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.84 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -69.65 -42.49 74.18 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.746 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.9 p -62.59 -29.67 47.44 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.7 mt -53.16 -25.77 14.73 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.5 pt-20 -66.24 -28.92 69.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.491 0.662 . . . . 0.0 110.966 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.4 m -158.42 76.66 3.47 Favored Pre-proline 0 C--N 1.315 -0.894 0 C-N-CA 124.227 1.011 . . . . 0.0 108.805 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 33' ' ' VAL . 61.1 Cg_endo -75.59 -24.43 11.93 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.472 1.448 . . . . 0.0 111.466 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 2.4 ppt_? -78.38 62.57 3.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.166 0.984 . . . . 0.0 112.907 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.84 124.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.25 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -35.94 67.37 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.16 0.984 . . . . 0.0 112.263 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.62 -15.98 61.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.549 0.69 . . . . 0.0 111.399 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.4 m-20 -104.68 -7.0 19.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 21.8 ttmt -85.9 138.59 31.92 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -172.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -86.45 129.09 34.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.948 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -74.87 116.52 15.68 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.847 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.49 49.66 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.862 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.1 mmm -101.93 137.18 19.45 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.07 95.16 0.14 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 123.205 2.604 . . . . 0.0 112.71 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 45.86 46.27 12.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 125.015 1.326 . . . . 0.0 113.012 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.38 141.61 33.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 43' ' ' LYS . 79.6 m-85 -131.66 145.84 51.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.424 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -115.86 141.15 48.48 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 123.618 0.573 . . . . 0.0 110.066 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.13 138.44 51.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -119.42 132.78 55.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.285 0.366 . . . . 0.0 110.389 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 tt -84.27 117.78 23.76 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -51.74 -57.28 9.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -76.12 -53.59 8.09 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.184 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -63.86 -34.84 78.84 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.67 26.68 49.63 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.327 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.54 150.33 20.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -123.5 141.53 51.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -126.3 131.89 51.77 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.18 122.72 67.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 CA-C-O 121.405 0.621 . . . . 0.0 110.494 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -131.78 157.97 42.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.055 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.16 139.77 48.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 73' ' ' VAL . 77.5 t -88.63 112.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 mt -98.54 95.64 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.466 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.26 -35.76 76.25 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.28 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -104.8 -1.31 26.27 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.013 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t 59.14 33.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.378 0 CA-C-O 122.722 1.248 . . . . 0.0 110.267 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.04 141.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.528 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 66' ' ' VAL . 17.6 m -98.17 128.07 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.112 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 87.1 t80 -103.09 110.04 21.83 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.401 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -75.52 120.79 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.4 mt -95.06 -42.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.341 0.591 . . . . 0.0 109.521 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.7 m -153.0 153.31 32.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.014 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.06 148.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.81 -111.86 0.72 Allowed Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.3 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -124.59 142.81 51.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.49 116.17 21.38 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -126.35 -35.04 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 123.517 0.51 . . . . 0.0 110.276 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.44 -69.29 0.75 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.495 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -159.96 24.18 0.17 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.821 0.819 . . . . 0.0 110.259 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 7.6 mp0 -61.46 -51.8 67.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.433 -175.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.2 m -74.06 -8.11 11.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.615 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -92.31 -52.08 4.85 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -61.46 -49.91 74.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.49 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.98 -29.55 67.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.459 ' O ' HG13 ' A' ' 94' ' ' ILE . . . -73.41 -51.04 18.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.298 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.41 -35.01 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.019 0.437 . . . . 0.0 110.768 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.14 -17.09 60.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.291 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -92.11 -18.97 22.8 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.241 0.543 . . . . 0.0 111.17 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 90' ' ' ALA . 83.4 mt -75.92 -46.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.45 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 tm? . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.666 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 CA--C 1.498 -1.039 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.85 135.9 17.55 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -87.47 164.91 15.9 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.652 0.595 . . . . 0.0 109.544 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.4 157.48 22.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.449 HD23 HD21 ' A' ' 34' ' ' LEU . 1.3 tm? -126.16 128.55 47.46 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -140.37 157.13 46.01 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.18 142.23 49.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 122.395 0.278 . . . . 0.0 110.433 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.69 155.02 40.19 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.49 -29.64 67.99 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 12.6 mmt85 -71.75 -43.02 66.52 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.32 81.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.04 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.6 mt -63.16 -43.26 98.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 110.774 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.212 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 37.3 mm-40 -68.36 -37.54 80.57 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 123.528 0.517 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.69 -45.11 94.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.064 0.945 . . . . 0.0 111.033 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.3 -22.71 57.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.858 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -77.09 -31.67 56.1 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.427 1.491 . . . . 0.0 110.732 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.71 152.2 27.35 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.932 0.893 . . . . 0.0 111.786 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -69.49 147.19 45.1 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 15.0 m -49.18 -54.6 15.73 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.289 1.035 . . . . 0.0 112.455 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -63.54 -34.55 78.04 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.277 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.83 -48.85 61.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 7.3 ptt180 -69.24 -35.58 76.29 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 43.2 mt-10 -57.15 -49.46 75.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 120.45 0.166 . . . . 0.0 110.6 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.59 ' HB3' HD11 ' A' ' 55' ' ' LEU . 2.9 mp0 -68.51 -34.98 76.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.1 mt -66.91 -42.77 84.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.56 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -59.05 -41.9 89.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.185 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.4 mttt -59.23 -41.29 88.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.1 mptp? -64.32 -34.79 78.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.158 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -68.92 -47.31 66.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.44 -38.63 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.886 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 10.5 pt-20 -68.31 -43.14 78.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.945 0.402 . . . . 0.0 110.563 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.7 p -64.47 -30.56 50.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.838 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.8 mt -54.03 -25.46 21.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 14.6 pt-20 -75.17 -25.45 58.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.058 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.0 p -158.09 74.46 3.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.702 0.401 . . . . 0.0 110.125 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' HG22 ' A' ' 33' ' ' VAL . 94.3 Cg_endo -85.04 -1.34 9.37 Favored 'Trans proline' 0 C--O 1.206 -1.106 0 C-N-CA 122.057 1.838 . . . . 0.0 113.796 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 32.78 0.74 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.55 112.37 20.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -57.75 -29.04 64.46 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.82 -15.94 63.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.953 0.406 . . . . 0.0 111.725 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -102.41 -1.63 30.38 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.743 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.499 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 42.5 mtpt -74.03 144.67 45.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.084 0.469 . . . . 0.0 111.474 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 59.7 mt -74.41 133.46 42.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -73.26 107.61 5.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 32.41 9.23 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.736 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.551 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 77.2 mmm -133.98 142.72 44.45 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 47' ' ' MET . 9.5 Cg_exo -70.64 93.47 0.6 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.765 2.31 . . . . 0.0 112.714 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 50.0 41.73 23.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 124.993 1.317 . . . . 0.0 113.986 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 m -100.31 141.58 32.96 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.1 m-85 -130.01 146.24 51.68 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -115.14 140.4 49.11 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.28 0.562 . . . . 0.0 110.869 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.44 127.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -104.51 145.12 30.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.502 178.469 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 25' ' ' GLN . 15.5 tp -85.59 143.32 28.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -89.83 -30.27 18.06 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.639 0.733 . . . . 0.0 109.219 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -65.47 -29.77 70.47 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.069 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 23.4 t -164.17 158.71 19.43 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.06 50.63 3.08 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -99.02 143.42 29.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -122.96 142.65 50.59 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -120.64 126.85 51.29 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.9 t -116.59 123.46 71.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.181 0.515 . . . . 0.0 109.947 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.58 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.5 p90 -135.58 158.96 43.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.188 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -112.08 139.53 47.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.5 t -97.74 111.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.622 0.725 . . . . 0.0 110.056 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 70' ' ' LYS . 38.4 mt -100.08 95.06 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.37 -29.88 64.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.476 0.655 . . . . 0.0 109.76 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.73 -40.16 75.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.97 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 67' ' ' ILE . 95.3 mttt -108.06 4.29 24.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.509 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p 51.86 40.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.704 1.602 . . . . 0.0 111.879 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.91 138.96 50.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.748 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.86 115.24 42.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -108.87 112.92 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.665 -173.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.52 121.48 27.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -95.42 -42.74 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.374 0.606 . . . . 0.0 109.624 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -149.43 149.97 31.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.315 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.21 131.97 6.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.02 -155.78 26.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -81.09 152.92 27.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.369 0.604 . . . . 0.0 110.839 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.17 33.15 3.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.994 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -46.52 -55.72 7.1 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.747 1.279 . . . . 0.0 110.335 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.27 53.97 1.13 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.695 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p 56.4 31.92 19.65 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.741 1.216 . . . . 0.0 113.261 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 9.1 tp10 -57.67 -52.13 66.67 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.999 0.519 . . . . 0.0 111.388 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.36 -11.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -81.56 -44.07 17.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.436 ' HA ' HG12 ' A' ' 91' ' ' VAL . 18.2 t -66.57 -34.68 78.44 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 39.7 mm-40 -60.88 -47.89 84.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.543 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -67.11 -55.97 11.96 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.178 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 88' ' ' SER . 13.7 p -60.29 -38.65 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.45 -12.75 59.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -93.45 -15.97 25.03 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 90' ' ' ALA . 39.7 mm -82.65 -49.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.019 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.9 pp . . . . . 0 N--CA 1.438 -1.061 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.255 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 CA--C 1.505 -0.784 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.38 33.83 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.95 168.86 14.6 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.727 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -89.01 161.05 16.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -126.06 132.37 51.95 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.79 155.49 47.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -123.36 135.49 54.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 117.791 0.269 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.85 155.71 38.76 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 6.5 pt-20 -53.19 -40.82 64.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 117.809 0.277 . . . . 0.0 111.429 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.516 ' HG3' ' HD3' ' A' ' 93' ' ' ARG . 25.5 mmm180 -69.86 -38.06 76.3 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.99 93.32 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.925 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 44.7 mt -66.58 -42.85 86.34 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.164 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -61.32 -43.92 98.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -69.97 -39.57 75.89 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.765 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.11 -42.22 98.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.1 0.96 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 81.9 mtp180 -73.07 -26.63 61.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.041 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -71.84 -35.71 69.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.497 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -60.85 152.74 26.46 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.514 0.673 . . . . 0.0 112.528 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.0 155.77 49.67 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.778 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 3.0 p -55.73 -53.97 50.05 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 124.138 0.975 . . . . 0.0 112.801 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -57.62 -42.14 82.71 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 124.225 1.01 . . . . 0.0 110.899 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 93.7 t -68.58 -48.21 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.99 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.3 ptt-85 -68.72 -35.42 77.11 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 20' ' ' SER . 37.5 mt-10 -59.7 -45.41 92.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.399 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.639 ' HB3' HD11 ' A' ' 55' ' ' LEU . 2.6 mp0 -70.86 -34.74 71.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 85.1 mt -62.92 -44.06 97.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.397 174.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -56.38 -42.61 78.16 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.945 0.403 . . . . 0.0 110.498 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 98.9 mttt -60.24 -45.48 93.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.67 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.0 mptp? -59.95 -38.52 82.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.86 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.4 mt -65.96 -46.33 78.49 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.296 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.21 -37.73 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.737 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 8.2 pt-20 -68.6 -42.66 77.87 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.705 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.98 -29.37 47.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.49 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -52.85 -24.95 10.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.91 -30.37 70.95 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.683 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 t -161.72 75.81 2.32 Favored Pre-proline 0 C--O 1.2 -1.541 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 33' ' ' VAL . 85.3 Cg_endo -83.46 -9.68 10.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.0 1.8 . . . . 0.0 114.461 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 43.3 0.63 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.45 0.643 . . . . 0.0 111.881 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.14 101.32 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.793 0.806 . . . . 0.0 110.185 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.15 -25.2 65.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.629 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.75 -15.23 63.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.983 0.42 . . . . 0.0 110.81 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -113.87 11.12 17.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.383 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -80.49 144.69 32.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 120.98 0.419 . . . . 0.0 111.917 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.82 150.73 23.93 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.494 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -95.08 127.74 41.37 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.349 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.54 12.62 84.06 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.36 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.0 mmm -121.83 120.1 28.71 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.6 100.67 0.16 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.194 2.596 . . . . 0.0 113.598 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' GLN . 4.5 m-20 62.16 31.37 17.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 111.793 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.91 141.72 32.35 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.773 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.48 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 68.8 m-85 -136.5 156.54 48.45 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 140.46 47.11 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 112.536 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.26 141.28 34.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -113.23 144.3 42.93 Favored 'General case' 0 N--CA 1.403 -2.813 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 25' ' ' GLN . 18.5 tp -98.51 118.47 35.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -70.78 -34.59 71.95 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.196 0.522 . . . . 0.0 110.346 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 m -61.9 -39.49 92.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -124.96 -12.37 7.02 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 21.36 57.3 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.493 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -93.52 156.64 16.62 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.096 -0.65 . . . . 0.0 110.938 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -121.8 143.73 49.23 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.69 0.796 . . . . 0.0 108.982 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.43 127.67 37.93 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.41 125.66 72.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 CA-C-O 121.035 0.445 . . . . 0.0 110.022 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.1 p90 -136.93 158.83 43.56 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.245 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 4.0 pt20 -111.44 133.72 53.54 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 173.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -98.0 110.88 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.7 mt -99.65 95.79 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.69 -25.03 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.055 0.455 . . . . 0.0 110.247 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.57 -36.28 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.636 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HB2' HG12 ' A' ' 72' ' ' VAL . 96.7 mttt -107.68 -1.87 20.68 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.835 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t 58.5 32.52 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.234 1.414 . . . . 0.0 110.388 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -129.67 139.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.018 -1.051 . . . . 0.0 110.964 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -98.88 114.98 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -106.07 110.33 22.56 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.682 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.18 121.95 24.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.4 mt -94.89 -42.27 12.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.734 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.8 m -152.99 153.18 32.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.97 142.97 18.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.34 -131.72 3.18 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.176 -1.011 . . . . 0.0 111.797 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -124.03 167.06 14.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.468 -0.431 . . . . 0.0 110.641 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.57 55.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.481 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.39 126.53 28.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.15 18.51 10.99 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.262 1.025 . . . . 0.0 111.219 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 61.21 29.33 18.68 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.06 -50.86 71.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.55 0.74 . . . . 0.0 111.505 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -62.83 -25.9 39.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -80.92 -42.85 20.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.983 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -64.53 -41.49 96.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 12.2 tp10 -62.42 -46.8 86.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.076 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.37 56.58 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.819 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.73 -36.56 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.991 0.424 . . . . 0.0 111.164 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -71.36 -23.19 61.86 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HD3' ' HG3' ' A' ' 10' ' ' ARG . 12.8 mmm180 -77.48 -15.26 59.4 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.671 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.3 mt -82.27 -31.18 9.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.917 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.309 -1.162 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.79 133.63 55.84 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -91.06 162.88 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.89 155.03 23.1 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.403 HD23 HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -118.06 124.1 47.26 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -130.62 160.81 33.1 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.11 144.73 50.92 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 13.1 t70 -79.42 154.4 28.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 169.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -29.54 66.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 4.4 mmt85 -63.82 -45.0 91.56 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.07 93.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.386 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.99 -41.03 99.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 123.207 0.317 . . . . 0.0 111.749 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.67 -43.83 97.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.272 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 57.4 mm-40 -69.09 -39.5 78.97 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.272 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -61.3 -46.61 89.58 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.571 1.148 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -73.03 -28.58 62.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.529 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.4 -38.73 88.14 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.377 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.56 153.91 12.2 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.644 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.19 147.51 37.84 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.3 m -50.15 -48.04 53.96 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -67.27 -36.87 82.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.689 0.28 . . . . 0.0 110.966 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.16 -48.59 68.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 19.4 ptt180 -68.77 -35.43 77.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 24.0 mt-10 -57.93 -42.44 84.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.529 ' CB ' HD11 ' A' ' 55' ' ' LEU . 43.5 mt-30 -70.64 -35.11 72.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.128 0.489 . . . . 0.0 110.193 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.04 -41.87 85.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.956 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 18.6 ptmt -63.18 -36.73 84.59 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.898 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -59.63 -39.02 82.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 29' ' ' LYS . 72.9 mmtt -65.02 -36.21 83.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.689 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.661 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 71.7 mt -63.72 -43.62 96.0 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 27' ' ' LYS . 96.2 t -63.73 -45.46 97.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.717 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.2 pt-20 -69.09 -43.92 73.55 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.754 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.88 -29.76 47.9 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 81.5 mt -53.45 -25.32 15.71 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -75.09 -25.45 58.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.197 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -154.2 74.19 6.15 Favored Pre-proline 0 C--O 1.213 -0.829 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 33' ' ' VAL . 84.4 Cg_endo -80.98 -7.31 13.23 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 121.515 1.476 . . . . 0.0 113.386 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 38.69 0.94 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.58 0.705 . . . . 0.0 112.074 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.52 108.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.4 -24.68 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.54 -8.19 44.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 87.0 m-20 -108.94 3.8 22.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 9.9 mtpm? -71.18 142.41 50.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.11 126.17 32.84 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 168.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -85.77 114.56 22.82 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 6.47 16.74 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -131.28 139.05 34.23 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.75 -71.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.323 2.682 . . . . 0.0 112.677 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -137.96 78.04 1.66 Allowed 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.9 m -126.88 141.38 51.83 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 40.4 m-85 -133.75 155.43 49.78 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -126.39 139.83 52.97 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.641 0.588 . . . . 0.0 110.033 177.667 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 mt -108.71 142.55 21.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -117.1 129.34 55.92 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' A' ' 25' ' ' GLN . 14.6 tp -81.71 143.52 31.8 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -73.66 -36.64 65.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.1 m -99.62 150.2 22.5 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 71.82 -43.88 0.58 Allowed 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.68 35.16 5.25 Favored Glycine 0 C--O 1.239 0.447 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.767 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.44 155.76 17.16 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 122.622 -0.34 . . . . 0.0 110.22 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.8 mpt_? -129.52 151.33 50.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -128.26 131.32 48.75 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 86' ' ' VAL . 84.1 t -118.38 124.37 73.02 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-O 121.229 0.538 . . . . 0.0 110.943 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.4 p90 -137.48 158.88 43.44 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.977 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -112.23 141.28 46.12 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG22 ' HE1' ' A' ' 51' ' ' TYR . 12.0 m -101.37 123.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.561 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.83 94.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.168 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.2 -23.38 62.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.975 0.893 . . . . 0.0 109.51 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.99 -36.55 83.92 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.262 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 72' ' ' VAL . 99.5 mttt -107.31 -4.27 18.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.463 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t 63.35 34.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-O 122.678 1.228 . . . . 0.0 109.616 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.1 p -131.9 139.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.26 115.37 38.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 88.4 t80 -106.11 110.55 22.84 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.27 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.81 121.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.8 -42.61 12.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.881 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 m -151.39 153.92 35.65 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.3 139.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.85 -137.97 6.85 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -99.03 91.21 4.91 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.291 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.27 125.38 34.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -134.7 -37.31 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.742 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.69 -77.08 0.18 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 t -117.67 -12.74 10.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -58.38 -37.75 75.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -173.278 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 63' ' ' VAL . 29.9 m -86.62 -30.97 6.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.428 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -67.64 -47.5 69.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 120.691 0.281 . . . . 0.0 110.621 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.668 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 51.1 m -59.21 -41.79 89.42 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 4.7 tp10 -70.37 -42.1 72.23 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.85 81.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.75 -32.36 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.668 ' HE3' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -77.85 -32.39 52.05 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.444 175.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 13.0 tpt180 -74.82 -45.87 40.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -174.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.64 83.86 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.993 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.24 154.38 45.75 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.42 175.68 5.85 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.87 159.35 15.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.1 130.84 51.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -145.35 158.35 43.85 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.24 144.17 45.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.006 0.431 . . . . 0.0 111.987 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.39 155.97 28.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.96 -38.23 64.77 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.911 0.323 . . . . 0.0 111.229 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.81 -45.36 93.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.79 98.02 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.835 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -63.4 -45.42 91.11 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -63.29 -44.12 95.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.776 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -70.05 -37.97 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.442 ' O ' ' HD3' ' A' ' 23' ' ' ARG . 61.9 t-105 -63.04 -45.01 94.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.789 1.236 . . . . 0.0 110.674 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -72.19 -27.14 62.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.298 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.65 -38.5 64.95 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.479 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.4 150.65 17.98 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 124.434 1.094 . . . . 0.0 111.923 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.54 144.32 48.22 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -50.03 -50.25 48.18 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.144 . . . . 0.0 111.972 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.8 m -68.99 -37.77 78.94 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.271 0.628 . . . . 0.0 111.148 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.37 -47.67 80.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 10.1 ptt-85 -68.75 -35.96 77.76 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.571 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 33.4 mt-10 -66.69 -31.69 72.52 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.638 ' HB3' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.83 -34.37 71.61 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.649 175.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -65.48 -42.13 92.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.579 172.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' O ' HG23 ' A' ' 31' ' ' VAL . 30.9 ttpt -55.3 -44.76 76.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.648 0.779 . . . . 0.0 109.585 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -58.42 -38.02 76.56 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.929 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.7 mptp? -69.99 -35.22 74.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.155 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 85.7 mt -65.78 -41.63 91.77 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.154 0.502 . . . . 0.0 109.698 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' LYS . 92.7 t -62.64 -44.47 99.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.374 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -68.85 -45.73 70.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.988 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.424 HG21 ' OH ' ' A' ' 64' ' ' TYR . 3.4 p -62.94 -30.27 49.18 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.805 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 72.4 mt -53.35 -25.53 15.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.4 pt-20 -76.71 -28.03 55.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.118 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 m -152.37 69.41 7.37 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.686 -0.633 . . . . 0.0 110.454 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 33' ' ' VAL . 95.1 Cg_endo -87.63 -2.94 7.5 Favored 'Trans proline' 0 C--O 1.21 -0.887 0 C-N-CA 121.961 1.774 . . . . 0.0 112.828 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 37.94 0.94 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.949 0.881 . . . . 0.0 111.93 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.3 mt -82.7 100.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 12.6 pt-20 -57.48 -24.5 56.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.64 66.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.851 0.358 . . . . 0.0 111.143 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -99.5 3.89 45.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.437 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 10.1 mtpm? -72.23 139.39 48.11 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.213 0.53 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 63.0 mt -80.14 138.25 36.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.398 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -72.31 106.61 4.53 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.56 32.46 10.23 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.103 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -135.75 132.68 19.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.65 99.08 0.37 Allowed 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.682 2.255 . . . . 0.0 113.319 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 60.36 31.92 20.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.637 1.175 . . . . 0.0 111.681 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.3 m -100.09 141.44 32.91 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.801 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 7.4 m-85 -132.0 160.4 35.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -130.51 146.95 52.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -124.93 139.6 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.3 131.01 56.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.638 HD11 ' HB3' ' A' ' 25' ' ' GLN . 19.2 tp -77.61 96.59 4.84 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.421 0.629 . . . . 0.0 110.423 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -68.44 78.8 0.27 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.078 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t 172.63 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.279 1.432 . . . . 0.0 107.886 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 m -111.37 -23.44 10.79 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.82 49.32 Favored Glycine 0 C--O 1.241 0.544 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.585 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -88.01 150.21 23.55 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 122.61 -0.347 . . . . 0.0 110.16 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.13 147.88 46.31 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.181 0.515 . . . . 0.0 109.77 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -132.18 129.05 39.26 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.2 127.13 73.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 O-C-N 123.606 0.566 . . . . 0.0 110.102 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.2 p90 -138.08 158.78 43.63 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.9 pt20 -108.92 130.37 55.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -99.52 110.5 26.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.0 mt -99.01 100.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.83 -34.48 78.02 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.039 0.536 . . . . 0.0 111.828 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.44 -36.74 85.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.321 0.388 . . . . 0.0 111.595 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HB2' HG12 ' A' ' 72' ' ' VAL . 96.7 mttt -98.51 -6.97 29.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.05 0.453 . . . . 0.0 110.473 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 t 61.33 32.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 124.951 1.3 . . . . 0.0 109.936 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.3 p -129.42 138.78 53.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 111.148 -176.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.3 114.88 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.03 110.69 21.34 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.94 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 59.6 t -74.77 121.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.14 -42.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.533 0.682 . . . . 0.0 110.218 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 m -145.87 149.91 35.14 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.17 145.91 17.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.65 -144.94 12.63 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -98.54 162.79 12.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 118.095 0.948 . . . . 0.0 109.388 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.04 109.1 9.78 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -68.0 0.82 Allowed 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.3 -59.82 1.08 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.916 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -125.87 10.95 7.71 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.781 -174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -57.98 -52.32 66.01 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 m -89.37 -6.12 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.03 0.443 . . . . 0.0 111.684 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -89.24 -44.53 10.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.931 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.637 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 68.5 m -64.99 -48.03 75.45 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.94 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -60.6 -31.6 70.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.804 0.335 . . . . 0.0 110.421 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.63 -54.75 6.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.344 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 88' ' ' SER . 8.9 p -63.6 -29.92 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 88' ' ' SER . 32.9 mmtp -71.12 -13.12 61.85 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 122.178 -0.326 . . . . 0.0 111.196 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.412 ' HA ' ' HE ' ' A' ' 93' ' ' ARG . 13.0 mmm-85 -86.09 -17.83 34.01 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.382 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 mp -89.67 -33.12 5.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--N 1.306 -1.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.095 179.057 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.09 135.02 44.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 124.022 0.827 . . . . 0.0 108.806 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -96.05 168.93 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.157 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.2 159.88 16.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD23 HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -125.65 123.53 39.17 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -137.55 152.71 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.86 137.82 52.53 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -70.48 154.8 41.5 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.256 0.7 OUTLIER -59.75 -31.15 69.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.03 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -70.94 -38.11 72.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.205 0.526 . . . . 0.0 109.638 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.36 88.05 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.202 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 63.7 mt -61.28 -43.79 98.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.406 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -61.66 -44.76 96.35 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -69.76 -37.43 76.4 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.275 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -60.93 -37.24 81.63 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.997 0.919 . . . . 0.0 110.593 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 97.5 mtt180 -74.86 -28.98 60.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.597 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -77.04 -26.3 53.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.444 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.11 151.25 43.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.931 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.68 145.62 42.26 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -45.56 -53.02 9.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.623 1.169 . . . . 0.0 112.114 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -68.61 -36.29 78.47 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.372 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.0 -48.47 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.14 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -69.3 -35.59 76.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.6 mt-10 -57.41 -41.53 80.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' CB ' HD11 ' A' ' 55' ' ' LEU . 41.4 mt-30 -70.93 -35.75 72.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.012 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.2 mt -68.63 -39.81 80.62 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.268 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 31' ' ' VAL . 36.4 ttpt -60.11 -42.61 95.08 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.477 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.6 mttm -57.06 -41.6 79.05 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.7 mmtt -64.0 -37.6 88.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.298 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.1 mt -64.97 -41.19 95.66 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.333 0.587 . . . . 0.0 109.809 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 27' ' ' LYS . 95.8 t -65.37 -45.66 92.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.576 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.4 pt-20 -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.905 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' OH ' ' A' ' 64' ' ' TYR . 5.0 p -64.08 -31.3 52.76 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -55.21 -27.42 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.15 -8.01 34.33 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.097 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -154.81 63.72 4.05 Favored Pre-proline 0 C--O 1.211 -0.973 0 C-N-CA 122.62 0.368 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HA ' HG22 ' A' ' 33' ' ' VAL . 97.5 Cg_endo -80.54 -4.73 13.09 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.103 1.869 . . . . 0.0 114.902 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.02 40.2 1.04 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -82.34 113.68 22.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.832 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 41' ' ' ALA . 3.6 pt-20 -58.49 -33.2 69.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.715 0.806 . . . . 0.0 111.828 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 40' ' ' GLU . . . -70.0 -23.36 63.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.675 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 94.8 m-20 -103.04 -11.87 17.83 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.208 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -65.9 142.41 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 120.802 0.334 . . . . 0.0 111.772 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HE2' ' A' ' 52' ' ' LYS . 60.7 mt -72.24 168.33 18.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -58.61 -46.36 87.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 111.161 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.19 86.77 0.09 OUTLIER Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 89.7 mmm -149.01 146.1 20.81 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.92 89.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.424 2.75 . . . . 0.0 113.998 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 48.46 44.9 20.83 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.923 1.289 . . . . 0.0 112.099 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 58.8 m -101.85 142.34 33.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.377 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.653 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 29.3 m-85 -130.48 161.47 31.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' HD23 ' A' ' 44' ' ' LEU . 15.3 ptpt -116.28 158.94 22.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.983 0.913 . . . . 0.0 109.165 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 70.6 mt -129.55 133.77 64.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -116.73 123.21 46.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 25' ' ' GLN . 16.6 tp -73.79 136.16 43.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.074 0.464 . . . . 0.0 110.805 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.43 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -84.15 -63.48 1.34 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 18.3 m -104.96 160.77 14.76 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.48 64.95 3.73 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.504 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -114.05 139.59 49.16 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 98.0 mtt180 -128.13 137.91 52.3 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.823 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -122.23 136.65 54.94 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.3 t -124.66 128.06 73.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.653 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 17.1 p90 -137.69 158.3 44.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 27.0 pt20 -108.53 133.89 52.05 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.86 111.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 70' ' ' LYS . 55.9 mt -91.62 95.38 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -22.96 63.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.764 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.65 -40.12 96.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.193 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.499 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.1 mttm -107.41 -1.97 20.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.1 t 62.96 41.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 122.48 1.134 . . . . 0.0 109.242 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 70' ' ' LYS . 9.9 p -134.84 139.01 48.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.601 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 5' ' ' LEU . 93.9 t -95.57 115.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.59 -1.634 . . . . 0.0 106.59 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.03 111.72 23.26 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -173.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.76 121.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.22 -42.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.045 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -154.38 154.01 32.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.01 143.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.61 -139.83 7.86 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.581 -1.295 . . . . 0.0 112.435 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -107.44 91.22 3.56 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.545 0.688 . . . . 0.0 109.741 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.01 113.88 26.27 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.347 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -47.72 68.0 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.94 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.11 -51.33 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.531 0.732 . . . . 0.0 111.16 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -104.75 -15.15 15.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.77 -52.5 65.18 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.015 0.436 . . . . 0.0 111.765 -174.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.49 -30.33 22.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -63.71 -41.82 98.03 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.183 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 m -67.58 -43.09 81.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.517 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.02 -37.23 81.84 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 123.42 0.45 . . . . 0.0 110.773 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.83 -55.69 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.29 -32.92 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -77.06 -29.02 54.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.718 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -87.35 -34.81 18.69 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.23 113.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.719 0.771 . . . . 0.0 109.285 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.7 tp . . . . . 0 N--CA 1.414 -2.244 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -177.304 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -98.43 129.14 45.05 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -91.2 173.42 7.94 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.025 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.51 162.56 13.42 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 6' ' ' ASP . 1.5 tm? -126.77 136.59 52.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 5' ' ' LEU . 38.2 t70 -141.25 154.12 45.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 173.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.79 128.58 56.47 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.473 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' CG ' HH12 ' A' ' 93' ' ' ARG . 30.4 t70 -67.69 156.64 36.45 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 123.969 0.793 . . . . 0.0 111.247 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 8.7 pt-20 -52.89 -38.88 62.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.148 0.979 . . . . 0.0 111.359 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 74.3 mtt180 -72.31 -42.06 65.87 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.244 0.545 . . . . 0.0 110.104 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.16 78.55 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.511 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.3 mt -66.92 -37.79 84.99 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 53.9 mttm -62.28 -46.77 87.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.66 -38.74 73.84 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.968 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -60.81 -43.31 98.35 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.546 0.738 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.29 -20.79 58.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -81.51 -24.01 36.94 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 124.673 1.189 . . . . 0.0 109.812 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.45 157.75 35.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.987 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.12 141.86 28.62 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 1.9 p -53.39 -41.96 66.47 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -175.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -40.89 83.93 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.1 -47.25 85.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 120.835 0.35 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -65.48 -34.85 79.24 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.798 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 20' ' ' SER . 35.3 mt-10 -58.35 -38.54 77.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -70.12 -38.41 75.56 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 89.2 mt -64.25 -42.68 96.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.695 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 31' ' ' VAL . 31.5 ttpt -56.66 -44.46 81.4 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 123.302 0.641 . . . . 0.0 110.595 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.19 -42.11 90.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.833 0.349 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.5 mptp? -64.55 -34.68 78.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.182 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.687 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.3 mt -68.44 -43.7 76.53 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 27' ' ' LYS . 92.4 t -60.84 -45.5 97.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.988 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.6 pt-20 -69.29 -43.34 74.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.673 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.3 p -64.0 -29.87 48.49 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.785 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.997 -175.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 90.2 mt -54.38 -25.94 27.3 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.7 pt-20 -77.11 -20.81 55.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.927 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 p -155.27 69.67 5.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HA ' HG22 ' A' ' 33' ' ' VAL . 94.5 Cg_endo -80.13 -9.65 14.0 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 121.823 1.682 . . . . 0.0 112.484 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -89.04 38.7 0.9 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.767 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.19 109.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.557 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.949 0.404 . . . . 0.0 111.703 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -101.44 -2.94 29.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.095 -0.378 . . . . 0.0 112.002 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 21.1 mtpp -70.96 146.28 49.57 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.886 0.374 . . . . 0.0 110.985 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.29 164.09 15.08 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.165 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -91.81 131.08 37.42 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.13 0.572 . . . . 0.0 109.914 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.79 76.58 Favored Glycine 0 CA--C 1.506 -0.506 0 O-C-N 123.505 0.503 . . . . 0.0 113.198 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.437 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 95.9 mmm -126.17 129.99 24.07 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.25 98.9 0.34 Allowed 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.49 2.127 . . . . 0.0 112.859 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 52.51 42.03 31.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.204 1.002 . . . . 0.0 113.022 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 61.9 m -100.26 141.48 33.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.12 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.582 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 45.1 m-85 -134.0 159.6 40.26 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -134.39 140.54 46.37 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.858 177.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.56 144.06 29.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -127.13 140.26 52.38 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 120.907 0.384 . . . . 0.0 111.668 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.0 mt -85.62 115.65 23.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -66.13 -30.53 71.04 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -66.49 -65.1 0.72 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.93 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -89.98 -22.48 21.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.66 64.46 Favored Glycine 0 C--O 1.239 0.455 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.154 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -96.55 144.69 26.38 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.397 0.279 . . . . 0.0 110.403 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -122.2 147.57 46.02 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -131.4 134.36 46.18 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.23 128.55 75.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 C-N-CA 123.188 0.595 . . . . 0.0 110.262 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 7.5 p90 -138.84 158.78 43.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -112.03 137.47 50.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.85 112.81 29.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -95.79 95.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.84 -26.63 65.25 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 0.0 110.661 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.66 -30.26 69.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.424 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.7 mttm -105.47 -6.25 19.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.245 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.42 29.36 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 122.569 1.176 . . . . 0.0 109.089 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.0 p -130.87 139.09 52.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 O-C-N 121.206 -0.934 . . . . 0.0 111.197 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.8 120.85 46.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -109.08 110.6 21.9 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.834 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.3 t -76.56 121.72 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.6 mt -98.35 -42.04 10.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.565 0.698 . . . . 0.0 110.076 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.8 m -142.48 147.46 36.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.224 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.23 142.11 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.0 -115.36 0.71 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.295 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -137.54 149.57 46.84 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 110.577 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.35 91.13 3.53 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -42.76 57.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.62 -66.8 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.1 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 m -153.49 20.32 0.55 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.79 -42.4 84.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.282 0.947 . . . . 0.0 111.931 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.23 -19.73 24.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.226 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -91.72 -40.91 10.99 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 m -56.98 -51.18 70.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.963 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.14 -28.91 69.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.67 -47.97 13.28 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.058 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.09 -34.79 72.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 O-C-N 122.423 -0.173 . . . . 0.0 111.184 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.29 -10.69 59.0 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.285 0.564 . . . . 0.0 112.038 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' A' ' 8' ' ' ASP . 12.2 tpt180 -88.73 -26.45 21.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.73 -41.76 12.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.112 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 N--CA 1.435 -1.204 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.194 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 CA--C 1.489 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -98.24 146.81 25.26 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.029 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -124.64 173.99 8.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -86.72 159.55 19.12 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -124.8 125.9 44.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.69 167.1 22.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.31 141.05 51.55 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' OD2' ' HG3' ' A' ' 10' ' ' ARG . 19.5 t70 -80.23 154.87 27.63 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.14 -29.33 65.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 25.5 mtp-105 -68.37 -48.18 65.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.38 68.44 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.52 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -70.91 -37.46 72.96 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.931 0.396 . . . . 0.0 110.998 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.81 -42.87 90.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.44 -43.13 86.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.948 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -63.2 -41.4 99.16 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.329 1.052 . . . . 0.0 110.795 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.23 -24.61 57.73 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.491 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -67.57 -32.16 72.72 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.12 141.44 58.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.609 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.48 -83.43 0.05 OUTLIER Glycine 0 C--N 1.312 -0.8 0 O-C-N 124.837 1.336 . . . . 0.0 114.392 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 t -163.74 -60.85 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 ' OE1' ' A' ' 25' ' ' GLN . 4.9 m -63.07 -45.37 92.48 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.359 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.41 -47.52 90.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.899 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -68.42 -35.4 77.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.557 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.3 mt-10 -63.6 -42.17 98.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.0 mp0 -62.64 -45.24 93.77 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.131 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 88.9 mt -58.61 -43.15 89.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.422 0.451 . . . . 0.0 111.46 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -58.16 -44.33 87.86 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.295 0.372 . . . . 0.0 110.254 175.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -64.93 -34.68 78.99 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.75 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 13.0 mmmm -67.38 -34.47 77.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.4 mt -68.96 -40.77 78.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.81 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 27' ' ' LYS . 76.6 t -61.11 -45.68 98.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -69.29 -38.17 78.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.036 0.446 . . . . 0.0 111.281 177.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -67.02 -30.34 49.23 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.791 -176.353 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 mt -53.86 -24.57 16.31 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.1 pt-20 -70.71 -24.96 62.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.318 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 39' ' ' ILE . 43.8 p -162.05 76.04 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 123.152 0.581 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HA ' HG22 ' A' ' 33' ' ' VAL . 73.7 Cg_endo -80.37 -4.97 13.33 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.722 1.615 . . . . 0.0 112.175 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 40.91 1.05 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.89 0.852 . . . . 0.0 111.624 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' SER . 85.0 mt -82.42 93.58 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 43' ' ' LYS . 9.7 pt-20 -55.57 -18.74 8.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.05 1.34 . . . . 0.0 113.993 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.72 74.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.975 0.417 . . . . 0.0 110.97 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -100.77 9.47 42.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.892 0.377 . . . . 0.0 110.625 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 56.9 tttt -80.96 144.33 31.94 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 86.0 mt -79.54 152.53 30.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -63.15 -74.28 0.1 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.44 43.28 1.7 Allowed Glycine 0 CA--C 1.502 -0.756 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.886 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 92.6 mmm -124.57 124.96 25.62 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.91 99.11 0.13 Allowed 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 123.139 2.559 . . . . 0.0 112.809 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 17.7 m-20 52.75 39.27 28.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.823 1.249 . . . . 0.0 113.395 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 56.0 m -100.09 141.55 32.77 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 47.3 m-85 -131.84 157.77 43.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.13 144.43 51.03 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.29 129.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -106.17 140.09 39.68 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.681 174.446 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.46 139.4 39.64 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -66.04 -48.7 70.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.24 123.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.8 m 69.51 -173.69 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.004 0.922 . . . . 0.0 111.585 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.35 42.31 1.99 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.46 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -91.38 136.96 32.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -133.99 141.89 47.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.789 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -123.75 138.18 54.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.7 t -123.85 129.59 74.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 18.9 p90 -138.84 159.26 42.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.164 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.5 pt20 -119.74 138.08 53.54 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.418 HG22 ' HE1' ' A' ' 51' ' ' TYR . 10.2 m -95.81 121.26 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -99.29 95.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.18 -28.57 67.39 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.673 0.749 . . . . 0.0 109.046 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.21 -38.68 77.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.959 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.6 mttt -107.84 -4.17 18.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.615 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.4 t 61.9 29.46 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 CA-C-O 122.382 1.087 . . . . 0.0 109.868 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.1 p -131.32 141.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 121.008 -1.057 . . . . 0.0 111.214 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.46 121.14 53.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 124.146 0.978 . . . . 0.0 108.588 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -107.78 120.55 42.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -74.86 124.08 31.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -93.65 -42.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 123.464 0.477 . . . . 0.0 110.83 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 t -155.45 150.85 27.09 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.25 132.95 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.237 0.542 . . . . 0.0 110.551 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.14 -111.58 0.48 Allowed Glycine 0 N--CA 1.418 -2.548 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.425 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -132.9 158.07 43.51 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.58 -78.35 0.36 Allowed 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 58.35 -45.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 128.39 2.676 . . . . 0.0 113.671 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.61 18.18 6.86 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 125.827 1.651 . . . . 0.0 107.195 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.2 m 61.78 31.37 18.43 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.321 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 41.9 tt0 -57.96 -51.3 70.23 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.05 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 m -58.98 -24.76 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -84.67 -28.47 26.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 m -69.59 -43.73 72.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.7 mm-40 -61.15 -36.56 80.13 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.909 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.37 -49.47 55.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.478 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.33 -26.21 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.044 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -69.36 -11.96 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -79.69 -25.04 41.34 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.329 0.585 . . . . 0.0 109.678 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.83 -49.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.954 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.787 179.097 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.9 ptm . . . . . 0 CA--C 1.497 -1.096 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.45 152.65 50.81 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -108.84 167.63 9.94 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.73 151.59 35.99 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 34' ' ' LEU . 1.1 tm? -125.83 122.17 35.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -132.83 157.04 46.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.78 140.84 52.56 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.79 155.59 40.26 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -53.56 -38.91 64.32 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.275 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.5 ptm180 -67.14 -38.75 86.07 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.37 -37.4 87.38 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.191 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 mt -67.73 -43.09 80.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.651 0.262 . . . . 0.0 110.852 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.35 -42.02 98.89 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 46.7 mt-10 -69.41 -39.59 77.84 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.833 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -60.69 -41.27 94.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 0.0 110.376 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -73.42 -31.16 63.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.401 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.8 -43.93 82.58 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.821 0.701 . . . . 0.0 109.818 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mp -53.08 153.05 3.76 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.464 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.37 142.06 41.98 Favored Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -54.17 -46.11 72.26 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.875 0.87 . . . . 0.0 113.085 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 m -68.51 -36.29 78.67 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.025 0.441 . . . . 0.0 110.88 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.73 -47.97 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.23 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.369 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -57.23 -43.61 83.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.695 0.225 . . . . 0.0 110.575 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.92 -38.64 86.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 -179.302 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.7 mt -67.25 -42.69 83.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 176.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -57.09 -43.38 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.036 0.534 . . . . 0.0 110.594 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -56.94 -43.21 81.29 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.397 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 75.3 mmtt -65.48 -38.47 89.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.912 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.4 mt -65.46 -46.94 77.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.57 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.26 -41.37 89.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.401 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -69.9 -37.72 76.08 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.694 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -64.45 -30.22 49.56 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.774 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.404 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.2 mt -54.47 -26.46 31.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.569 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 1.9 pp20? -80.41 -29.63 37.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.382 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -142.87 72.49 19.12 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' HG22 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -73.45 -27.94 12.65 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 121.547 1.498 . . . . 0.0 112.223 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.49 65.95 4.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -103.71 115.08 45.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 11.0 pt-20 -59.81 -28.67 67.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.21 65.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.41 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -107.1 -2.25 21.18 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.029 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 38.5 mtpt -75.42 139.57 42.4 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 92.7 mt -78.19 149.47 33.71 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.677 174.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.38 -65.07 0.75 Allowed 'General case' 0 C--N 1.311 -1.084 0 O-C-N 124.072 0.857 . . . . 0.0 111.945 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.83 61.43 0.36 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.475 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.3 mmm -141.2 140.97 21.96 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.4 95.76 0.53 Allowed 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.984 2.456 . . . . 0.0 112.787 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 48.21 44.64 19.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.764 1.226 . . . . 0.0 112.145 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.5 m -100.8 142.07 32.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.644 ' CE2' ' HG2' ' A' ' 43' ' ' LYS . 25.7 m-85 -130.91 156.47 45.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -126.02 139.51 53.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.426 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.2 mt -111.98 138.89 39.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.84 123.57 38.99 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 -178.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.7 91.37 6.99 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -62.88 -8.69 7.51 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.916 1.686 . . . . 0.0 113.279 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -100.13 -13.06 19.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.765 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -134.78 -36.03 0.86 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.249 -0.981 . . . . 0.0 113.083 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.44 28.92 6.17 Favored Glycine 0 C--O 1.247 0.932 0 C-N-CA 119.415 -1.374 . . . . 0.0 112.007 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.09 146.35 29.26 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -135.1 147.3 49.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.43 133.48 45.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.91 128.73 75.73 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 CA-C-O 121.015 0.436 . . . . 0.0 109.884 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 15.9 p90 -139.14 158.86 43.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.729 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 17.2 pt20 -110.27 138.89 46.04 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.0 t -103.15 112.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.81 94.68 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.35 -34.08 74.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.09 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.22 -35.42 71.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.141 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 98.4 mttt -103.81 -1.1 28.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.277 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p 54.81 40.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.405 1.882 . . . . 0.0 111.821 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.6 p -128.65 138.36 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.814 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -102.46 115.36 44.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -110.23 112.22 24.05 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.5 t -77.06 121.45 29.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.73 -42.32 12.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.133 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -151.01 148.07 27.91 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.042 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.07 141.25 21.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.04 -97.63 0.19 Allowed Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -137.61 144.18 41.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.41 77.81 3.39 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -97.49 106.49 18.82 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.086 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 72.87 -87.84 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 124.983 1.313 . . . . 0.0 111.128 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.4 m -153.24 7.24 0.38 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.94 -50.25 74.01 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.262 0.937 . . . . 0.0 113.374 -171.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m -62.91 -30.03 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.94 -43.6 13.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.428 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.468 ' HA ' HG12 ' A' ' 91' ' ' VAL . 56.0 m -67.4 -29.27 68.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.17 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 9.5 tp10 -61.15 -50.08 74.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.34 23.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.017 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 88' ' ' SER . 12.3 p -66.67 -34.51 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -78.21 -13.39 59.88 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 50.5 ttt180 -84.14 -46.21 12.16 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.807 -175.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.21 85.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.422 -1.866 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -178.784 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.506 -0.714 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -122.3 153.23 39.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.376 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.84 171.29 7.96 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.03 156.89 18.58 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -126.18 130.09 50.3 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.63 158.11 44.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -119.21 133.83 55.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.67 155.95 39.1 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.167 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.517 ' OE1' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -56.43 -36.85 69.45 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.33 0.394 . . . . 0.0 110.783 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG3' ' OE1' ' A' ' 9' ' ' GLU . 35.8 mtt180 -60.06 -48.93 79.66 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.65 77.23 Favored 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.861 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.9 mt -64.02 -38.66 91.89 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 120.988 0.423 . . . . 0.0 110.753 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -65.11 -43.49 91.85 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.5 mt-10 -69.39 -36.41 76.74 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.181 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.37 -38.41 90.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.021 0.928 . . . . 0.0 109.864 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -75.06 -26.4 59.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 61.4 tttm -72.36 -39.99 67.67 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.785 0.834 . . . . 0.0 109.102 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.36 151.53 43.73 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.54 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.95 147.8 40.34 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.658 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 23.2 m -51.05 -49.83 59.81 Favored 'General case' 0 C--O 1.205 -1.259 0 C-N-CA 123.994 0.918 . . . . 0.0 112.014 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -63.67 -38.55 91.55 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.244 0.545 . . . . 0.0 110.849 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.07 -47.48 81.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.399 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -68.42 -34.77 76.59 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.173 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.658 ' HG3' ' O ' ' A' ' 20' ' ' SER . 70.0 mt-10 -57.53 -42.25 82.52 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.052 0.387 . . . . 0.0 111.32 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.17 -39.35 89.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.7 mt -66.48 -40.92 89.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 31' ' ' VAL . 32.0 ttpt -56.5 -44.62 80.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.137 0.575 . . . . 0.0 110.38 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.62 -39.64 88.95 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.262 0.553 . . . . 0.0 110.234 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 mptp? -65.29 -37.41 87.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.068 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -66.25 -41.44 89.95 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 27' ' ' LYS . 99.5 t -65.26 -44.74 94.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.5 pt-20 -68.75 -44.15 74.36 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.948 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.3 p -62.66 -29.92 48.08 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.228 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 89.9 mt -53.59 -25.56 17.89 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.6 pt-20 -71.46 -27.86 63.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.473 ' O ' HG13 ' A' ' 39' ' ' ILE . 48.2 m -152.6 73.95 7.28 Favored Pre-proline 0 C--O 1.209 -1.046 0 C-N-CA 123.558 0.743 . . . . 0.0 109.167 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.51 ' HA ' HG22 ' A' ' 33' ' ' VAL . 61.2 Cg_endo -74.72 -13.21 22.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.057 1.838 . . . . 0.0 112.622 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -87.51 41.45 0.98 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.427 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' SER . 91.9 mt -80.61 98.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.75 -19.32 10.75 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.738 1.615 . . . . 0.0 114.288 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.4 -25.86 65.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.594 0.711 . . . . 0.0 109.912 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.67 -1.75 39.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.811 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.9 142.07 49.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-O 121.201 0.524 . . . . 0.0 110.658 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.6 176.61 9.55 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.816 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -110.09 120.02 41.14 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.022 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.28 54.37 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.126 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.53 131.54 23.41 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -47.02 -59.06 1.39 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 124.401 3.401 . . . . 0.0 114.256 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.679 ' OD1' ' HB ' ' A' ' 66' ' ' VAL . 7.7 t70 -154.66 83.65 1.1 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.1 m -139.47 141.77 37.39 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.7 m-85 -138.23 153.78 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.3 pttt -126.18 139.43 53.36 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.2 mt -111.68 130.88 64.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 145.28 29.98 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 58' ' ' SER . 3.0 tt -88.78 143.08 27.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -93.48 -42.56 9.18 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.217 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 m -89.32 5.08 46.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' ' 55' ' ' LEU . 20.7 m -152.89 138.3 17.6 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.39 73.04 2.07 Favored Glycine 0 C--N 1.314 -0.673 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.533 -175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -135.23 156.45 48.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HD2' ' N ' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -144.82 149.48 35.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -119.88 133.37 55.6 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.95 126.42 70.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.2 p90 -136.4 158.94 43.24 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -113.51 140.03 48.46 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.679 ' HB ' ' OD1' ' A' ' 49' ' ' ASP . 81.7 t -99.59 113.03 33.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.748 0.785 . . . . 0.0 109.849 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.69 94.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.25 -27.9 65.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.866 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.08 -37.34 76.86 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.037 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.3 mttt -107.78 -1.76 20.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.149 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t 62.32 35.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.638 1.209 . . . . 0.0 109.69 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 70' ' ' LYS . 11.3 p -133.3 138.7 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.96 121.76 49.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.26 115.48 29.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -173.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.5 t -80.85 121.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 90' ' ' ALA . 21.7 mt -97.66 -42.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 123.585 0.553 . . . . 0.0 110.909 -174.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 p -145.56 149.68 35.03 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.108 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.04 127.19 2.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.261 0.553 . . . . 0.0 112.112 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.78 -123.31 1.28 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 119.141 -1.504 . . . . 0.0 112.936 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -113.74 157.1 22.66 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.26 16.03 19.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.36 126.69 28.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.621 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.11 9.92 7.49 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 111.568 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.3 m 62.56 27.38 16.2 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.967 0.907 . . . . 0.0 112.508 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -57.93 -44.34 86.85 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -62.87 -26.66 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.95 -44.64 15.08 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.1 t -58.81 -49.44 77.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.52 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 10' ' ' ARG . 14.3 tp10 -62.04 -29.77 70.51 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 110.667 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . -77.65 -44.47 28.03 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.93 -33.51 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 88' ' ' SER . 46.7 mmtm -65.48 -20.8 66.5 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.941 0.401 . . . . 0.0 110.172 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.795 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.79 128.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.741 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.424 -1.769 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.966 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.9 ttt . . . . . 0 CA--C 1.488 -1.44 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.19 152.73 37.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 123.521 0.513 . . . . 0.0 109.778 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -121.3 160.66 23.5 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -80.35 160.31 25.47 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.08 131.56 52.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.76 155.8 43.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -120.05 137.06 54.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.729 0.411 . . . . 0.0 111.19 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.54 154.8 31.39 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 170.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 6.8 pt-20 -53.55 -41.89 66.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.117 0.417 . . . . 0.0 111.934 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 90.0 mtt180 -72.25 -37.77 69.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.627 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.36 75.83 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.5 tp -73.47 -34.16 65.22 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.799 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 87.6 mttt -66.15 -44.41 84.2 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -67.43 -38.73 84.99 Favored 'General case' 0 C--O 1.199 -1.598 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.459 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -60.26 -40.25 89.65 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.604 0.762 . . . . 0.0 111.469 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -74.21 -33.94 63.55 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.601 0.715 . . . . 0.0 110.917 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.02 -19.41 58.68 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.29 162.5 29.38 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.317 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.08 152.58 43.96 Favored Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.897 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -53.58 -54.05 42.93 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 125.033 1.333 . . . . 0.0 112.248 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 m -63.1 -34.67 78.09 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.301 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.15 -48.18 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.756 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -63.35 -40.52 97.52 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.509 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.8 mt-10 -61.43 -43.6 98.59 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -69.84 -43.27 72.29 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.546 178.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.8 mt -58.81 -40.79 85.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 117.612 0.187 . . . . 0.0 110.92 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.3 ttpt -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 123.59 0.557 . . . . 0.0 110.07 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.1 mttt -63.09 -38.07 89.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 28.7 mmmt -66.82 -35.1 79.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.668 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 88.9 mt -68.87 -43.6 75.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 27' ' ' LYS . 53.9 t -60.54 -44.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.831 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 9.7 pt-20 -69.07 -44.76 71.9 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.79 -29.64 47.53 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.343 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.54 -26.65 22.12 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -79.09 -24.76 43.25 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.387 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -148.66 69.3 10.19 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.2 -11.29 9.8 Favored 'Trans proline' 0 C--O 1.209 -0.939 0 C-N-CA 121.542 1.495 . . . . 0.0 111.799 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.48 39.22 0.72 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -82.94 107.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.33 -24.35 67.28 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.61 67.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.888 0.375 . . . . 0.0 111.677 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 90.6 m-20 -97.66 -0.4 45.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.553 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 50' ' ' CYS . 10.0 mtpm? -73.95 138.57 44.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.197 0.522 . . . . 0.0 111.402 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 67.6 mt -82.43 141.77 32.48 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -68.61 -42.53 77.99 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.03 18.56 57.3 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.435 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.518 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 83.8 mmm -130.71 145.68 58.65 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.88 -74.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.942 1.761 . . . . 0.0 114.722 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.14 36.8 4.21 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 40.0 m -100.32 141.24 33.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.507 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 29.6 m-85 -132.86 156.89 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.23 142.44 50.85 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.251 0.548 . . . . 0.0 111.025 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.91 144.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -120.17 126.43 50.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.432 HD12 ' HG ' ' A' ' 26' ' ' LEU . 2.1 tt -99.04 90.39 4.6 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -75.62 95.03 3.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.826 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . 35.9 t 171.61 -39.75 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.869 1.667 . . . . 0.0 107.298 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 p -125.37 -17.04 5.72 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.24 9.86 61.51 Favored Glycine 0 C--O 1.241 0.579 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.15 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.89 148.97 25.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.123 0.487 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -125.25 151.84 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.85 125.36 29.82 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.15 126.94 70.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.217 0.532 . . . . 0.0 109.955 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -139.22 159.71 41.51 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.952 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.417 ' NE2' HG12 ' A' ' 67' ' ' ILE . 11.0 pt20 -114.08 141.24 47.71 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 170.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -91.21 114.23 28.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' NE2' ' A' ' 65' ' ' GLN . 22.7 mt -99.95 95.15 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.84 -33.17 73.37 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.79 0.329 . . . . 0.0 110.581 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.54 -33.71 70.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.982 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.2 mttt -104.09 -6.7 20.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.204 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t 63.01 32.26 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.31 0 C-N-CA 124.449 1.1 . . . . 0.0 109.671 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.6 p -131.58 138.83 52.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 111.065 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.1 t -96.37 115.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -106.07 111.78 24.55 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.981 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.33 121.9 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.6 mt -95.08 -40.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.258 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -155.75 151.95 27.93 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -149.44 147.03 16.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.6 -151.4 23.59 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.259 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -89.75 137.58 32.21 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.25 104.38 7.01 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -80.38 -40.49 26.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.19 -76.77 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.347 1.059 . . . . 0.0 110.783 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -65.76 -31.41 72.37 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.26 -51.82 67.83 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.25 -30.98 14.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.906 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -74.38 -45.3 47.73 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 m -64.82 -40.0 94.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 8.5 tp10 -65.14 -47.33 77.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.41 -49.63 71.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.37 -30.75 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 120.838 0.351 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -77.9 -11.27 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 20.8 mmm180 -87.69 -15.97 35.64 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.052 0.387 . . . . 0.0 111.482 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -128.3 99.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.68 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 C--N 1.304 -1.376 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.954 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 C--O 1.238 0.463 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.11 164.05 24.16 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -115.89 163.91 15.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.21 161.72 17.87 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.89 123.17 36.64 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.89 169.18 17.48 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.8 136.9 47.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.08 155.65 16.63 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 7.3 pt-20 -52.6 -41.93 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.317 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -63.87 -48.16 77.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.23 0.538 . . . . 0.0 111.055 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.6 71.55 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.051 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 9' ' ' GLU . 1.1 mptm? -65.06 -42.09 94.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.77 -35.74 77.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.672 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -60.56 -38.0 83.12 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 110.121 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.38 -35.03 65.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.666 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.38 -32.89 74.69 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.325 1.05 . . . . 0.0 110.71 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.25 147.61 52.04 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.272 0.558 . . . . 0.0 112.495 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.24 147.92 41.69 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.505 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 11.9 p -51.04 -54.93 20.26 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 124.334 1.053 . . . . 0.0 112.839 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -59.08 -40.39 85.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.039 0.535 . . . . 0.0 111.402 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.14 -47.06 80.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.016 0.436 . . . . 0.0 109.885 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -67.61 -34.96 78.05 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 46.8 mt-10 -58.57 -45.73 88.39 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 117.781 0.264 . . . . 0.0 111.435 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.89 -35.23 78.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.76 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 81.7 mt -65.34 -41.76 93.58 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.214 174.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -59.29 -43.18 92.6 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.1 mttm -59.24 -42.7 91.73 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.208 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -64.33 -41.06 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.166 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 91.8 mt -64.3 -47.18 80.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 28' ' ' LYS . 9.1 p -67.24 -36.48 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.579 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -69.46 -45.72 68.37 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.877 175.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -62.37 -29.65 47.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 C-N-CA 123.229 0.612 . . . . 0.0 112.393 -174.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.41 -24.93 13.83 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.4 pt-20 -68.23 -31.44 70.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 111.049 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.2 m -157.57 77.58 3.73 Favored Pre-proline 0 C--O 1.208 -1.127 0 C-N-CA 123.356 0.663 . . . . 0.0 110.056 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.0 Cg_endo -80.96 -0.12 10.39 Favored 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 121.771 1.647 . . . . 0.0 112.08 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 27.63 1.08 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.517 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.89 103.55 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 12.0 pt-20 -66.02 -15.68 63.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.75 -26.21 68.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.232 0.539 . . . . 0.0 109.987 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -103.86 8.51 37.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.848 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.684 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 2.6 tttm -72.25 148.29 45.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.465 0.65 . . . . 0.0 112.522 -177.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 81.2 mt -91.47 127.25 36.84 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.74 -1.118 . . . . 0.0 107.993 171.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -81.11 128.76 34.09 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 122.953 0.501 . . . . 0.0 110.591 -177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.52 11.26 66.55 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.4 mmm -123.61 140.91 35.19 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.87 101.62 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.496 1.464 . . . . 0.0 111.911 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 47.54 54.99 8.93 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.169 1.387 . . . . 0.0 113.911 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -113.24 141.7 46.67 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 38.0 m-85 -136.61 160.22 39.45 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HD2' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.76 140.27 47.97 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.789 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -110.57 140.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.504 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -126.74 133.36 50.89 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.022 0.439 . . . . 0.0 109.917 -177.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.09 135.79 33.69 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -106.76 -15.6 14.7 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.811 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -78.07 -27.93 48.69 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.346 0.593 . . . . 0.0 109.632 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -144.11 140.35 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.62 74.62 0.9 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.815 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -124.14 141.27 52.2 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.883 0.473 . . . . 0.0 110.333 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -126.43 149.38 49.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 tt -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.8 t -116.27 129.14 73.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.5 p90 -138.64 158.77 43.62 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.59 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -109.24 140.92 42.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.21 112.18 29.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 mt -91.3 95.87 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.61 -30.5 71.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.817 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.77 -39.91 90.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.394 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.6 mttt -107.46 -5.0 17.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.2 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.2 t 60.54 41.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 123.067 1.413 . . . . 0.0 109.537 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -135.79 138.93 47.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.359 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -94.22 115.35 32.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -107.19 110.42 22.48 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.197 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.1 123.41 27.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.0 mt -89.99 -42.26 14.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.57 0.7 . . . . 0.0 109.664 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -154.68 149.91 27.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.93 134.44 18.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.59 -147.75 18.38 Favored Glycine 0 C--N 1.3 -1.419 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.21 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -93.1 141.54 28.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 117.226 0.513 . . . . 0.0 110.315 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.41 116.77 13.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.15 -45.66 5.31 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.396 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.68 -54.55 0.67 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.6 p -145.2 9.33 1.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.207 -0.997 . . . . 0.0 113.2 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -56.99 -48.88 77.37 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 112.005 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.83 -3.46 10.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.003 0.43 . . . . 0.0 111.016 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.33 -40.63 11.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.41 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 p -63.04 -42.15 99.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.591 0.71 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 6.1 mm-40 -65.24 -34.24 77.9 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.678 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.46 -44.61 50.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.374 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.4 p -69.92 -30.85 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.203 0.525 . . . . 0.0 110.798 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.49 -9.88 59.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 11.7 mmm180 -69.85 -22.69 63.24 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.88 75.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 C--N 1.31 -1.146 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.242 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.094 0 CA-C-O 121.048 0.452 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.17 172.47 6.79 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -94.87 164.84 12.75 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -125.72 132.29 52.4 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -135.7 160.43 38.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.01 141.86 49.39 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.776 0.43 . . . . 0.0 110.604 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -76.86 150.22 36.08 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.95 -28.92 70.15 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.32 -41.62 66.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.33 85.52 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.713 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.56 -37.77 87.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.9 -44.31 90.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.51 -38.76 77.74 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.16 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -60.47 -46.72 89.05 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.136 0.974 . . . . 0.0 110.951 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.86 -21.17 59.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.229 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -77.31 -34.88 55.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.4 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.53 150.52 18.78 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.09 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 140.36 48.04 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -50.01 -52.33 34.91 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.175 0.99 . . . . 0.0 112.083 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.0 m -68.7 -29.99 68.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 HD12 ' A' ' 55' ' ' LEU . 97.2 t -72.32 -49.1 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -68.84 -35.11 76.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.946 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 9.6 mm-40 -57.14 -46.8 82.38 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 116.858 -0.156 . . . . 0.0 111.346 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -70.33 -37.09 74.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.791 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 79.4 mt -63.99 -41.33 97.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 31' ' ' VAL . 34.3 ttpt -60.09 -44.32 94.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 92.9 mttt -64.06 -35.45 80.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.632 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.4 mmtt -64.06 -39.61 94.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.592 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -63.65 -42.87 98.05 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 123.653 0.596 . . . . 0.0 109.558 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 27' ' ' LYS . 69.9 t -63.45 -45.96 96.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.537 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.7 pt-20 -69.76 -39.37 76.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.98 -29.89 48.3 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.73 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.724 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.2 mt -53.32 -24.44 11.82 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.6 pt-20 -66.07 -27.36 68.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.149 0.5 . . . . 0.0 110.699 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.545 ' O ' HG13 ' A' ' 39' ' ' ILE . 12.3 t -160.16 77.92 2.66 Favored Pre-proline 0 C--O 1.205 -1.253 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.32 -25.41 49.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.988 1.792 . . . . 0.0 112.785 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -87.3 60.74 6.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.284 1.04 . . . . 0.0 113.122 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 36' ' ' SER . 85.5 mt -89.96 115.93 30.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.606 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.59 -30.88 61.64 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 123.732 0.813 . . . . 0.0 112.493 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -18.33 61.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.967 0.413 . . . . 0.0 111.59 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.554 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.3 m-20 -103.16 -16.02 15.85 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -63.19 145.75 54.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.603 0.761 . . . . 0.0 112.559 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 91.9 mt -96.75 123.78 40.54 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 169.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -87.25 130.87 34.41 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.18 -34.01 6.06 Favored Glycine 0 C--N 1.306 -1.12 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 94.5 mmm -86.37 125.5 67.52 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -35.84 -66.56 0.11 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 124.733 3.622 . . . . 0.0 114.029 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 55.54 0.98 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.75 142.3 34.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 21.2 m-85 -135.04 152.19 51.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.29 139.96 53.25 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.103 178.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.6 mt -122.89 132.69 70.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -113.37 149.98 33.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.907 0.384 . . . . 0.0 111.961 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.49 HD12 HG13 ' A' ' 22' ' ' VAL . 15.4 mt -94.47 136.66 34.52 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -62.09 -32.21 72.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.462 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -71.68 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p -102.45 2.21 36.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.56 46.04 9.11 Favored Glycine 0 C--N 1.32 -0.319 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.86 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -97.25 145.45 26.07 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 54' ' ' LYS . 5.6 mpt_? -120.98 149.59 42.42 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.88 130.88 45.75 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.12 122.84 70.24 Favored 'Isoleucine or valine' 0 C--O 1.251 1.155 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 25.9 p90 -132.75 159.35 39.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.668 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.6 138.43 48.15 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.31 111.62 25.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.24 95.81 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.22 -31.0 71.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.133 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.0 -40.27 76.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.377 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HB2' HG12 ' A' ' 72' ' ' VAL . 53.1 mttm -107.65 -6.74 16.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.714 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t 65.83 33.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 122.881 1.324 . . . . 0.0 110.066 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.2 p -133.8 140.22 46.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 O-C-N 121.35 -0.844 . . . . 0.0 110.353 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.451 ' HB ' HD22 ' A' ' 5' ' ' LEU . 91.2 t -96.69 117.98 42.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -108.22 117.94 35.46 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.501 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -77.45 121.08 29.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.72 -41.89 13.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.573 0.701 . . . . 0.0 109.119 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -148.79 153.37 38.04 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.0 p -148.85 138.99 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.88 -114.8 0.64 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.38 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -127.82 155.73 43.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.516 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.227 0.537 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -81.17 -24.34 37.61 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.55 -35.49 80.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.958 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -72.04 -50.44 28.4 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.158 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.782 . . . . 0.0 113.05 -177.206 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.987 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.15 172.93 6.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.43 160.57 17.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.3 128.9 47.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -142.59 169.11 18.19 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -129.63 141.68 50.89 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.083 0.553 . . . . 0.0 110.178 -175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.59 154.9 41.1 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 4.6 pt-20 -61.31 -31.91 71.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.424 0.556 . . . . 0.0 110.634 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 75.3 mtt180 -63.81 -42.59 97.65 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.6 82.27 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.89 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.4 mt -63.8 -43.13 97.19 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.657 0.265 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -61.25 -43.73 98.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.368 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.21 -39.71 78.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.923 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -62.55 -43.73 98.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -75.58 -20.93 58.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.341 0.591 . . . . 0.0 110.893 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -74.54 -35.47 63.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.405 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD11 ' HA2' ' A' ' 79' ' ' GLY . 3.3 mp -62.59 156.95 21.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.376 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.33 149.85 47.71 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 22.8 t -57.86 -49.05 78.01 Favored 'General case' 0 C--O 1.205 -1.251 0 C-N-CA 122.555 0.342 . . . . 0.0 111.812 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.462 HG22 ' OE1' ' A' ' 25' ' ' GLN . 15.6 m -68.53 -38.19 80.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.38 -47.13 94.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.274 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.37 -35.29 79.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.333 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 20' ' ' SER . 44.5 mt-10 -63.51 -39.51 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.462 ' OE1' HG22 ' A' ' 21' ' ' THR . 2.0 mp0 -63.75 -41.29 98.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.401 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 93.0 mt -62.44 -41.98 99.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.06 -42.28 89.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 99.5 mttt -59.54 -36.98 77.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.678 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 53' ' ' ILE . 5.6 mptp? -69.0 -37.89 78.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.32 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.6 mt -62.51 -47.53 83.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.573 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.44 -41.08 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.319 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 13.1 pt-20 -69.65 -44.0 71.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.708 0.29 . . . . 0.0 111.709 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.7 -29.67 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.5 mt -53.05 -25.3 12.07 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.7 pt-20 -68.77 -26.81 65.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.122 0.419 . . . . 0.0 110.924 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -162.55 80.21 1.78 Allowed Pre-proline 0 C--O 1.212 -0.884 0 C-N-CA 123.138 0.575 . . . . 0.0 109.504 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -82.62 5.75 6.2 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.139 1.893 . . . . 0.0 112.662 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 36.15 0.87 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.328 0.585 . . . . 0.0 111.614 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.8 mt -81.89 105.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.33 -32.12 62.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.833 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.99 72.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.382 0.61 . . . . 0.0 110.929 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -94.17 -2.5 52.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.016 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -78.22 138.35 38.6 Favored 'General case' 0 N--CA 1.4 -2.948 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.09 155.55 21.45 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.666 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -87.12 122.66 31.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.4 83.68 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.58 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.6 mmm -111.15 131.44 22.2 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.18 95.13 0.17 Allowed 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 122.804 2.336 . . . . 0.0 112.362 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 48.16 45.99 19.7 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.696 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -102.58 141.29 35.64 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 58.4 m-85 -133.66 150.98 51.56 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 55.2 pttt -118.98 144.86 46.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.134 0.492 . . . . 0.0 110.569 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 29' ' ' LYS . 82.0 mt -109.39 132.9 56.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.93 137.75 40.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 124.06 0.85 . . . . 0.0 109.255 173.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.2 tt -88.9 -11.75 43.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 74.27 -62.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.502 1.521 . . . . 0.0 111.29 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -75.59 -59.77 2.6 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -68.61 -25.9 65.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.55 49.16 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.197 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -98.75 149.19 23.1 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 120.837 0.351 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 mpt_? -131.51 144.22 50.96 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.812 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -127.01 127.72 45.23 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.33 123.17 69.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-O 121.073 0.463 . . . . 0.0 110.009 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.1 p90 -133.57 159.51 40.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 4.2 pt20 -111.89 140.82 46.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.47 111.46 25.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.1 mt -97.8 95.45 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.07 -29.23 63.92 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.416 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.58 -40.55 87.75 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.5 mttm -98.37 -7.15 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.334 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.87 36.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.775 1.274 . . . . 0.0 109.237 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 70' ' ' LYS . 11.3 p -134.22 138.72 49.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.71 115.34 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -111.34 112.82 24.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.03 124.96 33.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.1 mt -98.03 -41.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.461 0.648 . . . . 0.0 110.095 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.1 m -148.11 151.55 35.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.219 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.43 147.57 16.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' HD11 ' A' ' 18' ' ' LEU . . . 146.92 -124.23 1.93 Allowed Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -123.09 167.67 13.36 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 121.495 0.664 . . . . 0.0 109.306 -175.352 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -82.87 -41.57 18.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -58.79 -43.67 90.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.834 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.21 -49.86 70.32 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.861 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.275 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.95 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -134.43 167.23 21.14 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.45 157.77 24.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -125.69 122.56 36.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -140.41 169.34 17.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -129.89 147.9 51.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.69 154.46 38.83 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -32.53 72.51 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.452 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 57.5 mtp180 -72.8 -34.21 66.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.716 0.293 . . . . 0.0 111.034 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.04 79.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 mt -66.99 -43.54 82.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.924 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 89.2 mttt -59.49 -44.59 93.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.269 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 16.7 mm-40 -69.5 -37.67 77.29 Favored 'General case' 0 C--O 1.202 -1.406 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.5 -42.5 96.47 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 110.132 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.86 -24.11 58.52 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.096 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -78.3 -29.64 47.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.375 1.07 . . . . 0.0 111.175 177.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mp -63.67 161.11 15.55 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.71 0.804 . . . . 0.0 111.322 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.77 145.37 33.83 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -46.6 64.95 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.149 0.98 . . . . 0.0 111.287 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 m -62.43 -46.54 88.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.173 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -47.29 85.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.713 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.5 ptt180 -67.01 -35.04 79.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.077 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 35.4 mt-10 -59.71 -39.12 83.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.072 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.07 -39.32 79.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.831 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.3 mt -63.04 -43.83 97.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.684 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 27' ' ' LYS . 19.4 ptmt -64.22 -34.04 77.18 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.1 mttm -58.79 -43.87 90.58 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.8 mptp? -66.62 -34.69 78.44 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.8 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 82.1 mt -61.82 -47.96 82.75 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.576 0.547 . . . . 0.0 110.491 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.22 -40.92 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -68.76 -42.91 76.84 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.99 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 65.4 mt -54.78 -26.35 33.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 pt-20 -79.16 -18.76 52.53 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.492 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.9 m -157.47 67.47 3.92 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 123.027 0.531 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.82 -0.34 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.847 0 C-N-CA 122.112 1.875 . . . . 0.0 114.218 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 25.75 0.23 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -82.31 100.33 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.642 0.734 . . . . 0.0 110.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.93 -20.42 57.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.626 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.76 64.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.431 0.634 . . . . 0.0 110.813 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -104.27 -1.22 27.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.364 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -84.22 138.88 32.72 Favored 'General case' 0 N--CA 1.404 -2.73 0 CA-C-O 121.357 0.598 . . . . 0.0 112.009 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -91.49 124.55 35.75 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.869 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.93 120.41 28.17 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.859 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.92 46.37 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.9 mmm -117.58 131.42 24.09 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.03 94.4 0.16 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.773 2.316 . . . . 0.0 112.937 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 45.57 50.05 10.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 125.117 1.367 . . . . 0.0 113.532 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 59.2 m -100.28 142.01 32.34 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.428 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 59.3 m-85 -133.28 154.99 50.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -126.15 147.44 49.62 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.893 0.854 . . . . 0.0 112.653 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 78.5 mt -109.19 141.57 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 138.41 41.6 Favored 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 123.213 0.32 . . . . 0.0 110.3 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 55' ' ' LEU . 13.0 mt -79.73 161.94 25.47 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.967 0.413 . . . . 0.0 111.139 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 -99.46 -40.91 7.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -88.78 0.22 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -152.57 163.7 39.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.21 29.82 10.62 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.022 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -83.02 136.56 34.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.088 0.471 . . . . 0.0 110.99 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.3 mpt_? -128.31 149.63 50.42 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.112 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -129.9 125.15 34.88 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.07 127.65 72.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 16.8 p90 -136.01 158.62 43.97 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.271 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HB3' HD11 ' A' ' 76' ' ' ILE . 4.1 pt20 -112.81 139.6 48.3 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.4 t -93.22 111.7 25.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.69 95.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.13 -30.95 65.55 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.074 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.65 -32.51 71.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.114 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -100.02 -3.26 32.47 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.334 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.24 25.1 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 CA-C-O 122.451 1.119 . . . . 0.0 110.403 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.55 138.83 52.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.985 -1.072 . . . . 0.0 111.281 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.2 t -97.96 117.37 42.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -107.57 114.56 28.63 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.351 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.96 121.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 65' ' ' GLN . 57.8 mt -95.84 -42.86 12.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.406 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 m -150.41 150.34 31.24 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.116 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.2 136.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -130.6 2.36 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -113.55 165.9 12.04 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 117.505 0.652 . . . . 0.0 111.01 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.656 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.214 -0.765 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -85.22 -47.33 10.2 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.056 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 p -66.57 -36.44 82.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.438 0.637 . . . . 0.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.57 -44.64 86.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.461 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.589 -179.235 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.11 169.87 9.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.687 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -92.88 162.1 14.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -126.53 125.12 41.49 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -130.27 151.61 50.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.21 135.48 54.66 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.642 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 18.0 t70 -71.45 154.09 41.77 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.83 -32.48 69.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.304 0.502 . . . . 0.0 112.164 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.642 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 7.7 ptm180 -62.64 -39.22 93.18 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.194 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 -38.61 84.23 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.079 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.25 -43.5 97.83 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 122.579 0.351 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -63.01 -43.99 97.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.989 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.4 mm-40 -69.38 -37.17 77.44 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.05 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -60.62 -42.72 97.43 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 124.419 1.088 . . . . 0.0 110.224 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -74.63 -23.68 58.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.693 0.759 . . . . 0.0 110.194 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 85.4 tttt -74.44 -21.57 59.54 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.9 1.28 . . . . 0.0 109.864 177.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -76.75 165.26 24.96 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.386 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.13 154.16 40.58 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 p -55.21 -46.72 75.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 12.0 m -69.52 -42.45 74.65 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.39 -47.89 91.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.355 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 24' ' ' GLU . 9.8 ptt180 -63.29 -41.44 98.97 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 23' ' ' ARG 0.324 42.6 mt-10 -67.84 -33.63 75.15 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 21' ' ' THR . 30.4 mm-40 -60.05 -44.43 94.69 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -66.93 -41.51 86.9 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.323 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 33.3 ttpt -56.99 -43.59 81.87 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -58.95 -41.82 88.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.565 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.18 -38.31 87.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.545 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.5 mt -64.7 -47.31 78.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.534 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.42 -40.87 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.377 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.5 pt-20 -69.73 -42.88 73.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.78 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.43 -30.99 51.2 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 C-N-CA 122.392 0.277 . . . . 0.0 111.201 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 73.4 mt -54.5 -26.36 31.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.9 pt-20 -67.58 -26.52 66.32 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.658 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p -162.9 77.66 1.85 Allowed Pre-proline 0 N--CA 1.436 -1.132 0 C-N-CA 122.685 0.394 . . . . 0.0 111.483 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.11 12.12 1.59 Allowed 'Trans proline' 0 C--O 1.209 -0.937 0 C-N-CA 122.891 2.394 . . . . 0.0 113.554 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.52 28.16 0.78 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 111.836 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.7 94.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.771 0.796 . . . . 0.0 110.119 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.25 -23.29 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.041 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.97 66.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.129 0.49 . . . . 0.0 110.772 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.17 -8.09 18.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -75.71 136.53 40.35 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.482 0.658 . . . . 0.0 112.658 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.508 HD21 ' HD3' ' A' ' 52' ' ' LYS . 92.1 mt -81.44 139.45 35.23 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.793 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -92.03 121.31 33.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.35 58.4 Favored Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.991 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 81.3 mmm -126.26 131.32 23.91 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.43 90.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.228 2.618 . . . . 0.0 113.419 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 49.55 44.61 24.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.911 1.684 . . . . 0.0 112.629 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -100.18 142.74 31.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.571 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 22.4 m-85 -129.74 152.85 48.79 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HD3' HD21 ' A' ' 44' ' ' LEU . 55.6 pttt -125.93 139.82 53.14 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.574 0.546 . . . . 0.0 109.569 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.18 144.71 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -123.26 140.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.0 tt -83.08 137.22 34.18 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -74.34 -57.35 4.0 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -61.37 -63.84 1.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.592 0.557 . . . . 0.0 110.709 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 5.5 p -103.86 122.94 46.18 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.5 73.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.67 0 O-C-N 123.837 0.71 . . . . 0.0 114.537 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.67 144.53 36.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -125.52 150.68 47.2 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.75 133.15 39.59 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.01 127.66 75.97 Favored 'Isoleucine or valine' 0 C--O 1.255 1.362 0 C-N-CA 123.169 0.588 . . . . 0.0 109.431 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 12.9 p90 -138.32 158.63 43.91 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.7 pt20 -109.55 141.0 42.67 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.7 112.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.47 94.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.38 -25.22 62.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.617 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.09 -41.25 92.09 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.134 0.897 . . . . 0.0 110.142 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -105.72 -3.43 22.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.155 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t 65.19 34.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 122.66 1.219 . . . . 0.0 109.437 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.91 138.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.37 122.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -110.23 110.58 21.47 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.353 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.15 127.74 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.509 HG21 ' HA ' ' A' ' 90' ' ' ALA . 19.6 mt -110.73 -42.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.954 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -133.75 140.38 46.94 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.72 135.89 12.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.38 -146.5 18.12 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -95.25 140.17 30.53 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.532 0.666 . . . . 0.0 109.358 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -77.42 -50.45 12.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -62.34 -42.91 99.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.294 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.09 -30.49 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 110.381 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.509 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.913 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.909 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.05 159.64 15.34 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -81.13 160.58 24.38 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 34' ' ' LEU . 1.1 tm? -125.68 127.95 47.04 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -138.92 155.16 48.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.6 143.15 45.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.73 156.36 32.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.6 pt-20 -53.51 -37.14 62.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.913 0.485 . . . . 0.0 110.975 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -70.43 -44.79 67.15 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.79 70.25 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.613 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.08 -36.92 75.29 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.787 0.327 . . . . 0.0 111.681 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 57.3 mttm -67.98 -43.86 77.98 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -67.56 -39.32 84.94 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -60.9 -38.5 85.93 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.842 0.857 . . . . 0.0 109.999 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -73.15 -37.81 66.46 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.655 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -74.88 -16.34 60.68 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.721 0.772 . . . . 0.0 111.131 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 149.63 38.27 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.486 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.14 139.35 42.26 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 16.4 m -50.97 -46.48 61.24 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.918 0.887 . . . . 0.0 111.227 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 43.2 m -62.88 -43.22 99.37 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.06 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.21 -47.09 79.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.731 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.9 ptt180 -66.41 -33.92 76.79 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.016 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 26.5 mm-40 -60.24 -41.08 92.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 118.111 0.414 . . . . 0.0 111.136 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 21' ' ' THR . 73.9 mm-40 -65.76 -46.56 78.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.6 mt -61.47 -40.67 95.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.065 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.7 ttpt -57.25 -44.63 84.06 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.174 0.59 . . . . 0.0 110.245 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.3 mttt -57.7 -43.39 85.15 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.4 mptp? -62.34 -40.54 96.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.703 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -62.94 -45.73 91.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 123.516 0.51 . . . . 0.0 109.767 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 27' ' ' LYS . 62.5 t -64.49 -45.1 96.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.451 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.4 pt-20 -68.86 -44.06 74.11 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.621 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 37' ' ' PRO . 3.4 p -62.22 -29.78 47.37 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 123.327 0.651 . . . . 0.0 112.099 -173.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 87.9 mt -53.03 -25.36 12.14 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.37 -22.09 59.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.723 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -164.52 78.78 1.42 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 121.308 0.575 . . . . 0.0 111.683 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.5 Cg_endo -85.89 -9.73 7.46 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.384 2.056 . . . . 0.0 112.764 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.62 34.16 0.48 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.623 0.725 . . . . 0.0 112.956 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -83.25 110.57 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.819 0.818 . . . . 0.0 109.16 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -55.02 -29.34 57.18 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 126.246 1.818 . . . . 0.0 113.303 -175.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.23 -13.81 62.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -111.44 8.25 21.11 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.986 -0.446 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 17.2 ptmt -89.58 147.47 23.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.072 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 96.3 mt -69.91 155.69 40.19 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.46 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.64 -55.29 36.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.68 23.22 7.12 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.011 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.471 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -102.12 132.37 21.6 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 122.548 -0.384 . . . . 0.0 110.632 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.87 95.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.273 2.649 . . . . 0.0 112.642 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 50.83 47.06 25.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 113.015 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.0 m -106.64 141.09 38.48 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 38.5 m-85 -128.7 153.33 47.44 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 139.69 43.91 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.168 0.509 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.36 131.26 61.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.86 140.86 36.59 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -94.76 112.77 24.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -78.71 81.81 4.98 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.184 0.516 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 m -165.57 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.116 1.366 . . . . 0.0 109.137 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -161.17 179.17 8.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.04 51.78 4.15 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 121.108 -0.568 . . . . 0.0 114.397 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -108.14 142.64 38.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 151.05 38.27 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 123.689 0.796 . . . . 0.0 109.17 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.62 128.13 50.27 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.08 124.79 70.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.061 0 O-C-N 123.619 0.574 . . . . 0.0 110.248 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.3 p90 -136.67 158.83 43.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 4.3 pt20 -108.86 137.99 45.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.92 114.77 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.01 95.6 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.58 -36.61 84.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.722 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -60.93 -30.14 70.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.5 mttm -108.28 -5.32 16.86 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.627 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t 60.79 39.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.707 1.241 . . . . 0.0 109.624 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.5 p -132.31 139.01 51.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 121.335 -0.853 . . . . 0.0 111.173 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.63 115.39 42.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -110.63 111.62 22.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 61.1 t -75.45 122.49 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.528 HG21 ' HA ' ' A' ' 90' ' ' ALA . 48.4 mt -100.17 -42.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.204 0.526 . . . . 0.0 110.409 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m -147.98 149.85 32.92 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 122.152 -0.342 . . . . 0.0 110.43 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.14 139.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.97 -144.03 12.98 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.7 155.31 16.83 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.016 0.408 . . . . 0.0 110.022 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--O 1.214 -0.779 0 CA-C-O 120.724 0.297 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.94 -41.48 67.75 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -59.27 -51.15 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.981 0.8 . . . . 0.0 110.833 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.41 -35.67 73.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.539 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.04 168.85 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.11 160.13 14.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.86 132.36 52.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -141.79 156.86 45.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.67 147.59 41.81 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.035 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.04 154.77 40.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -32.42 72.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.626 0.25 . . . . 0.0 110.863 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -66.99 -46.53 74.3 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.552 0.691 . . . . 0.0 109.598 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.15 75.42 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.219 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.57 -40.83 96.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.024 0.44 . . . . 0.0 111.326 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.48 -43.4 85.53 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.58 -37.29 76.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.274 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.49 1.116 . . . . 0.0 110.824 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -74.69 -23.14 58.58 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.915 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.82 -40.32 61.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.128 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mp -58.95 147.11 35.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 124.541 1.136 . . . . 0.0 112.725 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -70.49 146.49 42.32 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.666 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 m -52.75 -45.88 67.24 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.058 0.943 . . . . 0.0 112.213 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 m -68.4 -36.7 79.5 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.893 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.14 -47.18 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.277 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.8 ptt180 -67.38 -33.83 76.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.186 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.07 -48.68 75.61 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.615 0.189 . . . . 0.0 110.702 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HB2' HD11 ' A' ' 55' ' ' LEU . 36.7 mt-30 -57.85 -41.97 83.47 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.014 0.821 . . . . 0.0 110.546 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.575 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 96.6 mt -66.65 -45.15 79.9 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.186 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.8 -44.2 94.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.515 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 94.9 mttt -62.97 -35.14 79.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.198 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.74 -35.03 72.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.81 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 mt -68.61 -46.12 70.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.04 -39.91 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.245 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.1 pt-20 -69.19 -42.8 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.2 p -63.87 -29.71 48.02 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.207 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 94.4 mt -53.73 -25.04 16.78 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.4 pt-20 -80.39 -19.71 45.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.078 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -155.2 70.99 5.66 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.839 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HB2' HG21 ' A' ' 66' ' ' VAL . 79.0 Cg_endo -77.3 -14.3 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.528 1.485 . . . . 0.0 111.606 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -83.11 61.08 5.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.71 0.767 . . . . 0.0 112.833 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -101.95 110.59 29.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.025 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.48 -22.04 66.84 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.51 -19.89 60.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 111.536 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -107.04 -7.6 16.86 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.013 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -70.35 133.64 47.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 123.568 0.747 . . . . 0.0 110.269 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.3 121.61 28.28 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -64.04 123.38 18.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.254 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.26 -29.4 8.91 Favored Glycine 0 C--N 1.324 -0.129 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.698 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.9 mmm -75.8 139.53 70.18 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 122.817 0.447 . . . . 0.0 110.053 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.92 90.88 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.869 2.379 . . . . 0.0 112.603 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 46.54 46.09 14.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 125.159 1.384 . . . . 0.0 113.014 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.5 m -99.88 142.34 31.5 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.569 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.3 m-85 -133.92 151.55 51.54 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -120.47 140.41 51.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 123.447 0.467 . . . . 0.0 110.62 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.01 134.94 61.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 157.86 17.68 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.479 0.487 . . . . 0.0 111.9 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 58' ' ' SER . 9.0 tp -94.11 166.06 12.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.501 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 37.9 mmt180 -90.22 -55.15 3.72 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.259 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 m -58.03 -59.86 4.63 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.539 ' H ' HD23 ' A' ' 55' ' ' LEU . 66.7 m -133.59 -177.42 4.54 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 122.069 -0.394 . . . . 0.0 110.692 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.75 62.83 4.46 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -103.32 139.66 38.45 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.522 HH11 ' HB3' ' A' ' 81' ' ' ALA . 2.9 mpt_? -136.26 142.93 44.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.15 0.5 . . . . 0.0 109.775 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -119.98 129.02 54.09 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.27 126.49 73.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.9 p90 -135.44 159.23 42.24 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.617 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.7 pt20 -109.09 140.66 42.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 37' ' ' PRO . 90.2 t -100.45 111.89 31.48 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mt -97.11 94.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.31 -29.84 68.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.168 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.2 -38.9 74.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.779 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -108.65 2.61 22.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.195 0.522 . . . . 0.0 111.374 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 t 61.54 34.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.824 1.249 . . . . 0.0 109.957 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.93 138.83 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.292 -0.88 . . . . 0.0 111.513 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -98.27 115.75 39.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -110.86 114.75 28.33 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.623 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.09 123.94 29.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.5 -42.49 11.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.096 0.474 . . . . 0.0 110.485 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 m -146.83 145.78 29.99 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.096 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.1 141.38 17.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.73 -152.93 24.6 Favored Glycine 0 CA--C 1.497 -1.05 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -91.44 149.04 21.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.522 ' HB3' HH11 ' A' ' 61' ' ' ARG . . . . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.292 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.08 -42.09 10.14 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.233 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 m -68.09 -45.22 74.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.152 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -29.66 63.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.591 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.733 179.06 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -116.47 172.31 7.29 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -87.23 156.92 19.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.25 127.92 50.51 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.87 155.17 50.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.61 133.58 54.99 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 33.9 t70 -71.99 151.94 42.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pp20? -58.55 -34.34 70.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.0 mtt180 -69.69 -44.91 69.46 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.17 73.38 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 17.0 tp -72.3 -34.84 68.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.9 mttm -66.41 -42.09 88.3 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 36.0 mm-40 -63.65 -39.15 93.63 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -60.87 -39.56 89.65 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.09 1.356 . . . . 0.0 110.754 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 88.3 mtt180 -74.55 -32.75 62.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -72.81 -28.12 62.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 110.842 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -63.77 152.76 38.49 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.33 0.652 . . . . 0.0 112.103 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -68.78 143.37 39.97 Favored Glycine 0 N--CA 1.424 -2.119 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.602 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 8.1 m -48.99 -54.55 15.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.584 1.154 . . . . 0.0 112.411 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.8 m -64.66 -34.77 79.07 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.879 0.472 . . . . 0.0 110.713 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.83 -48.18 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 6.1 ptt180 -68.57 -35.54 77.54 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 20' ' ' SER . 54.1 mt-10 -58.03 -50.06 74.72 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.992 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -63.28 -35.3 79.91 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.213 0.32 . . . . 0.0 111.691 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.4 mt -66.77 -44.94 80.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.987 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.82 -41.98 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.5 mttt -59.47 -35.44 74.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.146 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.5 mptp? -70.96 -35.81 72.3 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.144 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.6 mt -66.32 -46.27 77.44 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.754 0.312 . . . . 0.0 110.897 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.83 -38.54 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.43 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 pt-20 -69.99 -43.43 71.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.85 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -63.08 -30.12 48.9 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.478 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 77.2 mt -54.18 -25.38 22.36 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -84.0 -8.54 59.11 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.022 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 39' ' ' ILE . 26.8 p -159.29 62.19 1.99 Allowed Pre-proline 0 C--O 1.206 -1.185 0 C-N-CA 124.038 0.935 . . . . 0.0 110.576 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 33' ' ' VAL . 73.0 Cg_endo -75.01 -20.6 16.69 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.777 1.651 . . . . 0.0 113.752 -172.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -89.69 54.76 2.97 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.148 0.975 . . . . 0.0 113.247 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 36' ' ' SER . 98.1 mt -83.19 110.86 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.732 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.15 -27.18 68.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.74 68.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.088 0.471 . . . . 0.0 111.067 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.02 -1.44 57.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.987 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.45 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 8.3 mtpm? -62.74 146.55 52.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.62 173.02 12.75 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.459 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -85.75 -55.02 4.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.33 52.51 0.82 Allowed Glycine 0 CA--C 1.5 -0.887 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.299 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.407 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 96.9 mmm -135.78 132.34 19.47 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.53 102.25 0.34 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.906 2.404 . . . . 0.0 113.309 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.8 35.3 24.22 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 124.347 1.059 . . . . 0.0 111.952 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 63.5 m -101.65 141.23 34.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.245 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.621 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 18.4 m-85 -131.75 153.66 49.84 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 47.9 pttt -126.5 140.35 52.53 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.41 0.624 . . . . 0.0 111.246 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.48 129.26 65.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -110.39 133.51 53.2 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.44 96.32 10.33 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -44.82 -41.77 7.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 126.598 1.959 . . . . 0.0 113.963 -172.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -82.38 -44.36 16.23 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 m -77.31 -36.0 54.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.7 14.63 49.25 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.354 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.99 158.26 15.54 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.75 147.59 33.14 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.461 0.648 . . . . 0.0 111.843 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -119.59 126.98 52.5 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.63 123.34 66.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 121.032 0.444 . . . . 0.0 110.297 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -133.82 157.63 45.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.677 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HB3' HD11 ' A' ' 76' ' ' ILE . 20.6 pt20 -107.71 131.67 54.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.53 111.05 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 70' ' ' LYS . 31.8 mt -99.04 96.01 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.32 -32.77 73.96 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.34 -35.52 74.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.082 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.423 ' H ' HG22 ' A' ' 67' ' ' ILE . 99.3 mttt -104.46 -2.41 25.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.53 33.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.525 1.13 . . . . 0.0 109.754 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.15 138.99 50.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 O-C-N 121.161 -0.962 . . . . 0.0 111.304 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -99.14 114.81 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 81.8 t80 -107.94 111.21 23.19 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.469 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -73.15 121.43 23.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.455 HG21 ' HA ' ' A' ' 90' ' ' ALA . 29.8 mt -98.09 -42.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.613 0.571 . . . . 0.0 110.373 -174.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 t -153.38 151.85 30.4 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.11 138.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.15 -139.86 8.43 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.394 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -101.83 158.7 15.93 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.999 0.428 . . . . 0.0 109.921 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.845 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.211 -0.941 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.77 -48.59 16.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.272 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.7 m -60.95 -42.93 99.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.557 0.536 . . . . 0.0 110.828 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -68.35 -35.83 78.33 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.91 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 CA--C 1.503 -0.865 0 CA-C-O 121.169 0.509 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.35 167.09 9.97 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.738 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.51 153.39 24.43 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 30' ' ' LEU . 1.9 tm? -125.56 124.39 41.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.65 156.05 49.46 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.413 0.625 . . . . 0.0 110.385 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.88 134.95 47.14 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.27 142.34 57.78 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 10.1 pt-20 -56.27 -31.32 63.5 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -72.34 -40.11 67.63 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.274 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.27 -31.19 70.48 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.869 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -68.16 -34.91 77.2 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.3 mttm -63.61 -42.8 98.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.893 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 42.0 mm-40 -68.69 -37.47 79.59 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.088 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -60.68 -45.01 95.77 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.83 0.852 . . . . 0.0 110.643 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -74.78 -21.18 59.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.587 0.708 . . . . 0.0 110.175 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 80.2 tttt -74.86 -25.43 58.96 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.79 1.236 . . . . 0.0 110.154 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 14' ' ' GLU . 5.5 mp -68.06 168.07 12.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.253 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.03 -138.68 1.56 Allowed Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.056 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -106.5 -60.47 1.65 Allowed 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.585 -0.95 . . . . 0.0 108.86 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -52.23 -43.36 64.24 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.93 1.292 . . . . 0.0 113.096 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.13 -48.35 79.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.135 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -69.08 -33.91 74.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -56.07 -45.96 79.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.444 ' HB3' HD21 ' A' ' 55' ' ' LEU . 45.8 mt-30 -70.61 -38.98 74.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.953 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 92.5 mt -63.46 -44.04 95.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.36 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -58.87 -43.2 90.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.186 0.517 . . . . 0.0 110.346 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.512 ' HA ' HG12 ' A' ' 31' ' ' VAL . 97.8 mttt -62.89 -37.7 87.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.9 mptp? -64.32 -37.57 87.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.582 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.1 mt -68.36 -45.28 73.26 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 28' ' ' LYS . 7.8 p -68.75 -36.21 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.799 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -68.75 -44.94 72.7 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 37' ' ' PRO . 3.7 p -62.93 -30.66 50.1 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.124 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.627 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 71.0 mt -53.91 -25.62 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 8.1 pt-20 -64.48 -28.85 69.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.084 0.856 . . . . 0.0 111.19 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -160.1 77.5 2.72 Favored Pre-proline 0 C--O 1.206 -1.207 0 C-N-CA 124.059 0.944 . . . . 0.0 108.493 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 33' ' ' VAL . 89.8 Cg_endo -85.25 -1.27 9.21 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.679 2.253 . . . . 0.0 113.537 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 40.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.549 0.69 . . . . 0.0 110.885 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.15 100.88 5.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.359 1.076 . . . . 0.0 110.352 -173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -55.42 -27.48 48.15 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.706 2.003 . . . . 0.0 112.509 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.23 61.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.064 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.73 1.47 17.88 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -80.25 135.63 36.28 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 121.07 0.462 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.8 mt -82.68 122.87 28.7 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.595 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -89.27 120.03 30.26 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.09 6.77 42.07 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 95.2 mmm -127.0 138.68 33.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' MET . 14.1 Cg_exo -67.2 95.13 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.601 2.201 . . . . 0.0 112.971 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 52.5 39.02 27.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.041 1.337 . . . . 0.0 113.573 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.5 m -99.99 142.49 31.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.9 m-85 -132.4 156.24 47.04 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -133.37 141.97 48.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.27 0.557 . . . . 0.0 112.402 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.78 122.85 68.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 128.61 49.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.423 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 25' ' ' GLN . 1.3 tm? -76.12 102.95 5.93 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 -173.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -56.44 -39.58 73.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -88.26 20.38 3.28 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -156.05 -45.53 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.668 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.99 22.5 7.21 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.672 -1.251 . . . . 0.0 112.341 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -95.69 154.09 17.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 122.222 -0.575 . . . . 0.0 109.818 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -122.95 135.62 54.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.74 124.95 34.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -117.07 128.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.6 p90 -133.48 158.16 43.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.747 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HB3' HD11 ' A' ' 76' ' ' ILE . 20.5 pt20 -105.46 138.19 42.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.63 111.2 34.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.1 mt -97.35 101.75 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.01 -36.57 80.18 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.561 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.64 -40.31 96.59 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.17 -6.05 42.62 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.6 t 58.49 37.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.429 1.109 . . . . 0.0 109.711 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.1 140.31 40.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 121.365 -0.834 . . . . 0.0 110.902 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.83 124.99 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 124.461 1.104 . . . . 0.0 108.771 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.08 116.92 29.91 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.7 t -68.99 121.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 65' ' ' GLN . 59.0 mt -96.28 -43.11 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.993 0.425 . . . . 0.0 110.638 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 p -141.3 143.5 34.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 120.877 0.37 . . . . 0.0 110.567 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.1 141.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.22 -140.24 7.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -116.71 155.44 28.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.351 0.575 . . . . 0.0 110.002 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.768 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -79.75 -44.92 19.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -62.84 -43.15 99.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.853 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.1 -28.18 68.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.847 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.158 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -118.33 168.57 10.5 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -99.03 163.17 12.69 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 123.062 0.226 . . . . 0.0 111.172 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.11 130.96 53.17 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.52 149.6 46.89 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.91 134.85 46.14 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 20.2 t70 -72.05 153.43 41.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.96 -32.53 66.13 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -68.27 -42.25 79.85 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.12 75.25 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.737 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.0 mt -69.84 -39.29 76.51 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.443 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -62.36 -44.29 96.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.068 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 32.5 mt-10 -70.01 -37.51 75.69 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.066 0.46 . . . . 0.0 111.4 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -62.37 -42.0 99.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 123.737 0.815 . . . . 0.0 110.33 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -75.24 -23.26 57.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 48.5 tttp -67.84 -45.4 74.75 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 14' ' ' GLU . 6.5 mp -58.69 151.15 21.6 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.623 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -75.42 152.12 42.7 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.5 t -52.44 -53.24 47.95 Favored 'General case' 0 C--O 1.201 -1.454 0 C-N-CA 123.058 0.543 . . . . 0.0 111.291 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.0 m -57.82 -38.0 74.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 123.507 0.723 . . . . 0.0 111.577 -176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -72.18 -47.87 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 109.944 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 9.2 ptt180 -68.45 -34.57 76.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.4 mt-10 -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.817 0.447 . . . . 0.0 111.599 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -66.01 -35.31 80.21 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.673 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.5 mt -67.24 -43.43 81.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.667 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -59.33 -44.37 92.63 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 110.5 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 90.5 mttt -62.49 -35.1 78.29 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.555 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.6 mptp? -65.71 -39.56 91.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.869 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.3 mt -61.63 -44.61 96.67 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 27' ' ' LYS . 87.9 t -61.67 -45.31 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.84 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -69.65 -42.49 74.18 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.746 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.9 p -62.59 -29.67 47.44 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.7 mt -53.16 -25.77 14.73 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.5 pt-20 -66.24 -28.92 69.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.491 0.662 . . . . 0.0 110.966 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.4 m -158.42 76.66 3.47 Favored Pre-proline 0 C--N 1.315 -0.894 0 C-N-CA 124.227 1.011 . . . . 0.0 108.805 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 33' ' ' VAL . 61.1 Cg_endo -75.59 -24.43 11.93 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.472 1.448 . . . . 0.0 111.466 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 2.4 ppt_? -78.38 62.57 3.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.166 0.984 . . . . 0.0 112.907 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.84 124.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.25 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -35.94 67.37 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.16 0.984 . . . . 0.0 112.263 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.62 -15.98 61.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.549 0.69 . . . . 0.0 111.399 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.4 m-20 -104.68 -7.0 19.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 21.8 ttmt -85.9 138.59 31.92 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -172.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -86.45 129.09 34.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.948 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -74.87 116.52 15.68 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.847 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.49 49.66 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.862 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.1 mmm -101.93 137.18 19.45 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.07 95.16 0.14 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 123.205 2.604 . . . . 0.0 112.71 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 45.86 46.27 12.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 125.015 1.326 . . . . 0.0 113.012 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.38 141.61 33.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 43' ' ' LYS . 79.6 m-85 -131.66 145.84 51.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.424 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -115.86 141.15 48.48 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 123.618 0.573 . . . . 0.0 110.066 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.13 138.44 51.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -119.42 132.78 55.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.285 0.366 . . . . 0.0 110.389 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 tt -84.27 117.78 23.76 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -51.74 -57.28 9.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -76.12 -53.59 8.09 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.184 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -63.86 -34.84 78.84 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.67 26.68 49.63 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.327 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.54 150.33 20.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -123.5 141.53 51.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -126.3 131.89 51.77 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.18 122.72 67.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 CA-C-O 121.405 0.621 . . . . 0.0 110.494 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -131.78 157.97 42.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.055 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.16 139.77 48.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 73' ' ' VAL . 77.5 t -88.63 112.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 mt -98.54 95.64 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.466 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.26 -35.76 76.25 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.28 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -104.8 -1.31 26.27 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.013 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t 59.14 33.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.378 0 CA-C-O 122.722 1.248 . . . . 0.0 110.267 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.04 141.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.528 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 66' ' ' VAL . 17.6 m -98.17 128.07 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.112 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 87.1 t80 -103.09 110.04 21.83 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.401 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -75.52 120.79 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.4 mt -95.06 -42.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.341 0.591 . . . . 0.0 109.521 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.7 m -153.0 153.31 32.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.014 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.06 148.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.81 -111.86 0.72 Allowed Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.3 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -124.59 142.81 51.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.533 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.204 -1.292 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -92.31 -52.08 4.85 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -61.46 -49.91 74.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.49 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.98 -29.55 67.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.298 -179.102 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -87.47 164.91 15.9 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.652 0.595 . . . . 0.0 109.544 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.4 157.48 22.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.449 HD23 HD21 ' A' ' 34' ' ' LEU . 1.3 tm? -126.16 128.55 47.46 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -140.37 157.13 46.01 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.18 142.23 49.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 122.395 0.278 . . . . 0.0 110.433 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.69 155.02 40.19 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.49 -29.64 67.99 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 12.6 mmt85 -71.75 -43.02 66.52 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.32 81.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.04 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.6 mt -63.16 -43.26 98.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 110.774 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.212 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 37.3 mm-40 -68.36 -37.54 80.57 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 123.528 0.517 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.69 -45.11 94.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.064 0.945 . . . . 0.0 111.033 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.3 -22.71 57.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.858 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -77.09 -31.67 56.1 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.427 1.491 . . . . 0.0 110.732 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.71 152.2 27.35 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.932 0.893 . . . . 0.0 111.786 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -69.49 147.19 45.1 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 15.0 m -49.18 -54.6 15.73 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.289 1.035 . . . . 0.0 112.455 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -63.54 -34.55 78.04 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.277 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.83 -48.85 61.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 7.3 ptt180 -69.24 -35.58 76.29 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 43.2 mt-10 -57.15 -49.46 75.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 120.45 0.166 . . . . 0.0 110.6 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.59 ' HB3' HD11 ' A' ' 55' ' ' LEU . 2.9 mp0 -68.51 -34.98 76.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.1 mt -66.91 -42.77 84.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.56 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -59.05 -41.9 89.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.185 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.4 mttt -59.23 -41.29 88.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.1 mptp? -64.32 -34.79 78.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.158 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -68.92 -47.31 66.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.44 -38.63 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.886 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 10.5 pt-20 -68.31 -43.14 78.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.945 0.402 . . . . 0.0 110.563 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.7 p -64.47 -30.56 50.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.838 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.8 mt -54.03 -25.46 21.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 14.6 pt-20 -75.17 -25.45 58.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.058 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.0 p -158.09 74.46 3.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.702 0.401 . . . . 0.0 110.125 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' HG22 ' A' ' 33' ' ' VAL . 94.3 Cg_endo -85.04 -1.34 9.37 Favored 'Trans proline' 0 C--O 1.206 -1.106 0 C-N-CA 122.057 1.838 . . . . 0.0 113.796 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 32.78 0.74 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.55 112.37 20.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -57.75 -29.04 64.46 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.82 -15.94 63.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.953 0.406 . . . . 0.0 111.725 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -102.41 -1.63 30.38 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.743 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.499 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 42.5 mtpt -74.03 144.67 45.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.084 0.469 . . . . 0.0 111.474 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 59.7 mt -74.41 133.46 42.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -73.26 107.61 5.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 32.41 9.23 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.736 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.551 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 77.2 mmm -133.98 142.72 44.45 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 47' ' ' MET . 9.5 Cg_exo -70.64 93.47 0.6 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.765 2.31 . . . . 0.0 112.714 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 50.0 41.73 23.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 124.993 1.317 . . . . 0.0 113.986 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 m -100.31 141.58 32.96 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.1 m-85 -130.01 146.24 51.68 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -115.14 140.4 49.11 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.28 0.562 . . . . 0.0 110.869 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.44 127.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HD2' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -104.51 145.12 30.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.502 178.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 25' ' ' GLN . 15.5 tp -85.59 143.32 28.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -89.83 -30.27 18.06 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.639 0.733 . . . . 0.0 109.219 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -65.47 -29.77 70.47 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.069 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 23.4 t -164.17 158.71 19.43 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.06 50.63 3.08 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -99.02 143.42 29.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -122.96 142.65 50.59 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -120.64 126.85 51.29 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.9 t -116.59 123.46 71.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.181 0.515 . . . . 0.0 109.947 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.58 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.5 p90 -135.58 158.96 43.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.188 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -112.08 139.53 47.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.5 t -97.74 111.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.622 0.725 . . . . 0.0 110.056 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 70' ' ' LYS . 38.4 mt -100.08 95.06 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.37 -29.88 64.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.476 0.655 . . . . 0.0 109.76 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.73 -40.16 75.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.97 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 67' ' ' ILE . 95.3 mttt -108.06 4.29 24.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.509 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p 51.86 40.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.704 1.602 . . . . 0.0 111.879 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.91 138.96 50.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.748 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.86 115.24 42.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -108.87 112.92 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.665 -173.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.52 121.48 27.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -95.42 -42.74 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.374 0.606 . . . . 0.0 109.624 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -149.43 149.97 31.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.315 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.21 131.97 6.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.02 -155.78 26.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -81.09 152.92 27.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.369 0.604 . . . . 0.0 110.839 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.202 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.994 -176.827 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -81.56 -44.07 17.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 t -66.57 -34.68 78.44 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -60.88 -47.89 84.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.543 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.913 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.178 -178.217 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.95 168.86 14.6 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.727 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -89.01 161.05 16.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -126.06 132.37 51.95 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.79 155.49 47.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -123.36 135.49 54.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 117.791 0.269 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.85 155.71 38.76 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 6.5 pt-20 -53.19 -40.82 64.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 117.809 0.277 . . . . 0.0 111.429 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 25.5 mmm180 -69.86 -38.06 76.3 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.99 93.32 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.925 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 44.7 mt -66.58 -42.85 86.34 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.164 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -61.32 -43.92 98.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -69.97 -39.57 75.89 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.765 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.11 -42.22 98.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.1 0.96 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 81.9 mtp180 -73.07 -26.63 61.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.041 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -71.84 -35.71 69.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.497 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -60.85 152.74 26.46 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.514 0.673 . . . . 0.0 112.528 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.0 155.77 49.67 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.778 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 3.0 p -55.73 -53.97 50.05 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 124.138 0.975 . . . . 0.0 112.801 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -57.62 -42.14 82.71 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 124.225 1.01 . . . . 0.0 110.899 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 93.7 t -68.58 -48.21 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.99 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.3 ptt-85 -68.72 -35.42 77.11 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 20' ' ' SER . 37.5 mt-10 -59.7 -45.41 92.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.399 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.639 ' HB3' HD11 ' A' ' 55' ' ' LEU . 2.6 mp0 -70.86 -34.74 71.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 85.1 mt -62.92 -44.06 97.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.397 174.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -56.38 -42.61 78.16 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.945 0.403 . . . . 0.0 110.498 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 98.9 mttt -60.24 -45.48 93.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.67 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.0 mptp? -59.95 -38.52 82.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.86 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.4 mt -65.96 -46.33 78.49 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.296 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.21 -37.73 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.737 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 8.2 pt-20 -68.6 -42.66 77.87 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.705 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.98 -29.37 47.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.49 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -52.85 -24.95 10.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.91 -30.37 70.95 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.683 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 t -161.72 75.81 2.32 Favored Pre-proline 0 C--O 1.2 -1.541 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 33' ' ' VAL . 85.3 Cg_endo -83.46 -9.68 10.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.0 1.8 . . . . 0.0 114.461 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 43.3 0.63 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.45 0.643 . . . . 0.0 111.881 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.14 101.32 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.793 0.806 . . . . 0.0 110.185 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.15 -25.2 65.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.629 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.75 -15.23 63.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.983 0.42 . . . . 0.0 110.81 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -113.87 11.12 17.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.383 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -80.49 144.69 32.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 120.98 0.419 . . . . 0.0 111.917 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.82 150.73 23.93 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.494 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -95.08 127.74 41.37 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.349 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.54 12.62 84.06 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.36 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.0 mmm -121.83 120.1 28.71 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.6 100.67 0.16 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.194 2.596 . . . . 0.0 113.598 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' GLN . 4.5 m-20 62.16 31.37 17.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 111.793 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.91 141.72 32.35 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.773 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.48 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 68.8 m-85 -136.5 156.54 48.45 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 140.46 47.11 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 112.536 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.26 141.28 34.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -113.23 144.3 42.93 Favored 'General case' 0 N--CA 1.403 -2.813 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 25' ' ' GLN . 18.5 tp -98.51 118.47 35.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -70.78 -34.59 71.95 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.196 0.522 . . . . 0.0 110.346 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 m -61.9 -39.49 92.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -124.96 -12.37 7.02 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 21.36 57.3 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.493 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -93.52 156.64 16.62 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.096 -0.65 . . . . 0.0 110.938 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -121.8 143.73 49.23 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.69 0.796 . . . . 0.0 108.982 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.43 127.67 37.93 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.41 125.66 72.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 CA-C-O 121.035 0.445 . . . . 0.0 110.022 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.1 p90 -136.93 158.83 43.56 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.245 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 4.0 pt20 -111.44 133.72 53.54 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 173.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -98.0 110.88 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.7 mt -99.65 95.79 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.69 -25.03 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.055 0.455 . . . . 0.0 110.247 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.57 -36.28 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.636 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HB2' HG12 ' A' ' 72' ' ' VAL . 96.7 mttt -107.68 -1.87 20.68 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.835 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t 58.5 32.52 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.234 1.414 . . . . 0.0 110.388 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -129.67 139.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.018 -1.051 . . . . 0.0 110.964 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -98.88 114.98 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -106.07 110.33 22.56 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.682 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.18 121.95 24.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.4 mt -94.89 -42.27 12.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.734 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.8 m -152.99 153.18 32.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.97 142.97 18.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.34 -131.72 3.18 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.176 -1.011 . . . . 0.0 111.797 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -124.03 167.06 14.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.468 -0.431 . . . . 0.0 110.641 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.943 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.481 -176.587 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.213 -0.848 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -80.92 -42.85 20.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.983 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -64.53 -41.49 96.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -62.42 -46.8 86.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.076 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.535 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.819 -176.415 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -91.06 162.88 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.89 155.03 23.1 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.403 HD23 HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -118.06 124.1 47.26 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -130.62 160.81 33.1 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.11 144.73 50.92 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 13.1 t70 -79.42 154.4 28.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 169.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -29.54 66.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 4.4 mmt85 -63.82 -45.0 91.56 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.07 93.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.386 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.99 -41.03 99.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 123.207 0.317 . . . . 0.0 111.749 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.67 -43.83 97.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.272 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 57.4 mm-40 -69.09 -39.5 78.97 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.272 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -61.3 -46.61 89.58 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.571 1.148 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -73.03 -28.58 62.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.529 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.4 -38.73 88.14 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.377 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.56 153.91 12.2 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.644 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.19 147.51 37.84 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.3 m -50.15 -48.04 53.96 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -67.27 -36.87 82.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.689 0.28 . . . . 0.0 110.966 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.16 -48.59 68.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 19.4 ptt180 -68.77 -35.43 77.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 24.0 mt-10 -57.93 -42.44 84.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.529 ' CB ' HD11 ' A' ' 55' ' ' LEU . 43.5 mt-30 -70.64 -35.11 72.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.128 0.489 . . . . 0.0 110.193 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.04 -41.87 85.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.956 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 18.6 ptmt -63.18 -36.73 84.59 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.898 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -59.63 -39.02 82.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 29' ' ' LYS . 72.9 mmtt -65.02 -36.21 83.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.689 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.661 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 71.7 mt -63.72 -43.62 96.0 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 27' ' ' LYS . 96.2 t -63.73 -45.46 97.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.717 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.2 pt-20 -69.09 -43.92 73.55 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.754 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.88 -29.76 47.9 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 81.5 mt -53.45 -25.32 15.71 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -75.09 -25.45 58.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.197 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -154.2 74.19 6.15 Favored Pre-proline 0 C--O 1.213 -0.829 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 33' ' ' VAL . 84.4 Cg_endo -80.98 -7.31 13.23 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 121.515 1.476 . . . . 0.0 113.386 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 38.69 0.94 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.58 0.705 . . . . 0.0 112.074 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.52 108.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.4 -24.68 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.54 -8.19 44.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 87.0 m-20 -108.94 3.8 22.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 9.9 mtpm? -71.18 142.41 50.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.11 126.17 32.84 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 168.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -85.77 114.56 22.82 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 6.47 16.74 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -131.28 139.05 34.23 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.75 -71.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.323 2.682 . . . . 0.0 112.677 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -137.96 78.04 1.66 Allowed 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.9 m -126.88 141.38 51.83 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 40.4 m-85 -133.75 155.43 49.78 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -126.39 139.83 52.97 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.641 0.588 . . . . 0.0 110.033 177.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 mt -108.71 142.55 21.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -117.1 129.34 55.92 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' A' ' 25' ' ' GLN . 14.6 tp -81.71 143.52 31.8 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -73.66 -36.64 65.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.1 m -99.62 150.2 22.5 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 71.82 -43.88 0.58 Allowed 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.68 35.16 5.25 Favored Glycine 0 C--O 1.239 0.447 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.767 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.44 155.76 17.16 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 122.622 -0.34 . . . . 0.0 110.22 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.8 mpt_? -129.52 151.33 50.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -128.26 131.32 48.75 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 86' ' ' VAL . 84.1 t -118.38 124.37 73.02 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-O 121.229 0.538 . . . . 0.0 110.943 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.4 p90 -137.48 158.88 43.44 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.977 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -112.23 141.28 46.12 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG22 ' HE1' ' A' ' 51' ' ' TYR . 12.0 m -101.37 123.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.561 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.83 94.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.168 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.2 -23.38 62.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.975 0.893 . . . . 0.0 109.51 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.99 -36.55 83.92 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.262 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 72' ' ' VAL . 99.5 mttt -107.31 -4.27 18.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.463 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t 63.35 34.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-O 122.678 1.228 . . . . 0.0 109.616 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.1 p -131.9 139.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.26 115.37 38.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 88.4 t80 -106.11 110.55 22.84 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.27 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.81 121.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.8 -42.61 12.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.881 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 m -151.39 153.92 35.65 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.3 139.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.85 -137.97 6.85 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -99.03 91.21 4.91 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.291 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.773 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 63' ' ' VAL . 29.9 m . . . . . 0 N--CA 1.446 -0.625 0 CA-C-O 120.567 0.223 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -67.64 -47.5 69.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 120.691 0.281 . . . . 0.0 110.621 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.1 m -59.21 -41.79 89.42 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.37 -42.1 72.23 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.423 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.42 175.68 5.85 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.87 159.35 15.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.1 130.84 51.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -145.35 158.35 43.85 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.24 144.17 45.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.006 0.431 . . . . 0.0 111.987 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.39 155.97 28.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.96 -38.23 64.77 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.911 0.323 . . . . 0.0 111.229 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.81 -45.36 93.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.79 98.02 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.835 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -63.4 -45.42 91.11 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -63.29 -44.12 95.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.776 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -70.05 -37.97 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.442 ' O ' ' HD3' ' A' ' 23' ' ' ARG . 61.9 t-105 -63.04 -45.01 94.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.789 1.236 . . . . 0.0 110.674 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -72.19 -27.14 62.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.298 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.65 -38.5 64.95 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.479 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.4 150.65 17.98 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 124.434 1.094 . . . . 0.0 111.923 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.54 144.32 48.22 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -50.03 -50.25 48.18 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.144 . . . . 0.0 111.972 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.8 m -68.99 -37.77 78.94 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.271 0.628 . . . . 0.0 111.148 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.37 -47.67 80.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 10.1 ptt-85 -68.75 -35.96 77.76 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.571 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 33.4 mt-10 -66.69 -31.69 72.52 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.638 ' HB3' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.83 -34.37 71.61 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.649 175.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -65.48 -42.13 92.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.579 172.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' O ' HG23 ' A' ' 31' ' ' VAL . 30.9 ttpt -55.3 -44.76 76.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.648 0.779 . . . . 0.0 109.585 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -58.42 -38.02 76.56 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.929 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.7 mptp? -69.99 -35.22 74.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.155 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 85.7 mt -65.78 -41.63 91.77 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.154 0.502 . . . . 0.0 109.698 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' LYS . 92.7 t -62.64 -44.47 99.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.374 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -68.85 -45.73 70.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.988 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.424 HG21 ' OH ' ' A' ' 64' ' ' TYR . 3.4 p -62.94 -30.27 49.18 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.805 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 72.4 mt -53.35 -25.53 15.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.4 pt-20 -76.71 -28.03 55.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.118 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 m -152.37 69.41 7.37 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.686 -0.633 . . . . 0.0 110.454 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 33' ' ' VAL . 95.1 Cg_endo -87.63 -2.94 7.5 Favored 'Trans proline' 0 C--O 1.21 -0.887 0 C-N-CA 121.961 1.774 . . . . 0.0 112.828 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 37.94 0.94 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.949 0.881 . . . . 0.0 111.93 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.3 mt -82.7 100.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 12.6 pt-20 -57.48 -24.5 56.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.64 66.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.851 0.358 . . . . 0.0 111.143 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -99.5 3.89 45.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.437 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 10.1 mtpm? -72.23 139.39 48.11 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.213 0.53 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 63.0 mt -80.14 138.25 36.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.398 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -72.31 106.61 4.53 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.56 32.46 10.23 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.103 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -135.75 132.68 19.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.65 99.08 0.37 Allowed 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.682 2.255 . . . . 0.0 113.319 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 60.36 31.92 20.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.637 1.175 . . . . 0.0 111.681 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.3 m -100.09 141.44 32.91 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.801 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 7.4 m-85 -132.0 160.4 35.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -130.51 146.95 52.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -124.93 139.6 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.3 131.01 56.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.638 HD11 ' HB3' ' A' ' 25' ' ' GLN . 19.2 tp -77.61 96.59 4.84 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.421 0.629 . . . . 0.0 110.423 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -68.44 78.8 0.27 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.078 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t 172.63 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.279 1.432 . . . . 0.0 107.886 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 m -111.37 -23.44 10.79 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.82 49.32 Favored Glycine 0 C--O 1.241 0.544 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.585 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -88.01 150.21 23.55 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 122.61 -0.347 . . . . 0.0 110.16 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.13 147.88 46.31 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.181 0.515 . . . . 0.0 109.77 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -132.18 129.05 39.26 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.2 127.13 73.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 O-C-N 123.606 0.566 . . . . 0.0 110.102 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.2 p90 -138.08 158.78 43.63 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.9 pt20 -108.92 130.37 55.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -99.52 110.5 26.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.0 mt -99.01 100.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.83 -34.48 78.02 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.039 0.536 . . . . 0.0 111.828 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.44 -36.74 85.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.321 0.388 . . . . 0.0 111.595 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HB2' HG12 ' A' ' 72' ' ' VAL . 96.7 mttt -98.51 -6.97 29.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.05 0.453 . . . . 0.0 110.473 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 t 61.33 32.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 124.951 1.3 . . . . 0.0 109.936 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.3 p -129.42 138.78 53.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 111.148 -176.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.3 114.88 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.03 110.69 21.34 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.94 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 59.6 t -74.77 121.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.14 -42.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.533 0.682 . . . . 0.0 110.218 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 m -145.87 149.91 35.14 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.17 145.91 17.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.65 -144.94 12.63 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -98.54 162.79 12.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 118.095 0.948 . . . . 0.0 109.388 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.682 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 121.03 0.443 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -89.24 -44.53 10.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.931 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -64.99 -48.03 75.45 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.94 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -60.6 -31.6 70.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.804 0.335 . . . . 0.0 110.421 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.291 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.344 179.785 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -96.05 168.93 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.157 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.2 159.88 16.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD23 HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -125.65 123.53 39.17 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -137.55 152.71 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.86 137.82 52.53 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -70.48 154.8 41.5 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.256 0.7 OUTLIER -59.75 -31.15 69.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.03 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -70.94 -38.11 72.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.205 0.526 . . . . 0.0 109.638 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.36 88.05 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.202 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 63.7 mt -61.28 -43.79 98.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.406 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -61.66 -44.76 96.35 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -69.76 -37.43 76.4 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.275 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -60.93 -37.24 81.63 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.997 0.919 . . . . 0.0 110.593 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 97.5 mtt180 -74.86 -28.98 60.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.597 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -77.04 -26.3 53.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.444 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.11 151.25 43.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.931 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.68 145.62 42.26 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -45.56 -53.02 9.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.623 1.169 . . . . 0.0 112.114 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -68.61 -36.29 78.47 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.372 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.0 -48.47 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.14 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -69.3 -35.59 76.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.6 mt-10 -57.41 -41.53 80.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.536 ' CB ' HD11 ' A' ' 55' ' ' LEU . 41.4 mt-30 -70.93 -35.75 72.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.012 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.2 mt -68.63 -39.81 80.62 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.268 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 31' ' ' VAL . 36.4 ttpt -60.11 -42.61 95.08 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.477 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.6 mttm -57.06 -41.6 79.05 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.7 mmtt -64.0 -37.6 88.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.298 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.1 mt -64.97 -41.19 95.66 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.333 0.587 . . . . 0.0 109.809 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 27' ' ' LYS . 95.8 t -65.37 -45.66 92.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.576 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.4 pt-20 -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.905 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' OH ' ' A' ' 64' ' ' TYR . 5.0 p -64.08 -31.3 52.76 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -55.21 -27.42 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.15 -8.01 34.33 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.097 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -154.81 63.72 4.05 Favored Pre-proline 0 C--O 1.211 -0.973 0 C-N-CA 122.62 0.368 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HA ' HG22 ' A' ' 33' ' ' VAL . 97.5 Cg_endo -80.54 -4.73 13.09 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.103 1.869 . . . . 0.0 114.902 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.02 40.2 1.04 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -82.34 113.68 22.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.832 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 41' ' ' ALA . 3.6 pt-20 -58.49 -33.2 69.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.715 0.806 . . . . 0.0 111.828 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 40' ' ' GLU . . . -70.0 -23.36 63.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.675 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 94.8 m-20 -103.04 -11.87 17.83 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.208 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -65.9 142.41 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 120.802 0.334 . . . . 0.0 111.772 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HE2' ' A' ' 52' ' ' LYS . 60.7 mt -72.24 168.33 18.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -58.61 -46.36 87.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 111.161 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.19 86.77 0.09 OUTLIER Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 89.7 mmm -149.01 146.1 20.81 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.92 89.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.424 2.75 . . . . 0.0 113.998 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 48.46 44.9 20.83 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.923 1.289 . . . . 0.0 112.099 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 58.8 m -101.85 142.34 33.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.377 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.653 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 29.3 m-85 -130.48 161.47 31.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' HD23 ' A' ' 44' ' ' LEU . 15.3 ptpt -116.28 158.94 22.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.983 0.913 . . . . 0.0 109.165 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 70.6 mt -129.55 133.77 64.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -116.73 123.21 46.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 25' ' ' GLN . 16.6 tp -73.79 136.16 43.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.074 0.464 . . . . 0.0 110.805 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.43 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -84.15 -63.48 1.34 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 18.3 m -104.96 160.77 14.76 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.48 64.95 3.73 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.504 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -114.05 139.59 49.16 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 98.0 mtt180 -128.13 137.91 52.3 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.823 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -122.23 136.65 54.94 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.3 t -124.66 128.06 73.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.653 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 17.1 p90 -137.69 158.3 44.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.8 pt20 -108.53 133.89 52.05 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.86 111.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 70' ' ' LYS . 55.9 mt -91.62 95.38 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -22.96 63.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.764 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.65 -40.12 96.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.193 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.499 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.1 mttm -107.41 -1.97 20.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.1 t 62.96 41.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 122.48 1.134 . . . . 0.0 109.242 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 70' ' ' LYS . 9.9 p -134.84 139.01 48.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.601 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 5' ' ' LEU . 93.9 t -95.57 115.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.59 -1.634 . . . . 0.0 106.59 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.03 111.72 23.26 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -173.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.76 121.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.22 -42.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.045 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -154.38 154.01 32.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.01 143.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.61 -139.83 7.86 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.581 -1.295 . . . . 0.0 112.435 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -107.44 91.22 3.56 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.545 0.688 . . . . 0.0 109.741 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.643 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.347 -179.382 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -63.71 -41.82 98.03 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.183 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 m -67.58 -43.09 81.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.517 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.02 -37.23 81.84 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 123.42 0.45 . . . . 0.0 110.773 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.281 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -91.2 173.42 7.94 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.025 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.51 162.56 13.42 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 6' ' ' ASP . 1.5 tm? -126.77 136.59 52.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 5' ' ' LEU . 38.2 t70 -141.25 154.12 45.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 173.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.79 128.58 56.47 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.473 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -67.69 156.64 36.45 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 123.969 0.793 . . . . 0.0 111.247 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 8.7 pt-20 -52.89 -38.88 62.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.148 0.979 . . . . 0.0 111.359 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 74.3 mtt180 -72.31 -42.06 65.87 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.244 0.545 . . . . 0.0 110.104 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.16 78.55 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.511 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.3 mt -66.92 -37.79 84.99 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 53.9 mttm -62.28 -46.77 87.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.66 -38.74 73.84 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.968 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -60.81 -43.31 98.35 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.546 0.738 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.29 -20.79 58.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -81.51 -24.01 36.94 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 124.673 1.189 . . . . 0.0 109.812 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.45 157.75 35.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.987 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.12 141.86 28.62 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 1.9 p -53.39 -41.96 66.47 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -175.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -40.89 83.93 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.1 -47.25 85.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 120.835 0.35 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -65.48 -34.85 79.24 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.798 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 20' ' ' SER . 35.3 mt-10 -58.35 -38.54 77.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -70.12 -38.41 75.56 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 89.2 mt -64.25 -42.68 96.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.695 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 31' ' ' VAL . 31.5 ttpt -56.66 -44.46 81.4 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 123.302 0.641 . . . . 0.0 110.595 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.19 -42.11 90.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.833 0.349 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.5 mptp? -64.55 -34.68 78.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.182 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.687 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.3 mt -68.44 -43.7 76.53 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 27' ' ' LYS . 92.4 t -60.84 -45.5 97.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.988 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.6 pt-20 -69.29 -43.34 74.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.673 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.3 p -64.0 -29.87 48.49 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.785 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.997 -175.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 90.2 mt -54.38 -25.94 27.3 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.7 pt-20 -77.11 -20.81 55.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.927 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 p -155.27 69.67 5.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HA ' HG22 ' A' ' 33' ' ' VAL . 94.5 Cg_endo -80.13 -9.65 14.0 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 121.823 1.682 . . . . 0.0 112.484 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -89.04 38.7 0.9 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.767 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.19 109.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.557 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.949 0.404 . . . . 0.0 111.703 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -101.44 -2.94 29.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.095 -0.378 . . . . 0.0 112.002 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 21.1 mtpp -70.96 146.28 49.57 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.886 0.374 . . . . 0.0 110.985 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.29 164.09 15.08 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.165 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -91.81 131.08 37.42 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.13 0.572 . . . . 0.0 109.914 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.79 76.58 Favored Glycine 0 CA--C 1.506 -0.506 0 O-C-N 123.505 0.503 . . . . 0.0 113.198 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.437 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 95.9 mmm -126.17 129.99 24.07 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.25 98.9 0.34 Allowed 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.49 2.127 . . . . 0.0 112.859 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 52.51 42.03 31.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.204 1.002 . . . . 0.0 113.022 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 61.9 m -100.26 141.48 33.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.12 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.582 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 45.1 m-85 -134.0 159.6 40.26 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -134.39 140.54 46.37 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.858 177.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.56 144.06 29.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -127.13 140.26 52.38 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 120.907 0.384 . . . . 0.0 111.668 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.0 mt -85.62 115.65 23.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -66.13 -30.53 71.04 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -66.49 -65.1 0.72 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.93 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -89.98 -22.48 21.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.66 64.46 Favored Glycine 0 C--O 1.239 0.455 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.154 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -96.55 144.69 26.38 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.397 0.279 . . . . 0.0 110.403 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -122.2 147.57 46.02 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -131.4 134.36 46.18 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.23 128.55 75.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 C-N-CA 123.188 0.595 . . . . 0.0 110.262 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 7.5 p90 -138.84 158.78 43.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -112.03 137.47 50.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.85 112.81 29.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -95.79 95.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.84 -26.63 65.25 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 0.0 110.661 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.66 -30.26 69.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.424 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.7 mttm -105.47 -6.25 19.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.245 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.42 29.36 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 122.569 1.176 . . . . 0.0 109.089 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.0 p -130.87 139.09 52.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 O-C-N 121.206 -0.934 . . . . 0.0 111.197 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.8 120.85 46.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -109.08 110.6 21.9 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.834 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.3 t -76.56 121.72 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.6 mt -98.35 -42.04 10.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.565 0.698 . . . . 0.0 110.076 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.8 m -142.48 147.46 36.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.224 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.23 142.11 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.0 -115.36 0.71 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.295 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -137.54 149.57 46.84 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 110.577 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.321 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.178 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.217 -0.637 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -91.72 -40.91 10.99 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 m -56.98 -51.18 70.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.963 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.14 -28.91 69.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.107 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.058 -179.313 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.192 0 CA-C-O 121.107 0.479 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -124.64 173.99 8.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -86.72 159.55 19.12 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -124.8 125.9 44.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.69 167.1 22.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.31 141.05 51.55 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' OD2' ' HG3' ' A' ' 10' ' ' ARG . 19.5 t70 -80.23 154.87 27.63 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.14 -29.33 65.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 25.5 mtp-105 -68.37 -48.18 65.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.38 68.44 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.52 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -70.91 -37.46 72.96 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.931 0.396 . . . . 0.0 110.998 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.81 -42.87 90.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.44 -43.13 86.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.948 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -63.2 -41.4 99.16 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.329 1.052 . . . . 0.0 110.795 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.23 -24.61 57.73 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.491 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -67.57 -32.16 72.72 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.12 141.44 58.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.609 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.48 -83.43 0.05 OUTLIER Glycine 0 C--N 1.312 -0.8 0 O-C-N 124.837 1.336 . . . . 0.0 114.392 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 t -163.74 -60.85 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 ' OE1' ' A' ' 25' ' ' GLN . 4.9 m -63.07 -45.37 92.48 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.359 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.41 -47.52 90.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.899 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -68.42 -35.4 77.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.557 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.3 mt-10 -63.6 -42.17 98.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.0 mp0 -62.64 -45.24 93.77 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.131 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 88.9 mt -58.61 -43.15 89.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.422 0.451 . . . . 0.0 111.46 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -58.16 -44.33 87.86 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.295 0.372 . . . . 0.0 110.254 175.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -64.93 -34.68 78.99 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.75 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 13.0 mmmm -67.38 -34.47 77.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.4 mt -68.96 -40.77 78.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.81 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 27' ' ' LYS . 76.6 t -61.11 -45.68 98.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -69.29 -38.17 78.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.036 0.446 . . . . 0.0 111.281 177.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -67.02 -30.34 49.23 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.791 -176.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 mt -53.86 -24.57 16.31 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.1 pt-20 -70.71 -24.96 62.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.318 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 39' ' ' ILE . 43.8 p -162.05 76.04 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 123.152 0.581 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HA ' HG22 ' A' ' 33' ' ' VAL . 73.7 Cg_endo -80.37 -4.97 13.33 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.722 1.615 . . . . 0.0 112.175 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 40.91 1.05 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.89 0.852 . . . . 0.0 111.624 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' SER . 85.0 mt -82.42 93.58 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 43' ' ' LYS . 9.7 pt-20 -55.57 -18.74 8.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.05 1.34 . . . . 0.0 113.993 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.72 74.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.975 0.417 . . . . 0.0 110.97 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -100.77 9.47 42.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.892 0.377 . . . . 0.0 110.625 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 56.9 tttt -80.96 144.33 31.94 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 86.0 mt -79.54 152.53 30.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -63.15 -74.28 0.1 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.44 43.28 1.7 Allowed Glycine 0 CA--C 1.502 -0.756 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.886 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 92.6 mmm -124.57 124.96 25.62 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.91 99.11 0.13 Allowed 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 123.139 2.559 . . . . 0.0 112.809 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.452 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 17.7 m-20 52.75 39.27 28.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.823 1.249 . . . . 0.0 113.395 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 56.0 m -100.09 141.55 32.77 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 47.3 m-85 -131.84 157.77 43.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.13 144.43 51.03 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.29 129.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -106.17 140.09 39.68 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.681 174.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.46 139.4 39.64 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -66.04 -48.7 70.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.24 123.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.8 m 69.51 -173.69 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.004 0.922 . . . . 0.0 111.585 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.35 42.31 1.99 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.46 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -91.38 136.96 32.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -133.99 141.89 47.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.789 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -123.75 138.18 54.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.7 t -123.85 129.59 74.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 18.9 p90 -138.84 159.26 42.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.164 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 4.0 pt20 -119.74 138.08 53.54 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.418 HG22 ' HE1' ' A' ' 51' ' ' TYR . 10.2 m -95.81 121.26 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -99.29 95.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.18 -28.57 67.39 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.673 0.749 . . . . 0.0 109.046 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.21 -38.68 77.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.959 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.6 mttt -107.84 -4.17 18.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.615 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.4 t 61.9 29.46 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 CA-C-O 122.382 1.087 . . . . 0.0 109.868 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.1 p -131.32 141.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 121.008 -1.057 . . . . 0.0 111.214 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.46 121.14 53.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 124.146 0.978 . . . . 0.0 108.588 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -107.78 120.55 42.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -74.86 124.08 31.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -93.65 -42.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 123.464 0.477 . . . . 0.0 110.83 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 t -155.45 150.85 27.09 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.25 132.95 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.237 0.542 . . . . 0.0 110.551 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.14 -111.58 0.48 Allowed Glycine 0 N--CA 1.418 -2.548 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.425 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -132.9 158.07 43.51 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.408 -2.547 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.022 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -84.67 -28.47 26.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 m -69.59 -43.73 72.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -61.15 -36.56 80.13 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.909 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.478 179.178 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -108.84 167.63 9.94 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.73 151.59 35.99 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 34' ' ' LEU . 1.1 tm? -125.83 122.17 35.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -132.83 157.04 46.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.78 140.84 52.56 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.79 155.59 40.26 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -53.56 -38.91 64.32 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.275 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.5 ptm180 -67.14 -38.75 86.07 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.37 -37.4 87.38 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.191 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 mt -67.73 -43.09 80.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.651 0.262 . . . . 0.0 110.852 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.35 -42.02 98.89 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 46.7 mt-10 -69.41 -39.59 77.84 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.833 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -60.69 -41.27 94.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 0.0 110.376 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -73.42 -31.16 63.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.401 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.8 -43.93 82.58 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.821 0.701 . . . . 0.0 109.818 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mp -53.08 153.05 3.76 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.464 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.37 142.06 41.98 Favored Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -54.17 -46.11 72.26 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.875 0.87 . . . . 0.0 113.085 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 m -68.51 -36.29 78.67 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.025 0.441 . . . . 0.0 110.88 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.73 -47.97 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.23 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.369 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -57.23 -43.61 83.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.695 0.225 . . . . 0.0 110.575 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.92 -38.64 86.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 -179.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.7 mt -67.25 -42.69 83.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 176.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -57.09 -43.38 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.036 0.534 . . . . 0.0 110.594 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -56.94 -43.21 81.29 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.397 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 75.3 mmtt -65.48 -38.47 89.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.912 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.4 mt -65.46 -46.94 77.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.57 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.26 -41.37 89.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.401 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -69.9 -37.72 76.08 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.694 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -64.45 -30.22 49.56 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.774 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.404 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.2 mt -54.47 -26.46 31.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.569 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 1.9 pp20? -80.41 -29.63 37.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.382 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -142.87 72.49 19.12 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' HG22 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -73.45 -27.94 12.65 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 121.547 1.498 . . . . 0.0 112.223 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.49 65.95 4.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -103.71 115.08 45.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 11.0 pt-20 -59.81 -28.67 67.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.21 65.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.41 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -107.1 -2.25 21.18 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.029 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 38.5 mtpt -75.42 139.57 42.4 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 92.7 mt -78.19 149.47 33.71 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.677 174.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.38 -65.07 0.75 Allowed 'General case' 0 C--N 1.311 -1.084 0 O-C-N 124.072 0.857 . . . . 0.0 111.945 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.83 61.43 0.36 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.475 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.3 mmm -141.2 140.97 21.96 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.4 95.76 0.53 Allowed 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.984 2.456 . . . . 0.0 112.787 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 48.21 44.64 19.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.764 1.226 . . . . 0.0 112.145 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.5 m -100.8 142.07 32.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.644 ' CE2' ' HG2' ' A' ' 43' ' ' LYS . 25.7 m-85 -130.91 156.47 45.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -126.02 139.51 53.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.426 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.2 mt -111.98 138.89 39.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.84 123.57 38.99 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 -178.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.7 91.37 6.99 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -62.88 -8.69 7.51 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.916 1.686 . . . . 0.0 113.279 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -100.13 -13.06 19.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.765 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -134.78 -36.03 0.86 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.249 -0.981 . . . . 0.0 113.083 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.44 28.92 6.17 Favored Glycine 0 C--O 1.247 0.932 0 C-N-CA 119.415 -1.374 . . . . 0.0 112.007 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.09 146.35 29.26 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -135.1 147.3 49.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.43 133.48 45.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.91 128.73 75.73 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 CA-C-O 121.015 0.436 . . . . 0.0 109.884 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 15.9 p90 -139.14 158.86 43.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.729 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 17.2 pt20 -110.27 138.89 46.04 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.0 t -103.15 112.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.81 94.68 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.35 -34.08 74.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.09 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.22 -35.42 71.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.141 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 98.4 mttt -103.81 -1.1 28.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.277 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p 54.81 40.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.405 1.882 . . . . 0.0 111.821 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.6 p -128.65 138.36 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.814 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -102.46 115.36 44.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -110.23 112.22 24.05 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.5 t -77.06 121.45 29.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.73 -42.32 12.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.133 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -151.01 148.07 27.91 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.042 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.07 141.25 21.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.04 -97.63 0.19 Allowed Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -137.61 144.18 41.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.095 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.94 -43.6 13.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.428 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.0 m -67.4 -29.27 68.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.17 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.15 -50.08 74.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.017 -176.935 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 120.605 0.24 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.84 171.29 7.96 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.03 156.89 18.58 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -126.18 130.09 50.3 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.63 158.11 44.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -119.21 133.83 55.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.67 155.95 39.1 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.167 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.517 ' OE1' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -56.43 -36.85 69.45 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.33 0.394 . . . . 0.0 110.783 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG3' ' OE1' ' A' ' 9' ' ' GLU . 35.8 mtt180 -60.06 -48.93 79.66 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.65 77.23 Favored 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.861 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.9 mt -64.02 -38.66 91.89 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 120.988 0.423 . . . . 0.0 110.753 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -65.11 -43.49 91.85 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.5 mt-10 -69.39 -36.41 76.74 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.181 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.37 -38.41 90.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.021 0.928 . . . . 0.0 109.864 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -75.06 -26.4 59.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 61.4 tttm -72.36 -39.99 67.67 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.785 0.834 . . . . 0.0 109.102 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.36 151.53 43.73 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.54 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.95 147.8 40.34 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.658 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 23.2 m -51.05 -49.83 59.81 Favored 'General case' 0 C--O 1.205 -1.259 0 C-N-CA 123.994 0.918 . . . . 0.0 112.014 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -63.67 -38.55 91.55 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.244 0.545 . . . . 0.0 110.849 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.07 -47.48 81.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.399 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -68.42 -34.77 76.59 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.173 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.658 ' HG3' ' O ' ' A' ' 20' ' ' SER . 70.0 mt-10 -57.53 -42.25 82.52 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.052 0.387 . . . . 0.0 111.32 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.17 -39.35 89.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.7 mt -66.48 -40.92 89.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 31' ' ' VAL . 32.0 ttpt -56.5 -44.62 80.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.137 0.575 . . . . 0.0 110.38 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.62 -39.64 88.95 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.262 0.553 . . . . 0.0 110.234 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 mptp? -65.29 -37.41 87.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.068 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -66.25 -41.44 89.95 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 27' ' ' LYS . 99.5 t -65.26 -44.74 94.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.5 pt-20 -68.75 -44.15 74.36 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.948 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.3 p -62.66 -29.92 48.08 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.228 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 89.9 mt -53.59 -25.56 17.89 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.6 pt-20 -71.46 -27.86 63.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.473 ' O ' HG13 ' A' ' 39' ' ' ILE . 48.2 m -152.6 73.95 7.28 Favored Pre-proline 0 C--O 1.209 -1.046 0 C-N-CA 123.558 0.743 . . . . 0.0 109.167 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.51 ' HA ' HG22 ' A' ' 33' ' ' VAL . 61.2 Cg_endo -74.72 -13.21 22.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.057 1.838 . . . . 0.0 112.622 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -87.51 41.45 0.98 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.427 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' SER . 91.9 mt -80.61 98.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.75 -19.32 10.75 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.738 1.615 . . . . 0.0 114.288 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.4 -25.86 65.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.594 0.711 . . . . 0.0 109.912 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.67 -1.75 39.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.811 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.9 142.07 49.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-O 121.201 0.524 . . . . 0.0 110.658 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.6 176.61 9.55 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.816 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -110.09 120.02 41.14 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.022 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.28 54.37 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.126 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.53 131.54 23.41 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -47.02 -59.06 1.39 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 124.401 3.401 . . . . 0.0 114.256 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.679 ' OD1' ' HB ' ' A' ' 66' ' ' VAL . 7.7 t70 -154.66 83.65 1.1 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.1 m -139.47 141.77 37.39 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.7 m-85 -138.23 153.78 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.3 pttt -126.18 139.43 53.36 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.2 mt -111.68 130.88 64.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 145.28 29.98 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 58' ' ' SER . 3.0 tt -88.78 143.08 27.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -93.48 -42.56 9.18 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.217 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 m -89.32 5.08 46.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' ' 55' ' ' LEU . 20.7 m -152.89 138.3 17.6 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.39 73.04 2.07 Favored Glycine 0 C--N 1.314 -0.673 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.533 -175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -135.23 156.45 48.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' N ' ' HD2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -144.82 149.48 35.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -119.88 133.37 55.6 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.95 126.42 70.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.2 p90 -136.4 158.94 43.24 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -113.51 140.03 48.46 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.679 ' HB ' ' OD1' ' A' ' 49' ' ' ASP . 81.7 t -99.59 113.03 33.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.748 0.785 . . . . 0.0 109.849 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.69 94.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.25 -27.9 65.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.866 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.08 -37.34 76.86 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.037 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.3 mttt -107.78 -1.76 20.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.149 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t 62.32 35.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.638 1.209 . . . . 0.0 109.69 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 70' ' ' LYS . 11.3 p -133.3 138.7 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.96 121.76 49.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.26 115.48 29.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -173.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.5 t -80.85 121.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 90' ' ' ALA . 21.7 mt -97.66 -42.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 123.585 0.553 . . . . 0.0 110.909 -174.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 p -145.56 149.68 35.03 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.108 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.04 127.19 2.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.261 0.553 . . . . 0.0 112.112 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.78 -123.31 1.28 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 119.141 -1.504 . . . . 0.0 112.936 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -113.74 157.1 22.66 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 -175.593 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.95 -44.64 15.08 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.1 t -58.81 -49.44 77.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.52 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 10' ' ' ARG . 14.3 tp10 -62.04 -29.77 70.51 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 110.667 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.898 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -121.3 160.66 23.5 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -80.35 160.31 25.47 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.08 131.56 52.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.76 155.8 43.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -120.05 137.06 54.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.729 0.411 . . . . 0.0 111.19 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.54 154.8 31.39 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 170.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 6.8 pt-20 -53.55 -41.89 66.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.117 0.417 . . . . 0.0 111.934 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 90.0 mtt180 -72.25 -37.77 69.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.627 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.36 75.83 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.5 tp -73.47 -34.16 65.22 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.799 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 87.6 mttt -66.15 -44.41 84.2 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -67.43 -38.73 84.99 Favored 'General case' 0 C--O 1.199 -1.598 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.459 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -60.26 -40.25 89.65 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.604 0.762 . . . . 0.0 111.469 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -74.21 -33.94 63.55 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.601 0.715 . . . . 0.0 110.917 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.02 -19.41 58.68 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.29 162.5 29.38 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.317 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.08 152.58 43.96 Favored Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.897 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -53.58 -54.05 42.93 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 125.033 1.333 . . . . 0.0 112.248 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 m -63.1 -34.67 78.09 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.301 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.15 -48.18 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.756 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -63.35 -40.52 97.52 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.509 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.8 mt-10 -61.43 -43.6 98.59 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -69.84 -43.27 72.29 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.546 178.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.8 mt -58.81 -40.79 85.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 117.612 0.187 . . . . 0.0 110.92 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.3 ttpt -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 123.59 0.557 . . . . 0.0 110.07 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.1 mttt -63.09 -38.07 89.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 28.7 mmmt -66.82 -35.1 79.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.668 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 88.9 mt -68.87 -43.6 75.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 27' ' ' LYS . 53.9 t -60.54 -44.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.831 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 9.7 pt-20 -69.07 -44.76 71.9 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.79 -29.64 47.53 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.343 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.54 -26.65 22.12 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.5 pt-20 -79.09 -24.76 43.25 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.387 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -148.66 69.3 10.19 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.2 -11.29 9.8 Favored 'Trans proline' 0 C--O 1.209 -0.939 0 C-N-CA 121.542 1.495 . . . . 0.0 111.799 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.48 39.22 0.72 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -82.94 107.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.33 -24.35 67.28 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.61 67.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.888 0.375 . . . . 0.0 111.677 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 90.6 m-20 -97.66 -0.4 45.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.553 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 50' ' ' CYS . 10.0 mtpm? -73.95 138.57 44.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.197 0.522 . . . . 0.0 111.402 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 67.6 mt -82.43 141.77 32.48 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -68.61 -42.53 77.99 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.03 18.56 57.3 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.435 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.518 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 83.8 mmm -130.71 145.68 58.65 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.88 -74.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.942 1.761 . . . . 0.0 114.722 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.14 36.8 4.21 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 40.0 m -100.32 141.24 33.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.507 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 29.6 m-85 -132.86 156.89 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.23 142.44 50.85 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.251 0.548 . . . . 0.0 111.025 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.91 144.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -120.17 126.43 50.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.432 HD12 ' HG ' ' A' ' 26' ' ' LEU . 2.1 tt -99.04 90.39 4.6 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -75.62 95.03 3.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.826 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . 35.9 t 171.61 -39.75 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.869 1.667 . . . . 0.0 107.298 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 p -125.37 -17.04 5.72 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.24 9.86 61.51 Favored Glycine 0 C--O 1.241 0.579 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.15 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.89 148.97 25.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.123 0.487 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -125.25 151.84 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.85 125.36 29.82 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.15 126.94 70.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.217 0.532 . . . . 0.0 109.955 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -139.22 159.71 41.51 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.952 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.417 HE21 HG12 ' A' ' 67' ' ' ILE . 11.0 pt20 -114.08 141.24 47.71 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 170.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -91.21 114.23 28.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 HE21 ' A' ' 65' ' ' GLN . 22.7 mt -99.95 95.15 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.84 -33.17 73.37 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.79 0.329 . . . . 0.0 110.581 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.54 -33.71 70.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.982 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.2 mttt -104.09 -6.7 20.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.204 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t 63.01 32.26 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.31 0 C-N-CA 124.449 1.1 . . . . 0.0 109.671 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.6 p -131.58 138.83 52.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 111.065 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.1 t -96.37 115.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -106.07 111.78 24.55 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.981 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.33 121.9 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.6 mt -95.08 -40.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.258 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -155.75 151.95 27.93 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -149.44 147.03 16.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.6 -151.4 23.59 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.259 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -89.75 137.58 32.21 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.506 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.088 -175.207 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -74.38 -45.3 47.73 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 m -64.82 -40.0 94.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -65.14 -47.33 77.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -115.89 163.91 15.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.21 161.72 17.87 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.89 123.17 36.64 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.89 169.18 17.48 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.8 136.9 47.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.08 155.65 16.63 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 7.3 pt-20 -52.6 -41.93 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.317 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -63.87 -48.16 77.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.23 0.538 . . . . 0.0 111.055 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.6 71.55 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.051 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 9' ' ' GLU . 1.1 mptm? -65.06 -42.09 94.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.77 -35.74 77.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.672 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -60.56 -38.0 83.12 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 110.121 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.38 -35.03 65.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.666 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.38 -32.89 74.69 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.325 1.05 . . . . 0.0 110.71 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.25 147.61 52.04 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.272 0.558 . . . . 0.0 112.495 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.24 147.92 41.69 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.505 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 11.9 p -51.04 -54.93 20.26 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 124.334 1.053 . . . . 0.0 112.839 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -59.08 -40.39 85.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.039 0.535 . . . . 0.0 111.402 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.14 -47.06 80.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.016 0.436 . . . . 0.0 109.885 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -67.61 -34.96 78.05 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 46.8 mt-10 -58.57 -45.73 88.39 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 117.781 0.264 . . . . 0.0 111.435 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.89 -35.23 78.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.76 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 81.7 mt -65.34 -41.76 93.58 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.214 174.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -59.29 -43.18 92.6 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.1 mttm -59.24 -42.7 91.73 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.208 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -64.33 -41.06 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.166 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 91.8 mt -64.3 -47.18 80.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 28' ' ' LYS . 9.1 p -67.24 -36.48 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.579 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -69.46 -45.72 68.37 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.877 175.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -62.37 -29.65 47.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 C-N-CA 123.229 0.612 . . . . 0.0 112.393 -174.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.41 -24.93 13.83 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.4 pt-20 -68.23 -31.44 70.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 111.049 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.2 m -157.57 77.58 3.73 Favored Pre-proline 0 C--O 1.208 -1.127 0 C-N-CA 123.356 0.663 . . . . 0.0 110.056 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.0 Cg_endo -80.96 -0.12 10.39 Favored 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 121.771 1.647 . . . . 0.0 112.08 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 27.63 1.08 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.517 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.89 103.55 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 12.0 pt-20 -66.02 -15.68 63.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.75 -26.21 68.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.232 0.539 . . . . 0.0 109.987 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -103.86 8.51 37.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.848 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.684 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 2.6 tttm -72.25 148.29 45.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.465 0.65 . . . . 0.0 112.522 -177.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 81.2 mt -91.47 127.25 36.84 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.74 -1.118 . . . . 0.0 107.993 171.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -81.11 128.76 34.09 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 122.953 0.501 . . . . 0.0 110.591 -177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.52 11.26 66.55 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.4 mmm -123.61 140.91 35.19 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.87 101.62 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.496 1.464 . . . . 0.0 111.911 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 47.54 54.99 8.93 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.169 1.387 . . . . 0.0 113.911 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -113.24 141.7 46.67 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 38.0 m-85 -136.61 160.22 39.45 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HD2' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.76 140.27 47.97 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.789 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -110.57 140.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.504 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -126.74 133.36 50.89 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.022 0.439 . . . . 0.0 109.917 -177.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.09 135.79 33.69 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -106.76 -15.6 14.7 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.811 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -78.07 -27.93 48.69 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.346 0.593 . . . . 0.0 109.632 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -144.11 140.35 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.62 74.62 0.9 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.815 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -124.14 141.27 52.2 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.883 0.473 . . . . 0.0 110.333 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -126.43 149.38 49.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 tt -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.8 t -116.27 129.14 73.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.5 p90 -138.64 158.77 43.62 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.59 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -109.24 140.92 42.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.21 112.18 29.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 mt -91.3 95.87 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.61 -30.5 71.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.817 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.77 -39.91 90.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.394 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.6 mttt -107.46 -5.0 17.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.2 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.2 t 60.54 41.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 123.067 1.413 . . . . 0.0 109.537 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -135.79 138.93 47.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.359 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -94.22 115.35 32.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -107.19 110.42 22.48 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.197 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.1 123.41 27.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.0 mt -89.99 -42.26 14.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.57 0.7 . . . . 0.0 109.664 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -154.68 149.91 27.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.93 134.44 18.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.59 -147.75 18.38 Favored Glycine 0 C--N 1.3 -1.419 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.21 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -93.1 141.54 28.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 117.226 0.513 . . . . 0.0 110.315 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.542 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.376 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 121.003 0.43 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.33 -40.63 11.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.41 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 p -63.04 -42.15 99.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.591 0.71 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.24 -34.24 77.9 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.678 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.374 -178.679 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.71 141.44 51.16 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.048 0.452 . . . . 0.0 110.002 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.17 172.47 6.79 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -94.87 164.84 12.75 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' A' ' 73' ' ' VAL . 0.3 OUTLIER -125.72 132.29 52.4 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -135.7 160.43 38.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.01 141.86 49.39 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 122.776 0.43 . . . . 0.0 110.604 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -76.86 150.22 36.08 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.95 -28.92 70.15 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.32 -41.62 66.33 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -37.33 85.52 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.713 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.56 -37.77 87.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.9 -44.31 90.0 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.51 -38.76 77.74 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.16 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -60.47 -46.72 89.05 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 124.136 0.974 . . . . 0.0 110.951 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.86 -21.17 59.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.229 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -77.31 -34.88 55.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.4 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.53 150.52 18.78 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.09 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 140.36 48.04 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.6 m -50.01 -52.33 34.91 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.175 0.99 . . . . 0.0 112.083 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.0 m -68.7 -29.99 68.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 HD12 ' A' ' 55' ' ' LEU . 97.2 t -72.32 -49.1 44.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.521 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -68.84 -35.11 76.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.946 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 9.6 mm-40 -57.14 -46.8 82.38 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 116.858 -0.156 . . . . 0.0 111.346 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -70.33 -37.09 74.61 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.791 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 79.4 mt -63.99 -41.33 97.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 31' ' ' VAL . 34.3 ttpt -60.09 -44.32 94.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.48 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 92.9 mttt -64.06 -35.45 80.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.632 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.4 mmtt -64.06 -39.61 94.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.592 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -63.65 -42.87 98.05 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 123.653 0.596 . . . . 0.0 109.558 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 27' ' ' LYS . 69.9 t -63.45 -45.96 96.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.537 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.7 pt-20 -69.76 -39.37 76.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.98 -29.89 48.3 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.73 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.724 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.2 mt -53.32 -24.44 11.82 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.6 pt-20 -66.07 -27.36 68.02 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.149 0.5 . . . . 0.0 110.699 177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.545 ' O ' HG13 ' A' ' 39' ' ' ILE . 12.3 t -160.16 77.92 2.66 Favored Pre-proline 0 C--O 1.205 -1.253 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.32 -25.41 49.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.988 1.792 . . . . 0.0 112.785 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -87.3 60.74 6.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 122.284 1.04 . . . . 0.0 113.122 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 36' ' ' SER . 85.5 mt -89.96 115.93 30.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.606 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.59 -30.88 61.64 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 123.732 0.813 . . . . 0.0 112.493 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -18.33 61.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.967 0.413 . . . . 0.0 111.59 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.554 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.3 m-20 -103.16 -16.02 15.85 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -63.19 145.75 54.82 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.603 0.761 . . . . 0.0 112.559 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 91.9 mt -96.75 123.78 40.54 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 169.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -87.25 130.87 34.41 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.18 -34.01 6.06 Favored Glycine 0 C--N 1.306 -1.12 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 94.5 mmm -86.37 125.5 67.52 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -35.84 -66.56 0.11 Allowed 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 124.733 3.622 . . . . 0.0 114.029 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 55.54 0.98 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.75 142.3 34.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 21.2 m-85 -135.04 152.19 51.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.29 139.96 53.25 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.103 178.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.6 mt -122.89 132.69 70.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -113.37 149.98 33.29 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.907 0.384 . . . . 0.0 111.961 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.49 HD12 HG13 ' A' ' 22' ' ' VAL . 15.4 mt -94.47 136.66 34.52 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -62.09 -32.21 72.74 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 112.773 -2.012 . . . . 0.0 111.462 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -71.68 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p -102.45 2.21 36.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.56 46.04 9.11 Favored Glycine 0 C--N 1.32 -0.319 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.86 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -97.25 145.45 26.07 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 54' ' ' LYS . 5.6 mpt_? -120.98 149.59 42.42 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.88 130.88 45.75 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.12 122.84 70.24 Favored 'Isoleucine or valine' 0 C--O 1.251 1.155 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 25.9 p90 -132.75 159.35 39.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.668 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.6 138.43 48.15 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.31 111.62 25.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.24 95.81 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.22 -31.0 71.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.133 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.0 -40.27 76.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.377 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HB2' HG12 ' A' ' 72' ' ' VAL . 53.1 mttm -107.65 -6.74 16.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.714 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t 65.83 33.01 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 122.881 1.324 . . . . 0.0 110.066 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.597 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.2 p -133.8 140.22 46.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 O-C-N 121.35 -0.844 . . . . 0.0 110.353 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.451 ' HB ' HD22 ' A' ' 5' ' ' LEU . 91.2 t -96.69 117.98 42.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -108.22 117.94 35.46 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.501 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -77.45 121.08 29.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.72 -41.89 13.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.573 0.701 . . . . 0.0 109.119 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -148.79 153.37 38.04 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.0 p -148.85 138.99 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.89 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.88 -114.8 0.64 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.38 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.572 ' HB3' ' OE1' ' A' ' 82' ' ' GLU . 63.0 mtpt -127.82 155.73 43.64 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.6 6.07 4.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' OE1' ' HB3' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -78.81 -15.54 58.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 122.064 -0.398 . . . . 0.0 111.917 -177.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.17 -2.79 30.45 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.314 0.578 . . . . 0.0 109.502 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m 63.73 15.19 8.81 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.844 1.258 . . . . 0.0 113.813 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.79 -28.7 68.6 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.162 0.585 . . . . 0.0 112.22 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.0 m -72.72 -21.26 19.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.227 0.537 . . . . 0.0 111.303 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -81.17 -24.34 37.61 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.55 -35.49 80.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.958 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -72.04 -50.44 28.4 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.158 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -55.35 -51.5 66.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.782 . . . . 0.0 113.05 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.79 -37.91 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -77.06 -24.53 51.96 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -77.71 -28.45 50.91 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.66 -177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 90' ' ' ALA . 43.7 mm -80.38 79.35 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.976 0 CA-C-O 121.166 0.507 . . . . 0.0 111.682 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.425 -1.713 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 172.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.78 163.51 32.0 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -117.15 172.93 6.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.43 160.57 17.49 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.3 128.9 47.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -142.59 169.11 18.19 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -129.63 141.68 50.89 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.083 0.553 . . . . 0.0 110.178 -175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -71.59 154.9 41.1 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 4.6 pt-20 -61.31 -31.91 71.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.424 0.556 . . . . 0.0 110.634 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 75.3 mtt180 -63.81 -42.59 97.65 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.11 -36.6 82.27 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.89 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.4 mt -63.8 -43.13 97.19 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.657 0.265 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -61.25 -43.73 98.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.368 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.21 -39.71 78.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.923 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -62.55 -43.73 98.08 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -75.58 -20.93 58.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.341 0.591 . . . . 0.0 110.893 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -74.54 -35.47 63.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.405 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD11 ' HA2' ' A' ' 79' ' ' GLY . 3.3 mp -62.59 156.95 21.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.376 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.33 149.85 47.71 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 22.8 t -57.86 -49.05 78.01 Favored 'General case' 0 C--O 1.205 -1.251 0 C-N-CA 122.555 0.342 . . . . 0.0 111.812 -175.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.462 HG22 ' OE1' ' A' ' 25' ' ' GLN . 15.6 m -68.53 -38.19 80.65 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.38 -47.13 94.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.274 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -67.37 -35.29 79.05 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.333 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 20' ' ' SER . 44.5 mt-10 -63.51 -39.51 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' OE1' HG22 ' A' ' 21' ' ' THR . 2.0 mp0 -63.75 -41.29 98.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.401 174.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 93.0 mt -62.44 -41.98 99.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.06 -42.28 89.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 99.5 mttt -59.54 -36.98 77.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.678 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 53' ' ' ILE . 5.6 mptp? -69.0 -37.89 78.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.32 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.6 mt -62.51 -47.53 83.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.973 0.416 . . . . 0.0 110.573 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.44 -41.08 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.319 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 13.1 pt-20 -69.65 -44.0 71.45 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.708 0.29 . . . . 0.0 111.709 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.7 -29.67 47.54 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.5 mt -53.05 -25.3 12.07 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.7 pt-20 -68.77 -26.81 65.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.122 0.419 . . . . 0.0 110.924 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -162.55 80.21 1.78 Allowed Pre-proline 0 C--O 1.212 -0.884 0 C-N-CA 123.138 0.575 . . . . 0.0 109.504 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -82.62 5.75 6.2 Favored 'Trans proline' 0 C--O 1.218 -0.48 0 C-N-CA 122.139 1.893 . . . . 0.0 112.662 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 36.15 0.87 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.328 0.585 . . . . 0.0 111.614 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.8 mt -81.89 105.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.33 -32.12 62.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.833 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.99 72.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.382 0.61 . . . . 0.0 110.929 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -94.17 -2.5 52.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.016 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -78.22 138.35 38.6 Favored 'General case' 0 N--CA 1.4 -2.948 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.09 155.55 21.45 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.666 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -87.12 122.66 31.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.4 83.68 Favored Glycine 0 CA--C 1.501 -0.841 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.58 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.6 mmm -111.15 131.44 22.2 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.18 95.13 0.17 Allowed 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 122.804 2.336 . . . . 0.0 112.362 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 48.16 45.99 19.7 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.696 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -102.58 141.29 35.64 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 58.4 m-85 -133.66 150.98 51.56 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 55.2 pttt -118.98 144.86 46.25 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.134 0.492 . . . . 0.0 110.569 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 29' ' ' LYS . 82.0 mt -109.39 132.9 56.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -102.93 137.75 40.71 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 124.06 0.85 . . . . 0.0 109.255 173.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 55' ' ' LEU . 4.2 tt -88.9 -11.75 43.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 74.27 -62.27 0.47 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.502 1.521 . . . . 0.0 111.29 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -75.59 -59.77 2.6 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -68.61 -25.9 65.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 20.55 49.16 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.197 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -98.75 149.19 23.1 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 120.837 0.351 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 mpt_? -131.51 144.22 50.96 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.812 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -127.01 127.72 45.23 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.33 123.17 69.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-O 121.073 0.463 . . . . 0.0 110.009 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.1 p90 -133.57 159.51 40.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.497 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 4.2 pt20 -111.89 140.82 46.23 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 174.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.47 111.46 25.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.1 mt -97.8 95.45 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.07 -29.23 63.92 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.416 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.58 -40.55 87.75 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.909 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.5 mttm -98.37 -7.15 29.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.334 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t 64.87 36.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 122.775 1.274 . . . . 0.0 109.237 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 70' ' ' LYS . 11.3 p -134.22 138.72 49.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.71 115.34 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -111.34 112.82 24.85 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.03 124.96 33.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.1 mt -98.03 -41.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.461 0.648 . . . . 0.0 110.095 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.1 m -148.11 151.55 35.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.219 -176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.43 147.57 16.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' HD11 ' A' ' 18' ' ' LEU . . . 146.92 -124.23 1.93 Allowed Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -123.09 167.67 13.36 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.58 31.78 5.63 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.495 0.664 . . . . 0.0 109.306 -175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.73 -40.61 95.62 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.695 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.22 15.63 15.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.6 m 66.1 22.6 11.1 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.508 1.123 . . . . 0.0 110.76 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -58.86 -41.45 87.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.92 0.888 . . . . 0.0 112.672 -174.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.01 -24.3 32.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.402 ' O ' HG12 ' A' ' 91' ' ' VAL . 57.2 m-85 -82.87 -41.57 18.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -58.79 -43.67 90.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.834 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -64.21 -49.86 70.32 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.861 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -51.19 68.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.275 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 87' ' ' TYR . 11.3 p -66.65 -32.32 57.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 7.5 mmpt? -77.41 -15.37 59.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -79.9 -34.92 38.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.4 mt -83.31 -34.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.081 -176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.464 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.504 -0.798 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.3 165.5 13.76 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -134.43 167.23 21.14 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.45 157.77 24.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -125.69 122.56 36.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -140.41 169.34 17.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -129.89 147.9 51.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.69 154.46 38.83 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 170.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -32.53 72.51 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.452 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 57.5 mtp180 -72.8 -34.21 66.75 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.716 0.293 . . . . 0.0 111.034 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.65 -35.04 79.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 mt -66.99 -43.54 82.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.924 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 89.2 mttt -59.49 -44.59 93.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.269 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 16.7 mm-40 -69.5 -37.67 77.29 Favored 'General case' 0 C--O 1.202 -1.406 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.5 -42.5 96.47 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 110.132 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.86 -24.11 58.52 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.096 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -78.3 -29.64 47.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.375 1.07 . . . . 0.0 111.175 177.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mp -63.67 161.11 15.55 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.71 0.804 . . . . 0.0 111.322 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.77 145.37 33.83 Favored Glycine 0 N--CA 1.422 -2.293 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -46.6 64.95 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.149 0.98 . . . . 0.0 111.287 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.1 m -62.43 -46.54 88.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.173 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -47.29 85.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.713 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.5 ptt180 -67.01 -35.04 79.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.077 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 35.4 mt-10 -59.71 -39.12 83.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.072 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.07 -39.32 79.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.831 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.3 mt -63.04 -43.83 97.59 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.684 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 27' ' ' LYS . 19.4 ptmt -64.22 -34.04 77.18 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.1 mttm -58.79 -43.87 90.58 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.8 mptp? -66.62 -34.69 78.44 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.8 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 82.1 mt -61.82 -47.96 82.75 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.576 0.547 . . . . 0.0 110.491 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.22 -40.92 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -68.76 -42.91 76.84 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.99 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -176.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 65.4 mt -54.78 -26.35 33.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 pt-20 -79.16 -18.76 52.53 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.492 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.9 m -157.47 67.47 3.92 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 123.027 0.531 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.82 -0.34 10.11 Favored 'Trans proline' 0 C--O 1.211 -0.847 0 C-N-CA 122.112 1.875 . . . . 0.0 114.218 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 25.75 0.23 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -82.31 100.33 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.642 0.734 . . . . 0.0 110.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.93 -20.42 57.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.738 -1.119 . . . . 0.0 113.626 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.76 64.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.431 0.634 . . . . 0.0 110.813 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -104.27 -1.22 27.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.364 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -84.22 138.88 32.72 Favored 'General case' 0 N--CA 1.404 -2.73 0 CA-C-O 121.357 0.598 . . . . 0.0 112.009 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -91.49 124.55 35.75 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.869 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -86.93 120.41 28.17 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.859 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.43 -0.92 46.37 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 87.9 mmm -117.58 131.42 24.09 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.03 94.4 0.16 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.773 2.316 . . . . 0.0 112.937 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 45.57 50.05 10.64 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 125.117 1.367 . . . . 0.0 113.532 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 59.2 m -100.28 142.01 32.34 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.428 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 59.3 m-85 -133.28 154.99 50.2 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -126.15 147.44 49.62 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.893 0.854 . . . . 0.0 112.653 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 78.5 mt -109.19 141.57 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.35 138.41 41.6 Favored 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 123.213 0.32 . . . . 0.0 110.3 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 55' ' ' LEU . 13.0 mt -79.73 161.94 25.47 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.967 0.413 . . . . 0.0 111.139 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 -99.46 -40.91 7.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 t -88.78 0.22 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -152.57 163.7 39.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.21 29.82 10.62 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.022 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -83.02 136.56 34.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.088 0.471 . . . . 0.0 110.99 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.3 mpt_? -128.31 149.63 50.42 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.112 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -129.9 125.15 34.88 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.07 127.65 72.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 16.8 p90 -136.01 158.62 43.97 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.271 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HB3' HD11 ' A' ' 76' ' ' ILE . 4.1 pt20 -112.81 139.6 48.3 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.4 t -93.22 111.7 25.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.69 95.44 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -72.13 -30.95 65.55 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.074 -174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.65 -32.51 71.22 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.114 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -100.02 -3.26 32.47 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.334 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t 64.24 25.1 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.603 0 CA-C-O 122.451 1.119 . . . . 0.0 110.403 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.55 138.83 52.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 120.985 -1.072 . . . . 0.0 111.281 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.2 t -97.96 117.37 42.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -107.57 114.56 28.63 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.351 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.96 121.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 65' ' ' GLN . 57.8 mt -95.84 -42.86 12.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.406 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 m -150.41 150.34 31.24 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.116 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -148.2 136.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.64 -130.6 2.36 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 85' ' ' GLU . 32.6 mtmm -113.55 165.9 12.04 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 117.505 0.652 . . . . 0.0 111.01 -176.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.17 70.55 1.41 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -40.18 64.23 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.753 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.77 -67.13 0.32 Allowed 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.5 m -151.53 26.32 0.67 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 80' ' ' LYS . 29.2 tt0 -56.27 -51.91 66.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -82.37 -9.94 11.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -85.22 -47.33 10.2 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.056 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.7 p -66.57 -36.44 82.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.438 0.637 . . . . 0.0 109.99 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.57 -44.64 86.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.461 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 94' ' ' ILE . . . -63.02 -56.24 18.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.589 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.446 HG13 ' HD2' ' A' ' 92' ' ' LYS . 9.4 p -60.95 -35.82 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.446 ' HD2' HG13 ' A' ' 91' ' ' VAL . 13.5 mptt -76.56 -15.25 59.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.914 -0.491 . . . . 0.0 112.105 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -89.03 -28.29 20.27 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.059 -0.401 . . . . 0.0 110.248 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 90' ' ' ALA . 57.0 mt -82.67 -52.12 13.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.834 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--O 1.252 1.192 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.746 -179.395 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.31 135.54 33.41 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.146 0.498 . . . . 0.0 110.948 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.11 169.87 9.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.687 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -92.88 162.1 14.22 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -126.53 125.12 41.49 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -130.27 151.61 50.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -119.21 135.48 54.66 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.642 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 18.0 t70 -71.45 154.09 41.77 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 172.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -58.83 -32.48 69.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 118.304 0.502 . . . . 0.0 112.164 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.642 ' HG2' ' OD1' ' A' ' 8' ' ' ASP . 7.7 ptm180 -62.64 -39.22 93.18 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.194 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 -38.61 84.23 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.079 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.25 -43.5 97.83 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 122.579 0.351 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -63.01 -43.99 97.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.989 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.4 mm-40 -69.38 -37.17 77.44 Favored 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.05 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -60.62 -42.72 97.43 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 124.419 1.088 . . . . 0.0 110.224 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -74.63 -23.68 58.73 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.693 0.759 . . . . 0.0 110.194 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 85.4 tttt -74.44 -21.57 59.54 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.9 1.28 . . . . 0.0 109.864 177.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -76.75 165.26 24.96 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.386 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.13 154.16 40.58 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 p -55.21 -46.72 75.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 12.0 m -69.52 -42.45 74.65 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 110.118 -0.326 . . . . 0.0 110.118 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.39 -47.89 91.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.355 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 24' ' ' GLU . 9.8 ptt180 -63.29 -41.44 98.97 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 23' ' ' ARG 0.324 42.6 mt-10 -67.84 -33.63 75.15 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 21' ' ' THR . 30.4 mm-40 -60.05 -44.43 94.69 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -66.93 -41.51 86.9 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.323 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 27' ' ' LYS . 33.3 ttpt -56.99 -43.59 81.87 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.713 0.805 . . . . 0.0 109.88 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -58.95 -41.82 88.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.565 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -66.18 -38.31 87.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.545 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 86.5 mt -64.7 -47.31 78.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.534 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.9 p -64.42 -40.87 90.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.377 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.5 pt-20 -69.73 -42.88 73.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.78 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.43 -30.99 51.2 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 C-N-CA 122.392 0.277 . . . . 0.0 111.201 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 73.4 mt -54.5 -26.36 31.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 10.9 pt-20 -67.58 -26.52 66.32 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.658 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p -162.9 77.66 1.85 Allowed Pre-proline 0 N--CA 1.436 -1.132 0 C-N-CA 122.685 0.394 . . . . 0.0 111.483 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.11 12.12 1.59 Allowed 'Trans proline' 0 C--O 1.209 -0.937 0 C-N-CA 122.891 2.394 . . . . 0.0 113.554 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.52 28.16 0.78 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 124.075 0.95 . . . . 0.0 111.836 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 90.9 mt -82.7 94.02 2.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.771 0.796 . . . . 0.0 110.119 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -58.25 -23.29 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.041 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.97 66.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.129 0.49 . . . . 0.0 110.772 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.17 -8.09 18.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.319 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -75.71 136.53 40.35 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.482 0.658 . . . . 0.0 112.658 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.508 HD21 ' HD3' ' A' ' 52' ' ' LYS . 92.1 mt -81.44 139.45 35.23 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.662 -1.153 . . . . 0.0 109.793 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -92.03 121.31 33.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.75 16.35 58.4 Favored Glycine 0 C--N 1.314 -0.646 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.991 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 81.3 mmm -126.26 131.32 23.91 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.43 90.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.228 2.618 . . . . 0.0 113.419 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 49.55 44.61 24.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.911 1.684 . . . . 0.0 112.629 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.1 m -100.18 142.74 31.25 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.571 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 22.4 m-85 -129.74 152.85 48.79 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HD3' HD21 ' A' ' 44' ' ' LEU . 55.6 pttt -125.93 139.82 53.14 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.574 0.546 . . . . 0.0 109.569 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.18 144.71 34.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -123.26 140.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.0 tt -83.08 137.22 34.18 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -74.34 -57.35 4.0 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 t -61.37 -63.84 1.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.592 0.557 . . . . 0.0 110.709 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 5.5 p -103.86 122.94 46.18 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.5 73.6 0.76 Allowed Glycine 0 N--CA 1.446 -0.67 0 O-C-N 123.837 0.71 . . . . 0.0 114.537 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.67 144.53 36.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -125.52 150.68 47.2 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.75 133.15 39.59 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.01 127.66 75.97 Favored 'Isoleucine or valine' 0 C--O 1.255 1.362 0 C-N-CA 123.169 0.588 . . . . 0.0 109.431 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 12.9 p90 -138.32 158.63 43.91 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.7 pt20 -109.55 141.0 42.67 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.7 112.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.47 94.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.38 -25.22 62.27 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.617 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -60.09 -41.25 92.09 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.134 0.897 . . . . 0.0 110.142 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -105.72 -3.43 22.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.155 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t 65.19 34.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 CA-C-O 122.66 1.219 . . . . 0.0 109.437 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.8 p -132.91 138.93 50.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.8 t -99.37 122.93 51.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -110.23 110.58 21.47 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.353 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.15 127.74 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.509 HG21 ' HA ' ' A' ' 90' ' ' ALA . 19.6 mt -110.73 -42.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.954 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -133.75 140.38 46.94 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.72 135.89 12.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.38 -146.5 18.12 Favored Glycine 0 CA--C 1.49 -1.471 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -95.25 140.17 30.53 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.532 0.666 . . . . 0.0 109.358 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.71 101.3 9.94 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -113.3 -34.19 5.71 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.368 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.08 8.84 32.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.5 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 66.49 25.39 10.16 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.967 1.365 . . . . 0.0 109.847 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -69.04 -37.4 78.57 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 112.67 -2.059 . . . . 0.0 110.791 -176.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m -58.37 -26.56 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -77.42 -50.45 12.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -62.34 -42.91 99.77 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.294 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 85' ' ' GLU . 51.1 mt-10 -66.09 -30.49 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 110.381 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.509 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . -71.88 -53.34 13.48 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.909 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 p -63.13 -36.59 76.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.879 0.371 . . . . 0.0 111.407 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -76.59 -10.85 59.68 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -86.26 -32.64 21.01 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.42 -49.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.817 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.488 -179.109 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptm . . . . . 0 CA--C 1.505 -0.784 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.97 151.08 20.67 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.05 159.64 15.34 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -81.13 160.58 24.38 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 34' ' ' LEU . 1.1 tm? -125.68 127.95 47.04 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -138.92 155.16 48.28 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.6 143.15 45.97 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.79 0.329 . . . . 0.0 110.661 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.73 156.36 32.52 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.6 pt-20 -53.51 -37.14 62.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.913 0.485 . . . . 0.0 110.975 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -70.43 -44.79 67.15 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.79 70.25 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.613 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.08 -36.92 75.29 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 120.787 0.327 . . . . 0.0 111.681 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 57.3 mttm -67.98 -43.86 77.98 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -67.56 -39.32 84.94 Favored 'General case' 0 C--O 1.205 -1.289 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.761 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -60.9 -38.5 85.93 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 123.842 0.857 . . . . 0.0 109.999 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -73.15 -37.81 66.46 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.655 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -74.88 -16.34 60.68 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.721 0.772 . . . . 0.0 111.131 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 149.63 38.27 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.486 175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.14 139.35 42.26 Favored Glycine 0 N--CA 1.423 -2.227 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 176.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 16.4 m -50.97 -46.48 61.24 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.918 0.887 . . . . 0.0 111.227 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 43.2 m -62.88 -43.22 99.37 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.06 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.0 t -68.21 -47.09 79.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.731 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.9 ptt180 -66.41 -33.92 76.79 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.016 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 26.5 mm-40 -60.24 -41.08 92.41 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 118.111 0.414 . . . . 0.0 111.136 174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 21' ' ' THR . 73.9 mm-40 -65.76 -46.56 78.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.6 mt -61.47 -40.67 95.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.065 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.7 ttpt -57.25 -44.63 84.06 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.174 0.59 . . . . 0.0 110.245 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.3 mttt -57.7 -43.39 85.15 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.4 mptp? -62.34 -40.54 96.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.703 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -62.94 -45.73 91.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 123.516 0.51 . . . . 0.0 109.767 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 27' ' ' LYS . 62.5 t -64.49 -45.1 96.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.451 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.4 pt-20 -68.86 -44.06 74.11 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.621 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 37' ' ' PRO . 3.4 p -62.22 -29.78 47.37 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 C-N-CA 123.327 0.651 . . . . 0.0 112.099 -173.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 87.9 mt -53.03 -25.36 12.14 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.37 -22.09 59.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.723 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -164.52 78.78 1.42 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 121.308 0.575 . . . . 0.0 111.683 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.5 Cg_endo -85.89 -9.73 7.46 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.384 2.056 . . . . 0.0 112.764 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.62 34.16 0.48 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.623 0.725 . . . . 0.0 112.956 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -83.25 110.57 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.819 0.818 . . . . 0.0 109.16 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -55.02 -29.34 57.18 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 126.246 1.818 . . . . 0.0 113.303 -175.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.23 -13.81 62.61 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -111.44 8.25 21.11 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 121.986 -0.446 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 17.2 ptmt -89.58 147.47 23.92 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.936 -1.106 . . . . 0.0 111.072 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 96.3 mt -69.91 155.69 40.19 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.46 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.64 -55.29 36.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.68 23.22 7.12 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.011 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.471 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -102.12 132.37 21.6 Favored Pre-proline 0 C--N 1.305 -1.369 0 O-C-N 122.548 -0.384 . . . . 0.0 110.632 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.87 95.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.273 2.649 . . . . 0.0 112.642 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 50.83 47.06 25.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 113.015 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.0 m -106.64 141.09 38.48 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.576 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 38.5 m-85 -128.7 153.33 47.44 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 139.69 43.91 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.168 0.509 . . . . 0.0 110.061 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -110.36 131.26 61.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.86 140.86 36.59 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -94.76 112.77 24.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -78.71 81.81 4.98 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.184 0.516 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 m -165.57 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.116 1.366 . . . . 0.0 109.137 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.9 t -161.17 179.17 8.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.04 51.78 4.15 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 121.108 -0.568 . . . . 0.0 114.397 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -108.14 142.64 38.05 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 151.05 38.27 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 123.689 0.796 . . . . 0.0 109.17 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.62 128.13 50.27 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.08 124.79 70.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.061 0 O-C-N 123.619 0.574 . . . . 0.0 110.248 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.3 p90 -136.67 158.83 43.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 4.3 pt20 -108.86 137.99 45.9 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.92 114.77 36.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.01 95.6 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -65.58 -36.61 84.26 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.722 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -60.93 -30.14 70.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.5 mttm -108.28 -5.32 16.86 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.627 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.0 t 60.79 39.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-O 122.707 1.241 . . . . 0.0 109.624 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.5 p -132.31 139.01 51.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 O-C-N 121.335 -0.853 . . . . 0.0 111.173 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.63 115.39 42.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -110.63 111.62 22.96 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 61.1 t -75.45 122.49 29.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.528 HG21 ' HA ' ' A' ' 90' ' ' ALA . 48.4 mt -100.17 -42.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.204 0.526 . . . . 0.0 110.409 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.3 m -147.98 149.85 32.92 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 122.152 -0.342 . . . . 0.0 110.43 -176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.14 139.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.97 -144.03 12.98 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.7 155.31 16.83 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.016 0.408 . . . . 0.0 110.022 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -141.97 101.79 4.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -68.2 -45.87 72.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.049 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -149.44 -61.62 0.22 Allowed 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.828 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -129.05 10.53 5.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -172.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -58.12 -52.48 65.36 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.328 0.585 . . . . 0.0 111.688 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.16 -25.61 16.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.518 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -71.94 -41.48 67.75 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.3 m -59.27 -51.15 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.981 0.8 . . . . 0.0 110.833 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.41 -35.67 73.57 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . -65.51 -49.35 69.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.539 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.57 -36.86 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.039 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.29 -11.01 59.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.134 0.492 . . . . 0.0 111.993 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -82.67 -34.65 27.36 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.4 mt -79.2 -48.71 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.739 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.411 -0.805 . . . . 0.0 110.799 -179.565 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.2 ttt . . . . . 0 CA--C 1.503 -0.846 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.92 143.41 46.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.04 168.85 8.92 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -94.11 160.13 14.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.86 132.36 52.2 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -141.79 156.86 45.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.67 147.59 41.81 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.824 0.345 . . . . 0.0 111.035 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.04 154.77 40.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -32.42 72.85 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.626 0.25 . . . . 0.0 110.863 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -66.99 -46.53 74.3 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.552 0.691 . . . . 0.0 109.598 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.15 75.42 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.219 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.57 -40.83 96.27 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.024 0.44 . . . . 0.0 111.326 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.48 -43.4 85.53 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.175 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.58 -37.29 76.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.274 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.49 1.116 . . . . 0.0 110.824 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -74.69 -23.14 58.58 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.915 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.82 -40.32 61.15 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.128 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mp -58.95 147.11 35.48 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 124.541 1.136 . . . . 0.0 112.725 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -70.49 146.49 42.32 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.666 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 m -52.75 -45.88 67.24 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.058 0.943 . . . . 0.0 112.213 -176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.8 m -68.4 -36.7 79.5 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.893 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.14 -47.18 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.277 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.8 ptt180 -67.38 -33.83 76.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.186 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.07 -48.68 75.61 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.615 0.189 . . . . 0.0 110.702 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HB2' HD11 ' A' ' 55' ' ' LEU . 36.7 mt-30 -57.85 -41.97 83.47 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.014 0.821 . . . . 0.0 110.546 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.575 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 96.6 mt -66.65 -45.15 79.9 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.186 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.8 -44.2 94.08 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 110.515 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 94.9 mttt -62.97 -35.14 79.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.198 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.74 -35.03 72.48 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.81 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 89.6 mt -68.61 -46.12 70.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.04 -39.91 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.245 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.1 pt-20 -69.19 -42.8 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.2 p -63.87 -29.71 48.02 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.207 -174.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 94.4 mt -53.73 -25.04 16.78 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -80.39 -19.71 45.69 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.078 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -155.2 70.99 5.66 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.839 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HB2' HG21 ' A' ' 66' ' ' VAL . 79.0 Cg_endo -77.3 -14.3 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.528 1.485 . . . . 0.0 111.606 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -83.11 61.08 5.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.71 0.767 . . . . 0.0 112.833 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -101.95 110.59 29.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.025 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.48 -22.04 66.84 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.51 -19.89 60.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.867 0.365 . . . . 0.0 111.536 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -107.04 -7.6 16.86 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.013 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -70.35 133.64 47.12 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 123.568 0.747 . . . . 0.0 110.269 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.3 121.61 28.28 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -64.04 123.38 18.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.254 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.26 -29.4 8.91 Favored Glycine 0 C--N 1.324 -0.129 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.698 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.9 mmm -75.8 139.53 70.18 Favored Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 122.817 0.447 . . . . 0.0 110.053 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.92 90.88 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.869 2.379 . . . . 0.0 112.603 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 46.54 46.09 14.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 125.159 1.384 . . . . 0.0 113.014 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.5 m -99.88 142.34 31.5 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.569 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.3 m-85 -133.92 151.55 51.54 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -120.47 140.41 51.45 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 123.447 0.467 . . . . 0.0 110.62 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.01 134.94 61.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.52 157.86 17.68 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.479 0.487 . . . . 0.0 111.9 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 58' ' ' SER . 9.0 tp -94.11 166.06 12.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.501 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 37.9 mmt180 -90.22 -55.15 3.72 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.259 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 m -58.03 -59.86 4.63 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.539 ' H ' HD23 ' A' ' 55' ' ' LEU . 66.7 m -133.59 -177.42 4.54 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 122.069 -0.394 . . . . 0.0 110.692 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.75 62.83 4.46 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -103.32 139.66 38.45 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.522 HH11 ' HB3' ' A' ' 81' ' ' ALA . 2.9 mpt_? -136.26 142.93 44.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.15 0.5 . . . . 0.0 109.775 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -119.98 129.02 54.09 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.27 126.49 73.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.9 p90 -135.44 159.23 42.24 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.617 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.7 pt20 -109.09 140.66 42.34 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 37' ' ' PRO . 90.2 t -100.45 111.89 31.48 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 mt -97.11 94.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.31 -29.84 68.69 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.168 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.2 -38.9 74.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.779 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -108.65 2.61 22.08 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.195 0.522 . . . . 0.0 111.374 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.9 t 61.54 34.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 124.824 1.249 . . . . 0.0 109.957 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.93 138.83 50.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.292 -0.88 . . . . 0.0 111.513 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -98.27 115.75 39.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -110.86 114.75 28.33 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.623 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.09 123.94 29.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.9 mt -98.5 -42.49 11.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.096 0.474 . . . . 0.0 110.485 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.5 m -146.83 145.78 29.99 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.096 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.1 141.38 17.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.73 -152.93 24.6 Favored Glycine 0 CA--C 1.497 -1.05 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -91.44 149.04 21.89 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.522 ' HB3' HH11 ' A' ' 61' ' ' ARG . . . -85.79 71.48 10.66 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.292 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.76 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 60.2 18.09 7.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.923 0.889 . . . . 0.0 112.385 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.7 m 60.89 32.67 20.04 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.164 0.986 . . . . 0.0 111.811 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.61 -51.75 68.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.391 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 m -66.65 -17.25 22.28 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.338 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.08 -42.09 10.14 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.233 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 m -68.09 -45.22 74.37 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.152 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -29.66 63.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.591 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.07 -52.31 65.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.733 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.41 -40.75 89.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.966 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -68.68 -17.59 64.11 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -79.52 -28.04 41.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.6 mt -93.28 -62.99 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.443 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 N--CA 1.429 -1.506 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.765 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 CA--C 1.5 -0.961 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 158.78 37.82 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -116.47 172.31 7.29 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -87.23 156.92 19.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.25 127.92 50.51 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.87 155.17 50.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.61 133.58 54.99 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 33.9 t70 -71.99 151.94 42.84 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.0 pp20? -58.55 -34.34 70.93 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.0 mtt180 -69.69 -44.91 69.46 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.17 73.38 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.928 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 17.0 tp -72.3 -34.84 68.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.9 mttm -66.41 -42.09 88.3 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 36.0 mm-40 -63.65 -39.15 93.63 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.918 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -60.87 -39.56 89.65 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.09 1.356 . . . . 0.0 110.754 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 88.3 mtt180 -74.55 -32.75 62.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -72.81 -28.12 62.38 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.046 0.938 . . . . 0.0 110.842 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -63.77 152.76 38.49 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 123.33 0.652 . . . . 0.0 112.103 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -68.78 143.37 39.97 Favored Glycine 0 N--CA 1.424 -2.119 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.602 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 8.1 m -48.99 -54.55 15.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 124.584 1.154 . . . . 0.0 112.411 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.8 m -64.66 -34.77 79.07 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 122.879 0.472 . . . . 0.0 110.713 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.83 -48.18 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 6.1 ptt180 -68.57 -35.54 77.54 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 20' ' ' SER . 54.1 mt-10 -58.03 -50.06 74.72 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.992 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -63.28 -35.3 79.91 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.213 0.32 . . . . 0.0 111.691 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.4 mt -66.77 -44.94 80.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.987 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.82 -41.98 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.796 0.331 . . . . 0.0 110.88 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.5 mttt -59.47 -35.44 74.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.146 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.5 mptp? -70.96 -35.81 72.3 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.144 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.6 mt -66.32 -46.27 77.44 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.754 0.312 . . . . 0.0 110.897 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.83 -38.54 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.43 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 pt-20 -69.99 -43.43 71.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.85 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -63.08 -30.12 48.9 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.478 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -174.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 77.2 mt -54.18 -25.38 22.36 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -84.0 -8.54 59.11 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.022 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 39' ' ' ILE . 26.8 p -159.29 62.19 1.99 Allowed Pre-proline 0 C--O 1.206 -1.185 0 C-N-CA 124.038 0.935 . . . . 0.0 110.576 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 33' ' ' VAL . 73.0 Cg_endo -75.01 -20.6 16.69 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 121.777 1.651 . . . . 0.0 113.752 -172.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -89.69 54.76 2.97 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 122.148 0.975 . . . . 0.0 113.247 -178.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 36' ' ' SER . 98.1 mt -83.19 110.86 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.732 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.15 -27.18 68.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.22 -27.74 68.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.088 0.471 . . . . 0.0 111.067 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.02 -1.44 57.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.987 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.45 ' HB3' ' NZ ' ' A' ' 43' ' ' LYS . 8.3 mtpm? -62.74 146.55 52.12 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.2 mt -81.62 173.02 12.75 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.459 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -85.75 -55.02 4.17 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -172.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.33 52.51 0.82 Allowed Glycine 0 CA--C 1.5 -0.887 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.299 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.407 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 96.9 mmm -135.78 132.34 19.47 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.53 102.25 0.34 Allowed 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.906 2.404 . . . . 0.0 113.309 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.8 35.3 24.22 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 124.347 1.059 . . . . 0.0 111.952 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 63.5 m -101.65 141.23 34.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.245 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.621 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 18.4 m-85 -131.75 153.66 49.84 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 47.9 pttt -126.5 140.35 52.53 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.41 0.624 . . . . 0.0 111.246 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.48 129.26 65.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -110.39 133.51 53.2 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.44 96.32 10.33 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -44.82 -41.77 7.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 126.598 1.959 . . . . 0.0 113.963 -172.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -82.38 -44.36 16.23 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.0 m -77.31 -36.0 54.44 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.7 14.63 49.25 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.354 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.99 158.26 15.54 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.75 147.59 33.14 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.461 0.648 . . . . 0.0 111.843 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -119.59 126.98 52.5 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.9 t -110.63 123.34 66.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.129 0 CA-C-O 121.032 0.444 . . . . 0.0 110.297 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -133.82 157.63 45.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.677 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' HB3' HD11 ' A' ' 76' ' ' ILE . 20.6 pt20 -107.71 131.67 54.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.53 111.05 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 70' ' ' LYS . 31.8 mt -99.04 96.01 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.32 -32.77 73.96 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.34 -35.52 74.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.082 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.423 ' H ' HG22 ' A' ' 67' ' ' ILE . 99.3 mttt -104.46 -2.41 25.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.53 33.5 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.525 1.13 . . . . 0.0 109.754 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.15 138.99 50.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 O-C-N 121.161 -0.962 . . . . 0.0 111.304 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -99.14 114.81 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 81.8 t80 -107.94 111.21 23.19 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.469 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -73.15 121.43 23.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.455 HG21 ' HA ' ' A' ' 90' ' ' ALA . 29.8 mt -98.09 -42.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.613 0.571 . . . . 0.0 110.373 -174.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 t -153.38 151.85 30.4 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.11 138.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.15 -139.86 8.43 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.394 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -101.83 158.7 15.93 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 120.999 0.428 . . . . 0.0 109.921 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.04 95.78 4.52 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.85 -41.91 2.33 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.278 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' HB3' ' OE2' ' A' ' 85' ' ' GLU . . . -123.86 29.48 6.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 m 72.89 35.92 0.95 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.858 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.464 ' OE2' ' HB3' ' A' ' 83' ' ' ALA . 18.3 mp0 -57.58 -51.93 67.49 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.28 -27.51 26.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.514 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.77 -48.59 16.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.272 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.7 m -60.95 -42.93 99.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.557 0.536 . . . . 0.0 110.828 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -68.35 -35.83 78.33 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.91 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -65.84 -54.84 21.42 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.0 -35.68 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.905 0.383 . . . . 0.0 111.75 -177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -77.12 -19.28 57.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.425 ' HE ' ' CG ' ' A' ' 8' ' ' ASP . 21.8 tpt180 -93.97 -6.71 44.81 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.528 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 90' ' ' ALA . 48.5 mm -74.42 102.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 170.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -174.006 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -92.66 128.12 38.41 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.595 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -104.35 167.09 9.97 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.738 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.51 153.39 24.43 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 30' ' ' LEU . 1.9 tm? -125.56 124.39 41.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.65 156.05 49.46 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.413 0.625 . . . . 0.0 110.385 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -104.88 134.95 47.14 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.27 142.34 57.78 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 10.1 pt-20 -56.27 -31.32 63.5 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -175.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -72.34 -40.11 67.63 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.274 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.27 -31.19 70.48 Favored 'General case' 0 C--O 1.209 -1.071 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.869 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -68.16 -34.91 77.2 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 60.3 mttm -63.61 -42.8 98.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.893 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 42.0 mm-40 -68.69 -37.47 79.59 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.088 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -60.68 -45.01 95.77 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.83 0.852 . . . . 0.0 110.643 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -74.78 -21.18 59.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.587 0.708 . . . . 0.0 110.175 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 80.2 tttt -74.86 -25.43 58.96 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 124.79 1.236 . . . . 0.0 110.154 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 14' ' ' GLU . 5.5 mp -68.06 168.07 12.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.253 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.03 -138.68 1.56 Allowed Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.056 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -106.5 -60.47 1.65 Allowed 'General case' 0 C--N 1.285 -2.237 0 O-C-N 121.585 -0.95 . . . . 0.0 108.86 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -52.23 -43.36 64.24 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.93 1.292 . . . . 0.0 113.096 -173.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.13 -48.35 79.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.135 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -69.08 -33.91 74.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -56.07 -45.96 79.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.444 ' HB3' HD21 ' A' ' 55' ' ' LEU . 45.8 mt-30 -70.61 -38.98 74.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.953 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 92.5 mt -63.46 -44.04 95.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.36 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -58.87 -43.2 90.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.186 0.517 . . . . 0.0 110.346 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' HA ' HG12 ' A' ' 31' ' ' VAL . 97.8 mttt -62.89 -37.7 87.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 4.9 mptp? -64.32 -37.57 87.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.582 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.1 mt -68.36 -45.28 73.26 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 28' ' ' LYS . 7.8 p -68.75 -36.21 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.799 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -68.75 -44.94 72.7 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 37' ' ' PRO . 3.7 p -62.93 -30.66 50.1 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.124 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.627 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 71.0 mt -53.91 -25.62 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 8.1 pt-20 -64.48 -28.85 69.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.084 0.856 . . . . 0.0 111.19 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -160.1 77.5 2.72 Favored Pre-proline 0 C--O 1.206 -1.207 0 C-N-CA 124.059 0.944 . . . . 0.0 108.493 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 33' ' ' VAL . 89.8 Cg_endo -85.25 -1.27 9.21 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.679 2.253 . . . . 0.0 113.537 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 40.96 0.77 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.549 0.69 . . . . 0.0 110.885 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.15 100.88 5.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.359 1.076 . . . . 0.0 110.352 -173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -55.42 -27.48 48.15 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.706 2.003 . . . . 0.0 112.509 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.9 -19.23 61.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.064 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.73 1.47 17.88 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -80.25 135.63 36.28 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-O 121.07 0.462 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.8 mt -82.68 122.87 28.7 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.595 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 mtt-85 -89.27 120.03 30.26 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.09 6.77 42.07 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 95.2 mmm -127.0 138.68 33.21 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' MET . 14.1 Cg_exo -67.2 95.13 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.601 2.201 . . . . 0.0 112.971 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 52.5 39.02 27.06 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.041 1.337 . . . . 0.0 113.573 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.5 m -99.99 142.49 31.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.9 m-85 -132.4 156.24 47.04 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -133.37 141.97 48.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.27 0.557 . . . . 0.0 112.402 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.78 122.85 68.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.87 128.61 49.57 Favored 'General case' 0 N--CA 1.405 -2.682 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.423 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 25' ' ' GLN . 1.3 tm? -76.12 102.95 5.93 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 -173.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -56.44 -39.58 73.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 p -88.26 20.38 3.28 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -156.05 -45.53 0.08 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.668 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.99 22.5 7.21 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.672 -1.251 . . . . 0.0 112.341 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -95.69 154.09 17.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 122.222 -0.575 . . . . 0.0 109.818 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -122.95 135.62 54.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 tt -129.74 124.95 34.71 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -117.07 128.24 74.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.6 p90 -133.48 158.16 43.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.747 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HB3' HD11 ' A' ' 76' ' ' ILE . 20.5 pt20 -105.46 138.19 42.06 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.63 111.2 34.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.1 mt -97.35 101.75 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.01 -36.57 80.18 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.561 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.64 -40.31 96.59 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -95.17 -6.05 42.62 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.6 t 58.49 37.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.429 1.109 . . . . 0.0 109.711 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.1 140.31 40.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 121.365 -0.834 . . . . 0.0 110.902 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -108.83 124.99 65.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 C-N-CA 124.461 1.104 . . . . 0.0 108.771 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.08 116.92 29.91 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.7 t -68.99 121.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 65' ' ' GLN . 59.0 mt -96.28 -43.11 12.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.993 0.425 . . . . 0.0 110.638 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 p -141.3 143.5 34.1 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 120.877 0.37 . . . . 0.0 110.567 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.1 141.5 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.22 -140.24 7.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -116.71 155.44 28.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 117.351 0.575 . . . . 0.0 110.002 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.88 128.87 41.45 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -94.26 -38.17 11.16 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.42 -63.27 0.89 Allowed 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.204 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 t -161.55 22.99 0.12 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 121.019 0.437 . . . . 0.0 110.924 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -58.41 -45.51 88.28 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.603 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.31 -25.49 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -79.75 -44.92 19.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.5 m -62.84 -43.15 99.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.853 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.1 -28.18 68.62 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.54 63.15 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.31 -23.28 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-O 121.124 0.488 . . . . 0.0 110.919 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -61.34 -26.23 67.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.183 0.993 . . . . 0.0 111.592 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -89.28 -12.07 41.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.595 0.712 . . . . 0.0 109.767 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.2 mt -94.62 -59.21 3.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.209 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.308 -1.23 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.727 177.551 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.496 -1.098 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.35 152.95 50.12 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -118.33 168.57 10.5 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -99.03 163.17 12.69 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 123.062 0.226 . . . . 0.0 111.172 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.11 130.96 53.17 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -137.52 149.6 46.89 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.91 134.85 46.14 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 20.2 t70 -72.05 153.43 41.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.96 -32.53 66.13 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -68.27 -42.25 79.85 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.12 75.25 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.737 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.0 mt -69.84 -39.29 76.51 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 120.683 0.278 . . . . 0.0 110.443 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -62.36 -44.29 96.82 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.068 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 32.5 mt-10 -70.01 -37.51 75.69 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-O 121.066 0.46 . . . . 0.0 111.4 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.1 t-105 -62.37 -42.0 99.06 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 123.737 0.815 . . . . 0.0 110.33 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -75.24 -23.26 57.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 48.5 tttp -67.84 -45.4 74.75 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 14' ' ' GLU . 6.5 mp -58.69 151.15 21.6 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.623 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -75.42 152.12 42.7 Favored Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.5 t -52.44 -53.24 47.95 Favored 'General case' 0 C--O 1.201 -1.454 0 C-N-CA 123.058 0.543 . . . . 0.0 111.291 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.0 m -57.82 -38.0 74.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 123.507 0.723 . . . . 0.0 111.577 -176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -72.18 -47.87 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 109.944 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 9.2 ptt180 -68.45 -34.57 76.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.4 mt-10 -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.817 0.447 . . . . 0.0 111.599 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -66.01 -35.31 80.21 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.673 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.5 mt -67.24 -43.43 81.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.667 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -59.33 -44.37 92.63 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 110.5 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 90.5 mttt -62.49 -35.1 78.29 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.555 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.6 mptp? -65.71 -39.56 91.33 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.869 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.3 mt -61.63 -44.61 96.67 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 27' ' ' LYS . 87.9 t -61.67 -45.31 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.84 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -69.65 -42.49 74.18 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.746 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.9 p -62.59 -29.67 47.44 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.7 mt -53.16 -25.77 14.73 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.5 pt-20 -66.24 -28.92 69.1 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.491 0.662 . . . . 0.0 110.966 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.4 m -158.42 76.66 3.47 Favored Pre-proline 0 C--N 1.315 -0.894 0 C-N-CA 124.227 1.011 . . . . 0.0 108.805 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' HG22 ' A' ' 33' ' ' VAL . 61.1 Cg_endo -75.59 -24.43 11.93 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.472 1.448 . . . . 0.0 111.466 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 2.4 ppt_? -78.38 62.57 3.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.166 0.984 . . . . 0.0 112.907 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.84 124.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.25 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -35.94 67.37 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.16 0.984 . . . . 0.0 112.263 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.62 -15.98 61.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.549 0.69 . . . . 0.0 111.399 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' LYS . 90.4 m-20 -104.68 -7.0 19.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 21.8 ttmt -85.9 138.59 31.92 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -172.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -86.45 129.09 34.98 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.948 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -74.87 116.52 15.68 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.847 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.49 49.66 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.862 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 96.1 mmm -101.93 137.18 19.45 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.07 95.16 0.14 Allowed 'Trans proline' 0 C--O 1.246 0.879 0 C-N-CA 123.205 2.604 . . . . 0.0 112.71 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 45.86 46.27 12.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 125.015 1.326 . . . . 0.0 113.012 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.38 141.61 33.0 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 43' ' ' LYS . 79.6 m-85 -131.66 145.84 51.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.424 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -115.86 141.15 48.48 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 123.618 0.573 . . . . 0.0 110.066 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.13 138.44 51.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -119.42 132.78 55.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.285 0.366 . . . . 0.0 110.389 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 tt -84.27 117.78 23.76 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -51.74 -57.28 9.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -76.12 -53.59 8.09 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.184 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -63.86 -34.84 78.84 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.67 26.68 49.63 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.327 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.54 150.33 20.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -123.5 141.53 51.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.2 tt -126.3 131.89 51.77 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.18 122.72 67.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 CA-C-O 121.405 0.621 . . . . 0.0 110.494 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -131.78 157.97 42.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.055 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.16 139.77 48.48 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 73' ' ' VAL . 77.5 t -88.63 112.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 mt -98.54 95.64 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.466 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.26 -35.76 76.25 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.28 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -104.8 -1.31 26.27 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.013 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t 59.14 33.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.378 0 CA-C-O 122.722 1.248 . . . . 0.0 110.267 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.04 141.04 37.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 109.528 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 66' ' ' VAL . 17.6 m -98.17 128.07 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.112 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 87.1 t80 -103.09 110.04 21.83 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.401 -175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -75.52 120.79 25.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.4 mt -95.06 -42.17 12.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.341 0.591 . . . . 0.0 109.521 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.7 m -153.0 153.31 32.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.014 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.06 148.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.81 -111.86 0.72 Allowed Glycine 0 N--CA 1.426 -2.013 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.3 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -124.59 142.81 51.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.49 116.17 21.38 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -126.35 -35.04 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 123.517 0.51 . . . . 0.0 110.276 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.44 -69.29 0.75 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.495 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -159.96 24.18 0.17 Allowed 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.821 0.819 . . . . 0.0 110.259 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 7.6 mp0 -61.46 -51.8 67.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.433 -175.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.2 m -74.06 -8.11 11.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.615 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -92.31 -52.08 4.85 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.2 m -61.46 -49.91 74.9 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.49 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.98 -29.55 67.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.746 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.459 ' O ' HG13 ' A' ' 94' ' ' ILE . . . -73.41 -51.04 18.7 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.298 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.41 -35.01 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.019 0.437 . . . . 0.0 110.768 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.14 -17.09 60.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.291 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -92.11 -18.97 22.8 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.241 0.543 . . . . 0.0 111.17 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 90' ' ' ALA . 83.4 mt -75.92 -46.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.45 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 tm? . . . . . 0 C--N 1.309 -1.193 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.666 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 CA--C 1.498 -1.039 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.85 135.9 17.55 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -87.47 164.91 15.9 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 123.652 0.595 . . . . 0.0 109.544 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -83.4 157.48 22.48 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.449 HD23 HD21 ' A' ' 34' ' ' LEU . 1.3 tm? -126.16 128.55 47.46 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -140.37 157.13 46.01 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.18 142.23 49.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 122.395 0.278 . . . . 0.0 110.433 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.69 155.02 40.19 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.49 -29.64 67.99 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 12.6 mmt85 -71.75 -43.02 66.52 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.32 81.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.04 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.6 mt -63.16 -43.26 98.79 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 110.774 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -66.07 -44.33 84.82 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.212 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 37.3 mm-40 -68.36 -37.54 80.57 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 123.528 0.517 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.69 -45.11 94.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.064 0.945 . . . . 0.0 111.033 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.3 -22.71 57.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.858 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -77.09 -31.67 56.1 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.427 1.491 . . . . 0.0 110.732 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.71 152.2 27.35 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.932 0.893 . . . . 0.0 111.786 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -69.49 147.19 45.1 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 15.0 m -49.18 -54.6 15.73 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.289 1.035 . . . . 0.0 112.455 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.9 m -63.54 -34.55 78.04 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.191 0.519 . . . . 0.0 111.277 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.83 -48.85 61.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 7.3 ptt180 -69.24 -35.58 76.29 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 43.2 mt-10 -57.15 -49.46 75.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 120.45 0.166 . . . . 0.0 110.6 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.59 ' HB3' HD11 ' A' ' 55' ' ' LEU . 2.9 mp0 -68.51 -34.98 76.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.664 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 80.1 mt -66.91 -42.77 84.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.56 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -59.05 -41.9 89.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.185 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 98.4 mttt -59.23 -41.29 88.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.1 mptp? -64.32 -34.79 78.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.158 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.6 mt -68.92 -47.31 66.08 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.44 -38.63 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.886 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 10.5 pt-20 -68.31 -43.14 78.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.945 0.402 . . . . 0.0 110.563 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.7 p -64.47 -30.56 50.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.838 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.8 mt -54.03 -25.46 21.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 14.6 pt-20 -75.17 -25.45 58.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.058 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.0 p -158.09 74.46 3.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 122.702 0.401 . . . . 0.0 110.125 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' HG22 ' A' ' 33' ' ' VAL . 94.3 Cg_endo -85.04 -1.34 9.37 Favored 'Trans proline' 0 C--O 1.206 -1.106 0 C-N-CA 122.057 1.838 . . . . 0.0 113.796 -177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 32.78 0.74 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.6 mt -82.55 112.37 20.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.499 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -57.75 -29.04 64.46 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.82 -15.94 63.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.953 0.406 . . . . 0.0 111.725 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -102.41 -1.63 30.38 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.743 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.499 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 42.5 mtpt -74.03 144.67 45.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.084 0.469 . . . . 0.0 111.474 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 59.7 mt -74.41 133.46 42.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -73.26 107.61 5.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.76 32.41 9.23 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.736 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.551 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 77.2 mmm -133.98 142.72 44.45 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 47' ' ' MET . 9.5 Cg_exo -70.64 93.47 0.6 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.765 2.31 . . . . 0.0 112.714 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 50.0 41.73 23.58 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 124.993 1.317 . . . . 0.0 113.986 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 m -100.31 141.58 32.96 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 8.1 m-85 -130.01 146.24 51.68 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -115.14 140.4 49.11 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.28 0.562 . . . . 0.0 110.869 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.0 mt -123.44 127.44 74.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HD2' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -104.51 145.12 30.74 Favored 'General case' 0 N--CA 1.426 -1.626 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.502 178.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 25' ' ' GLN . 15.5 tp -85.59 143.32 28.53 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -89.83 -30.27 18.06 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.639 0.733 . . . . 0.0 109.219 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -65.47 -29.77 70.47 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.069 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 23.4 t -164.17 158.71 19.43 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.06 50.63 3.08 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.182 0.833 . . . . 0.0 115.182 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -99.02 143.42 29.32 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -122.96 142.65 50.59 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -120.64 126.85 51.29 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.9 t -116.59 123.46 71.63 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.181 0.515 . . . . 0.0 109.947 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.58 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 9.5 p90 -135.58 158.96 43.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.188 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -112.08 139.53 47.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.5 t -97.74 111.67 28.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.622 0.725 . . . . 0.0 110.056 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 70' ' ' LYS . 38.4 mt -100.08 95.06 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.37 -29.88 64.18 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.476 0.655 . . . . 0.0 109.76 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.73 -40.16 75.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.97 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 67' ' ' ILE . 95.3 mttt -108.06 4.29 24.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.509 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.0 p 51.86 40.93 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 125.704 1.602 . . . . 0.0 111.879 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.91 138.96 50.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.748 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.86 115.24 42.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -108.87 112.92 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.665 -173.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.52 121.48 27.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -95.42 -42.74 12.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.374 0.606 . . . . 0.0 109.624 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m -149.43 149.97 31.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.315 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.21 131.97 6.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.02 -155.78 26.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -81.09 152.92 27.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.369 0.604 . . . . 0.0 110.839 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.17 33.15 3.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.994 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -46.52 -55.72 7.1 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.747 1.279 . . . . 0.0 110.335 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.27 53.97 1.13 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.695 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p 56.4 31.92 19.65 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.741 1.216 . . . . 0.0 113.261 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 9.1 tp10 -57.67 -52.13 66.67 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.999 0.519 . . . . 0.0 111.388 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.36 -11.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -81.56 -44.07 17.82 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.436 ' HA ' HG12 ' A' ' 91' ' ' VAL . 18.2 t -66.57 -34.68 78.44 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 39.7 mm-40 -60.88 -47.89 84.3 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.543 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -67.11 -55.97 11.96 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.178 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 88' ' ' SER . 13.7 p -60.29 -38.65 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.45 -12.75 59.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -93.45 -15.97 25.03 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 90' ' ' ALA . 39.7 mm -82.65 -49.58 16.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.019 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.9 pp . . . . . 0 N--CA 1.438 -1.061 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.255 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 CA--C 1.505 -0.784 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.38 33.83 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.95 168.86 14.6 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.727 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -89.01 161.05 16.79 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -126.06 132.37 51.95 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.79 155.49 47.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -123.36 135.49 54.19 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 117.791 0.269 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.85 155.71 38.76 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 10' ' ' ARG . 6.5 pt-20 -53.19 -40.82 64.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 117.809 0.277 . . . . 0.0 111.429 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.516 ' HG3' ' HD3' ' A' ' 93' ' ' ARG . 25.5 mmm180 -69.86 -38.06 76.3 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.99 93.32 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.925 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 44.7 mt -66.58 -42.85 86.34 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.164 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -61.32 -43.92 98.07 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.988 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -69.97 -39.57 75.89 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.765 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.11 -42.22 98.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.1 0.96 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 81.9 mtp180 -73.07 -26.63 61.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.041 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -71.84 -35.71 69.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.497 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -60.85 152.74 26.46 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.514 0.673 . . . . 0.0 112.528 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.0 155.77 49.67 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.778 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 3.0 p -55.73 -53.97 50.05 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 124.138 0.975 . . . . 0.0 112.801 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 m -57.62 -42.14 82.71 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 124.225 1.01 . . . . 0.0 110.899 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 93.7 t -68.58 -48.21 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.99 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 8.3 ptt-85 -68.72 -35.42 77.11 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 20' ' ' SER . 37.5 mt-10 -59.7 -45.41 92.21 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.399 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.639 ' HB3' HD11 ' A' ' 55' ' ' LEU . 2.6 mp0 -70.86 -34.74 71.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.715 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 85.1 mt -62.92 -44.06 97.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.397 174.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -56.38 -42.61 78.16 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.945 0.403 . . . . 0.0 110.498 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 98.9 mttt -60.24 -45.48 93.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.67 177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.0 mptp? -59.95 -38.52 82.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.86 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 92.4 mt -65.96 -46.33 78.49 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.296 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.21 -37.73 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.737 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 8.2 pt-20 -68.6 -42.66 77.87 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.705 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.98 -29.37 47.05 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.424 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.49 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -52.85 -24.95 10.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.91 -30.37 70.95 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.683 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.4 t -161.72 75.81 2.32 Favored Pre-proline 0 C--O 1.2 -1.541 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 33' ' ' VAL . 85.3 Cg_endo -83.46 -9.68 10.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.0 1.8 . . . . 0.0 114.461 -176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 43.3 0.63 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.45 0.643 . . . . 0.0 111.881 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.14 101.32 5.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.793 0.806 . . . . 0.0 110.185 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.15 -25.2 65.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.949 -1.478 . . . . 0.0 113.629 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.75 -15.23 63.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.983 0.42 . . . . 0.0 110.81 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -113.87 11.12 17.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.383 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -80.49 144.69 32.34 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 120.98 0.419 . . . . 0.0 111.917 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.82 150.73 23.93 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.494 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -95.08 127.74 41.37 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.349 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.54 12.62 84.06 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.36 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.0 mmm -121.83 120.1 28.71 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.6 100.67 0.16 Allowed 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.194 2.596 . . . . 0.0 113.598 -174.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 65' ' ' GLN . 4.5 m-20 62.16 31.37 17.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 111.793 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.1 m -99.91 141.72 32.35 Favored 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.773 -178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.48 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 68.8 m-85 -136.5 156.54 48.45 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.63 140.46 47.11 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 112.536 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.26 141.28 34.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -113.23 144.3 42.93 Favored 'General case' 0 N--CA 1.403 -2.813 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 25' ' ' GLN . 18.5 tp -98.51 118.47 35.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -70.78 -34.59 71.95 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.196 0.522 . . . . 0.0 110.346 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 m -61.9 -39.49 92.17 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 m -124.96 -12.37 7.02 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.11 21.36 57.3 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.493 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -93.52 156.64 16.62 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.096 -0.65 . . . . 0.0 110.938 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -121.8 143.73 49.23 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 123.69 0.796 . . . . 0.0 108.982 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -131.43 127.67 37.93 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.41 125.66 72.72 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 CA-C-O 121.035 0.445 . . . . 0.0 110.022 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.1 p90 -136.93 158.83 43.56 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.245 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 4.0 pt20 -111.44 133.72 53.54 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 173.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -98.0 110.88 26.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.7 mt -99.65 95.79 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.39 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.69 -25.03 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.055 0.455 . . . . 0.0 110.247 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.57 -36.28 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.636 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HB2' HG12 ' A' ' 72' ' ' VAL . 96.7 mttt -107.68 -1.87 20.68 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.835 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t 58.5 32.52 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.234 1.414 . . . . 0.0 110.388 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -129.67 139.27 52.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.018 -1.051 . . . . 0.0 110.964 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 80.9 t -98.88 114.98 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.105 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -106.07 110.33 22.56 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.682 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.18 121.95 24.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.4 mt -94.89 -42.27 12.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.734 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.8 m -152.99 153.18 32.41 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 -176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.2 p -148.97 142.97 18.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.34 -131.72 3.18 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.176 -1.011 . . . . 0.0 111.797 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -124.03 167.06 14.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.468 -0.431 . . . . 0.0 110.641 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.07 3.57 55.49 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.481 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.39 126.53 28.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 66.15 18.51 10.99 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.262 1.025 . . . . 0.0 111.219 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 61.21 29.33 18.68 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.06 -50.86 71.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.55 0.74 . . . . 0.0 111.505 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -62.83 -25.9 39.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.848 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -80.92 -42.85 20.71 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.983 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -64.53 -41.49 96.34 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 12.2 tp10 -62.42 -46.8 86.93 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.076 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.37 56.58 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.819 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.73 -36.56 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.991 0.424 . . . . 0.0 111.164 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -71.36 -23.19 61.86 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HD3' ' HG3' ' A' ' 10' ' ' ARG . 12.8 mmm180 -77.48 -15.26 59.4 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.671 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.3 mt -82.27 -31.18 9.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.917 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.309 -1.162 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.79 133.63 55.84 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -91.06 162.88 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.89 155.03 23.1 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.403 HD23 HD21 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -118.06 124.1 47.26 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -130.62 160.81 33.1 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -132.11 144.73 50.92 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . 13.1 t70 -79.42 154.4 28.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 169.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -29.54 66.4 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 4.4 mmt85 -63.82 -45.0 91.56 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.07 93.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.386 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.99 -41.03 99.46 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 123.207 0.317 . . . . 0.0 111.749 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.67 -43.83 97.81 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.272 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 57.4 mm-40 -69.09 -39.5 78.97 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.272 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -61.3 -46.61 89.58 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.571 1.148 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -73.03 -28.58 62.43 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.081 0.467 . . . . 0.0 110.529 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.4 -38.73 88.14 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.377 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.56 153.91 12.2 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.644 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -74.19 147.51 37.84 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.3 m -50.15 -48.04 53.96 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.3 m -67.27 -36.87 82.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.689 0.28 . . . . 0.0 110.966 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.16 -48.59 68.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 19.4 ptt180 -68.77 -35.43 77.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.583 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 24.0 mt-10 -57.93 -42.44 84.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 176.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.529 ' CB ' HD11 ' A' ' 55' ' ' LEU . 43.5 mt-30 -70.64 -35.11 72.74 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.128 0.489 . . . . 0.0 110.193 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.04 -41.87 85.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.956 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 18.6 ptmt -63.18 -36.73 84.59 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.898 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.583 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -59.63 -39.02 82.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 29' ' ' LYS . 72.9 mmtt -65.02 -36.21 83.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.689 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.661 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 71.7 mt -63.72 -43.62 96.0 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 27' ' ' LYS . 96.2 t -63.73 -45.46 97.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.717 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.2 pt-20 -69.09 -43.92 73.55 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.754 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.8 p -62.88 -29.76 47.9 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 81.5 mt -53.45 -25.32 15.71 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -75.09 -25.45 58.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.197 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -154.2 74.19 6.15 Favored Pre-proline 0 C--O 1.213 -0.829 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 33' ' ' VAL . 84.4 Cg_endo -80.98 -7.31 13.23 Favored 'Trans proline' 0 C--O 1.221 -0.373 0 C-N-CA 121.515 1.476 . . . . 0.0 113.386 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 38.69 0.94 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.58 0.705 . . . . 0.0 112.074 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.52 108.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.4 -24.68 66.67 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.54 -8.19 44.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 87.0 m-20 -108.94 3.8 22.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 9.9 mtpm? -71.18 142.41 50.66 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -84.11 126.17 32.84 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 168.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -85.77 114.56 22.82 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 6.47 16.74 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 95.8 mmm -131.28 139.05 34.23 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.75 -71.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.323 2.682 . . . . 0.0 112.677 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -137.96 78.04 1.66 Allowed 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.9 m -126.88 141.38 51.83 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 40.4 m-85 -133.75 155.43 49.78 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -126.39 139.83 52.97 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 123.641 0.588 . . . . 0.0 110.033 177.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 mt -108.71 142.55 21.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -117.1 129.34 55.92 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' A' ' 25' ' ' GLN . 14.6 tp -81.71 143.52 31.8 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -73.66 -36.64 65.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.1 m -99.62 150.2 22.5 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 71.82 -43.88 0.58 Allowed 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.68 35.16 5.25 Favored Glycine 0 C--O 1.239 0.447 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.767 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -93.44 155.76 17.16 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 122.622 -0.34 . . . . 0.0 110.22 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.8 mpt_? -129.52 151.33 50.26 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.8 tt -128.26 131.32 48.75 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 86' ' ' VAL . 84.1 t -118.38 124.37 73.02 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 CA-C-O 121.229 0.538 . . . . 0.0 110.943 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.4 p90 -137.48 158.88 43.44 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.977 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -112.23 141.28 46.12 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG22 ' HE1' ' A' ' 51' ' ' TYR . 12.0 m -101.37 123.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.561 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.83 94.82 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.168 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.2 -23.38 62.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.975 0.893 . . . . 0.0 109.51 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.99 -36.55 83.92 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.262 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 72' ' ' VAL . 99.5 mttt -107.31 -4.27 18.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.463 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t 63.35 34.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-O 122.678 1.228 . . . . 0.0 109.616 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.1 p -131.9 139.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.461 -0.774 . . . . 0.0 110.74 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.26 115.37 38.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 8' ' ' ASP . 88.4 t80 -106.11 110.55 22.84 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.27 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.81 121.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.8 -42.61 12.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.881 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 m -151.39 153.92 35.65 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -149.3 139.98 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.85 -137.97 6.85 Favored Glycine 0 N--CA 1.435 -1.39 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -99.03 91.21 4.91 Favored 'General case' 0 C--N 1.292 -1.934 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.291 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.27 125.38 34.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -134.7 -37.31 0.83 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.742 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.69 -77.08 0.18 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 t -117.67 -12.74 10.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -58.38 -37.75 75.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -173.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 63' ' ' VAL . 29.9 m -86.62 -30.97 6.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.428 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -67.64 -47.5 69.4 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 120.691 0.281 . . . . 0.0 110.621 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.668 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 51.1 m -59.21 -41.79 89.42 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 4.7 tp10 -70.37 -42.1 72.23 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.85 81.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.123 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -64.75 -32.36 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.668 ' HE3' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -77.85 -32.39 52.05 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.444 175.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 13.0 tpt180 -74.82 -45.87 40.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -174.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.64 83.86 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.993 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.24 154.38 45.75 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.42 175.68 5.85 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.87 159.35 15.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.1 130.84 51.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -145.35 158.35 43.85 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -118.24 144.17 45.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.006 0.431 . . . . 0.0 111.987 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.39 155.97 28.14 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.96 -38.23 64.77 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.911 0.323 . . . . 0.0 111.229 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -62.81 -45.36 93.0 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.79 98.02 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.835 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -63.4 -45.42 91.11 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -63.29 -44.12 95.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.776 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -70.05 -37.97 75.69 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.442 ' O ' ' HD3' ' A' ' 23' ' ' ARG . 61.9 t-105 -63.04 -45.01 94.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.789 1.236 . . . . 0.0 110.674 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -72.19 -27.14 62.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.298 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.65 -38.5 64.95 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.479 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.4 150.65 17.98 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 124.434 1.094 . . . . 0.0 111.923 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -64.54 144.32 48.22 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -50.03 -50.25 48.18 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.561 1.144 . . . . 0.0 111.972 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.8 m -68.99 -37.77 78.94 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.271 0.628 . . . . 0.0 111.148 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.37 -47.67 80.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 10.1 ptt-85 -68.75 -35.96 77.76 Favored 'General case' 0 C--O 1.2 -1.528 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.571 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 33.4 mt-10 -66.69 -31.69 72.52 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.638 ' HB3' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -70.83 -34.37 71.61 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.649 175.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 95.8 mt -65.48 -42.13 92.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.579 172.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' O ' HG23 ' A' ' 31' ' ' VAL . 30.9 ttpt -55.3 -44.76 76.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.648 0.779 . . . . 0.0 109.585 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -58.42 -38.02 76.56 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.929 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.7 mptp? -69.99 -35.22 74.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.155 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 85.7 mt -65.78 -41.63 91.77 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.154 0.502 . . . . 0.0 109.698 177.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' LYS . 92.7 t -62.64 -44.47 99.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.374 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 12.7 pt-20 -68.85 -45.73 70.33 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.988 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.424 HG21 ' OH ' ' A' ' 64' ' ' TYR . 3.4 p -62.94 -30.27 49.18 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.805 -173.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 72.4 mt -53.35 -25.53 15.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.4 pt-20 -76.71 -28.03 55.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.118 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 m -152.37 69.41 7.37 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.686 -0.633 . . . . 0.0 110.454 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 33' ' ' VAL . 95.1 Cg_endo -87.63 -2.94 7.5 Favored 'Trans proline' 0 C--O 1.21 -0.887 0 C-N-CA 121.961 1.774 . . . . 0.0 112.828 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.79 37.94 0.94 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.949 0.881 . . . . 0.0 111.93 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.3 mt -82.7 100.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 12.6 pt-20 -57.48 -24.5 56.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.64 66.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.851 0.358 . . . . 0.0 111.143 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -99.5 3.89 45.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.437 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 10.1 mtpm? -72.23 139.39 48.11 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 121.213 0.53 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 63.0 mt -80.14 138.25 36.87 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.398 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -72.31 106.61 4.53 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.56 32.46 10.23 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.103 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.1 mmm -135.75 132.68 19.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.65 99.08 0.37 Allowed 'Trans proline' 0 C--O 1.252 1.201 0 C-N-CA 122.682 2.255 . . . . 0.0 113.319 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 60.36 31.92 20.52 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.637 1.175 . . . . 0.0 111.681 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.3 m -100.09 141.44 32.91 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.801 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.562 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 7.4 m-85 -132.0 160.4 35.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -130.51 146.95 52.14 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -124.93 139.6 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.3 131.01 56.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.638 HD11 ' HB3' ' A' ' 25' ' ' GLN . 19.2 tp -77.61 96.59 4.84 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.421 0.629 . . . . 0.0 110.423 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 64.5 mtp180 -68.44 78.8 0.27 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.078 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t 172.63 -49.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 125.279 1.432 . . . . 0.0 107.886 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 m -111.37 -23.44 10.79 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.82 49.32 Favored Glycine 0 C--O 1.241 0.544 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.585 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -88.01 150.21 23.55 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 122.61 -0.347 . . . . 0.0 110.16 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.13 147.88 46.31 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.181 0.515 . . . . 0.0 109.77 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 tt -132.18 129.05 39.26 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.2 127.13 73.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 O-C-N 123.606 0.566 . . . . 0.0 110.102 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 6.2 p90 -138.08 158.78 43.63 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.741 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.9 pt20 -108.92 130.37 55.44 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -99.52 110.5 26.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.0 mt -99.01 100.74 11.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -63.83 -34.48 78.02 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.039 0.536 . . . . 0.0 111.828 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.44 -36.74 85.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.321 0.388 . . . . 0.0 111.595 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HB2' HG12 ' A' ' 72' ' ' VAL . 96.7 mttt -98.51 -6.97 29.19 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.05 0.453 . . . . 0.0 110.473 -178.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.7 t 61.33 32.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 124.951 1.3 . . . . 0.0 109.936 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.3 p -129.42 138.78 53.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 111.148 -176.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.3 114.88 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.03 110.69 21.34 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.94 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 64' ' ' TYR . 59.6 t -74.77 121.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.8 mt -98.14 -42.06 11.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.533 0.682 . . . . 0.0 110.218 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 m -145.87 149.91 35.14 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.17 145.91 17.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.65 -144.94 12.63 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -98.54 162.79 12.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 118.095 0.948 . . . . 0.0 109.388 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -132.04 109.1 9.78 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.63 -68.0 0.82 Allowed 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.3 -59.82 1.08 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.916 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -125.87 10.95 7.71 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 120.211 -0.595 . . . . 0.0 111.781 -174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -57.98 -52.32 66.01 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.4 m -89.37 -6.12 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.03 0.443 . . . . 0.0 111.684 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -89.24 -44.53 10.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.931 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.637 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 68.5 m -64.99 -48.03 75.45 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.94 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -60.6 -31.6 70.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.804 0.335 . . . . 0.0 110.421 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.63 -54.75 6.49 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.344 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 88' ' ' SER . 8.9 p -63.6 -29.92 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 88' ' ' SER . 32.9 mmtp -71.12 -13.12 61.85 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 122.178 -0.326 . . . . 0.0 111.196 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.412 ' HE ' ' HA ' ' A' ' 93' ' ' ARG . 13.0 mmm-85 -86.09 -17.83 34.01 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.382 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 mp -89.67 -33.12 5.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--N 1.306 -1.299 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.095 179.057 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.09 135.02 44.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 124.022 0.827 . . . . 0.0 108.806 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -96.05 168.93 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.157 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.2 159.88 16.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD23 HD21 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -125.65 123.53 39.17 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -137.55 152.71 49.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.86 137.82 52.53 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -70.48 154.8 41.5 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.256 0.7 OUTLIER -59.75 -31.15 69.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.03 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -70.94 -38.11 72.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.205 0.526 . . . . 0.0 109.638 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.36 88.05 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.202 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 63.7 mt -61.28 -43.79 98.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.406 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -61.66 -44.76 96.35 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.948 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -69.76 -37.43 76.4 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.275 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -60.93 -37.24 81.63 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.997 0.919 . . . . 0.0 110.593 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 97.5 mtt180 -74.86 -28.98 60.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.597 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -77.04 -26.3 53.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.444 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.11 151.25 43.68 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.931 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.68 145.62 42.26 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -45.56 -53.02 9.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 124.623 1.169 . . . . 0.0 112.114 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.6 m -68.61 -36.29 78.47 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.372 -175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.0 -48.47 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.14 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -69.3 -35.59 76.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.6 mt-10 -57.41 -41.53 80.52 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' CB ' HD11 ' A' ' 55' ' ' LEU . 41.4 mt-30 -70.93 -35.75 72.37 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.012 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.2 mt -68.63 -39.81 80.62 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.268 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 31' ' ' VAL . 36.4 ttpt -60.11 -42.61 95.08 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.477 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.6 mttm -57.06 -41.6 79.05 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 72.7 mmtt -64.0 -37.6 88.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.298 176.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.1 mt -64.97 -41.19 95.66 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.333 0.587 . . . . 0.0 109.809 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 27' ' ' LYS . 95.8 t -65.37 -45.66 92.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.576 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.476 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 8.4 pt-20 -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.905 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG21 ' OH ' ' A' ' 64' ' ' TYR . 5.0 p -64.08 -31.3 52.76 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 85.9 mt -55.21 -27.42 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.15 -8.01 34.33 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.097 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -154.81 63.72 4.05 Favored Pre-proline 0 C--O 1.211 -0.973 0 C-N-CA 122.62 0.368 . . . . 0.0 110.326 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HA ' HG22 ' A' ' 33' ' ' VAL . 97.5 Cg_endo -80.54 -4.73 13.09 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.103 1.869 . . . . 0.0 114.902 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.02 40.2 1.04 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.3 mt -82.34 113.68 22.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.832 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 41' ' ' ALA . 3.6 pt-20 -58.49 -33.2 69.54 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.715 0.806 . . . . 0.0 111.828 -177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' N ' ' HG3' ' A' ' 40' ' ' GLU . . . -70.0 -23.36 63.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.675 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 94.8 m-20 -103.04 -11.87 17.83 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.208 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -65.9 142.41 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 120.802 0.334 . . . . 0.0 111.772 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HE2' ' A' ' 52' ' ' LYS . 60.7 mt -72.24 168.33 18.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -58.61 -46.36 87.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 111.161 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.19 86.77 0.09 OUTLIER Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 89.7 mmm -149.01 146.1 20.81 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.92 89.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.424 2.75 . . . . 0.0 113.998 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 48.46 44.9 20.83 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.923 1.289 . . . . 0.0 112.099 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 58.8 m -101.85 142.34 33.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.377 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.653 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 29.3 m-85 -130.48 161.47 31.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -176.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' HD23 ' A' ' 44' ' ' LEU . 15.3 ptpt -116.28 158.94 22.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.983 0.913 . . . . 0.0 109.165 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 70.6 mt -129.55 133.77 64.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -116.73 123.21 46.63 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 25' ' ' GLN . 16.6 tp -73.79 136.16 43.55 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.074 0.464 . . . . 0.0 110.805 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.43 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -84.15 -63.48 1.34 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 18.3 m -104.96 160.77 14.76 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.48 64.95 3.73 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.504 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -114.05 139.59 49.16 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.947 0.403 . . . . 0.0 110.439 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 98.0 mtt180 -128.13 137.91 52.3 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.823 -176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -122.23 136.65 54.94 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 74.3 t -124.66 128.06 73.2 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.653 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 17.1 p90 -137.69 158.3 44.66 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.165 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 3.8 pt20 -108.53 133.89 52.05 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.6 t -90.86 111.52 23.76 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 70' ' ' LYS . 55.9 mt -91.62 95.38 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -22.96 63.83 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.764 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.65 -40.12 96.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.193 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.499 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.1 mttm -107.41 -1.97 20.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.235 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.1 t 62.96 41.0 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-O 122.48 1.134 . . . . 0.0 109.242 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 70' ' ' LYS . 9.9 p -134.84 139.01 48.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.601 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 5' ' ' LEU . 93.9 t -95.57 115.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.59 -1.634 . . . . 0.0 106.59 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.03 111.72 23.26 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -173.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.76 121.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.22 -42.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.045 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -154.38 154.01 32.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.01 143.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.61 -139.83 7.86 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.581 -1.295 . . . . 0.0 112.435 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -107.44 91.22 3.56 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.545 0.688 . . . . 0.0 109.741 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.01 113.88 26.27 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.347 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -47.72 68.0 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.94 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.11 -51.33 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.531 0.732 . . . . 0.0 111.16 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -104.75 -15.15 15.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -57.77 -52.5 65.18 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.015 0.436 . . . . 0.0 111.765 -174.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.49 -30.33 22.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -63.71 -41.82 98.03 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.183 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 m -67.58 -43.09 81.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.517 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.02 -37.23 81.84 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 123.42 0.45 . . . . 0.0 110.773 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.83 -55.69 4.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.29 -32.92 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -77.06 -29.02 54.93 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.718 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -87.35 -34.81 18.69 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.23 113.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.719 0.771 . . . . 0.0 109.285 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.7 tp . . . . . 0 N--CA 1.414 -2.244 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -177.304 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -98.43 129.14 45.05 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -91.2 173.42 7.94 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.025 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -96.51 162.56 13.42 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 6' ' ' ASP . 1.5 tm? -126.77 136.59 52.61 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 5' ' ' LEU . 38.2 t70 -141.25 154.12 45.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 173.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.79 128.58 56.47 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.473 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' CG ' HH12 ' A' ' 93' ' ' ARG . 30.4 t70 -67.69 156.64 36.45 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 123.969 0.793 . . . . 0.0 111.247 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 8.7 pt-20 -52.89 -38.88 62.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.148 0.979 . . . . 0.0 111.359 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 74.3 mtt180 -72.31 -42.06 65.87 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.244 0.545 . . . . 0.0 110.104 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.16 78.55 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.511 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.3 mt -66.92 -37.79 84.99 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 53.9 mttm -62.28 -46.77 87.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.66 -38.74 73.84 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.968 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -60.81 -43.31 98.35 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.546 0.738 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.29 -20.79 58.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -81.51 -24.01 36.94 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 124.673 1.189 . . . . 0.0 109.812 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.45 157.75 35.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.987 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.12 141.86 28.62 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 1.9 p -53.39 -41.96 66.47 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -175.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -40.89 83.93 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -66.1 -47.25 85.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 120.835 0.35 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -65.48 -34.85 79.24 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.798 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 20' ' ' SER . 35.3 mt-10 -58.35 -38.54 77.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -70.12 -38.41 75.56 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 89.2 mt -64.25 -42.68 96.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.695 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 31' ' ' VAL . 31.5 ttpt -56.66 -44.46 81.4 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 123.302 0.641 . . . . 0.0 110.595 176.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.19 -42.11 90.1 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.833 0.349 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.5 mptp? -64.55 -34.68 78.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.182 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.687 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.3 mt -68.44 -43.7 76.53 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 27' ' ' LYS . 92.4 t -60.84 -45.5 97.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.988 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 11.6 pt-20 -69.29 -43.34 74.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.673 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.3 p -64.0 -29.87 48.49 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.785 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.997 -175.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 90.2 mt -54.38 -25.94 27.3 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.7 pt-20 -77.11 -20.81 55.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.927 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 p -155.27 69.67 5.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HA ' HG22 ' A' ' 33' ' ' VAL . 94.5 Cg_endo -80.13 -9.65 14.0 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 121.823 1.682 . . . . 0.0 112.484 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -89.04 38.7 0.9 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.767 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -84.19 109.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.557 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 10.8 pt-20 -61.15 -26.94 68.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.57 63.08 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.949 0.404 . . . . 0.0 111.703 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -101.44 -2.94 29.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.095 -0.378 . . . . 0.0 112.002 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HG3' ' HA ' ' A' ' 40' ' ' GLU . 21.1 mtpp -70.96 146.28 49.57 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 120.886 0.374 . . . . 0.0 110.985 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.29 164.09 15.08 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.165 174.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -91.81 131.08 37.42 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 123.13 0.572 . . . . 0.0 109.914 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.79 76.58 Favored Glycine 0 CA--C 1.506 -0.506 0 O-C-N 123.505 0.503 . . . . 0.0 113.198 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.437 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 95.9 mmm -126.17 129.99 24.07 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.25 98.9 0.34 Allowed 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.49 2.127 . . . . 0.0 112.859 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 52.51 42.03 31.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.204 1.002 . . . . 0.0 113.022 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 61.9 m -100.26 141.48 33.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.12 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.582 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 45.1 m-85 -134.0 159.6 40.26 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -134.39 140.54 46.37 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.858 177.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.56 144.06 29.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -127.13 140.26 52.38 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 120.907 0.384 . . . . 0.0 111.668 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.0 mt -85.62 115.65 23.43 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -66.13 -30.53 71.04 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -66.49 -65.1 0.72 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.93 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 m -89.98 -22.48 21.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.89 14.66 64.46 Favored Glycine 0 C--O 1.239 0.455 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.154 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -96.55 144.69 26.38 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.397 0.279 . . . . 0.0 110.403 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -122.2 147.57 46.02 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -131.4 134.36 46.18 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.2 t -119.23 128.55 75.83 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 C-N-CA 123.188 0.595 . . . . 0.0 110.262 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 7.5 p90 -138.84 158.78 43.59 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -112.03 137.47 50.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.85 112.81 29.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.1 mt -95.79 95.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.84 -26.63 65.25 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.119 0.485 . . . . 0.0 110.661 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.66 -30.26 69.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.424 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HB2' HG12 ' A' ' 72' ' ' VAL . 68.7 mttm -105.47 -6.25 19.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.936 0.398 . . . . 0.0 110.245 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.42 29.36 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-O 122.569 1.176 . . . . 0.0 109.089 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.0 p -130.87 139.09 52.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 O-C-N 121.206 -0.934 . . . . 0.0 111.197 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.8 120.85 46.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -109.08 110.6 21.9 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.834 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.3 t -76.56 121.72 29.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.6 mt -98.35 -42.04 10.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.565 0.698 . . . . 0.0 110.076 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.8 m -142.48 147.46 36.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.224 -175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.23 142.11 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.0 -115.36 0.71 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.295 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -137.54 149.57 46.84 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 110.577 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.35 91.13 3.53 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -42.76 57.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.62 -66.8 0.41 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.1 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 m -153.49 20.32 0.55 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.79 -42.4 84.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.282 0.947 . . . . 0.0 111.931 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.23 -19.73 24.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.226 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -91.72 -40.91 10.99 Favored 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 m -56.98 -51.18 70.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.309 0.643 . . . . 0.0 111.963 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -66.14 -28.91 69.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.67 -47.97 13.28 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.058 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.09 -34.79 72.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 O-C-N 122.423 -0.173 . . . . 0.0 111.184 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -69.29 -10.69 59.0 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.285 0.564 . . . . 0.0 112.038 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' A' ' 8' ' ' ASP . 12.2 tpt180 -88.73 -26.45 21.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 mp -93.73 -41.76 12.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.112 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 N--CA 1.435 -1.204 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.194 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 CA--C 1.489 -1.374 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -98.24 146.81 25.26 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.029 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -124.64 173.99 8.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -86.72 159.55 19.12 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -124.8 125.9 44.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -136.69 167.1 22.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.31 141.05 51.55 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' OD2' ' HG3' ' A' ' 10' ' ' ARG . 19.5 t70 -80.23 154.87 27.63 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.14 -29.33 65.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HG3' ' OD2' ' A' ' 8' ' ' ASP . 25.5 mtp-105 -68.37 -48.18 65.45 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -27.38 68.44 Favored 'General case' 0 C--O 1.202 -1.403 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.52 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -70.91 -37.46 72.96 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.931 0.396 . . . . 0.0 110.998 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -65.81 -42.87 90.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.44 -43.13 86.47 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.948 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -63.2 -41.4 99.16 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 124.329 1.052 . . . . 0.0 110.795 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.23 -24.61 57.73 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.491 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -67.57 -32.16 72.72 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.12 141.44 58.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.609 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.48 -83.43 0.05 OUTLIER Glycine 0 C--N 1.312 -0.8 0 O-C-N 124.837 1.336 . . . . 0.0 114.392 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.2 t -163.74 -60.85 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 ' OE1' ' A' ' 25' ' ' GLN . 4.9 m -63.07 -45.37 92.48 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.359 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.41 -47.52 90.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.899 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -68.42 -35.4 77.57 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.557 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.3 mt-10 -63.6 -42.17 98.27 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.0 mp0 -62.64 -45.24 93.77 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.131 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 88.9 mt -58.61 -43.15 89.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.422 0.451 . . . . 0.0 111.46 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.2 ttpt -58.16 -44.33 87.86 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 123.295 0.372 . . . . 0.0 110.254 175.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -64.93 -34.68 78.99 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.75 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 13.0 mmmm -67.38 -34.47 77.35 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 26' ' ' LEU . 86.4 mt -68.96 -40.77 78.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.81 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 27' ' ' LYS . 76.6 t -61.11 -45.68 98.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.157 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.3 pt-20 -69.29 -38.17 78.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.036 0.446 . . . . 0.0 111.281 177.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -67.02 -30.34 49.23 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.791 -176.353 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 55.0 mt -53.86 -24.57 16.31 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 11.1 pt-20 -70.71 -24.96 62.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.318 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 39' ' ' ILE . 43.8 p -162.05 76.04 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 123.152 0.581 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HA ' HG22 ' A' ' 33' ' ' VAL . 73.7 Cg_endo -80.37 -4.97 13.33 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.722 1.615 . . . . 0.0 112.175 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.68 40.91 1.05 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.89 0.852 . . . . 0.0 111.624 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' SER . 85.0 mt -82.42 93.58 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 43' ' ' LYS . 9.7 pt-20 -55.57 -18.74 8.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.05 1.34 . . . . 0.0 113.993 -175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.72 74.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.975 0.417 . . . . 0.0 110.97 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -100.77 9.47 42.35 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.892 0.377 . . . . 0.0 110.625 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 56.9 tttt -80.96 144.33 31.94 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.238 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 86.0 mt -79.54 152.53 30.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.657 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -63.15 -74.28 0.1 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.44 43.28 1.7 Allowed Glycine 0 CA--C 1.502 -0.756 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.886 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 92.6 mmm -124.57 124.96 25.62 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.91 99.11 0.13 Allowed 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 123.139 2.559 . . . . 0.0 112.809 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.452 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 17.7 m-20 52.75 39.27 28.35 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.823 1.249 . . . . 0.0 113.395 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 56.0 m -100.09 141.55 32.77 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 47.3 m-85 -131.84 157.77 43.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.13 144.43 51.03 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.853 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.29 129.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -106.17 140.09 39.68 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.681 174.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.46 139.4 39.64 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -66.04 -48.7 70.23 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -75.24 123.78 25.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.8 m 69.51 -173.69 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.004 0.922 . . . . 0.0 111.585 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.35 42.31 1.99 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.46 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -91.38 136.96 32.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -133.99 141.89 47.44 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.789 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tt -123.75 138.18 54.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.7 t -123.85 129.59 74.31 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 18.9 p90 -138.84 159.26 42.56 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.164 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 4.0 pt20 -119.74 138.08 53.54 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.418 HG22 ' HE1' ' A' ' 51' ' ' TYR . 10.2 m -95.81 121.26 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -99.29 95.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.18 -28.57 67.39 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.673 0.749 . . . . 0.0 109.046 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.21 -38.68 77.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.959 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.6 mttt -107.84 -4.17 18.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.615 -176.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.4 t 61.9 29.46 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 CA-C-O 122.382 1.087 . . . . 0.0 109.868 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.1 p -131.32 141.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 121.008 -1.057 . . . . 0.0 111.214 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.46 121.14 53.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 124.146 0.978 . . . . 0.0 108.588 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -107.78 120.55 42.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -74.86 124.08 31.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.8 mt -93.65 -42.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 123.464 0.477 . . . . 0.0 110.83 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.1 t -155.45 150.85 27.09 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -149.25 132.95 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.237 0.542 . . . . 0.0 110.551 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.14 -111.58 0.48 Allowed Glycine 0 N--CA 1.418 -2.548 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.425 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -132.9 158.07 43.51 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.58 -78.35 0.36 Allowed 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 58.35 -45.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 128.39 2.676 . . . . 0.0 113.671 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.61 18.18 6.86 Favored 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 125.827 1.651 . . . . 0.0 107.195 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.2 m 61.78 31.37 18.43 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.321 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 41.9 tt0 -57.96 -51.3 70.23 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.05 -175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 m -58.98 -24.76 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -84.67 -28.47 26.38 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 m -69.59 -43.73 72.23 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.7 mm-40 -61.15 -36.56 80.13 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.909 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.37 -49.47 55.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.478 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.33 -26.21 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.044 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -69.36 -11.96 61.26 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -79.69 -25.04 41.34 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.329 0.585 . . . . 0.0 109.678 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.83 -49.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.954 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.787 179.097 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.9 ptm . . . . . 0 CA--C 1.497 -1.096 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.45 152.65 50.81 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -108.84 167.63 9.94 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.73 151.59 35.99 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 34' ' ' LEU . 1.1 tm? -125.83 122.17 35.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -132.83 157.04 46.03 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.78 140.84 52.56 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.79 155.59 40.26 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -53.56 -38.91 64.32 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.275 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 12.5 ptm180 -67.14 -38.75 86.07 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.37 -37.4 87.38 Favored 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.191 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.5 mt -67.73 -43.09 80.79 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 120.651 0.262 . . . . 0.0 110.852 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.35 -42.02 98.89 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 46.7 mt-10 -69.41 -39.59 77.84 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.833 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -60.69 -41.27 94.82 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 0.0 110.376 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -73.42 -31.16 63.69 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.401 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -66.8 -43.93 82.58 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.821 0.701 . . . . 0.0 109.818 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mp -53.08 153.05 3.76 Favored 'General case' 0 C--O 1.254 1.31 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.464 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.37 142.06 41.98 Favored Glycine 0 N--CA 1.418 -2.501 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -54.17 -46.11 72.26 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 123.875 0.87 . . . . 0.0 113.085 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 m -68.51 -36.29 78.67 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.025 0.441 . . . . 0.0 110.88 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.73 -47.97 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.23 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.369 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 37.2 mt-10 -57.23 -43.61 83.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.695 0.225 . . . . 0.0 110.575 174.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.92 -38.64 86.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.292 -179.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 90.7 mt -67.25 -42.69 83.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.403 176.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -57.09 -43.38 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.036 0.534 . . . . 0.0 110.594 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.4 mttm -56.94 -43.21 81.29 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.397 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 75.3 mmtt -65.48 -38.47 89.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.912 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 93.4 mt -65.46 -46.94 77.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.57 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -66.26 -41.37 89.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.401 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -69.9 -37.72 76.08 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.694 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -64.45 -30.22 49.56 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.774 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.404 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 95.2 mt -54.47 -26.46 31.28 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.569 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 1.9 pp20? -80.41 -29.63 37.73 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.382 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -142.87 72.49 19.12 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' HG22 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -73.45 -27.94 12.65 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 121.547 1.498 . . . . 0.0 112.223 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.49 65.95 4.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 78.1 mt -103.71 115.08 45.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 11.0 pt-20 -59.81 -28.67 67.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.27 -19.21 65.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.41 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -107.1 -2.25 21.18 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.029 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.644 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 38.5 mtpt -75.42 139.57 42.4 Favored 'General case' 0 C--O 1.258 1.507 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 92.7 mt -78.19 149.47 33.71 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.677 174.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.38 -65.07 0.75 Allowed 'General case' 0 C--N 1.311 -1.084 0 O-C-N 124.072 0.857 . . . . 0.0 111.945 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.83 61.43 0.36 Allowed Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.475 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 94.3 mmm -141.2 140.97 21.96 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.4 95.76 0.53 Allowed 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.984 2.456 . . . . 0.0 112.787 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 48.21 44.64 19.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.764 1.226 . . . . 0.0 112.145 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 60.5 m -100.8 142.07 32.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.644 ' CE2' ' HG2' ' A' ' 43' ' ' LYS . 25.7 m-85 -130.91 156.47 45.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -126.02 139.51 53.36 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.426 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.2 mt -111.98 138.89 39.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -125.84 123.57 38.99 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 -178.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.7 91.37 6.99 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -62.88 -8.69 7.51 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.916 1.686 . . . . 0.0 113.279 -172.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -100.13 -13.06 19.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.765 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -134.78 -36.03 0.86 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.249 -0.981 . . . . 0.0 113.083 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.44 28.92 6.17 Favored Glycine 0 C--O 1.247 0.932 0 C-N-CA 119.415 -1.374 . . . . 0.0 112.007 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.09 146.35 29.26 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -135.1 147.3 49.5 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.43 133.48 45.25 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.91 128.73 75.73 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 CA-C-O 121.015 0.436 . . . . 0.0 109.884 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 15.9 p90 -139.14 158.86 43.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.729 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 17.2 pt20 -110.27 138.89 46.04 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.0 t -103.15 112.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.81 94.68 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.35 -34.08 74.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.09 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.22 -35.42 71.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.141 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 72' ' ' VAL . 98.4 mttt -103.81 -1.1 28.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.277 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 7.3 p 54.81 40.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.405 1.882 . . . . 0.0 111.821 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 70' ' ' LYS . 7.6 p -128.65 138.36 54.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.814 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -102.46 115.36 44.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -110.23 112.22 24.05 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.324 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.5 t -77.06 121.45 29.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.7 mt -93.73 -42.32 12.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.133 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -151.01 148.07 27.91 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.042 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.07 141.25 21.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.04 -97.63 0.19 Allowed Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -137.61 144.18 41.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.41 77.81 3.39 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -97.49 106.49 18.82 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.086 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 72.87 -87.84 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 124.983 1.313 . . . . 0.0 111.128 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.4 m -153.24 7.24 0.38 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.94 -50.25 74.01 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.262 0.937 . . . . 0.0 113.374 -171.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m -62.91 -30.03 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -85.94 -43.6 13.07 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.428 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.468 ' HA ' HG12 ' A' ' 91' ' ' VAL . 56.0 m -67.4 -29.27 68.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.17 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 9.5 tp10 -61.15 -50.08 74.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.34 23.35 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.017 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 88' ' ' SER . 12.3 p -66.67 -34.51 70.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -78.21 -13.39 59.88 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 50.5 ttt180 -84.14 -46.21 12.16 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.807 -175.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.21 85.54 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.422 -1.866 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -178.784 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.506 -0.714 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 34' ' ' LEU . . . -122.3 153.23 39.2 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.376 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.84 171.29 7.96 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -89.03 156.89 18.58 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -126.18 130.09 50.3 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.63 158.11 44.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -119.21 133.83 55.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.67 155.95 39.1 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.167 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.517 ' OE1' ' HG3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -56.43 -36.85 69.45 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.33 0.394 . . . . 0.0 110.783 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG3' ' OE1' ' A' ' 9' ' ' GLU . 35.8 mtt180 -60.06 -48.93 79.66 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.65 77.23 Favored 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.861 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.9 mt -64.02 -38.66 91.89 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 120.988 0.423 . . . . 0.0 110.753 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -65.11 -43.49 91.85 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 28.5 mt-10 -69.39 -36.41 76.74 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.181 177.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.37 -38.41 90.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.021 0.928 . . . . 0.0 109.864 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -75.06 -26.4 59.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.443 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 61.4 tttm -72.36 -39.99 67.67 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 123.785 0.834 . . . . 0.0 109.102 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.36 151.53 43.73 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.54 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.95 147.8 40.34 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.658 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 23.2 m -51.05 -49.83 59.81 Favored 'General case' 0 C--O 1.205 -1.259 0 C-N-CA 123.994 0.918 . . . . 0.0 112.014 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -63.67 -38.55 91.55 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.244 0.545 . . . . 0.0 110.849 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.07 -47.48 81.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.399 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -68.42 -34.77 76.59 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.173 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.658 ' HG3' ' O ' ' A' ' 20' ' ' SER . 70.0 mt-10 -57.53 -42.25 82.52 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.052 0.387 . . . . 0.0 111.32 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.17 -39.35 89.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.7 mt -66.48 -40.92 89.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 31' ' ' VAL . 32.0 ttpt -56.5 -44.62 80.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.137 0.575 . . . . 0.0 110.38 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.62 -39.64 88.95 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.262 0.553 . . . . 0.0 110.234 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HA ' ' HG2' ' A' ' 32' ' ' GLU . 5.9 mptp? -65.29 -37.41 87.08 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.068 177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 87.2 mt -66.25 -41.44 89.95 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 27' ' ' LYS . 99.5 t -65.26 -44.74 94.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.157 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' A' ' 29' ' ' LYS . 9.5 pt-20 -68.75 -44.15 74.36 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.948 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 37' ' ' PRO . 1.3 p -62.66 -29.92 48.08 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.228 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 89.9 mt -53.59 -25.56 17.89 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.6 pt-20 -71.46 -27.86 63.55 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.799 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.473 ' O ' HG13 ' A' ' 39' ' ' ILE . 48.2 m -152.6 73.95 7.28 Favored Pre-proline 0 C--O 1.209 -1.046 0 C-N-CA 123.558 0.743 . . . . 0.0 109.167 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.51 ' HA ' HG22 ' A' ' 33' ' ' VAL . 61.2 Cg_endo -74.72 -13.21 22.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.057 1.838 . . . . 0.0 112.622 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -87.51 41.45 0.98 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.427 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' SER . 91.9 mt -80.61 98.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.75 -19.32 10.75 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.738 1.615 . . . . 0.0 114.288 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.4 -25.86 65.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.594 0.711 . . . . 0.0 109.912 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.67 -1.75 39.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.811 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -71.9 142.07 49.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-O 121.201 0.524 . . . . 0.0 110.658 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 mt -79.6 176.61 9.55 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.816 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -110.09 120.02 41.14 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.022 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.28 54.37 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.126 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 97.1 mmm -130.53 131.54 23.41 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -47.02 -59.06 1.39 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 124.401 3.401 . . . . 0.0 114.256 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.679 ' OD1' ' HB ' ' A' ' 66' ' ' VAL . 7.7 t70 -154.66 83.65 1.1 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.1 m -139.47 141.77 37.39 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . 57.7 m-85 -138.23 153.78 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.3 pttt -126.18 139.43 53.36 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 59.2 mt -111.68 130.88 64.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 145.28 29.98 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 58' ' ' SER . 3.0 tt -88.78 143.08 27.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -93.48 -42.56 9.18 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.217 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 m -89.32 5.08 46.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' ' 55' ' ' LEU . 20.7 m -152.89 138.3 17.6 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.39 73.04 2.07 Favored Glycine 0 C--N 1.314 -0.673 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.533 -175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -135.23 156.45 48.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.558 ' N ' ' HD2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -144.82 149.48 35.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 7.4 tt -119.88 133.37 55.6 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.95 126.42 70.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-O 121.224 0.535 . . . . 0.0 110.548 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.2 p90 -136.4 158.94 43.24 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -113.51 140.03 48.46 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.679 ' HB ' ' OD1' ' A' ' 49' ' ' ASP . 81.7 t -99.59 113.03 33.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.748 0.785 . . . . 0.0 109.849 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mt -95.69 94.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.25 -27.9 65.86 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.866 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.08 -37.34 76.86 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.037 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB2' HG12 ' A' ' 72' ' ' VAL . 97.3 mttt -107.78 -1.76 20.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.149 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t 62.32 35.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.638 1.209 . . . . 0.0 109.69 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 70' ' ' LYS . 11.3 p -133.3 138.7 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 O-C-N 121.44 -0.788 . . . . 0.0 110.619 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.96 121.76 49.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.26 115.48 29.41 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -173.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.5 t -80.85 121.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 90' ' ' ALA . 21.7 mt -97.66 -42.35 11.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 O-C-N 123.585 0.553 . . . . 0.0 110.909 -174.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 p -145.56 149.68 35.03 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.108 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.04 127.19 2.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.261 0.553 . . . . 0.0 112.112 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.78 -123.31 1.28 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 119.141 -1.504 . . . . 0.0 112.936 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -113.74 157.1 22.66 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.26 16.03 19.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.36 126.69 28.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.621 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.11 9.92 7.49 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.346 1.058 . . . . 0.0 111.568 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.3 m 62.56 27.38 16.2 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.967 0.907 . . . . 0.0 112.508 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -57.93 -44.34 86.85 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.2 m -62.87 -26.66 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -82.95 -44.64 15.08 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.1 t -58.81 -49.44 77.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.52 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 10' ' ' ARG . 14.3 tp10 -62.04 -29.77 70.51 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 110.667 -178.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 76' ' ' ILE . . . -77.65 -44.47 28.03 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.93 -33.51 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 88' ' ' SER . 46.7 mmtm -65.48 -20.8 66.5 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.941 0.401 . . . . 0.0 110.172 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.795 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.79 128.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.741 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.424 -1.769 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.966 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 26.9 ttt . . . . . 0 CA--C 1.488 -1.44 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.19 152.73 37.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 123.521 0.513 . . . . 0.0 109.778 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -121.3 160.66 23.5 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -80.35 160.31 25.47 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.08 131.56 52.1 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.76 155.8 43.72 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -120.05 137.06 54.33 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.729 0.411 . . . . 0.0 111.19 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -63.54 154.8 31.39 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 170.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 6.8 pt-20 -53.55 -41.89 66.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.117 0.417 . . . . 0.0 111.934 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 90.0 mtt180 -72.25 -37.77 69.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.627 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.36 75.83 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.5 tp -73.47 -34.16 65.22 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.799 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 87.6 mttt -66.15 -44.41 84.2 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -67.43 -38.73 84.99 Favored 'General case' 0 C--O 1.199 -1.598 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.459 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -60.26 -40.25 89.65 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 123.604 0.762 . . . . 0.0 111.469 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -74.21 -33.94 63.55 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.601 0.715 . . . . 0.0 110.917 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -76.02 -19.41 58.68 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.29 162.5 29.38 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.317 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.08 152.58 43.96 Favored Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.897 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -53.58 -54.05 42.93 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 125.033 1.333 . . . . 0.0 112.248 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 m -63.1 -34.67 78.09 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.301 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.15 -48.18 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.756 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -63.35 -40.52 97.52 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.509 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 40.8 mt-10 -61.43 -43.6 98.59 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 0.3 OUTLIER -69.84 -43.27 72.29 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.546 178.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 87.8 mt -58.81 -40.79 85.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 117.612 0.187 . . . . 0.0 110.92 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 31' ' ' VAL . 35.3 ttpt -59.67 -44.77 93.46 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 123.59 0.557 . . . . 0.0 110.07 177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 97.1 mttt -63.09 -38.07 89.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 25' ' ' GLN . 28.7 mmmt -66.82 -35.1 79.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.966 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.668 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 88.9 mt -68.87 -43.6 75.01 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 27' ' ' LYS . 53.9 t -60.54 -44.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.831 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' LYS . 9.7 pt-20 -69.07 -44.76 71.9 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.79 -29.64 47.53 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.343 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.54 -26.65 22.12 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -79.09 -24.76 43.25 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.387 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -148.66 69.3 10.19 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.591 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.2 -11.29 9.8 Favored 'Trans proline' 0 C--O 1.209 -0.939 0 C-N-CA 121.542 1.495 . . . . 0.0 111.799 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.48 39.22 0.72 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -82.94 107.54 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.33 -24.35 67.28 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.61 67.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.888 0.375 . . . . 0.0 111.677 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 51' ' ' TYR . 90.6 m-20 -97.66 -0.4 45.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.553 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 50' ' ' CYS . 10.0 mtpm? -73.95 138.57 44.29 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.197 0.522 . . . . 0.0 111.402 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 47' ' ' MET . 67.6 mt -82.43 141.77 32.48 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.887 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -68.61 -42.53 77.99 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.03 18.56 57.3 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.435 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.518 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 83.8 mmm -130.71 145.68 58.65 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.88 -74.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 121.942 1.761 . . . . 0.0 114.722 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.14 36.8 4.21 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 47' ' ' MET . 40.0 m -100.32 141.24 33.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.507 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 29.6 m-85 -132.86 156.89 46.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.23 142.44 50.85 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.251 0.548 . . . . 0.0 111.025 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.91 144.4 17.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -120.17 126.43 50.66 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.432 HD12 ' HG ' ' A' ' 26' ' ' LEU . 2.1 tt -99.04 90.39 4.6 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -75.62 95.03 3.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.826 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 55' ' ' LEU . 35.9 t 171.61 -39.75 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.869 1.667 . . . . 0.0 107.298 -177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 p -125.37 -17.04 5.72 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.24 9.86 61.51 Favored Glycine 0 C--O 1.241 0.579 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.15 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.89 148.97 25.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.123 0.487 . . . . 0.0 110.878 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -125.25 151.84 45.4 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.85 125.36 29.82 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.15 126.94 70.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.217 0.532 . . . . 0.0 109.955 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -139.22 159.71 41.51 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.952 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.417 HE21 HG12 ' A' ' 67' ' ' ILE . 11.0 pt20 -114.08 141.24 47.71 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 170.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -91.21 114.23 28.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 HE21 ' A' ' 65' ' ' GLN . 22.7 mt -99.95 95.15 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.84 -33.17 73.37 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.79 0.329 . . . . 0.0 110.581 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.54 -33.71 70.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.982 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.2 mttt -104.09 -6.7 20.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.204 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t 63.01 32.26 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.31 0 C-N-CA 124.449 1.1 . . . . 0.0 109.671 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 70' ' ' LYS . 13.6 p -131.58 138.83 52.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 111.065 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.1 t -96.37 115.24 35.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -106.07 111.78 24.55 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.981 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.33 121.9 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.6 mt -95.08 -40.89 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.258 -174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -155.75 151.95 27.93 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -149.44 147.03 16.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.6 -151.4 23.59 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.259 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -89.75 137.58 32.21 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.25 104.38 7.01 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -80.38 -40.49 26.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -178.19 -76.77 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.347 1.059 . . . . 0.0 110.783 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.5 t -65.76 -31.41 72.37 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.26 -51.82 67.83 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.25 -30.98 14.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.906 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -74.38 -45.3 47.73 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 m -64.82 -40.0 94.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.447 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 8.5 tp10 -65.14 -47.33 77.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.41 -49.63 71.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.37 -30.75 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 120.838 0.351 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -77.9 -11.27 59.88 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 20.8 mmm180 -87.69 -15.97 35.64 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.052 0.387 . . . . 0.0 111.482 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -128.3 99.59 5.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.68 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 C--N 1.304 -1.376 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 C--O 1.238 0.463 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.11 164.05 24.16 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -115.89 163.91 15.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.21 161.72 17.87 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.89 123.17 36.64 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -133.89 169.18 17.48 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.8 136.9 47.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.08 155.65 16.63 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 7.3 pt-20 -52.6 -41.93 64.11 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.317 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -63.87 -48.16 77.8 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.23 0.538 . . . . 0.0 111.055 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.5 -33.6 71.55 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.051 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.8 tp -67.13 -40.52 86.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 9' ' ' GLU . 1.1 mptm? -65.06 -42.09 94.52 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.107 0.48 . . . . 0.0 109.725 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.77 -35.74 77.45 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.672 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -60.56 -38.0 83.12 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 110.121 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -73.38 -35.03 65.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.666 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.38 -32.89 74.69 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.325 1.05 . . . . 0.0 110.71 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp -64.25 147.61 52.04 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.272 0.558 . . . . 0.0 112.495 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.24 147.92 41.69 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.505 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 11.9 p -51.04 -54.93 20.26 Favored 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 124.334 1.053 . . . . 0.0 112.839 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -59.08 -40.39 85.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 123.039 0.535 . . . . 0.0 111.402 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.14 -47.06 80.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.016 0.436 . . . . 0.0 109.885 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -67.61 -34.96 78.05 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 46.8 mt-10 -58.57 -45.73 88.39 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 117.781 0.264 . . . . 0.0 111.435 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.89 -35.23 78.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.76 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 81.7 mt -65.34 -41.76 93.58 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.214 174.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -59.29 -43.18 92.6 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 68.1 mttm -59.24 -42.7 91.73 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.208 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -64.33 -41.06 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.166 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.669 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 91.8 mt -64.3 -47.18 80.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 28' ' ' LYS . 9.1 p -67.24 -36.48 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.579 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 10.9 pt-20 -69.46 -45.72 68.37 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.877 175.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 37' ' ' PRO . 2.4 p -62.37 -29.65 47.21 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 C-N-CA 123.229 0.612 . . . . 0.0 112.393 -174.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 91.9 mt -53.41 -24.93 13.83 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 12.4 pt-20 -68.23 -31.44 70.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 111.049 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 67.2 m -157.57 77.58 3.73 Favored Pre-proline 0 C--O 1.208 -1.127 0 C-N-CA 123.356 0.663 . . . . 0.0 110.056 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 33' ' ' VAL . 93.0 Cg_endo -80.96 -0.12 10.39 Favored 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 121.771 1.647 . . . . 0.0 112.08 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 27.63 1.08 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.517 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.89 103.55 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 12.0 pt-20 -66.02 -15.68 63.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.75 -26.21 68.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.232 0.539 . . . . 0.0 109.987 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -103.86 8.51 37.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.848 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.684 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 2.6 tttm -72.25 148.29 45.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.465 0.65 . . . . 0.0 112.522 -177.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' CD2' ' HD2' ' A' ' 52' ' ' LYS . 81.2 mt -91.47 127.25 36.84 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.74 -1.118 . . . . 0.0 107.993 171.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -81.11 128.76 34.09 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 122.953 0.501 . . . . 0.0 110.591 -177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.52 11.26 66.55 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 92.4 mmm -123.61 140.91 35.19 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.87 101.62 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.496 1.464 . . . . 0.0 111.911 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 47.54 54.99 8.93 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 125.169 1.387 . . . . 0.0 113.911 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -113.24 141.7 46.67 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' CE2' ' HG3' ' A' ' 43' ' ' LYS . 38.0 m-85 -136.61 160.22 39.45 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HD2' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.76 140.27 47.97 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.789 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.9 mt -110.57 140.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.504 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -126.74 133.36 50.89 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.022 0.439 . . . . 0.0 109.917 -177.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.09 135.79 33.69 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -106.76 -15.6 14.7 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.811 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -78.07 -27.93 48.69 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.346 0.593 . . . . 0.0 109.632 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -144.11 140.35 29.38 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.62 74.62 0.9 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.815 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -124.14 141.27 52.2 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.883 0.473 . . . . 0.0 110.333 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -126.43 149.38 49.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 tt -133.01 125.0 28.75 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.8 t -116.27 129.14 73.18 Favored 'Isoleucine or valine' 0 C--O 1.25 1.106 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 51' ' ' TYR . 5.5 p90 -138.64 158.77 43.62 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.59 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -109.24 140.92 42.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.21 112.18 29.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 mt -91.3 95.87 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.61 -30.5 71.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.817 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.77 -39.91 90.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.394 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 72' ' ' VAL . 93.6 mttt -107.46 -5.0 17.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.2 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.2 t 60.54 41.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 123.067 1.413 . . . . 0.0 109.537 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 70' ' ' LYS . 12.7 p -135.79 138.93 47.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.359 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -94.22 115.35 32.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -107.19 110.42 22.48 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.197 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.1 123.41 27.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.793 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.0 mt -89.99 -42.26 14.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.57 0.7 . . . . 0.0 109.664 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -154.68 149.91 27.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.93 134.44 18.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.59 -147.75 18.38 Favored Glycine 0 C--N 1.3 -1.419 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.21 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -93.1 141.54 28.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 117.226 0.513 . . . . 0.0 110.315 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.41 116.77 13.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.15 -45.66 5.31 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.396 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.68 -54.55 0.67 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.6 p -145.2 9.33 1.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.207 -0.997 . . . . 0.0 113.2 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -56.99 -48.88 77.37 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 112.005 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.9 m -94.83 -3.46 10.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.003 0.43 . . . . 0.0 111.016 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.33 -40.63 11.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.41 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 p -63.04 -42.15 99.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.591 0.71 . . . . 0.0 109.732 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 6.1 mm-40 -65.24 -34.24 77.9 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.475 -1.238 . . . . 0.0 109.678 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.46 -44.61 50.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.374 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.4 p -69.92 -30.85 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.203 0.525 . . . . 0.0 110.798 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -72.49 -9.88 59.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 11.7 mmm180 -69.85 -22.69 63.24 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -93.88 75.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 C--N 1.31 -1.146 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.242 . . . . . . . . 0 0 . 1 stop_ save_